Document_and_Entity_Informatio
Document and Entity Information (USD $) | 12 Months Ended | ||
Dec. 31, 2014 | Jan. 26, 2015 | Jun. 30, 2014 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | FALSE | ||
Document Period End Date | 31-Dec-14 | ||
Document Fiscal Year Focus | 2014 | ||
Document Fiscal Period Focus | FY | ||
Trading Symbol | RAI | ||
Entity Registrant Name | REYNOLDS AMERICAN INC | ||
Entity Central Index Key | 1275283 | ||
Current Fiscal Year End Date | -19 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Common Stock, Shares Outstanding | 531,283,513 | ||
Entity Public Float | $19,000,000,000 |
CONSOLIDATED_STATEMENTS_OF_INC
CONSOLIDATED STATEMENTS OF INCOME (USD $) | 3 Months Ended | 12 Months Ended | ||||||||||||||||||||||||
In Millions, except Per Share data, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||||||||||
Net sales | $8,160 | [1] | $7,899 | [1] | $7,962 | [1] | ||||||||||||||||||||
Net sales, related party | 311 | 337 | 342 | |||||||||||||||||||||||
Net sales | 2,134 | 2,240 | 2,162 | 1,935 | 2,039 | 2,135 | 2,179 | 1,883 | 8,471 | 8,236 | 8,304 | |||||||||||||||
Costs and expenses: | ||||||||||||||||||||||||||
Cost of products sold | 4,058 | 3,678 | 4,321 | |||||||||||||||||||||||
Selling, general and administrative expenses | 1,871 | 1,389 | 1,470 | |||||||||||||||||||||||
Amortization expense | 11 | 5 | 21 | |||||||||||||||||||||||
Trademark and other intangible asset impairment charges | 32 | 32 | 129 | |||||||||||||||||||||||
Restructuring charge | 149 | |||||||||||||||||||||||||
Operating income | 2,531 | [2],[3],[4],[5],[6] | 3,132 | [2],[3],[4],[5],[6] | 2,214 | [2],[3],[4],[5],[6] | ||||||||||||||||||||
Interest and debt expense | 286 | 259 | 234 | |||||||||||||||||||||||
Interest income | -3 | -5 | -7 | |||||||||||||||||||||||
Other (income) expense, net | -14 | 137 | 34 | |||||||||||||||||||||||
Income (loss) from continuing operations before income taxes | 2,262 | 2,741 | 1,953 | |||||||||||||||||||||||
Provision for income taxes | 817 | 1,023 | 681 | |||||||||||||||||||||||
Income (loss) from continuing operations | 148 | [7],[8] | 467 | [7],[8] | 492 | [7],[8] | 338 | [7],[8] | 1,445 | 1,718 | 1,272 | |||||||||||||||
Income from discontinued operations, net of tax | 25 | 25 | ||||||||||||||||||||||||
Net income | $148 | [7],[8] | $467 | [7],[8] | $492 | [7],[8] | $363 | [7],[8] | $292 | [10],[9] | $457 | [10],[9] | $461 | [10],[9] | $508 | [10],[9] | $1,470 | $1,718 | $1,272 | |||||||
Basic income per share: | ||||||||||||||||||||||||||
Income from continuing operations | $0.28 | [11] | $0.88 | [11] | $0.92 | [11] | $0.63 | [11] | $2.71 | $3.15 | $2.25 | |||||||||||||||
Income from discontinued operations | $0.05 | [11] | $0.05 | |||||||||||||||||||||||
Net income | $0.28 | [11] | $0.88 | [11] | $0.92 | [11] | $0.68 | [11] | $0.54 | [11] | $0.84 | [11] | $0.84 | [11] | $0.92 | [11] | $2.76 | $3.15 | $2.25 | |||||||
Diluted income per share: | ||||||||||||||||||||||||||
Income from continuing operations | $0.28 | [11] | $0.88 | [11] | $0.92 | [11] | $0.63 | [11] | $2.70 | $3.14 | $2.24 | |||||||||||||||
Income from discontinued operations | $0.04 | [11] | $0.05 | |||||||||||||||||||||||
Net income | $0.28 | [11] | $0.88 | [11] | $0.92 | [11] | $0.67 | [11] | $0.54 | [11] | $0.84 | [11] | $0.84 | [11] | $0.92 | [11] | $2.75 | $3.14 | $2.24 | |||||||
Dividends declared per share | $0.67 | $0.67 | $0.67 | $0.67 | $0.63 | $0.63 | $0.63 | $0.59 | $0.59 | $0.59 | $0.59 | $0.56 | $2.68 | $2.48 | $2.33 | |||||||||||
[1] | Excludes excise taxes of $3,625 million, $3,730 million and $3,923 million for the years ended December 31, 2014, 2013 and 2012, respectively. | |||||||||||||||||||||||||
[2] | Includes restructuring and/or asset impairment charges of $149 million for the year ended December 31, 2012, see "Restructuring Charges" in note 5. | |||||||||||||||||||||||||
[3] | Includes trademark, goodwill and/or other intangible asset impairment charges of $32 million and $129 million for the years ended December 31, 2013 and 2012, respectively, see "Intangible Assets" in note 4. | |||||||||||||||||||||||||
[4] | Includes NPM Adjustment credits of $341 million and $478 million for RJR Tobacco for the years ended December 31, 2014 and 2013, respectively, see "- Cost of Products Sold" in note 1. | |||||||||||||||||||||||||
[5] | Includes MTM adjustment of $422 million for RJR Tobacco, $4 million for American Snuff and $26 million for Corporate Expense for the year ended December 31, 2014. Includes MTM adjustment of $300 million for RJR Tobacco, $5 million for American Snuff and $24 million for Corporate Expense for the year ended December 31, 2012. | |||||||||||||||||||||||||
[6] | Includes NPM Adjustment credits of $4 million and $5 million for Santa Fe for the years ended December 31, 2014 and 2013, respectively, see "- Cost of Products Sold" in note 1. | |||||||||||||||||||||||||
[7] | Includes NPM Adjustment credits of $63 million in the first quarter of 2014, $125 million in the second quarter of 2014, $82 million in the third quarter of 2014 and $75 million in the fourth quarter of 2014, see "- Cost of Products Sold" in note 1. The fourth quarter of 2014 includes an MTM adjustment of $205 million. | |||||||||||||||||||||||||
[8] | Fourth quarter of 2014 includes an additional MTM adjustment of $247 million for a total of $452 million. | |||||||||||||||||||||||||
[9] | Includes NPM Adjustment credits of $261 million in the first quarter of 2013, $90 million in the second quarter of 2013, $69 million in the third quarter of 2013 and $63 million in the fourth quarter of 2013, see "- Cost of Products Sold" in note 1. | |||||||||||||||||||||||||
[10] | Fourth quarter of 2013 net income includes a $32 million trademark impairment charge. | |||||||||||||||||||||||||
[11] | Income per share is computed independently for each of the periods presented. The sum of the income per share amounts for the quarters may not equal the total for the year. |
CONSOLIDATED_STATEMENTS_OF_INC1
CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Excise taxes | $3,625 | $3,730 | $3,923 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||||||||
Net income | $148 | [1],[2] | $467 | [1],[2] | $492 | [1],[2] | $363 | [1],[2] | $292 | [3],[4] | $457 | [3],[4] | $461 | [3],[4] | $508 | [3],[4] | $1,470 | $1,718 | $1,272 |
Other comprehensive income (loss), net of tax: | |||||||||||||||||||
Retirement benefits, net of tax expense (benefit) (2014 - $(178); 2013 - $160; 2012 - $45) | -277 | 248 | 65 | ||||||||||||||||
Unrealized gain on long-term investments, net of tax expense (2014 - $1; 2013 - $3; 2012 - $5) | 2 | 5 | 7 | ||||||||||||||||
Realized loss on hedging instruments, net of tax benefit (2012 - $9) | -14 | ||||||||||||||||||
Amortization of realized loss on hedging instruments, net of tax expense (2014 - $1; 2013 - $1) | 1 | 1 | |||||||||||||||||
Cumulative translation adjustment and other, net of tax expense (benefit) (2014 - $(15); 2013 - $12; 2012 - $(3)) | -34 | 1 | 13 | ||||||||||||||||
Comprehensive income | $1,162 | $1,973 | $1,343 | ||||||||||||||||
[1] | Includes NPM Adjustment credits of $63 million in the first quarter of 2014, $125 million in the second quarter of 2014, $82 million in the third quarter of 2014 and $75 million in the fourth quarter of 2014, see "- Cost of Products Sold" in note 1. The fourth quarter of 2014 includes an MTM adjustment of $205 million. | ||||||||||||||||||
[2] | Fourth quarter of 2014 includes an additional MTM adjustment of $247 million for a total of $452 million. | ||||||||||||||||||
[3] | Includes NPM Adjustment credits of $261 million in the first quarter of 2013, $90 million in the second quarter of 2013, $69 million in the third quarter of 2013 and $63 million in the fourth quarter of 2013, see "- Cost of Products Sold" in note 1. | ||||||||||||||||||
[4] | Fourth quarter of 2013 net income includes a $32 million trademark impairment charge. |
CONSOLIDATED_STATEMENTS_OF_COM1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Tax expense (benefit), retirement benefits | ($178) | $160 | $45 |
Tax expense (benefit), unrealized gain (loss) on investments | 1 | 3 | 5 |
Realized loss on hedging instruments, tax benefit | 9 | ||
Tax expense (benefit), amortization of realized loss on hedging instruments | 1 | 1 | |
Tax expense (benefit), cumulative translation adjustment | ($15) | $12 | ($3) |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Cash flows from (used in) operating activities: | |||
Net income | $1,470 | $1,718 | $1,272 |
Income from discontinued operations, net of tax | -25 | ||
Adjustments to reconcile to net cash flows from (used in) operating activities: | |||
Depreciation and amortization | 106 | 103 | 131 |
Restructuring charge, net of cash payments | -17 | -14 | 109 |
Trademark and other intangible asset impairment charges | 32 | 129 | |
Loss on early extinguishment of debt | 124 | 21 | |
Deferred income tax expense (benefit) | -180 | 312 | -44 |
Other changes that provided (used) cash: | |||
Accounts and other receivables | -3 | -18 | 11 |
Inventories | -154 | -143 | -17 |
Related party, net | 10 | 5 | |
Accounts payable | -43 | -2 | 74 |
Accrued liabilities, including income taxes and other working capital | 47 | 92 | -174 |
Tobacco settlement | 92 | -763 | -40 |
Pension and postretirement | 317 | -185 | 129 |
Other, net | 13 | 42 | -38 |
Net cash flows from operating activities | 1,623 | 1,308 | 1,568 |
Cash flows from (used in) investing activities: | |||
Capital expenditures | -204 | -153 | -88 |
Proceeds from termination of joint venture | 35 | 31 | 30 |
Other, net | -36 | 9 | 4 |
Net cash flows from (used in) investing activities | -205 | -113 | -54 |
Cash flows from (used in) financing activities: | |||
Dividends paid on common stock | -1,411 | -1,335 | -1,307 |
Repurchase of common stock | -440 | -775 | -1,101 |
Excess tax benefit on stock-based compensation plans | 12 | 14 | 39 |
Principal borrowings under revolving credit facility | 1,000 | ||
Repayments under revolving credit facility | -1,000 | ||
Debt issuance costs and financing fees | -79 | -18 | -22 |
Principal borrowings under term-loan credit facility | 500 | 750 | |
Repayments under term-loan credit facility | -500 | -750 | |
Proceeds from issuance of long-term debt, net of discounts | 1,097 | 2,539 | |
Repayments of long-term debt | -1,035 | -1,076 | |
Make-whole premium for early extinguishment of debt | -155 | -20 | |
Payment to settle forward starting interest rate contracts | -23 | ||
Net cash flows from (used in) financing activities | -1,918 | -2,207 | -971 |
Effect of exchange rate changes on cash and cash equivalents | -34 | 10 | 3 |
Net change in cash and cash equivalents | -534 | -1,002 | 546 |
Cash and cash equivalents at beginning of year | 1,500 | 2,502 | 1,956 |
Cash and cash equivalents at end of year | 966 | 1,500 | 2,502 |
Income taxes paid, net of refunds | 974 | 713 | 785 |
Interest paid | $252 | $267 | $249 |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Current assets: | ||
Cash and cash equivalents | $966 | $1,500 |
Accounts receivable | 116 | 106 |
Accounts receivable, related party | 41 | 56 |
Notes receivable | 37 | |
Other receivables | 12 | 16 |
Inventories | 1,281 | 1,127 |
Deferred income taxes, net | 703 | 606 |
Prepaid expenses and other | 204 | 207 |
Total current assets | 3,323 | 3,655 |
Property, plant and equipment, at cost: | ||
Land and land improvements | 93 | 92 |
Buildings and leasehold improvements | 729 | 717 |
Machinery and equipment | 1,925 | 1,739 |
Construction-in-process | 83 | 105 |
Total property, plant and equipment | 2,830 | 2,653 |
Accumulated depreciation | -1,627 | -1,579 |
Property, plant and equipment, net | 1,203 | 1,074 |
Trademarks and other intangible assets, net of accumulated amortization | 2,421 | 2,417 |
Goodwill | 8,016 | 8,011 |
Other assets and deferred charges | 233 | 245 |
Total assets | 15,196 | 15,402 |
Current liabilities: | ||
Accounts payable | 142 | 185 |
Tobacco settlement accruals | 1,819 | 1,727 |
Due to related party | 1 | |
Deferred revenue, related party | 32 | 48 |
Current maturities of long-term debt | 450 | |
Other current liabilities | 1,100 | 1,116 |
Total current liabilities | 3,544 | 3,076 |
Long-term debt (less current maturities) | 4,633 | 5,099 |
Deferred income taxes, net | 383 | 658 |
Long-term retirement benefits (less current portion) | 1,997 | 1,221 |
Other noncurrent liabilities | 117 | 181 |
Commitments and contingencies: | ||
Shareholders' equity: | ||
Common stock (shares issued: 2014 - 531,283,513; 2013 - 538,053,024) | 0 | 0 |
Paid-in capital | 6,200 | 6,571 |
Accumulated deficit | -1,314 | -1,348 |
Accumulated other comprehensive loss | -364 | -56 |
Total shareholders' equity | 4,522 | 5,167 |
Total liabilities and shareholders' equity | $15,196 | $15,402 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Common stock, shares issued | 531,283,513 | 538,053,024 | 552,940,767 | 576,135,199 |
CONSOLIDATED_STATEMENTS_OF_SHA
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (USD $) | Total | Paid-In Capital | Accumulated Deficit | Accumulated Other Comprehensive Loss |
In Millions | ||||
Beginning Balance at Dec. 31, 2011 | $6,251 | $8,293 | ($1,660) | ($382) |
Net income | 1,272 | 1,272 | ||
Retirement benefits, net of $178 tax benefit | 65 | 65 | ||
Unrealized gain on investments, net of tax expense (2014 - $1; 2013 - $3; 2012 - $5) | 7 | 7 | ||
Realized loss on hedging instruments, net of tax benefit (2012 - $9) | -14 | -14 | ||
Cumulative translation adjustment and other, net of tax benefit (expense) (2014 - $(15); 2013 - $(12); 2012 - $3) | 13 | 13 | ||
Dividends - per share (2014 - $2.68; 2013 - $2.48; 2012 - $2.33) | -1,319 | -1,319 | ||
Common stock repurchased | -1,101 | -1,101 | ||
Equity incentive award plan and stock-based compensation | 44 | 44 | ||
Excess tax benefit on stock-based compensation plans | 39 | 39 | ||
Ending Balance at Dec. 31, 2012 | 5,257 | 7,275 | -1,707 | -311 |
Net income | 1,718 | 1,718 | ||
Retirement benefits, net of $178 tax benefit | 248 | 248 | ||
Unrealized gain on investments, net of tax expense (2014 - $1; 2013 - $3; 2012 - $5) | 5 | 5 | ||
Amortization of realized loss on hedging instruments, net of tax expense (2014 - $1; 2013 - $1) | 1 | 1 | ||
Cumulative translation adjustment and other, net of tax benefit (expense) (2014 - $(15); 2013 - $(12); 2012 - $3) | 1 | 1 | ||
Dividends - per share (2014 - $2.68; 2013 - $2.48; 2012 - $2.33) | -1,359 | -1,359 | ||
Common stock repurchased | -775 | -775 | ||
Equity incentive award plan and stock-based compensation | 57 | 57 | ||
Excess tax benefit on stock-based compensation plans | 14 | 14 | ||
Ending Balance at Dec. 31, 2013 | 5,167 | 6,571 | -1,348 | -56 |
Net income | 1,470 | 1,470 | ||
Retirement benefits, net of $178 tax benefit | -277 | -277 | ||
Unrealized gain on investments, net of tax expense (2014 - $1; 2013 - $3; 2012 - $5) | 2 | 2 | ||
Amortization of realized loss on hedging instruments, net of tax expense (2014 - $1; 2013 - $1) | 1 | 1 | ||
Cumulative translation adjustment and other, net of tax benefit (expense) (2014 - $(15); 2013 - $(12); 2012 - $3) | -34 | -34 | ||
Dividends - per share (2014 - $2.68; 2013 - $2.48; 2012 - $2.33) | -1,436 | -1,436 | ||
Common stock repurchased | -440 | -440 | ||
Equity incentive award plan and stock-based compensation | 57 | 57 | ||
Excess tax benefit on stock-based compensation plans | 12 | 12 | ||
Ending Balance at Dec. 31, 2014 | $4,522 | $6,200 | ($1,314) | ($364) |
CONSOLIDATED_STATEMENTS_OF_SHA1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||
In Millions, except Per Share data, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Tax expense (benefit), retirement benefits | ($178) | $160 | $45 | ||||||||||||
Tax expense, unrealized gain on investments | 1 | 3 | 5 | ||||||||||||
Tax expense, amortization of realized loss on hedging instruments | 1 | 1 | |||||||||||||
Realized loss on hedging instruments, tax benefit | 9 | ||||||||||||||
Tax expense (benefit), cumulative translation adjustment | ($15) | $12 | ($3) | ||||||||||||
Dividends, per share | $0.67 | $0.67 | $0.67 | $0.67 | $0.63 | $0.63 | $0.63 | $0.59 | $0.59 | $0.59 | $0.59 | $0.56 | $2.68 | $2.48 | $2.33 |
Business_and_Summary_of_Signif
Business and Summary of Significant Accounting Policies | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Business and Summary of Significant Accounting Policies | Note 1 — Business and Summary of Significant Accounting Policies | ||||||||||||
Overview | |||||||||||||
The consolidated financial statements include the accounts of Reynolds American Inc., referred to as RAI, and its wholly owned subsidiaries. RAI’s wholly owned operating subsidiaries include R. J. Reynolds Tobacco Company; American Snuff Company, LLC, referred to as American Snuff Co.; Santa Fe Natural Tobacco Company, Inc., referred to as SFNTC; R. J. Reynolds Vapor Company, referred to as RJR Vapor; Niconovum USA, Inc.; and Niconovum AB. | |||||||||||||
RAI was incorporated as a holding company in the State of North Carolina on January 2, 2004, and its common stock is listed on the New York Stock Exchange, referred to as the NYSE, under the symbol “RAI.” On July 30, 2004, the U.S. assets, liabilities and operations of Brown & Williamson Tobacco Corporation, now known as Brown & Williamson Holdings, Inc., referred to as B&W, an indirect, wholly owned subsidiary of British American Tobacco p.l.c., referred to as BAT, were combined with R. J. Reynolds Tobacco Company, a wholly owned operating subsidiary of R.J. Reynolds Tobacco Holdings, Inc., referred to as RJR. These July 30, 2004, transactions generally are referred to as the B&W business combination. | |||||||||||||
References to RJR Tobacco prior to July 30, 2004, relate to R. J. Reynolds Tobacco Company, a New Jersey corporation and a wholly owned subsidiary of RJR. References to RJR Tobacco on and subsequent to July 30, 2004, relate to the combined U.S. assets, liabilities and operations of B&W and R. J. Reynolds Tobacco Company, a North Carolina corporation. | |||||||||||||
RAI’s reportable operating segments are RJR Tobacco, American Snuff and Santa Fe. The RJR Tobacco segment consists principally of the primary operations of R. J. Reynolds Tobacco Company. The American Snuff segment consists of the primary operations of American Snuff Co. The Santa Fe segment consists of the domestic operations of SFNTC. Included in All Other, among other RAI subsidiaries, are RJR Vapor, Niconovum USA, Inc., Niconovum AB, SFR Tobacco International GmbH, referred to as SFRTI, and various foreign subsidiaries affiliated with SFRTI. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance. Certain of RAI’s operating subsidiaries have entered into intercompany agreements for products or services with other subsidiaries. As a result, certain activities of an operating subsidiary may be included in a different segment of RAI. | |||||||||||||
RAI’s operating subsidiaries primarily conduct their business in the United States. | |||||||||||||
Basis of Presentation | |||||||||||||
The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, referred to as GAAP, requires estimates and assumptions to be made that affect the reported amounts in the consolidated financial statements and accompanying notes. Volatile credit and equity markets, changes to regulatory and legal environments, and consumer spending may affect the uncertainty inherent in such estimates and assumptions. Actual results could differ from those estimates. | |||||||||||||
Certain reclassifications were made to conform prior years’ financial statements to the current presentation. Certain amounts presented in note 12 are rounded in the aggregate and may not sum from the individually presented components. All dollar amounts, other than per share amounts, are presented in millions, except for amounts set forth in note 12 and as otherwise noted. | |||||||||||||
Cash and Cash Equivalents | |||||||||||||
Cash balances are recorded net of book overdrafts when a bank right-of-offset exists. All other book overdrafts are recorded in accounts payable. Cash equivalents may include money market funds, commercial paper and time deposits in major institutions to minimize investment risk. As short-term, highly liquid investments readily convertible to known amounts of cash, with remaining maturities of three months or less at the time of purchase, cash equivalents have carrying values that approximate fair values. | |||||||||||||
Fair Value Measurement | |||||||||||||
RAI determines the fair value of assets and liabilities, if any, using a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity, and the reporting entity’s own assumptions about market participant assumptions based on the best information available in the circumstances. | |||||||||||||
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price. | |||||||||||||
The levels of the fair value hierarchy are: | |||||||||||||
Level 1: inputs are quoted prices, unadjusted, in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. | |||||||||||||
Level 2: inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. A Level 2 input must be observable for substantially the full term of the asset or liability. | |||||||||||||
Level 3: inputs are unobservable and reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. | |||||||||||||
Investments | |||||||||||||
Marketable securities are classified as available-for-sale and are carried at fair value. RAI reviews its investments on a quarterly basis to determine if it is probable that RAI will realize some portion of the unrealized loss and to determine the classification of the impairment as temporary or other-than-temporary. For those securities which RAI does not intend to sell and for which it is more likely than not that RAI will not be required to sell the securities prior to recovery, RAI recognizes the credit loss component of an other-than-temporary impairment of its debt securities in earnings and the noncredit component in accumulated other comprehensive loss. All losses deemed to be other than temporarily impaired are recorded in earnings. | |||||||||||||
RAI evaluates its investments for possible impairment based on current economic conditions, credit loss experience and other criteria on a quarterly basis. The evaluation of investments for impairment requires significant judgments, including: | |||||||||||||
• | the identification of potentially impaired securities; | ||||||||||||
• | the determination of their estimated fair value; | ||||||||||||
• | the assessment of whether any decline in estimated fair value is other-than-temporary; and | ||||||||||||
• | the likelihood of selling before recovery. | ||||||||||||
If there is a decline in a security’s net realizable value that is other-than-temporary and it is not likely to be sold before recovery, the decline is separated into the amount of impairment related to credit loss and the amount of impairment related to all other factors. The decline related to the credit loss is recognized in earnings, while the decline related to all other factors is recognized in accumulated other comprehensive loss. | |||||||||||||
Inventories | |||||||||||||
Inventories are stated at the lower of cost or market. The cost of tobacco inventories is determined principally under the last-in, first-out, or LIFO, method and is calculated at the end of each year. The cost of work in process and finished goods includes materials, direct labor, variable costs and overhead and full absorption of fixed manufacturing overhead. Stocks of tobacco, which have an operating cycle that exceeds 12 months due to aging requirements, are classified as current assets, consistent with recognized industry practice. | |||||||||||||
Long-lived Assets | |||||||||||||
Long-lived assets, such as property, plant and equipment, trademarks and other intangible assets with finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the book value of the asset may not be recoverable. Impairment of the carrying value of long-lived assets would be indicated if the best estimate of future undiscounted cash flows expected to be generated by the asset grouping is less than its carrying value. If an impairment is indicated, any loss is measured as the difference between estimated fair value and carrying value and is recognized in operating income. | |||||||||||||
Property, Plant and Equipment | |||||||||||||
Property, plant and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Useful lives range from 20 to 50 years for buildings and improvements, and from 3 to 30 years for machinery and equipment. The cost and related accumulated depreciation of assets sold or retired are removed from the accounts and the gain or loss on disposition is recognized in operating income. Depreciation expense was $95 million, $98 million and $110 million for the years ended December 31, 2014, 2013 and 2012, respectively. | |||||||||||||
Software Costs | |||||||||||||
Computer software and software development costs incurred in connection with developing or obtaining computer software for internal use that has an extended useful life are capitalized. These costs are amortized over their estimated useful life, which is typically five years or less. The following is a summary of balances and expenses for software costs as of and for the years ended December 31: | |||||||||||||
Balances: | |||||||||||||
2014 | 2013 | ||||||||||||
Unamortized software costs balance | $ | 41 | $ | 51 | |||||||||
Software costs — capitalized or included in construction-in-process | 5 | 13 | |||||||||||
Expenses: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Software amortization expense | $ | 15 | $ | 17 | $ | 21 | |||||||
Intangible Assets | |||||||||||||
Intangible assets include goodwill, trademarks and other intangible assets and are capitalized when acquired. The determination of fair value involves considerable estimates and judgment. In particular, the fair value of a reporting unit involves, among other things, developing forecasts of future cash flows, determining an appropriate discount rate, and when goodwill impairment is implied, determining the fair value of individual assets and liabilities, including unrecorded intangibles. Although RAI believes it has based its impairment testing and impairment charges of its intangibles on reasonable estimates and assumptions, the use of different estimates and assumptions could result in materially different results. If the current legal and regulatory environment, business or competitive climate worsens, or RAI’s operating companies’ strategic initiatives adversely affect their financial performance, the fair value of goodwill, trademarks and other intangible assets could be impaired in future periods. Trademarks and other intangible assets with indefinite lives are not amortized, but are tested for impairment annually, in the fourth quarter, and more frequently if events and circumstances indicate that the asset might be impaired. | |||||||||||||
Accounting for Derivative Instruments and Hedging Activities | |||||||||||||
RAI measures any derivative instruments, including certain derivative instruments embedded in other contracts, at fair value and records them in the balance sheet as either an asset or liability. Changes in fair value of derivatives are recorded in earnings unless hedge accounting criteria are met. For derivatives designated as fair value hedges, the changes in fair value of both the derivative instrument and the hedged item are recorded in earnings. For derivatives designated as cash flow hedges, the effective portions of changes in the fair value of the derivative are reported in accumulated other comprehensive loss. The ineffective portions of hedges are recognized in earnings in the current period. | |||||||||||||
RAI formally assesses at inception of the hedge and on an ongoing basis, whether each derivative is highly effective in offsetting changes in fair values or cash flows of the hedged item, and formally designates as a hedge those derivatives that qualify for hedge accounting. If it is determined that a derivative is not highly effective as a hedge or if a derivative ceases to be a highly effective hedge, RAI will discontinue hedge accounting prospectively. Any unrecognized gain or loss will be deferred and recognized into earnings as the formerly hedged item is recognized in earnings. At December 31, 2014 and 2013, RAI had no derivative instruments. | |||||||||||||
Revenue Recognition | |||||||||||||
Revenue from product sales is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the seller’s price to the buyer is fixed or determinable, and collectability is reasonably assured. These criteria are generally met when title and risk of loss pass to the customer. Payments received in advance of shipments are deferred and recorded in other accrued liabilities until shipment occurs. Certain sales of leaf to a related party, considered as bill-and-hold for accounting purposes, are recorded as deferred revenue when all of the above revenue recognition criteria are met except delivery, postponed at the customer’s request. Revenue is subsequently recognized upon delivery. The revenues recorded are presented net of excise tax collected on behalf of government authorities. | |||||||||||||
Shipping and handling costs are classified as cost of products sold. Net sales include certain sales incentives, including retail discounting, promotional allowances and coupons. | |||||||||||||
Cost of Products Sold | |||||||||||||
Cost of products sold includes the expenses for the Master Settlement Agreement, referred to as the MSA, and other settlement agreements with the States of Mississippi, Florida, Texas and Minnesota, which together with the MSA are collectively referred to as the State Settlement Agreements; the federal tobacco quota buyout (this assessment expired September 2014); and the user fees charged by the U.S. Food and Drug Administration, referred to as the FDA; which were as follows for the years ended December 31: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
State Settlement Agreements | $ | 1,917 | $ | 1,819 | $ | 2,370 | |||||||
Federal tobacco quota buyout | 163 | 209 | 218 | ||||||||||
FDA user fees | 135 | 127 | 122 | ||||||||||
In 2012, RJR Tobacco and certain other participating manufacturers, referred to as the PMs, including SFNTC, entered into a term sheet, referred to as the Term Sheet, with 17 states, the District of Columbia and Puerto Rico to settle certain claims related to the MSA non-participating manufacturer adjustment, referred to as the NPM Adjustment. The Term Sheet resolves claims related to volume years from 2003 through 2012 and puts in place a revised method to determine future adjustments from 2013 forward as to jurisdictions that join the agreement. On March 12, 2013, a single, nationwide arbitration panel of three former federal judges, referred to as the Arbitration Panel, hearing the dispute related to the 2003 NPM Adjustment (and related matters) issued an order, referred to as the Order, authorizing the implementation of the Term Sheet. In addition, after the Order, one additional state signed the Term Sheet on April 12, 2013; and, two additional states signed the Term Sheet on May 24, 2013. The Term Sheet is binding on all signatories. | |||||||||||||
Based on the jurisdictions bound by the Term Sheet through December 31, 2013, RJR Tobacco and SFNTC, collectively, will receive credits, currently estimated to total approximately $1.1 billion, with respect to their NPM Adjustment claims for the period from 2003 through 2012. These credits will be applied against annual payments under the MSA over a five-year period, which commenced with the April 2013 MSA payment. As a result of this binding Order, expenses for the MSA were reduced by $219 million for the year ended December 31, 2013. | |||||||||||||
In June 2014, two additional states agreed to settle the NPM Adjustment disputes on similar terms as set forth in the Term Sheet, except for certain provisions related to the determination of credits to be received by the PMs. RJR Tobacco and SFNTC, collectively, will receive credits, currently estimated to total approximately $170 million, with respect to their NPM Adjustment claims from 2003 through 2012. These credits will be applied against annual payments under the MSA over a five-year period effectively beginning with the April 2014 MSA payment related to the addition of these two states. As a result, expenses for the MSA were reduced by $34 million for the year ended December 31, 2014. | |||||||||||||
In addition, as a result of meeting the performance requirements associated with the Term Sheet, RJR Tobacco and Santa Fe, collectively, recognized additional credits of $311 million and $264 million for the years ended December 31, 2014 and 2013, respectively. RJR Tobacco expects to recognize additional credits through 2017, and Santa Fe expects to recognize additional credits through 2016. | |||||||||||||
For additional information related to the NPM Adjustment settlement, see “— Litigation Affecting the Cigarette Industry — State Settlement Agreements — Enforcement and Validity; Adjustments” in note 12. | |||||||||||||
Advertising | |||||||||||||
Advertising costs, which are expensed as incurred, were $140 million, $110 million and $72 million for the years ended December 31, 2014, 2013 and 2012, respectively. | |||||||||||||
Research and Development | |||||||||||||
Research and development costs, which are expensed as incurred, were $88 million, $72 million and $62 million for the years ended December 31, 2014, 2013 and 2012, respectively. | |||||||||||||
Income Taxes | |||||||||||||
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Interest and penalties related to uncertain tax positions are accounted for as tax expense. Federal income taxes for RAI and its subsidiaries are calculated on a consolidated basis. State income taxes for RAI and its subsidiaries are primarily calculated on a separate return basis. | |||||||||||||
RAI accounts for uncertain tax positions which require that a position taken or expected to be taken in a tax return be recognized in the financial statements when it is more likely than not (a likelihood of more than 50%) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. | |||||||||||||
Stock-Based Compensation | |||||||||||||
Stock-based compensation expense is recognized for all forms of share-based payment awards, including shares issued to employees under restricted stock units. | |||||||||||||
Litigation | |||||||||||||
RAI discloses information concerning litigation for which an unfavorable outcome is more than remote. RAI and its subsidiaries record their legal expenses and other litigation costs and related administrative costs as selling, general and administrative expenses as those costs are incurred. RAI and its subsidiaries will record any loss related to litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated on an individual case-by-case basis. When the reasonable estimate is a range, the recorded loss will be the best estimate within the range. If no amount in the range is a better estimate than any other amount, the minimum amount of the range will be recorded. | |||||||||||||
Pension and Postretirement | |||||||||||||
Pension and postretirement benefits require balance sheet recognition of the net asset or liability for the overfunded or underfunded status of defined benefit pension and other postretirement benefit plans, on a plan-by-plan basis, and recognition of changes in the funded status in the year in which the changes occur. | |||||||||||||
Actuarial gains or losses are changes in the amount of either the benefit obligation or the fair value of plan assets resulting from experience different from that assumed or from changes in assumptions. Differences between actual results and actuarial assumptions are accumulated and recognized in the year in which they occur as a mark-to-market adjustment, referred to as an MTM adjustment, to the extent such net gains and losses are in excess of 10% of the greater of the fair value of plan assets or benefit obligations, referred to as the corridor. Actuarial gains and losses outside the corridor are generally recognized annually as of December 31, or when a plan is remeasured during an interim period. | |||||||||||||
Prior service costs of pension benefits, which are changes in benefit obligations due to plan amendments, are amortized on a straight-line basis over the average remaining service period for active employees, or average remaining life expectancies for inactive employees if most of the plan obligations are due to inactive employees. Prior service costs of postretirement benefits, which are changes in benefit obligations due to plan amendments, are amortized on a straight-line basis over the expected service period to full eligibility age for active employees, or average remaining life expectancies for inactive employees if most of the plan obligations are due to inactive employees. | |||||||||||||
Recently Issued Accounting Pronouncements | |||||||||||||
In April 2014, the Financial Accounting Standards Board, referred to as the FASB, issued guidance for discontinued operations, which changes the criteria for determining which disposals should be presented as discontinued operations, modifies related disclosure requirements and requires new disclosures of certain other disposals that do not meet the definition of a discontinued operation. The guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. Early adoption is permitted, but only for those disposals that have not been reported in financial statements previously issued or available for guidance. The adoption of the amended guidance is not expected to have a material impact on RAI’s results of operations, cash flows or financial position. | |||||||||||||
In May 2014, the FASB issued amended guidance that replaces most existing GAAP revenue recognition guidance. The amended guidance is effective for RAI for interim and annual reporting periods beginning on January 1, 2017, and permits the use of either the retrospective or cumulative effect transition method. Early adoption is prohibited. RAI is evaluating the effect that this guidance will have on its consolidated financial statements and related disclosures. |
Proposed_Transactions
Proposed Transactions | 12 Months Ended |
Dec. 31, 2014 | |
Proposed Transactions | Note 2 — Proposed Transactions |
On July 15, 2014, RAI, a wholly owned subsidiary of RAI, referred to as Merger Sub, and Lorillard, Inc., referred to as Lorillard, entered into an agreement and plan of merger, referred to as the Merger Agreement, pursuant to which RAI agreed to acquire Lorillard in a cash and stock transaction, referred to as the Merger, valued at $27.4 billion (based on the closing price of RAI common stock on July 14, 2014), including the assumption of net debt. Upon completion of the Merger, each share of Lorillard common stock will be converted into the right to receive (1) 0.2909 of a share of RAI common stock plus (2) $50.50 in cash, collectively referred to as the Merger Consideration. | |
On July 15, 2014, RAI entered into an asset purchase agreement, referred to as the Asset Purchase Agreement, with Imperial Tobacco Group PLC, referred to as Imperial, and a wholly owned subsidiary of Imperial, referred to as Imperial Sub, pursuant to which Imperial Sub agreed to purchase the cigarette brands WINSTON, KOOL and SALEM (and, under certain circumstances, DORAL) owned by RAI subsidiaries, the cigarette brand Maverick and the “e-vapor” brand blu (including SKYCIG) owned by Lorillard subsidiaries, and other assets, and agreed to assume certain liabilities for a total consideration of approximately $7.1 billion. The closing of the sale of these assets, referred to as the Divestiture, to Imperial Sub is conditioned upon, among other things, RAI’s completion of the Merger and the approval of the Divestiture by Imperial’s shareholders. | |
In connection with these agreements, on July 15, 2014, BAT, RAI’s largest shareholder, and RAI entered into a subscription and support agreement, referred to as the Subscription Agreement, pursuant to which (1) BAT, directly or indirectly through one or more of its wholly owned subsidiaries, will subscribe for and purchase, at a price of approximately $4.7 billion in the aggregate, shares of RAI common stock sufficient to maintain BAT’s approximately 42% beneficial ownership in RAI (the foregoing purchase is referred to as the Share Purchase) and (2) BAT will cause all shares of RAI beneficially owned by BAT to be voted in favor of the issuance of the additional shares of RAI common stock contemplated by the Merger Agreement and Subscription Agreement. The issuance of these additional shares of RAI common stock as consideration to Lorillard shareholders in the Merger, referred to as the Lorillard Share Issuance, and to BAT in the Share Purchase is referred to collectively as the Share Issuance. | |
The proposed transactions described above, referred to collectively as the Proposed Transactions, are subject to customary closing conditions, including shareholder and regulatory approvals. On January 28, 2015, RAI and Lorillard held their respective shareholder meetings to approve aspects of the Proposed Transactions. Specifically, RAI’s shareholders approved the Share Issuance and Lorillard’s shareholders approved the Merger Agreement. In addition, on January 28, 2015, Imperial’s shareholders approved the asset acquisition pursuant to the Asset Purchase Agreement. As a result, all required shareholder approvals related to the Proposed Transactions have been obtained. The Merger Agreement contains certain other termination rights for each of RAI and Lorillard, including the right of each party to terminate the Merger Agreement if the Merger has not been completed by July 15, 2015, subject to an automatic six-month extension if, on July 15, 2015, the Merger has not yet received antitrust approval or certain specified legal restraints are in place but all other closing conditions have been satisfied. | |
In addition, on September 23, 2014, in accordance with the previously announced commitment letter, RAI entered into a bridge credit agreement, referred to as the Bridge Facility, with JPMorgan Chase Bank, N.A., Citibank, N.A., J.P. Morgan Securities LLC, Citigroup Global Markets Inc. and various other lending institutions party thereto, to provide a 364-day senior unsecured term loan bridge facility in an aggregate principal amount of up to $9 billion (subject to the satisfaction or waiver of the conditions stated therein) for the purpose of financing part of the cash portion of the Merger Consideration and related fees and expenses in connection with the transactions contemplated by the Merger Agreement. For additional information, see note 10. | |
There are a number of risks and uncertainties associated with the Proposed Transactions. For information, see Item 1A. Risk Factors, “— Cautionary Information Regarding Forward-Looking Statements” in Item 7 and the joint proxy statement/prospectus, referred to as Joint Proxy Statement/Prospectus, contained in the Registration Statement on Form S-4 that was declared effective by the U.S. Securities and Exchange Commission, referred to as the SEC, on December 22, 2014. |
Fair_Value_Measurement
Fair Value Measurement | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||||||
Fair Value Measurement | Note 3 — Fair Value Measurement | ||||||||||||||||||||||||||||||||
Fair Value of Financial Assets | |||||||||||||||||||||||||||||||||
Financial assets carried at fair value as of December 31, were as follows: | |||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||||
Cash and cash equivalents: | |||||||||||||||||||||||||||||||||
Cash equivalents | $ | 883 | $ | — | $ | — | $ | 883 | $ | 1,443 | $ | — | $ | — | $ | 1,443 | |||||||||||||||||
Other assets and deferred charges: | |||||||||||||||||||||||||||||||||
Auction rate securities | — | — | 79 | 79 | — | — | 76 | 76 | |||||||||||||||||||||||||
Mortgage-backed security | — | — | 12 | 12 | — | — | 13 | 13 | |||||||||||||||||||||||||
Marketable equity security | 2 | — | — | 2 | 4 | — | — | 4 | |||||||||||||||||||||||||
There were no transfers between the levels during the years ended December 31, 2014 and 2013. | |||||||||||||||||||||||||||||||||
RAI has investments in auction rate securities linked to corporate credit risk, investments in auction rate securities related to financial insurance companies, an investment in a mortgage-backed security and an investment in a marketable equity security. The unrealized gains and losses, net of tax, were included in accumulated other comprehensive loss in RAI’s consolidated balance sheets as of December 31, 2014 and 2013. The funds associated with the auction rate securities will not be accessible until a successful auction occurs or a buyer is found. | |||||||||||||||||||||||||||||||||
In determining if the difference between amortized cost and estimated fair value of the auction rate securities or the mortgage-backed security was deemed either temporarily or other-than-temporarily impaired, RAI evaluated each type of long-term investment using a set of criteria, including decline in value, duration of the decline, period until anticipated recovery, nature of investment, probability of recovery, financial condition and near-term prospects of the issuer, RAI’s intent and ability to retain the investment, attributes of the decline in value, status with rating agencies, status of principal and interest payments and any other issues related to the underlying securities. To assess credit losses, RAI uses historical default rates, debt ratings, credit default swap spreads and recovery rates. RAI has the intent and ability to hold these investments for a period of time sufficient to allow for the recovery in market value. | |||||||||||||||||||||||||||||||||
All of the fair values of the auction rate securities, classified as Level 3, are linked to the longer-term credit risk of a diverse range of corporations, including, but not limited to, manufacturing, financial and insurance sectors. The fair value was determined by utilizing an income approach model, which was based upon the weighted average present value of future cash payments, given the probability of certain events occurring within the market. RAI considers the market for its auction rate securities to be inactive. The income approach model utilized observable inputs, including the London interbank offered rate, referred to as LIBOR, based interest rate curves, corporate credit spreads and corporate ratings/market valuations. Additionally, unobservable factors incorporated into the model included default probability assumptions based on historical migration tables, various default recovery rates and how these factors changed as ratings on the underlying collateral migrated from one level to another. As related to the unobservable factors, substantial changes, relative to historical trends, of the levels of corporate defaults or default recovery rates would impact the fair value measurement of these securities. Maturity dates for the auction rate securities begin in 2017. | |||||||||||||||||||||||||||||||||
The fair value for the mortgage-backed security, classified as Level 3, utilized a market approach and was based upon the calculation of an overall weighted average valuation, derived from the actual, or modeled, market pricing of the specific collateral. The market approach utilized actual pricing inputs when observable and modeled pricing, based upon changes in observable market pricing, when unobservable. Substantial changes in the observable market pricing would directly impact the unobservable pricing and the fair value measurement of this security. RAI has deemed the market for its mortgage-backed security to be inactive. The maturity of the mortgage-backed security has been extended to March 2015, with the annual option to extend an additional year. Given the underlying collateral and RAI’s intent to continue to extend this security, it is classified as a noncurrent asset. | |||||||||||||||||||||||||||||||||
RAI determined the change in the fair value of the investment in a marketable equity security using quoted market prices as of December 31, 2014. | |||||||||||||||||||||||||||||||||
Financial assets classified as Level 3 investments were as follows: | |||||||||||||||||||||||||||||||||
December 31, 2014 | December 31, 2013 | ||||||||||||||||||||||||||||||||
Cost | Gross | Estimated | Cost | Gross | Estimated | ||||||||||||||||||||||||||||
Unrealized | Fair Value | Unrealized | Fair Value | ||||||||||||||||||||||||||||||
Loss(1) | Loss(1) | ||||||||||||||||||||||||||||||||
Auction rate securities | $ | 99 | $ | (20 | ) | $ | 79 | $ | 99 | $ | (23 | ) | $ | 76 | |||||||||||||||||||
Mortgage-backed security | 18 | (6 | ) | 12 | 20 | (7 | ) | 13 | |||||||||||||||||||||||||
$ | 117 | $ | (26 | ) | $ | 91 | $ | 119 | $ | (30 | ) | $ | 89 | ||||||||||||||||||||
(1) | Unrealized losses, net of tax, are reported in accumulated other comprehensive loss in RAI’s consolidated balance sheets as of December 31, 2014 and 2013. | ||||||||||||||||||||||||||||||||
The changes in the Level 3 investments were as follows: | |||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Auction Rate Securities | Auction Rate Securities | ||||||||||||||||||||||||||||||||
Cost | Gross | Estimated | Cost | Gross | Estimated | ||||||||||||||||||||||||||||
Unrealized | Fair Value | Unrealized | Fair Value | ||||||||||||||||||||||||||||||
Gain (Loss) | Gain (Loss) | ||||||||||||||||||||||||||||||||
Balance as of January 1 | $ | 99 | $ | (23 | ) | $ | 76 | $ | 99 | $ | (29 | ) | $ | 70 | |||||||||||||||||||
Unrealized gain | — | 3 | 3 | — | 6 | 6 | |||||||||||||||||||||||||||
Balance as of December 31 | $ | 99 | $ | (20 | ) | $ | 79 | $ | 99 | $ | (23 | ) | $ | 76 | |||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Mortgage-Backed Security | Mortgage-Backed Security | ||||||||||||||||||||||||||||||||
Cost | Gross | Estimated | Cost | Gross | Estimated | ||||||||||||||||||||||||||||
Unrealized | Fair Value | Unrealized | Fair Value | ||||||||||||||||||||||||||||||
Gain (Loss) | Gain (Loss) | ||||||||||||||||||||||||||||||||
Balance as of January 1 | $ | 20 | $ | (7 | ) | $ | 13 | $ | 22 | $ | (9 | ) | $ | 13 | |||||||||||||||||||
Unrealized gain | — | 1 | 1 | — | 2 | 2 | |||||||||||||||||||||||||||
Redemptions | (2 | ) | — | (2 | ) | (2 | ) | — | (2 | ) | |||||||||||||||||||||||
Balance as of December 31 | $ | 18 | $ | (6 | ) | $ | 12 | $ | 20 | $ | (7 | ) | $ | 13 | |||||||||||||||||||
Fair Value of Debt | |||||||||||||||||||||||||||||||||
The estimated fair value of RAI’s outstanding debt, in the aggregate, was $5.4 billion and $5.2 billion as of December 31, 2014 and 2013, respectively, with an effective average annual interest rate of approximately 4.5% for each year. The fair values are based on available market quotes, credit spreads and discounted cash flows, as appropriate. | |||||||||||||||||||||||||||||||||
Interest Rate Management | |||||||||||||||||||||||||||||||||
From time to time, RAI and RJR have used interest rate swaps to manage interest rate risk on a portion of their respective debt obligations. In 2009, RAI and RJR entered into offsetting floating to fixed interest rate swap agreements in the notional amount of $1.5 billion with maturity dates ranging from June 1, 2012 to June 15, 2017. The floating to fixed interest rate swap agreements were entered into with the same financial institution that held a notional amount of $1.5 billion of fixed to floating interest rate swaps. | |||||||||||||||||||||||||||||||||
In September 2011, RAI and RJR terminated the original and offsetting interest rate swap agreements, each with a notional amount of $1.5 billion, and received a total of $186 million cash in exchange for foregoing the future cash inflows associated with these swaps. These actions did not change the effective fixed rate of interest associated with the underlying debt. | |||||||||||||||||||||||||||||||||
In September 2013, RAI called for the redemption of, among other RAI notes, the $775 million outstanding principal amount of 7.625% notes due in 2016. Approximately $450 million of this outstanding principal amount was included in the interest rate swap agreements described above. A loss of $124 million on the early extinguishment for all redeemed notes, which includes $35 million of the unamortized portion of the interest rate swap agreement associated with the notes due in 2016, was included in other (income) expense, net in the consolidated statements of income for the year ended December 31, 2013. As a result of this action and the maturity of debt in June 2012, RAI had $700 million of previously swapped outstanding fixed rate debt with an effective rate of interest of approximately 3.8%, as of December 31, 2014 and 2013. | |||||||||||||||||||||||||||||||||
In May 2012, RAI entered into forward starting interest rate contracts with an aggregate notional amount of $1 billion. RAI designated those derivatives as cash flow hedges of a future debt issuance, and they were determined to be highly effective at inception. The forward starting interest rate contracts mitigated RAI’s exposure to changes in the benchmark interest rate from the date of inception until the date of the forecasted transaction. On October 31, 2012, RAI completed the sale of $2.55 billion in aggregate principal amount of senior notes, consisting of $450 million of 1.05% senior notes due October 30, 2015, $1.1 billion of 3.25% senior notes due November 1, 2022 and $1 billion of 4.75% senior notes due November 1, 2042. The forward starting interest rate contracts were terminated, and $23 million in associated losses were settled with cash payments to the counterparties. The effective portion of the losses are recorded in accumulated other comprehensive loss in the consolidated balance sheet as of December 31, 2014 and 2013, and will be amortized over the life of the related debt. An insignificant portion of the loss was deemed to be ineffective and recorded in the consolidated statements of income for the year ended December 31, 2012. | |||||||||||||||||||||||||||||||||
The amortization of derivative instruments impacted the consolidated statements of income for the years ended December 31 as follows: | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2012 | |||||||||||||||||||||||||||||||
Interest and debt expense | $ | (15 | ) | $ | (24 | ) | $ | (32 | ) | ||||||||||||||||||||||||
Other (income) expense, net | — | (35 | ) | — |
Intangible_Assets
Intangible Assets | 12 Months Ended | ||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||
Intangible Assets | Note 4 — Intangible Assets | ||||||||||||||||||||||||||||
The changes in the carrying amounts of goodwill by segment were as follows: | |||||||||||||||||||||||||||||
RJR | American | Santa Fe | All Other | Consolidated | |||||||||||||||||||||||||
Tobacco | Snuff | ||||||||||||||||||||||||||||
Goodwill | $ | 9,065 | $ | 2,501 | $ | 197 | $ | 38 | $ | 11,801 | |||||||||||||||||||
Less: accumulated impairment charges | (3,763 | ) | (28 | ) | — | — | (3,791 | ) | |||||||||||||||||||||
Net goodwill balance as of December 31, 2011 | 5,302 | 2,473 | 197 | 38 | 8,010 | ||||||||||||||||||||||||
2012 Activity | |||||||||||||||||||||||||||||
Foreign currency translation | — | — | — | 1 | 1 | ||||||||||||||||||||||||
Net goodwill balance as of December 31, 2012 and 2013 | 5,302 | 2,473 | 197 | 39 | 8,011 | ||||||||||||||||||||||||
2014 Activity | |||||||||||||||||||||||||||||
Asset acquisition | — | — | — | 7 | 7 | ||||||||||||||||||||||||
Foreign currency translation | — | — | — | (2 | ) | (2 | ) | ||||||||||||||||||||||
— | — | — | 5 | 5 | |||||||||||||||||||||||||
Net goodwill balance as of December 31, 2014 | $ | 5,302 | $ | 2,473 | $ | 197 | $ | 44 | $ | 8,016 | |||||||||||||||||||
On January 1, 2014, RAI completed its acquisition of certain assets and liabilities of a research and development company, for approximately $31 million in cash. The acquired assets will be used to provide additional research and development support for RAI’s operating subsidiaries. The estimated fair value of assets acquired, primarily real and personal property, and liabilities assumed was determined and recognized. The difference between the consideration paid and the acquisition-date value of the identifiable assets acquired and liabilities assumed was recognized as goodwill, as disclosed in the table above. The financial condition and results of operations of the acquired company do not meet the materiality criteria to be reportable and are therefore included in All Other. | |||||||||||||||||||||||||||||
The changes in the carrying amounts of indefinite-lived intangible assets by segment not subject to amortization were as follows: | |||||||||||||||||||||||||||||
RJR Tobacco | American | Santa Fe | All Other | Consolidated | |||||||||||||||||||||||||
Snuff | |||||||||||||||||||||||||||||
Trademarks | Other | Trademarks | Trademarks | Other | Trademarks | Other | |||||||||||||||||||||||
Balance as of December 31, 2011 | $ | 1,109 | $ | 99 | $ | 1,136 | $ | 155 | $ | 49 | $ | 2,400 | $ | 148 | |||||||||||||||
Impairment charge | (82 | ) | — | — | — | (47 | ) | (82 | ) | (47 | ) | ||||||||||||||||||
Foreign currency translation | — | — | — | — | 3 | — | 3 | ||||||||||||||||||||||
Balance as of December 31, 2012 | 1,027 | 99 | 1,136 | 155 | 5 | 2,318 | 104 | ||||||||||||||||||||||
Impairment charge | (32 | ) | — | — | — | — | (32 | ) | — | ||||||||||||||||||||
Foreign currency translation | — | — | — | — | (1 | ) | — | (1 | ) | ||||||||||||||||||||
Reclassified to finite-lived | (18 | ) | — | — | — | — | (18 | ) | — | ||||||||||||||||||||
Balance as of December 31, 2013 | 977 | 99 | 1,136 | 155 | 4 | 2,268 | 103 | ||||||||||||||||||||||
Balance as of December 31, 2014 | $ | 977 | $ | 99 | $ | 1,136 | $ | 155 | $ | 4 | $ | 2,268 | $ | 103 | |||||||||||||||
The changes in the carrying amounts of finite-lived intangible assets by segment subject to amortization were as follows: | |||||||||||||||||||||||||||||
RJR Tobacco | American | Consolidated | |||||||||||||||||||||||||||
Snuff | |||||||||||||||||||||||||||||
Trademarks | Other | Trademarks | Trademarks | Other | |||||||||||||||||||||||||
Balance as of December 31, 2011 | $ | 4 | $ | 39 | $ | 11 | $ | 15 | $ | 39 | |||||||||||||||||||
Amortization | (4 | ) | (15 | ) | (2 | ) | (6 | ) | (15 | ) | |||||||||||||||||||
Balance as of December 31, 2012 | — | 24 | 9 | 9 | 24 | ||||||||||||||||||||||||
Amortization | — | (4 | ) | (1 | ) | (1 | ) | (4 | ) | ||||||||||||||||||||
Reclassified from indefinite-lived | 18 | — | — | 18 | — | ||||||||||||||||||||||||
Balance as of December 31, 2013 | 18 | 20 | 8 | 26 | 20 | ||||||||||||||||||||||||
Amortization | (6 | ) | (4 | ) | (1 | ) | (7 | ) | (4 | ) | |||||||||||||||||||
Acquisition | — | 15 | — | — | 15 | ||||||||||||||||||||||||
Balance as of December 31, 2014 | $ | 12 | $ | 31 | $ | 7 | $ | 19 | $ | 31 | |||||||||||||||||||
On July 1, 2014, RJR Tobacco completed its acquisition of certain intellectual property for $15 million in cash. The intellectual property will be amortized over the remaining useful life of 15 years and is included in the RJR Tobacco segment. | |||||||||||||||||||||||||||||
Details of finite-lived intangible assets were as follows: | |||||||||||||||||||||||||||||
December 31, 2014 | December 31, 2013 | ||||||||||||||||||||||||||||
Gross | Accumulated | Net | Gross | Accumulated | Net | ||||||||||||||||||||||||
Amortization | Amortization | ||||||||||||||||||||||||||||
Contract manufacturing agreements | $ | 151 | $ | (135 | ) | $ | 16 | $ | 151 | $ | (131 | ) | $ | 20 | |||||||||||||||
Trademarks | 114 | (95 | ) | 19 | 114 | (88 | ) | 26 | |||||||||||||||||||||
Other intangibles | 15 | — | 15 | — | — | — | |||||||||||||||||||||||
$ | 280 | $ | (230 | ) | $ | 50 | $ | 265 | $ | (219 | ) | $ | 46 | ||||||||||||||||
The estimated remaining amortization associated with finite-lived intangible assets is expected to be expensed as follows: | |||||||||||||||||||||||||||||
Year | Amount | ||||||||||||||||||||||||||||
2015 | $ | 10 | |||||||||||||||||||||||||||
2016 | 9 | ||||||||||||||||||||||||||||
2017 | 9 | ||||||||||||||||||||||||||||
2018 | 8 | ||||||||||||||||||||||||||||
2019 | 2 | ||||||||||||||||||||||||||||
Thereafter | 12 | ||||||||||||||||||||||||||||
$ | 50 | ||||||||||||||||||||||||||||
The impairment testing of trademarks in the fourth quarters of 2014, 2013 and 2012 assumed a rate of decline in projected net sales of certain brands, compared with that assumed in the prior year strategic plan. The analysis of the fair value of trademarks was based on estimates of fair value on an income approach using a discounted cash flow valuation model under a relief from royalty methodology. The relief-from-royalty model includes the estimates of the royalty rate that a market participant might assume, projected revenues and judgment regarding the discount rate applied to those estimated cash flows, with that discount rate being 10.0% during 2014, 2013 and 2012. The determination of the discount rate was based on a cost of equity model, using a risk-free rate, adjusted by a stock beta-adjusted risk premium and a size premium. | |||||||||||||||||||||||||||||
As a result of these analyses, trademark impairment charges are recorded based on the excess of certain brands’ carrying values over their estimated fair values. No impairment charges were indicated for 2014. During 2013, impairment was indicated on four of RJR Tobacco’s brands, and one trademark brand was reclassified from indefinite-lived to finite-lived. During 2012, impairment was indicated on four of RJR Tobacco’s brands. These trademark impairment charges are reflected as decreases in the carrying value of the trademarks in the consolidated balance sheets as of December 31, 2014 and 2013, as trademark and other intangible asset impairment charges in the consolidated statements of income for the years ended December 31, 2013 and 2012, and had no impact on cash flows. Certain brands are being amortized over their remaining useful lives, which range from 1 to 8 years, consistent with the pattern of economic benefits estimated to be received. | |||||||||||||||||||||||||||||
During the fourth quarter of 2012, a change in the use of an other intangible asset within the All Other segment was determined. As a result, the $47 million carrying value of the other intangible asset was fully impaired. | |||||||||||||||||||||||||||||
For the annual impairment testing of the goodwill of RAI’s reporting units, each reporting unit’s estimated fair value was compared with its carrying value. A reporting unit is an operating segment or one level below an operating segment. The determination of estimated fair value of each reporting unit was calculated primarily utilizing an income approach model, based on the present value of the estimated future cash flows of the reporting unit assuming a discount rate during each of 2014, 2013 and 2012 of 9.75% for each of RJR Tobacco and American Snuff and 10.25% for Santa Fe. The determination of the discount rate was based on a weighted average cost of capital. Additionally, the aggregate estimated fair value of the reporting units, determined with the use of the income approach model, was compared with RAI’s market capitalization. The estimated fair value of each reporting unit was substantially greater than its respective carrying value. |
Restructuring_Charges
Restructuring Charges | 12 Months Ended | ||||
Dec. 31, 2014 | |||||
Restructuring Charges | Note 5 — Restructuring Charges | ||||
In 2012, RAI announced that it and its subsidiaries, RJR Tobacco and RAI Services Company, referred to as RAISC, had completed a business analysis designed to identify resources to reinvest in their businesses. As a result of this initiative, the total U.S. workforce of RAI and its subsidiaries will decline by a net of approximately 10% upon the completion of the restructuring by the end of 2015. All cash payments related to the restructuring will be complete by the end of 2016. | |||||
Under existing severance plans, $111 million of severance, benefits and related costs and $38 million of pension-related benefits comprised a restructuring charge of $149 million during 2012. Of this charge, $138 million was recorded in the RJR Tobacco segment. As of December 31, 2014, $109 million had been utilized. Accordingly, in the consolidated balance sheet as of December 31, 2014, $32 million was included in other current liabilities and $8 million was included in other noncurrent liabilities. | |||||
The components of the restructuring charge accrued and utilized were as follows: | |||||
Employee | |||||
Severance | |||||
and Benefits | |||||
Original accrual | $ | 149 | |||
Utilized in 2012 | (78 | ) | |||
Balance as of December 31, 2012 | 71 | ||||
Utilized in 2013 | (14 | ) | |||
Balance as of December 31, 2013 | 57 | ||||
Utilized in 2014 | (17 | ) | |||
Balance as of December 31, 2014 | $ | 40 | |||
Income_Per_Share
Income Per Share | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Income Per Share | Note 6 — Income Per Share | ||||||||||||
The components of the calculation of income per share were as follows: | |||||||||||||
For the Years Ended December 31, | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Income from continuing operations | $ | 1,445 | $ | 1,718 | $ | 1,272 | |||||||
Income from discontinued operations | 25 | — | — | ||||||||||
Net income | $ | 1,470 | $ | 1,718 | $ | 1,272 | |||||||
Basic weighted average shares, in thousands | 533,160 | 544,925 | 565,570 | ||||||||||
Effect of dilutive potential shares: | |||||||||||||
Restricted stock units | 1,810 | 2,024 | 2,303 | ||||||||||
Diluted weighted average shares, in thousands | 534,970 | 546,949 | 567,873 | ||||||||||
Inventories
Inventories | 12 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Inventories | Note 7 — Inventories | ||||||||
The major components of inventories at December 31 were as follows: | |||||||||
2014 | 2013 | ||||||||
Leaf tobacco | $ | 1,125 | $ | 1,049 | |||||
Other raw materials | 90 | 66 | |||||||
Work in process | 72 | 70 | |||||||
Finished products | 171 | 130 | |||||||
Other | 27 | 18 | |||||||
1,485 | 1,333 | ||||||||
LIFO allowance | (204 | ) | (206 | ) | |||||
$ | 1,281 | $ | 1,127 | ||||||
Inventories valued under the LIFO method were $456 million and $519 million at December 31, 2014 and 2013, respectively, net of the LIFO allowance. The LIFO allowance reflects the excess of the current cost of LIFO inventories at December 31, 2014 and 2013, over the amount at which these inventories were carried on the consolidated balance sheets. RAI recorded income of $2 million from LIFO inventory changes during 2014 and expense of $14 million and $7 million from LIFO inventory changes during 2013 and 2012, respectively. |
Other_Current_Liabilities
Other Current Liabilities | 12 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Other Current Liabilities | Note 8 — Other Current Liabilities | ||||||||
Other current liabilities at December 31 included the following: | |||||||||
2014 | 2013 | ||||||||
Payroll and employee benefits | $ | 178 | $ | 179 | |||||
Pension and other postretirement benefits | 75 | 79 | |||||||
Marketing and advertising | 134 | 117 | |||||||
Declared dividends | 356 | 339 | |||||||
Excise, franchise and property tax | 161 | 157 | |||||||
Restructuring | 32 | 19 | |||||||
Tobacco quota buyout | — | 52 | |||||||
Other | 164 | 174 | |||||||
$ | 1,100 | $ | 1,116 | ||||||
Income_Taxes
Income Taxes | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Income Taxes | Note 9 — Income Taxes | ||||||||||||
The components of the provision for income taxes from continuing operations for the years ended December 31 were as follows: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Current: | |||||||||||||
Federal | $ | 809 | $ | 563 | $ | 647 | |||||||
State and other | 188 | 148 | 78 | ||||||||||
997 | 711 | 725 | |||||||||||
Deferred: | |||||||||||||
Federal | (151 | ) | 254 | (45 | ) | ||||||||
State and other | (29 | ) | 58 | 1 | |||||||||
(180 | ) | 312 | (44 | ) | |||||||||
$ | 817 | $ | 1,023 | $ | 681 | ||||||||
Significant components of deferred tax assets and liabilities for the years ended December 31 included the following: | |||||||||||||
2014 | 2013 | ||||||||||||
Deferred tax assets: | |||||||||||||
Pension and other postretirement liabilities | $ | 823 | $ | 522 | |||||||||
Tobacco settlement accruals | 711 | 677 | |||||||||||
Other accrued liabilities | 127 | 71 | |||||||||||
Other noncurrent liabilities | 139 | 150 | |||||||||||
Subtotal | 1,800 | 1,420 | |||||||||||
Less: valuation allowance | (37 | ) | (36 | ) | |||||||||
1,763 | 1,384 | ||||||||||||
Deferred tax liabilities: | |||||||||||||
LIFO inventories | (150 | ) | (156 | ) | |||||||||
Property and equipment | (260 | ) | (232 | ) | |||||||||
Trademarks and other intangibles | (913 | ) | (916 | ) | |||||||||
Other | (111 | ) | (120 | ) | |||||||||
(1,434 | ) | (1,424 | ) | ||||||||||
Net deferred tax asset (liability) | $ | 329 | $ | (40 | ) | ||||||||
The current and noncurrent components of deferred tax assets and liabilities for the years ended December 31 were as follows: | |||||||||||||
2014 | 2013 | ||||||||||||
Current deferred tax assets | $ | 703 | $ | 606 | |||||||||
Noncurrent deferred tax assets | 9 | 12 | |||||||||||
Noncurrent deferred tax liabilities | (383 | ) | (658 | ) | |||||||||
$ | 329 | $ | (40 | ) | |||||||||
RAI had $108 million and $105 million of federal capital loss carryforwards at December 31, 2014, and December 31, 2013, respectively. The increase in 2014 resulted from the termination of investments during 2014. The federal capital loss carryforwards will expire in 2015 through 2019 and can be utilized only to the extent net capital gains are generated during the carryforward period. | |||||||||||||
In 2011, a $33 million valuation allowance was established to fully offset a deferred tax asset related to the federal capital loss carryforward. In 2014 and 2013, the valuation allowance was increased by $1 million and $3 million, respectively to $37 million at December 31, 2014, to fully offset a deferred tax asset related to capital losses resulting from the termination of investments. As of December 31, 2014 and 2013, RAI believes it is unlikely that this deferred tax asset will be realized through the expected generation of future net capital gains. No valuation allowance was established on other deferred tax assets at December 31, 2014 and 2013, as RAI believes it is more likely than not that all of such deferred tax assets will be realized through the expected generation of future taxable income. | |||||||||||||
Pre-tax income (loss) for domestic and foreign continuing operations for the years ended December 31 consisted of the following: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Domestic (includes U.S. exports) | $ | 2,235 | $ | 2,737 | $ | 1,983 | |||||||
Foreign | 27 | 4 | (30 | ) | |||||||||
$ | 2,262 | $ | 2,741 | $ | 1,953 | ||||||||
The differences between the provision for income taxes from continuing operations and income taxes computed at statutory U.S. federal income tax rates for the years ended December 31 were as follows: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Income taxes computed at the statutory U.S. federal income tax rate | $ | 792 | $ | 959 | $ | 684 | |||||||
State and local income taxes, net of federal tax benefits | 107 | 135 | 107 | ||||||||||
Domestic manufacturing deduction | (80 | ) | (55 | ) | (60 | ) | |||||||
Other items, net | (2 | ) | (16 | ) | (50 | ) | |||||||
Provision for income taxes from continuing operations | $ | 817 | $ | 1,023 | $ | 681 | |||||||
Effective tax rate | 36.1 | % | 37.3 | % | 34.9 | % | |||||||
The effective tax rate for 2014 was favorably impacted by a decrease in uncertain tax positions related to a federal audit settlement and an increase in the domestic manufacturing deduction of the American Jobs Creation Act of 2004, partially offset by an increase in tax attributable to nondeductible costs related to the Proposed Transactions. The effective tax rate for 2013 was unfavorably impacted by an increase in tax attributable to a decrease in the domestic manufacturing deduction. The effective tax rate for 2012 was favorably impacted by a decrease in uncertain tax positions related to various state statute expirations and audit settlements. The effective tax rate for each period differed from the federal statutory rate of 35% due to the impact of state taxes and certain nondeductible items, offset by the favorable impact of the domestic manufacturing deduction. | |||||||||||||
The audit of the 2010 and 2011 tax years by the Internal Revenue Service was closed on February 27, 2014. A tax benefit of $25 million attributable to a decrease in uncertain tax positions was recorded in discontinued operations. | |||||||||||||
On December 19, 2014, the Tax Increase Prevention Act of 2014, referred to as the TIPA, was signed into law. The TIPA retroactively reinstated and extended the Federal Research and Development Tax Credit from January 1, 2014 to December 31, 2014. The impact of the TIPA did not significantly impact RAI’s annual effective income tax rate in 2014. | |||||||||||||
At December 31, 2014, there were $486 million of accumulated and undistributed foreign earnings. Of this amount, RAI has invested $25 million and has plans to invest an additional $56 million overseas. RAI has recorded either current or deferred income taxes related to the $405 million of accumulated foreign earnings in excess of its historical and planned overseas investments. | |||||||||||||
The components of deferred tax benefits included in accumulated other comprehensive loss for the years ended December 31 were as follows: | |||||||||||||
2014 | 2013 | ||||||||||||
Retirement benefits | $ | 241 | $ | 63 | |||||||||
Unrealized gain (loss) on long-term investments | 10 | 11 | |||||||||||
Amortization of realized loss on hedging instruments | 7 | 8 | |||||||||||
Cumulative translation adjustment and other | 19 | 4 | |||||||||||
$ | 277 | $ | 86 | ||||||||||
The accruals for gross unrecognized income tax benefits, including interest and penalties, reflected in other noncurrent liabilities for the years ended December 31 were as follows: | |||||||||||||
2014 | 2013 | ||||||||||||
Unrecognized tax benefits | $ | 27 | $ | 62 | |||||||||
Accrued interest | 3 | 7 | |||||||||||
Accrued penalties | 1 | 1 | |||||||||||
$ | 31 | $ | 70 | ||||||||||
A reconciliation of the gross unrecognized income tax benefits is as follows: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Balance at beginning of year | $ | 62 | $ | 68 | $ | 128 | |||||||
Gross increases related to current period tax positions | 5 | 4 | 4 | ||||||||||
Gross increases related to tax positions in prior periods | — | — | 1 | ||||||||||
Gross decreases related to tax positions in prior periods | (31 | ) | (3 | ) | (7 | ) | |||||||
Gross decreases related to audit settlements | (6 | ) | (1 | ) | (31 | ) | |||||||
Gross decreases related to lapse of applicable statute of limitations | (3 | ) | (6 | ) | (27 | ) | |||||||
Balance at end of year | $ | 27 | $ | 62 | $ | 68 | |||||||
At December 31, 2014, $21 million of unrecognized income tax benefits including interest and penalties, if recognized, would decrease RAI’s effective tax rate. | |||||||||||||
RAI and its subsidiaries are subject to income taxes in the United States, certain foreign jurisdictions and multiple state jurisdictions. A number of years may elapse before a particular matter, for which RAI has established an accrual, is audited and finally resolved. The number of years with open tax audits varies depending on the tax jurisdiction. | |||||||||||||
RAI and its subsidiaries file income tax returns in the U.S. federal and various state and foreign jurisdictions. The U.S. federal statute of limitations remains open for the year 2012 and forward. State and foreign jurisdictions have statutes of limitations generally ranging from three to five years. Certain of RAI’s state tax returns are currently under examination by various states as part of routine audits conducted in the ordinary course of business. |
Borrowing_Arrangements
Borrowing Arrangements | 12 Months Ended | |||
Dec. 31, 2014 | ||||
Borrowing Arrangements | Note 10 — Borrowing Arrangements | |||
Credit Agreement | ||||
On December 18, 2014, RAI entered into a credit agreement, referred to as the Credit Agreement, with a syndicate of lenders, providing for a five-year, $2 billion senior unsecured revolving credit facility, which may be increased to $2.35 billion at the discretion of the lenders upon the request of RAI. The Credit Agreement replaced RAI’s four-year, $1.35 billion senior unsecured revolving credit facility dated October 8, 2013, referred to as the Prior Credit Agreement. | ||||
Subject to certain conditions, RAI is able to use the revolving credit facility under the Credit Agreement for borrowings and issuances of letters of credit at its option, subject to a $300 million sublimit on the aggregate amount of letters of credit. Issuances of letters of credit reduce availability under such revolving credit facility. Subject to certain conditions, RAI can also use borrowings under the revolving credit facility to finance part of the cash portion of the Merger Consideration and related fees and expenses in connection with the Proposed Transactions. | ||||
The Credit Agreement contains restrictive covenants which are substantially similar to those contained in the Prior Credit Agreement, that: | ||||
• | limit the ability of RAI and its subsidiaries to (1) pay dividends and repurchase stock, (2) engage in transactions with affiliates, (3) create liens and (4) engage in sale-leaseback transactions involving a Principal Property, as defined in the Credit Agreement; and | |||
• | limit the ability of RAI and its Material Subsidiaries (as such term is defined in the Credit Agreement) to sell or dispose of all or substantially all of their assets and engage in specified mergers or consolidations. | |||
The Credit Agreement also contains a restrictive covenant that limits the amount of debt that may be incurred by non-guarantor subsidiaries. The restrictive covenants in the Credit Agreement are subject to a number of qualifications and exceptions, with some new exceptions to accommodate existing provisions in debt instruments of Lorillard and its subsidiaries. | ||||
The Credit Agreement, like the Prior Credit Agreement, contains two financial covenants — a consolidated leverage ratio covenant and a consolidated interest coverage ratio covenant. Under the Credit Agreement, the consolidated leverage ratio may not exceed: | ||||
• | 3.00 to 1.00 as of the last day of any period of four consecutive fiscal quarters, referred to as a Reference Period, ending prior to the closing of the Merger; | |||
• | 4.50 to 1.00 for the Reference Periods ending on the last day of the fiscal quarter in which the Merger closes and on the last day of the next two succeeding fiscal quarters; | |||
• | 4.25 to 1.00 for the Reference Periods ending on the last day of the next three succeeding quarters; | |||
• | 3.75 to 1.00 for the Reference Periods ending on the last day of the next three succeeding quarters; and | |||
• | 3.50 to 1.00 thereafter. | |||
The Credit Agreement provides that the consolidated interest coverage ratio for any Reference Period ending on the last day of a fiscal quarter may not be less than 4.00 to 1.00. The foregoing covenant levels in the Credit Agreement are the same as those in the Prior Credit Agreement. | ||||
For purposes of calculating these two ratios prior to the closing of the Merger, subject to certain conditions and limitations, the amount of indebtedness (in the case of the leverage ratio) and related interest expense (in the case of the interest coverage ratio) incurred by RAI to finance the cash portion of the Merger Consideration and related fees and expenses are not included. | ||||
The cost to RAI of borrowings under the Credit Agreement has been reduced as compared with the Prior Credit Agreement, and the maturity date of the Credit Agreement is December 18, 2019 (which date may be extended, subject to certain terms and conditions, with the agreement of the requisite lenders, in two separate one-year increments) as compared with the maturity date of the Prior Credit Agreement of October 8, 2017. The Credit Agreement contains customary events of default, including upon a change in control (as defined therein), which could result in the acceleration of all amounts and cancellation of all commitments outstanding under the Credit Agreement. | ||||
The lender’s obligations under the Credit Agreement to fund borrowings are subject to the accuracy of RAI’s representations and warranties and the absence of any default, provided, however, that the accuracy of RAI’s representation as to the absence of any material adverse effect (as defined in the Credit Agreement) is not a condition to borrowing for the purpose of refinancing maturing commercial paper or similar obligations or the borrowing of up to $500 million to finance part of the cash portion of the Merger Consideration and related fees and expenses. Instead, in the case of borrowings of up to $500 million to help fund the Merger, the lenders’ obligations are subject to the absence of a “Lorillard Material Adverse Effect” (as defined in the Credit Agreement) and certain other conditions, including the accuracy of Lorillard’s representations and warranties in the Merger Agreement that are material to the interests of the lenders, but only to the extent RAI has the right to terminate its obligations under the Merger Agreement because of such inaccuracy. | ||||
Under the terms of the Credit Agreement, RAI is required to pay a facility fee of between 0.100% and 0.275%, based generally on the ratings of RAI’s senior, unsecured, long-term indebtedness, per annum on the lender commitments in respect of the revolving credit facility thereunder. | ||||
Borrowings under the Credit Agreement bear interest, at the option of RAI, at a rate equal to an applicable margin, again, based generally on the ratings of RAI’s senior, unsecured, long-term indebtedness, plus: | ||||
• | the alternate base rate, which is the higher of (1) the federal funds effective rate from time to time plus 0.5%, (2) the prime rate and (3) the reserve adjusted eurodollar rate for a one month interest period plus 1%; or | |||
• | the eurodollar rate, which is the reserve adjusted rate at which eurodollar deposits for one, two, three or six months are offered in the interbank eurodollar market. | |||
Overdue principal outstanding under the revolving credit facility under the Credit Agreement bears interest at a rate equal to the rate then in effect with respect to such borrowings, plus 2.0% per annum. Any amount besides principal that becomes overdue bears interest at a rate equal to 2.0% per annum in excess of the rate of interest applicable to base rate loans. | ||||
Certain of RAI’s subsidiaries, including its Material Subsidiaries, have guaranteed, on an unsecured basis, RAI’s obligations under the Credit Agreement. | ||||
As of December 31, 2014, there were no borrowings, and $5 million of letters of credit outstanding under the Credit Agreement. | ||||
Bridge Facility | ||||
On September 23, 2014, in accordance with the previously announced commitment letter, RAI entered into the Bridge Facility with JPMorgan Chase Bank, N.A., as Administrative Agent and a lender, Citibank, N.A., as Syndication Agent and a lender, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Bookrunners, and various other lending institutions party thereto as lenders, collectively referred to as the Lenders, pursuant to which the Lenders have agreed, subject to the terms and conditions set forth in the Bridge Facility, to provide a term loan in an aggregate principal amount of up to $9 billion for the purpose of financing part of the cash portion of the Merger Consideration and related fees and expenses in connection with the transactions contemplated by the Merger Agreement. The Bridge Facility may be drawn only in a single drawing upon the closing of the Merger, matures 364 days after such date and may be prepaid (but not reborrowed) without premium or penalty. The obligations of RAI under the Bridge Facility are unsecured. The Bridge Facility contains restrictive covenants that are substantially similar to those contained in the Credit Agreement. In addition, under the Bridge Facility, the consolidated leverage ratio may not exceed 4.50 to 1.00 for the Reference Periods ending on the last day of the fiscal quarter in which the Merger closes and on the last day of the next two succeeding fiscal quarters, and 4.25 to 1.00 thereafter; and the consolidated interest coverage ratio for any Reference Period ending on the last day of a fiscal quarter may not be less than 3.00 to 1.00. | ||||
The amount of the Bridge Facility available at closing is subject to reduction in accordance with its terms, including, but not limited to, reduction upon the issuance of debt and/or equity securities used to finance the Merger and related fees and expenses (subject to certain exceptions, including equity securities issued in the Share Issuance). | ||||
Borrowings under the Bridge Facility bear interest at a rate per annum equal to, at RAI’s election: | ||||
• | adjusted LIBOR for a one, two, three or six-month period; or | |||
• | the greatest of the (1) prime rate, (2) federal funds effective rate plus 50 basis points or (3) one-month adjusted LIBOR plus 100 basis points, plus, in each case, an applicable margin ranging from 50 to 275 basis points that depends upon RAI’s index debt rating established by rating services and the length of time that elapses from initial funding of the Bridge Facility until repayment thereof. | |||
Borrowings under the Bridge Facility are subject to certain conditions, including: | ||||
• | the completion of the Merger, the Share Purchase and the Divestiture; | |||
• | the absence of a “Company Material Adverse Effect”, as defined in the Merger Agreement, where “Company” refers to Lorillard; | |||
• | RAI’s delivery to the Bridge Facility agents or filing with the SEC of certain financial statements; | |||
• | RAI’s performance of certain activities in connection with the contemplated issuance of debt securities to finance the Merger and related fees and expenses; and | |||
• | the accuracy at the funding of the Bridge Facility of certain representations and warranties, including the accuracy of such of Lorillard’s representations and warranties as are material to the interests of the Lenders, but only to the extent RAI or Merger Sub have the right to terminate their obligations under the Merger Agreement because of such inaccuracy. | |||
Under the terms of the Bridge Facility, RAI is required to pay certain customary fees to the Lenders as provided therein and in certain fee letters. | ||||
Certain of RAI’s subsidiaries, including its Material Subsidiaries, as such term is defined in the Bridge Facility, have guaranteed, on an unsecured basis, RAI’s obligations under the Bridge Facility. For additional information on the Proposed Transactions, see note 2. |
LongTerm_Debt
Long-Term Debt | 12 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Long-Term Debt | Note 11 — Long-Term Debt | ||||||||
RAI | |||||||||
RAI’s long-term debt, net of discounts and including adjustments associated with interest rate swaps, as of December 31, consisted of the following: | |||||||||
2014 | 2013 | ||||||||
1.05% guaranteed, notes due 2015 | $ | — | $ | 450 | |||||
3.25% guaranteed, notes due 2022 | 1,099 | 1,099 | |||||||
4.75% guaranteed, notes due 2042 | 992 | 991 | |||||||
4.85% guaranteed, notes due 2023 | 550 | 550 | |||||||
6.15% guaranteed, notes due 2043 | 547 | 547 | |||||||
6.75% guaranteed, notes due 2017 | 747 | 765 | |||||||
7.25% guaranteed, notes due 2037 | 448 | 448 | |||||||
7.75% guaranteed, notes due 2018 | 250 | 249 | |||||||
Total long-term debt (less current maturities) | 4,633 | 5,099 | |||||||
Current maturities of long-term debt | 450 | — | |||||||
$ | 5,083 | $ | 5,099 | ||||||
As of December 31, 2014, the maturities of RAI’s notes, net of discounts, were as follows: | |||||||||
Year | Amount | ||||||||
2015 | $ | 450 | |||||||
2017 | 700 | ||||||||
2018 | 250 | ||||||||
2022 and thereafter | 3,636 | ||||||||
$ | 5,036 | ||||||||
In conjunction with their obligations under the Credit Agreement, RAI’s Material Subsidiaries, RJR Tobacco and American Snuff Co., among other subsidiaries, guaranteed the RAI notes. At its option, RAI may redeem any or all of its outstanding notes, in whole or in part at any time, subject to the payment of a make-whole premium. | |||||||||
In June 2012, RAI repaid $450 million in principal of debt due in 2012. | |||||||||
In October 2012, RAI completed the sale of $2.55 billion in aggregate principal amount of senior notes, consisting of $450 million of 1.05% senior notes due October 30, 2015, $1.1 billion of 3.25% senior notes due November 1, 2022 and $1 billion of 4.75% senior notes due November 1, 2042. A portion of the proceeds were used in December 2012 to redeem the $625 million principal amount of 7.25% notes due in 2013. A loss of $21 million on the early extinguishment was recorded in the fourth quarter of 2012, and was included in other (income) expense, net in the consolidated statements of income. Interest on these notes is paid semi-annually. | |||||||||
In September 2013, RAI completed the sale of $1.1 billion in aggregate principal amount of senior notes, consisting of $550 million 4.85% notes due September 15, 2023, and $550 million 6.15% notes due September 15, 2043. Interest on these notes is paid semi-annually. | |||||||||
In September 2013, RAI called for the redemption of the $200 million outstanding principal amount of its 7.30% notes due in 2015, and the $775 million outstanding principal amount of its 7.625% notes due in 2016. A loss of $124 million on the early extinguishment, which includes $35 million of the unamortized portion of the interest rate swap agreements associated with the 7.625% notes, was included in other (income) expense, net in the consolidated statements of income for the year ended December 31, 2013. | |||||||||
See note 3 for additional information on interest rate management. | |||||||||
RJR | |||||||||
In June 2012, RJR prepaid the remaining insignificant amount of its guaranteed, unsecured long-term debt that was due in 2015. In August 2013, RJR repaid at maturity $60 million in principal amount of its notes. RJR has no remaining outstanding debt. |
Commitments_and_Contingencies
Commitments and Contingencies | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||||||
Commitments and Contingencies | Note 12 — Commitments and Contingencies | ||||||||||||||||||||||||||||||||
Tobacco Litigation — General | |||||||||||||||||||||||||||||||||
Introduction | |||||||||||||||||||||||||||||||||
Various legal proceedings or claims, including litigation claiming that cancer and other diseases, as well as addiction, have resulted from the use of, or exposure to, RAI’s operating subsidiaries’ products, are pending or may be instituted against RJR Tobacco, American Snuff Co. or their affiliates, including RAI and RJR, or indemnitees, including B&W. These pending legal proceedings include claims relating to cigarette products manufactured by RJR Tobacco or certain of its affiliates and indemnitees, as well as claims relating to smokeless tobacco products manufactured by American Snuff Co. A discussion of the legal proceedings relating to cigarette products is set forth below under the heading “— Litigation Affecting the Cigarette Industry.” All of the references under that heading to tobacco-related litigation, smoking and health litigation and other similar references are references to legal proceedings relating to cigarette products and are not references to legal proceedings involving smokeless tobacco products, and case numbers under that heading include only cases involving cigarette products. The legal proceedings relating to the smokeless tobacco products manufactured by American Snuff Co. are discussed separately under the heading “— Smokeless Tobacco Litigation” below. | |||||||||||||||||||||||||||||||||
In connection with the B&W business combination, RJR Tobacco has agreed to indemnify B&W and its affiliates, including its indirect parent, BAT, against certain liabilities, costs and expenses incurred by B&W or its affiliates arising out of the U.S. cigarette and tobacco business of B&W. As a result of this indemnity, RJR Tobacco has assumed the defense of pending B&W-specific tobacco-related litigation, has paid the judgments and costs related to certain pre-business combination tobacco-related litigation of B&W, and has posted bonds on behalf of B&W, where necessary, in connection with cases decided since the B&W business combination. | |||||||||||||||||||||||||||||||||
Certain Terms and Phrases | |||||||||||||||||||||||||||||||||
Certain terms and phrases used in this disclosure may require some explanation. The term “judgment” or “final judgment” refers to the final decision of the court resolving the dispute and determining the rights and obligations of the parties. At the trial court level, for example, a final judgment generally is entered by the court after a jury verdict and after post-verdict motions have been decided. In most cases, the losing party can appeal a verdict only after a final judgment has been entered by the trial court. | |||||||||||||||||||||||||||||||||
The term “damages” refers to the amount of money sought by a plaintiff in a complaint, or awarded to a party by a jury or, in some cases, by a judge. “Compensatory damages” are awarded to compensate the prevailing party for actual losses suffered, if liability is proved. In cases in which there is a finding that a defendant has acted willfully, maliciously or fraudulently, generally based on a higher burden of proof than is required for a finding of liability for compensatory damages, a plaintiff also may be awarded “punitive damages.” Although damages may be awarded at the trial court stage, a losing party generally may be protected from paying any damages until all appellate avenues have been exhausted by posting a supersedeas bond. The amount of such a bond is governed by the law of the relevant jurisdiction and generally is set at the amount of damages plus some measure of statutory interest, modified at the discretion of the appropriate court or subject to limits set by court or statute. | |||||||||||||||||||||||||||||||||
The term “per curiam” refers to an opinion entered by a court. In most cases, it is used to indicate that the opinion entered is a brief announcement of the court’s decision and is not accompanied by a written opinion. | |||||||||||||||||||||||||||||||||
The term “settlement” refers to certain types of cases in which cigarette manufacturers, including RJR Tobacco and B&W, have agreed to resolve disputes with certain plaintiffs without resolving the case through trial. The principal terms of certain settlements entered into by RJR Tobacco and B&W are explained below under “— Accounting for Tobacco-Related Litigation Contingencies.” | |||||||||||||||||||||||||||||||||
Theories of Recovery | |||||||||||||||||||||||||||||||||
The plaintiffs seek recovery on a variety of legal theories, including negligence, strict liability in tort, design defect, failure to warn, fraud, misrepresentation, unfair trade practices, conspiracy, medical monitoring and violations of state and federal antitrust laws. In certain of these cases, the plaintiffs claim that cigarette smoking exacerbated injuries caused by exposure to asbestos. | |||||||||||||||||||||||||||||||||
The plaintiffs seek various forms of relief, including compensatory and, where available, punitive damages, treble or multiple damages and statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and other equitable relief. Although alleged damages often are not determinable from a complaint, and the law governing the pleading and calculation of damages varies from jurisdiction to jurisdiction, compensatory and punitive damages have been specifically pleaded in a number of cases, sometimes in amounts ranging into the hundreds of millions and even billions of dollars. | |||||||||||||||||||||||||||||||||
Defenses | |||||||||||||||||||||||||||||||||
The defenses raised by RJR Tobacco, American Snuff Co. and their affiliates and indemnitees include, where applicable and otherwise appropriate, preemption by the Federal Cigarette Labeling and Advertising Act of some or all claims arising after 1969, or by the Comprehensive Smokeless Tobacco Health Education Act for claims arising after 1986, the lack of any defect in the product, assumption of the risk, contributory or comparative fault, lack of proximate cause, remoteness, lack of standing and statutes of limitations or repose. RAI and RJR have asserted additional defenses, including jurisdictional defenses, in many of the cases in which they are named. | |||||||||||||||||||||||||||||||||
Accounting for Tobacco-Related Litigation Contingencies | |||||||||||||||||||||||||||||||||
In accordance with GAAP, RAI and its subsidiaries, including RJR Tobacco, American Snuff Co. and SFNTC, as applicable, record any loss concerning litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated on an individual case-by-case basis. For the reasons set forth below, RAI’s management continues to conclude that the loss of any particular pending smoking and health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees, or the loss of any particular claim concerning the use of smokeless tobacco products against American Snuff Co., when viewed on an individual basis, is not probable, except for the Engle Progeny cases noted below. | |||||||||||||||||||||||||||||||||
RJR Tobacco and its affiliates believe that they have valid defenses to the smoking and health tobacco litigation claims against them, as well as valid bases for appeal of adverse verdicts against them. RAI, RJR Tobacco and their affiliates and indemnitees have, through their counsel, filed pleadings and memoranda in pending smoking and health tobacco litigation that set forth and discuss a number of grounds and defenses that they and their counsel believe have a valid basis in law and fact. With the exception of the Engle Progeny cases described below, RJR Tobacco and its affiliates and indemnitees continue to win the majority of smoking and health tobacco litigation claims that reach trial, and a very high percentage of the tobacco-related litigation claims brought against them, including Engle Progeny cases, continue to be dismissed at or before trial. Based on their experience in smoking and health tobacco litigation and the strength of the defenses available to them in such litigation, RJR Tobacco and its affiliates believe that their successful defense of smoking and health tobacco litigation in the past will continue in the future. | |||||||||||||||||||||||||||||||||
An accrual of $13.9 million has been recorded in RAI’s consolidated balance sheet as of December 31, 2014. This amount includes $3.9 million for compensatory damages, attorneys’ fees and statutory interest for the following Engle Progeny cases — $2.1 million for compensatory and punitive damages and $1.8 million for attorneys’ fees and statutory interest for Hiott, Starr-Blundell, Clayton, Webb and Ward, and $10 million for estimated costs in connection with the U.S. Department of Justice case, described below. During the fourth quarter of 2014, aggregate payments of $14.6 million were made: $12 million for compensatory and punitive damages and $2.6 million for attorneys’ fees and statutory interest, in satisfaction of the adverse judgments in the Schlenther, Virginia Williams and Odum cases, described below. No other liabilities for pending smoking and health litigation have been recorded as of December 31, 2014. As other cases proceed through the appellate process, RAI will evaluate the need for further accruals on an individual case-by-case basis if an unfavorable outcome becomes probable and the amount can be reasonably estimated. | |||||||||||||||||||||||||||||||||
It is the policy of RJR Tobacco and its affiliates to defend tobacco-related litigation claims vigorously; generally, RJR Tobacco and its affiliates and indemnitees do not settle such claims. However, RJR Tobacco and its affiliates may enter into settlement discussions in some cases, if they believe it is in their best interests to do so. Exceptions to this general approach include actions taken pursuant to “offer of judgment” statutes, as described below in “— Litigation Affecting the Cigarette Industry,” as well as other historical examples discussed below. | |||||||||||||||||||||||||||||||||
With respect to smoking and health tobacco litigation claims, the only significant settlements reached by RJR Tobacco and B&W involved: | |||||||||||||||||||||||||||||||||
• | the State Settlement Agreements and the funding by various tobacco companies of a $5.2 billion trust fund contemplated by the MSA to benefit tobacco growers; and | ||||||||||||||||||||||||||||||||
• | the original Broin flight attendant case discussed below under “— Litigation Affecting the Cigarette Industry — Broin II Cases.” | ||||||||||||||||||||||||||||||||
The circumstances surrounding the State Settlement Agreements and the funding of a trust fund to benefit the tobacco growers are readily distinguishable from the current categories of smoking and health cases involving RJR Tobacco or its affiliates and indemnitees. The claims underlying the State Settlement Agreements were brought on behalf of the states to recover funds paid for health care and medical and other assistance to state citizens suffering from diseases and conditions allegedly related to tobacco use. The State Settlement Agreements settled all the health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions and contain releases of various additional present and future claims. In accordance with the MSA, various tobacco companies agreed to fund a $5.2 billion trust fund to be used to address the possible adverse economic impact of the MSA on tobacco growers. A discussion of the State Settlement Agreements, and a table depicting the related payment schedule, is set forth below under “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases.” | |||||||||||||||||||||||||||||||||
The states were a unique set of plaintiffs and are not involved in any of the smoking and health cases remaining against RJR Tobacco or its affiliates and indemnitees. Although RJR Tobacco and certain of its affiliates and indemnitees continue to be defendants in health-care cost recovery cases similar in theory to the state cases but involving other plaintiffs, such as Native American tribes and foreign governments, the vast majority of such cases have been dismissed on legal grounds. RJR Tobacco and its affiliates, including RAI, believe that the same legal principles that have resulted in dismissal of health-care cost recovery cases either at the trial court level or on appeal should compel dismissal of the similar pending cases. | |||||||||||||||||||||||||||||||||
As with claims that were resolved by the State Settlement Agreements, the other cases settled by RJR Tobacco can be distinguished from existing cases pending against RJR Tobacco and its affiliates and indemnitees. The original Broin case, discussed below under “— Litigation Affecting the Cigarette Industry — Broin II Cases,” was settled in the middle of trial during negotiations concerning a possible nation-wide settlement of claims similar to those underlying the State Settlement Agreements. | |||||||||||||||||||||||||||||||||
In 2010, RJR Tobacco entered into a comprehensive agreement with the Canadian federal, provincial and territorial governments, which resolved all civil claims related to the movement of contraband tobacco products in Canada during the period 1985 through 1999 that the Canadian governments could assert against RJR Tobacco and its affiliates. These claims were separate from any smoking and health tobacco litigation. | |||||||||||||||||||||||||||||||||
Likewise, in 2004, RJR Tobacco and B&W separately settled the antitrust case DeLoach v. Philip Morris Cos., Inc., which was brought by a unique class of plaintiffs: a class of all tobacco growers and tobacco allotment holders. The plaintiffs asserted that the defendants conspired to fix the price of tobacco leaf and to destroy the federal government’s tobacco quota and price support program. Despite legal defenses they believed to be valid, RJR Tobacco and B&W separately settled this case to avoid a long and contentious trial with the tobacco growers. The DeLoach case and the antitrust case currently pending against RJR Tobacco and B&W involve different types of plaintiffs and different theories of recovery under the antitrust laws than the smoking and health cases pending against RJR Tobacco and its affiliates and indemnitees. | |||||||||||||||||||||||||||||||||
Finally, as discussed under “— Litigation Affecting the Cigarette Industry — State Settlement Agreements — Enforcement and Validity; Adjustments,” RJR Tobacco and B&W each has settled certain cases brought by states concerning the enforcement of State Settlement Agreements. Despite legal defenses believed to be valid, these cases were settled to avoid further contentious litigation with the states involved. These enforcement actions involve alleged breaches of State Settlement Agreements based on specific actions taken by particular defendants. Accordingly, any future enforcement actions involving State Settlement Agreements will be reviewed by RJR Tobacco on the merits and should not be affected by the settlement of prior enforcement cases. | |||||||||||||||||||||||||||||||||
American Snuff Co. also believes that it has valid defenses to the smokeless tobacco products litigation against it. American Snuff Co. asserted and will continue to assert some or all of these defenses in each case at the time and in the manner deemed appropriate by American Snuff Co. and its counsel. No verdict or judgment has been returned or entered against American Snuff Co. on any claim for personal injuries allegedly resulting from the use of smokeless tobacco products. American Snuff Co. intends to defend vigorously all smokeless tobacco litigation claims asserted against it. No liability for pending smokeless tobacco litigation was recorded in RAI’s consolidated balance sheet as of December 31, 2014. | |||||||||||||||||||||||||||||||||
Cautionary Statement | |||||||||||||||||||||||||||||||||
Even though RAI’s management continues to conclude that the loss of particular pending smoking and health tobacco litigation claims against RJR Tobacco or its affiliates or indemnitees, or the loss of any particular case concerning the use of smokeless tobacco against American Snuff Co., when viewed on an individual case-by-case basis, is not probable or estimable (except for the Engle Progeny cases described below), the possibility of material losses related to such litigation is more than remote. Litigation is subject to many uncertainties, and generally, it is not possible to predict the outcome of any particular litigation pending against RJR Tobacco, American Snuff Co. or their affiliates or indemnitees, or to reasonably estimate the amount or range of any possible loss. | |||||||||||||||||||||||||||||||||
Although RJR Tobacco believes that it has valid bases for appeals of adverse verdicts in its pending cases, and RJR Tobacco and RAI believe they have valid defenses to all actions, and intend to defend them vigorously, it is possible that there could be further adverse developments in pending cases, and that additional cases could be decided unfavorably against RAI, RJR Tobacco or their affiliates or indemnitees. Determinations of liability or adverse rulings in such cases or in similar cases involving other cigarette manufacturers as defendants, even if such judgments are not final, could have a material adverse effect on the litigation against RJR Tobacco or its affiliates or indemnitees and could encourage the commencement of additional tobacco-related litigation. RJR Tobacco and its affiliates also may enter into settlement discussions in some cases, if they believe it is in their best interests to do so. In addition, a number of political, legislative, regulatory and other developments relating to the tobacco industry and cigarette smoking have received wide media attention. These developments may negatively affect the outcomes of tobacco-related legal actions and encourage the commencement of additional similar litigation. | |||||||||||||||||||||||||||||||||
Although it is impossible to predict the outcome of such events on pending litigation and the rate new lawsuits are filed against RJR Tobacco or its affiliates or indemnitees, a significant increase in litigation or in adverse outcomes for tobacco defendants, or difficulties in obtaining the bonding required to stay execution of judgments on appeal, could have a material adverse effect on any or all of these entities. Moreover, notwithstanding the quality of defenses available to RJR Tobacco and its affiliates and indemnitees in litigation matters, it is possible that RAI’s results of operations, cash flows or financial position could be materially adversely affected by the ultimate outcome of certain pending litigation matters against RJR Tobacco or its affiliates or indemnitees. | |||||||||||||||||||||||||||||||||
Similarly, smokeless tobacco litigation is subject to many uncertainties. Notwithstanding the quality of defenses available to American Snuff Co., it is possible that RAI’s results of operations, cash flows or financial position could be materially adversely affected by the ultimate outcome of certain pending litigation matters against American Snuff Co. | |||||||||||||||||||||||||||||||||
Litigation Affecting the Cigarette Industry | |||||||||||||||||||||||||||||||||
Overview | |||||||||||||||||||||||||||||||||
Introduction. In connection with the B&W business combination, RJR Tobacco agreed to indemnify B&W and its affiliates against, among other things, certain litigation liabilities, costs and expenses incurred by B&W or its affiliates arising out of the U.S. cigarette and tobacco business of B&W. Accordingly, the cases discussed below include cases brought against RJR Tobacco and its affiliates, including RAI and RJR; and against B&W. | |||||||||||||||||||||||||||||||||
During the fourth quarter of 2014, seven tobacco-related cases, including one Engle Progeny case, were served against RJR Tobacco or its affiliates or indemnitees. On December 31, 2014, there were 177 cases pending against RJR Tobacco or its affiliates or indemnitees: 161 in the United States and 16 in Canada, as compared with 165 total cases on December 31, 2013. The U.S. case number does not include the approximately 564 individual smoker cases pending in West Virginia state court as a consolidated action, 3,885 Engle Progeny cases, involving approximately 4,959 individual plaintiffs, and 2,558 Broin II cases (as hereinafter defined), pending in the United States against RJR Tobacco or its affiliates or indemnitees. Of the U.S. cases pending on December 31, 2014, 14 are pending in federal court, 146 in state court and 1 in tribal court, primarily in the following states: Maryland (29 cases); Florida (26 cases); Missouri (18 cases); and New York (13 cases). | |||||||||||||||||||||||||||||||||
The following table lists the categories of the U.S. tobacco-related cases pending against RJR Tobacco or its affiliates or indemnitees as of December 31, 2014, compared with the number of cases pending against RJR Tobacco, its affiliates or indemnitees as of September 30, 2014, as reported in RAI’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2014, filed with the SEC on October 21, 2014, and a cross-reference to the discussion of each case type. | |||||||||||||||||||||||||||||||||
Case Type | RJR Tobacco’s | Change in | Page | ||||||||||||||||||||||||||||||
U.S. Case Numbers | Number of | Reference | |||||||||||||||||||||||||||||||
as of December 31, 2014 | Cases Since | ||||||||||||||||||||||||||||||||
September 30, 2014 | |||||||||||||||||||||||||||||||||
Increase/(Decrease) | |||||||||||||||||||||||||||||||||
Individual Smoking and Health | 96 | 1 | 123 | ||||||||||||||||||||||||||||||
West Virginia IPIC (Number of Plaintiffs)* | 1 (approx. 564) | No change | 124 | ||||||||||||||||||||||||||||||
Engle Progeny (Number of Plaintiffs)** | 3,885 (approx. 4,959) | (184) (212) | 125 | ||||||||||||||||||||||||||||||
Broin II | 2,558 | -12 | 141 | ||||||||||||||||||||||||||||||
Class Action | 20 | 3 | 141 | ||||||||||||||||||||||||||||||
Health-Care Cost Recovery | 2 | No change | 144 | ||||||||||||||||||||||||||||||
State Settlement Agreements — Enforcement and Validity; Adjustments | 29 | (1 | ) | 152 | |||||||||||||||||||||||||||||
Antitrust | 1 | No change | 158 | ||||||||||||||||||||||||||||||
Other Litigation and Developments | 12 | (1 | ) | 158 | |||||||||||||||||||||||||||||
* | Includes as one case the approximately 564 cases pending as a consolidated action In Re: Tobacco Litigation Individual Personal Injury Cases, sometimes referred to as West Virginia IPIC cases, described below. The West Virginia IPIC cases have been separated from the Individual Smoking and Health cases for reporting purposes. | ||||||||||||||||||||||||||||||||
** | The Engle Progeny cases have been separated from the Individual Smoking and Health cases for reporting purposes. The number of cases has decreased as the result of many of the federal and state court cases being dismissed or duplicate actions being consolidated. | ||||||||||||||||||||||||||||||||
The following cases against RJR Tobacco and B&W have attracted significant attention: the Florida state court class-action case, Engle v. R. J. Reynolds Tobacco Co. and the related Engle Progeny cases; and the case brought by the U.S. Department of Justice under the federal Racketeer Influenced and Corrupt Organizations Act, referred to as RICO. | |||||||||||||||||||||||||||||||||
In 2000, a jury in Engle v. Liggett Group, a class action brought against the major U.S. cigarette manufacturers by Florida smokers allegedly harmed by their addiction to nicotine, rendered a $145 billion punitive damages verdict in favor of the class. In 2006, the Florida Supreme Court set aside that award, prospectively decertified the class, and preserved several of the Engle jury findings for use in subsequent individual actions to be filed within one year of its decision. The preserved findings include jury determinations that smoking causes various diseases, that nicotine is addictive, and that each defendant sold cigarettes that were defective and unreasonably dangerous, committed unspecified acts of negligence and individually and jointly concealed unspecified information about the health risks of smoking. | |||||||||||||||||||||||||||||||||
In the wake of Engle, thousands of individual progeny actions were filed in federal and state courts in Florida. Such actions are commonly referred to as “Engle Progeny” cases. As of December 31, 2014, 697 Engle Progeny cases were pending in federal court, and 3,188 of them were pending in state court. These cases include approximately 4,959 plaintiffs. In addition, as of December 31, 2014, RJR Tobacco was aware of 16 additional Engle Progeny cases that had been filed but not served. One hundred twenty-one Engle Progeny cases have been tried in Florida state and federal courts since the beginning of 2011, and numerous state court trials are scheduled for 2015. The number of pending cases fluctuates for a variety of reasons, including voluntary and involuntary dismissals. Voluntary dismissals include cases in which a plaintiff accepts an “offer of judgment,” referred to in Florida statutes as “proposals for settlement,” from RJR Tobacco and/or its affiliates. An offer of judgment, if rejected by the plaintiff, preserves RJR Tobacco’s right to recover attorneys’ fees under Florida law in the event of a verdict favorable to RJR Tobacco. Such offers are sometimes made through court-ordered mediations. | |||||||||||||||||||||||||||||||||
At the beginning of the Engle Progeny litigation, a central issue was the proper use of the preserved Engle findings. RJR Tobacco has argued that use of the Engle findings to establish individual elements of progeny claims (such as defect, negligence and concealment) is a violation of federal due process. In 2013, however, both the Florida Supreme Court and the U.S. Court of Appeals for the Eleventh Circuit, referred to as the Eleventh Circuit, rejected that argument. In addition to this global due process argument, RJR Tobacco raises many other factual and legal defenses as appropriate in each case. These defenses may include, among other things, arguing that the plaintiff is not a proper member of the Engle class, that the plaintiff did not rely on any statements by any tobacco company, that the trial was conducted unfairly, that some or all claims are preempted or barred by applicable statutes of limitation or statutes of repose, or that any injury was caused by the smoker’s own conduct. | |||||||||||||||||||||||||||||||||
Twenty-eight Engle Progeny cases have become final through December 31, 2014. These cases resulted in aggregate payments by RJR Tobacco of $213.4 million ($162.1 million for compensatory and punitive damages and $51.3 million for attorneys’ fees and statutory interest). During the fourth quarter of 2014, aggregate payments of $14.6 million were made: $12 million for compensatory and punitive damages and $2.6 million for attorneys’ fees and statutory interest in satisfaction of the adverse judgments in the Schlenther, Virginia Williams and Odum cases, described below. Based on RJR Tobacco’s evaluation, an accrual of $3.9 million ($2.1 million for compensatory and punitive damages and $1.8 million for attorneys’ fees and statutory interest for Hiott, Starr- Blundell, Clayton, Webb and Ward) was recorded in RAI’s consolidated balance sheet as of December 31, 2014. The following chart reflects the details related to Hiott, Starr-Blundell, Clayton and Webb: | |||||||||||||||||||||||||||||||||
Plaintiff Case | RJR Tobacco | Compensatory | Punitive | Appeal Status | |||||||||||||||||||||||||||||
Name | Allocation of | Damages (as | Damages | ||||||||||||||||||||||||||||||
Fault | adjusted)(1) | ||||||||||||||||||||||||||||||||
Hiott | 40 | % | $ | 730,000 | $ | — | Notice to invoke jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA Inc. | ||||||||||||||||||||||||||
Starr-Blundell | 10 | % | 50,000 | — | Pending — First DCA | ||||||||||||||||||||||||||||
Clayton | 10 | % | 60,000 | — | Pending — First DCA | ||||||||||||||||||||||||||||
Webb | 90 | % | 810,000 | 450,000 | Reversed and remanded for new trial | ||||||||||||||||||||||||||||
on damages; new trial completed on November 12, 2014; plaintiff’s motion for new trial on punitive damages was denied on December 5, 2014. | |||||||||||||||||||||||||||||||||
Totals | $ | 1,650,000 | $ | 450,000 | |||||||||||||||||||||||||||||
(1) | Compensatory damages are adjusted to reflect the reduction that may be required by the allocation of fault. Punitive damages are not adjusted and reflect the amount of the final judgment(s) signed by the trial court judge(s). The amounts listed above do not include attorneys’ fees or statutory interest. | ||||||||||||||||||||||||||||||||
The following chart reflects verdicts in all other individual Engle Progeny cases, pending as of December 31, 2014, in which a verdict has been returned against RJR Tobacco or B&W, or both, and has not been set aside on appeal. No liability for any of these cases has been recorded in RAI’s consolidated balance sheet as of December 31, 2014. This chart does not include the mistrials or verdicts returned in favor of RJR Tobacco or B&W, or both. | |||||||||||||||||||||||||||||||||
Plaintiff | RJR Tobacco | Compensatory | Punitive | Appeal Status | |||||||||||||||||||||||||||||
Case Name | Allocation of | Damages (as | Damages | ||||||||||||||||||||||||||||||
Fault | adjusted)(1) | ||||||||||||||||||||||||||||||||
Cohen | 33.3 | % | $ | 3,330,000 | $ | — | Punitive damages of $10 million set aside; remanded for partial new trial; notice to invoke jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA Inc. | ||||||||||||||||||||||||||
Putney | 30 | % | — | — | Reversed and remanded for further proceedings; notice to invoke jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA Inc. | ||||||||||||||||||||||||||||
Buonomo | 77.5 | % | 4,060,000 | — | Punitive damages of $25 million to be reinstated if plaintiff prevails on repose issue; remanded for new trial; notice to invoke jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA Inc. | ||||||||||||||||||||||||||||
Andy Allen | 24 | % | 2,475,000 | 7,756,000 | Reversed and remanded for new trial; new trial completed on November 26, 2014; final judgment has not been entered. | ||||||||||||||||||||||||||||
Jewett | 20 | % | — | — | Reversed and remanded for new trial; new trial has not been scheduled | ||||||||||||||||||||||||||||
Soffer | 40 | % | 2,000,000 | — | Pending — Florida Supreme Court | ||||||||||||||||||||||||||||
Ciccone | 30 | % | 1,000,000 | — | Pending — Florida Supreme Court | ||||||||||||||||||||||||||||
Hallgren | 25 | % | 500,000 | (2) | 750,000 | Notice to invoke jurisdiction of Florida Supreme Court pending; stayed | |||||||||||||||||||||||||||
Calloway | 27 | % | 16,100,000 | (2) | 17,250,000 | Pending — Fourth DCA | |||||||||||||||||||||||||||
Hancock | 5 | % | 700 | — | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Sikes | 51 | % | 3,520,000 | 2,000,000 | Notice to invoke jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA Inc. | ||||||||||||||||||||||||||||
James Smith | 55 | % | 600,000 | (2) | 20,000 | Pending — Eleventh Circuit | |||||||||||||||||||||||||||
Ballard | 55 | % | 5,000,000 | — | Pending — Third DCA | ||||||||||||||||||||||||||||
Evers | 60 | % | 1,938,000 | — | Punitive damages of $12.4 million set aside by trial court; pending — Second DCA | ||||||||||||||||||||||||||||
Schoeff | 75 | % | 7,875,000 | 30,000,000 | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Marotta | 58 | % | 3,480,000 | — | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Searcy | 30 | % | 1,000,000 | (2) | 1,670,000 | Pending — Eleventh Circuit | |||||||||||||||||||||||||||
Aycock | 72.5 | % | — | — | Eleventh Circuit reversed and remanded the case for a new trial | ||||||||||||||||||||||||||||
Earl Graham | 20 | % | 550,000 | — | Pending — Eleventh Circuit | ||||||||||||||||||||||||||||
Skolnick | 30 | % | 767,000 | — | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Thibault | 70 | % | 1,750,000 | (2) | 1,275,000 | First DCA affirmed the judgment, per curiam; notice to invoke the discretionary jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA, Inc. | |||||||||||||||||||||||||||
Grossman | 75 | % | 15,350,000 | (2) | 22,500,000 | Pending — Fourth DCA | |||||||||||||||||||||||||||
Gafney | 33 | % | 1,914,000 | — | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Harford | 18 | % | — | — | Plaintiff’s motion for new trial granted; new trial is scheduled for March 16, 2015 | ||||||||||||||||||||||||||||
Cheeley | 50 | % | 1,500,000 | 2,000,000 | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Goveia | 35 | % | 297,500 | 2,250,000 | Pending — Fifth DCA | ||||||||||||||||||||||||||||
Bowden | 30 | % | 1,500,000 | — | Pending — First DCA | ||||||||||||||||||||||||||||
Burkhart | 25 | % | 2,500,000 | (2) | 1,250,000 | Pending — Eleventh Circuit | |||||||||||||||||||||||||||
Bakst | 75 | % | 4,504,000 | 14,000,000 | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Robinson | 70.5 | % | 16,900,000 | 16,900,000 | Punitive damages remitted, remaining post-trial motions denied | ||||||||||||||||||||||||||||
Harris | 15 | % | 239,000 | — | Post-trial motions are pending(3) | ||||||||||||||||||||||||||||
Wilcox | 70 | % | 4,900,000 | 8,500,000 | Post-trial motions denied | ||||||||||||||||||||||||||||
Irimi | 14.5 | % | — | — | Defendants’ motion for a new trial granted | ||||||||||||||||||||||||||||
Hubbird | 50 | % | 3,000,000 | (2) | 25,000,000 | Pending — Third DCA | |||||||||||||||||||||||||||
Lourie | 3 | % | 41,000 | — | Pending — Second DCA | ||||||||||||||||||||||||||||
Kerrivan | 31 | % | 4,898,000 | 9,600,000 | Post-trial motions are pending(3) | ||||||||||||||||||||||||||||
Taylor | 58 | % | 4,116,000 | (2) | 521,000 | Pending — First DCA | |||||||||||||||||||||||||||
Schleider | 70 | % | 14,700,000 | — | Final judgment has not been entered | ||||||||||||||||||||||||||||
Perrotto | 20 | % | 818,000 | — | Post-trial motions are pending | ||||||||||||||||||||||||||||
Ellen Gray | 50 | % | 3,000,000 | — | Final judgment has not been entered | ||||||||||||||||||||||||||||
Totals | $ | 136,123,200 | $ | 163,242,000 | |||||||||||||||||||||||||||||
(1) | Unless otherwise noted, compensatory damages in these cases are adjusted to reflect the jury’s allocation of comparative fault. Punitive damages are not so adjusted. The amounts listed above do not include attorneys’ fees or statutory interest that may apply to the judgments. | ||||||||||||||||||||||||||||||||
(2) | The court did not apply comparative fault in the final judgment. | ||||||||||||||||||||||||||||||||
(3) | Should the pending post-trial motions be denied, RJR Tobacco will likely file a notice of appeal with the appropriate appellate court. | ||||||||||||||||||||||||||||||||
As of December 31, 2014, outstanding judgments in favor of the Engle Progeny plaintiffs have been entered and remain outstanding against RJR Tobacco in the amount of $136,123,200 in compensatory damages (as adjusted) and in the amount of $163,242,000 in punitive damages, for a total of $299,365,200. All of these verdicts are at various stages in the appellate process. RJR Tobacco continues to believe that it has valid defenses in these cases, including case-specific issues beyond the due process issue discussed above. It is the policy of RJR Tobacco and its affiliates to vigorously defend all smoking and health claims, including in Engle Progeny cases. | |||||||||||||||||||||||||||||||||
Should RJR Tobacco not prevail in any particular individual Engle Progeny case or determine that in any individual Engle Progeny case an unfavorable outcome has become probable and the amount can be reasonably estimated, a loss would be recognized, which could have a material adverse effect on earnings and cash flows of RAI in a particular quarter or year. This position on loss recognition for Engle Progeny cases as of December 31, 2014, is consistent with RAI’s and RJR Tobacco’s historic position on loss recognition for other smoking and health litigation. It is also the policy of RJR Tobacco to record any loss concerning litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated on an individual case-by-case basis. | |||||||||||||||||||||||||||||||||
In the U.S. Department of Justice case, brought in 1999 in the U.S. District Court for the District of Columbia, the government sought, among other forms of relief, the disgorgement of profits pursuant to the civil provisions of RICO. The U.S. Court of Appeals for the District of Columbia ruled in 2005 that disgorgement is not an available remedy in the case. The bench trial ended in June 2005, and the court, in August 2006, issued its ruling, among other things, finding certain defendants, including RJR Tobacco and B&W, liable for the RICO claims, imposing no direct financial penalties on the defendants, but ordering the defendants to make certain “corrective communications” in a variety of media and enjoining the defendants from using certain brand descriptors. Both sides appealed to the U.S. Court of Appeals for the District of Columbia. In May 2009, the U.S. Court of Appeals largely affirmed the findings against the tobacco company defendants and remanded to the trial court for further proceedings. The U.S. Supreme Court denied the parties’ petitions for writ of certiorari in June 2010. In June 2014, the district court issued an implementation order for the corrective-statements remedy. That order stays implementation until the exhaustion of the defendants’ appeal challenging the legality of the corrective statements. Additional remand proceedings remain ongoing. | |||||||||||||||||||||||||||||||||
For a detailed description of these cases, see “— Engle and Engle Progeny Cases” and “— Health-Care Cost Recovery Cases — U.S. Department of Justice Case” below. | |||||||||||||||||||||||||||||||||
In November 1998, the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, entered into the MSA with 46 U.S. states, Washington, D.C. and certain U.S. territories and possessions. These cigarette manufacturers previously settled four other cases, brought on behalf of Mississippi, Florida, Texas and Minnesota, by separate agreements with each state. These State Settlement Agreements: | |||||||||||||||||||||||||||||||||
• | settled all health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions; | ||||||||||||||||||||||||||||||||
• | released the major U.S. cigarette manufacturers from various additional present and potential future claims; | ||||||||||||||||||||||||||||||||
• | imposed future payment obligations in perpetuity on RJR Tobacco, B&W and other major U.S. cigarette manufacturers; and | ||||||||||||||||||||||||||||||||
• | placed significant restrictions on their ability to market and sell cigarettes and smokeless tobacco products. | ||||||||||||||||||||||||||||||||
Payments under the State Settlement Agreements are subject to various adjustments for, among other things, the volume of cigarettes sold, relevant market share and inflation. See “— Health-Care Cost Recovery Cases — State Settlement Agreements” below for a detailed discussion of the State Settlement Agreements, including RAI’s operating subsidiaries’ monetary obligations under these agreements. RJR Tobacco records the allocation of settlement charges as products are shipped. | |||||||||||||||||||||||||||||||||
Scheduled Trials. Trial schedules are subject to change, and many cases are dismissed before trial. It is likely that RJR Tobacco and other cigarette manufacturers will have an increased number of tobacco-related trials in 2015. There are six cases, exclusive of Engle Progeny cases, scheduled for trial as of December 31, 2014 through December 31, 2015, for RJR Tobacco or its affiliates and indemnitees: two non-smoking and health cases and four individual smoking and health cases. There are approximately 76 Engle Progeny cases against RJR Tobacco and/or B&W set for trial through December 31, 2015, but it is not known how many of these cases will actually be tried. | |||||||||||||||||||||||||||||||||
Trial Results. From January 1, 2011 through December 31, 2014, 127 smoking and health, Engle Progeny and health-care cost recovery cases in which RJR Tobacco or B&W were defendants were tried, including seven trials for cases where mistrials were declared in the original proceedings. Verdicts in favor of RJR Tobacco, B&W and, in some cases, RJR Tobacco, B&W and other defendants, were returned in 64 cases, including 19 mistrials, tried in Florida (61), Missouri (1) and West Virginia (2). Verdicts in favor of the plaintiffs were returned in 58 cases tried in Florida and one in New York. Three cases in Florida were dismissed during trial. One case in Florida was a retrial only as to the amount of damages. | |||||||||||||||||||||||||||||||||
In the fourth quarter of 2014, 11 Engle Progeny cases in which RJR Tobacco was a defendant were tried: | |||||||||||||||||||||||||||||||||
• | In Lourie v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Barbara Lourie, to be 63% at fault, RJR Tobacco to be 3% at fault and the remaining defendants collectively to be 34% at fault, and awarded approximately $1.37 million in compensatory damages. Punitive damages were not awarded. | ||||||||||||||||||||||||||||||||
• | In Kerrivan v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the plaintiff to be 19% at fault, RJR Tobacco to be 31% at fault and the remaining defendant to be 50% at fault; and awarded $15.8 million in compensatory damages, and $9.6 million and $15.7 million in punitive damages against RJR Tobacco and the remaining defendant, respectively. | ||||||||||||||||||||||||||||||||
• | In Russo v. Philip Morris USA, Inc., the court declared a mistrial because of the inability to seat a jury. | ||||||||||||||||||||||||||||||||
• | In Bishop v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants, including RJR Tobacco. | ||||||||||||||||||||||||||||||||
• | In Taylor v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the plaintiff to be 42% at fault and RJR Tobacco to be 58% at fault, and awarded approximately $4.5 million in compensatory damages and approximately $521,000 in punitive damages. | ||||||||||||||||||||||||||||||||
• | In the Webb v. R. J. Reynolds Tobacco Co. damages retrial, the jury returned a verdict of $900,000 in compensatory damages and $450,000 in punitive damages. | ||||||||||||||||||||||||||||||||
• | In Schleider v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Andrew Schleider, to be 30% at fault and RJR Tobacco to be 70% at fault, and awarded $21 million in compensatory damages. | ||||||||||||||||||||||||||||||||
• | In Perrotto v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Nicholas Perrotto, to be 49% at fault, RJR Tobacco to be 20% at fault and the remaining defendants collectively to be 31% at fault, and awarded approximately $4.1 million in compensatory damages, but refused to award punitive damages. | ||||||||||||||||||||||||||||||||
• | In the Andy Allen v. R. J. Reynolds Tobacco Co. retrial, the jury returned a verdict in favor of the plaintiff, found the decedent to be 70% at fault, RJR Tobacco to be 24% at fault and the remaining defendant to be 6% at fault, and awarded $3.1 million in compensatory damages and approximately $7.8 million in punitive damages against each defendant. | ||||||||||||||||||||||||||||||||
• | In Starbuck v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants, including RJR Tobacco. | ||||||||||||||||||||||||||||||||
• | In Haliburton v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of RJR Tobacco. | ||||||||||||||||||||||||||||||||
In addition, since the end of the fourth quarter of 2014, a decision was entered in the following Engle Progeny case: | |||||||||||||||||||||||||||||||||
• | In Gray v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the plaintiff, found the decedent, Henry Gray, to be 50% at fault and RJR Tobacco to be 50% at fault, and awarded $6 million in compensatory damages. Punitive damages were not awarded. | ||||||||||||||||||||||||||||||||
For a detailed description of the above-described cases, see “— Engle and Engle Progeny Cases” below. | |||||||||||||||||||||||||||||||||
In the fourth quarter of 2014, no non-Engle Progeny individual smoking and health cases in which RJR Tobacco was a defendant were tried. | |||||||||||||||||||||||||||||||||
The following chart reflects the verdicts in the non-Engle Progeny smoking and health cases or health-care cost recovery cases that have been tried and remain pending as of December 31, 2014, in which verdicts have been returned against RJR Tobacco or B&W, or both. For information on the verdicts in the Engle Progeny cases that have been tried and remain pending as of December 31, 2014, in which verdicts have been returned against RJR Tobacco or B&W, or both, see the Engle Progeny cases chart above. For information on the post-trial status of individual smoking and health cases and the governmental health-care cost recovery case, see “— Individual Smoking and Health Cases,” and “— Health-Care Cost Recovery Cases — U.S. Department of Justice Case,” respectively, below: | |||||||||||||||||||||||||||||||||
Date of Verdict | Case Name/Type | Jurisdiction | Verdict | ||||||||||||||||||||||||||||||
August 17, 2006 | United States v. Philip Morris USA, | U.S. District Court, District of Columbia (Washington, DC) | RJR Tobacco and B&W were found liable for civil RICO claims; were enjoined from using certain brand descriptors and from making certain misrepresentations; and were ordered to make corrective communications on five subjects, | ||||||||||||||||||||||||||||||
Inc. | including smoking and health and addiction, to reimburse the U.S. Department of Justice appropriate costs associated with the lawsuit, and to maintain document web sites. | ||||||||||||||||||||||||||||||||
[Governmental Health-Care Cost | |||||||||||||||||||||||||||||||||
Recovery] | |||||||||||||||||||||||||||||||||
May 26, 2010 | Izzarelli v. R. J. Reynolds Tobacco Co. | U.S. District Court, | $13.9 million in compensatory damages; 58% of fault assigned to RJR Tobacco, which reduced the award to $8.08 million against RJR Tobacco; $3.97 million in punitive damages. | ||||||||||||||||||||||||||||||
[Individual] | District of Connecticut, | ||||||||||||||||||||||||||||||||
(Bridgeport, CT) | |||||||||||||||||||||||||||||||||
Individual Smoking and Health Cases | |||||||||||||||||||||||||||||||||
As of December 31, 2014, 96 individual cases were pending in the United States against RJR Tobacco, B&W, as its indemnitee, or both. This category of cases includes smoking and health cases alleging personal injury brought by or on behalf of individual plaintiffs, but does not include the Broin II, Engle Progeny or West Virginia IPIC cases discussed below. A total of 94 of the individual cases are brought by or on behalf of individual smokers or their survivors, while the remaining two cases are brought by or on behalf of individuals or their survivors alleging personal injury as a result of exposure to environmental tobacco smoke, referred to as ETS. | |||||||||||||||||||||||||||||||||
Below is a description of the non-Engle Progeny individual smoking and health cases against RJR Tobacco or B&W, or both, which went to trial or were decided during the period from January 1, 2014 to December 31, 2014, or remained on appeal as of December 31, 2014. | |||||||||||||||||||||||||||||||||
On May 26, 2010, the jury returned a verdict in favor of the plaintiff in Izzarelli v. R. J. Reynolds Tobacco Co., a case filed in December 1999 in the U.S. District Court for the District of Connecticut. The plaintiff sought to recover damages for personal injuries that the plaintiff alleges she sustained as a result of unsafe and unreasonably dangerous cigarette products and for economic losses she sustained as a result of unfair trade practices of the defendant. The jury found RJR Tobacco to be 58% at fault and the plaintiff to be 42% at fault, awarded $13.9 million in compensatory damages and found the plaintiff to be entitled to punitive damages. In December 2010, the court awarded the plaintiff $3.97 million in punitive damages. Final judgment was entered in December 2010, in the amount of $11.95 million. The court granted the plaintiff’s motion for offer of judgment interest, and awarded the plaintiff $15.8 million for the period of December 6, 1999 up to and including December 5, 2010, and approximately $4,000 per day thereafter until an amended judgment was entered. The amended judgment was entered in the amount of approximately $28.1 million in March 2011. RJR Tobacco filed a notice of appeal in September 2011, and the plaintiff thereafter cross appealed with respect to the punitive damages award. In September 2013, the U.S. Court of Appeals for the Second Circuit issued an opinion that certified the following question to the Connecticut Supreme Court: “Does Comment i to section 402A of the Restatement (Second) of Torts preclude a suit premised on strict products liability against a cigarette manufacturer based on evidence that the defendant purposefully manufactured cigarettes to increase daily consumption without regard to the resultant increase in exposure to carcinogens, but in the absence of evidence of any adulteration or contamination?” Subsequently, the plaintiff submitted a motion to the U.S. Court of Appeals for the Second Circuit to amend the certification order to add a second question to the Connecticut Supreme Court: “Does Comment i to section 402A of the Restatement (Second) of Torts preclude a claim under the [Connecticut Products Liability Act] against a cigarette manufacturer for negligence (in the design of its cigarette products)?” The Second Circuit denied the plaintiff’s motion. The Connecticut Supreme Court accepted the certified question and denied the plaintiff’s request to amend the question with the same additional question that the plaintiff proposed to the Second Circuit. Briefing is complete. The Second Circuit has retained jurisdiction over the parties’ appeals and will decide the case after the Connecticut Supreme Court has completed its proceedings. | |||||||||||||||||||||||||||||||||
On June 19, 2013, in Whitney v. R. J. Reynolds Tobacco Co., the jury returned a verdict in favor of the defendants, including RJR Tobacco. The case was filed in January 2011, in the Circuit Court, Alachua County, Florida. The plaintiff alleged that as a result of using the defendants’ products, she suffers from lung cancer and emphysema. Final judgment was entered in July 2013. The plaintiff filed a notice of appeal to the First DCA, and the defendants filed a notice of cross appeal in August 2013. On December 5, 2014, the First DCA reversed the trial court’s directed verdict in favor of the defendants on the defect claims and remanded the case for a new trial. The defendants filed a motion for panel rehearing, rehearing en banc, or certification to the Florida Supreme Court on January 6, 2015. A decision is pending. | |||||||||||||||||||||||||||||||||
West Virginia IPIC | |||||||||||||||||||||||||||||||||
In re: Tobacco Litigation Individual Personal Injury Cases began in 1999, in West Virginia state court, as a series of roughly 1,200 individual plaintiff cases making claims with respect to cigarettes manufactured by Philip Morris, Lorillard, RJR Tobacco, B&W and The American Tobacco Company. The cases were consolidated for a Phase I trial on various defense conduct issues, to be followed in Phase II by individual trials of any claims left standing. Over the years, approximately 600 individual plaintiff claims were dismissed for failure to comply with the case management order, leaving 564 individual cases pending as of April 2013. On April 15, 2013, the Phase I jury trial began and ended with a virtually complete defense verdict on May 15, 2013. The jury found that cigarettes were not defectively designed, were not defective due to a failure to warn prior to July 1, 1969, that defendants were not negligent, did not breach warranties and did not engage in conduct which would warrant punitive damages. The only claim remaining after the verdict was the jury’s finding that all ventilated filter cigarettes manufactured and sold between 1964 and July 1, 1969 were defective for a failure to instruct. The defendants believe that there are only 30 plaintiffs remaining who arguably claim to have smoked a ventilated filter cigarette during the relevant period. The court initially entered judgment on the verdict identifying the 30 plaintiffs remaining, but vacated those orders as premature (leaving to a later day the task of identifying the plaintiffs who might be able to assert a ventilated filter failure to instruct claim during the narrow relevant period). The court entered a new judgment in October 2013, dismissing all claims lost by the plaintiffs and purporting to make those claims and all of the jury rulings immediately subject to appeal. The plaintiffs filed a notice of appeal to the West Virginia Supreme Court of Appeals in November 2013. The defendants briefed the issues and reserved the right to challenge the ventilated filter claim in the event any plaintiff pursues and succeeds on such a claim. In November 2014, the West Virginia Supreme Court affirmed the verdict, issuing an opinion without oral argument. In January 2015, the plaintiffs’ petition for rehearing was denied. The trial court has set February 26, 2015, for a hearing to address the remaining ventilated filter claim, which is not expected to result in more than 30 remaining plaintiffs. | |||||||||||||||||||||||||||||||||
Engle and Engle Progeny Cases | |||||||||||||||||||||||||||||||||
Trial began in July 1998 in Engle v. R. J. Reynolds Tobacco Co., a class action filed in Circuit Court, Miami-Dade County, Florida. The Engle class consisted of Florida citizens and residents, and their survivors, who suffer from or have died from diseases or medical conditions caused by an addiction to smoking. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W. In July 1999, the Engle jury found against RJR Tobacco, B&W and the other defendants in the initial phase of the trial, which addressed alleged common issues related to the defendants’ conduct, general causation, the addictiveness of cigarettes, and potential entitlement to punitive damages. | |||||||||||||||||||||||||||||||||
On July 14, 2000, in the second phase of the trial, the jury returned a punitive damages verdict in favor of the class of approximately $145 billion, including verdicts of $36.3 billion and $17.6 billion against RJR Tobacco and B&W, respectively. | |||||||||||||||||||||||||||||||||
On appeal, the Florida Supreme Court prospectively decertified the class, and it set aside the punitive damages award as both premature and excessive. However, the court preserved a number of findings from Phase I of the trial, including findings that cigarettes can cause certain diseases, that nicotine is addictive, and that defendants placed defective cigarettes on the market, breached duties of care, and concealed health-related information about cigarettes. The court authorized former class members to file individual lawsuits within one year, and it stated that the preserved findings would have res judicata effect in those actions. | |||||||||||||||||||||||||||||||||
In the wake of the Florida Supreme Court ruling, thousands of individuals filed separate lawsuits seeking to benefit from the Engle findings. As of December 31, 2014, RJR Tobacco was a defendant in 3,885 Engle Progeny cases in both state and federal courts in Florida. These cases include approximately 4,959 plaintiffs. Many of these cases are in active discovery or nearing trial. | |||||||||||||||||||||||||||||||||
At the beginning of the Engle Progeny litigation, a central issue was the proper use of the preserved Engle findings. RJR Tobacco has argued that use of the Engle findings to establish individual elements of progeny claims (such as defect, negligence and concealment) is a violation of federal due process. In 2013, however, both the Florida Supreme Court and the Eleventh Circuit rejected that argument. RJR Tobacco continues to press various other factual and legal defenses as appropriate in each case, including defenses based on express and implied preemption. | |||||||||||||||||||||||||||||||||
In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applied to all Engle Progeny cases in the aggregate. In May 2011, Florida removed the provision that would have allowed it to expire on December 31, 2012. The bond cap for any given individual Engle Progeny case varies depending on the number of judgments in effect at a given time, but never exceeds $5 million per case. The legislation, which became effective in June 2009 and 2011, applies to judgments entered after the original 2009 effective date. | |||||||||||||||||||||||||||||||||
Below is a description of the Engle Progeny cases against RJR Tobacco or B&W, or both, which went to trial or were decided during the period from January 1, 2014 to December 31, 2014, or remained on appeal as of December 31, 2014. | |||||||||||||||||||||||||||||||||
On February 25, 2010, in Grossman v. R. J. Reynolds Tobacco Co., a case filed in December 2007 in the Circuit Court, Broward County, Florida, the court declared a mistrial due to the jury’s inability to reach a decision. The plaintiff alleged that as a result of an addiction to cigarettes, the decedent, Laura Grossman, developed lung cancer and died. The plaintiff sought damages in excess of $15,000 and all taxable costs and interest. Retrial began in March 2010. In April 2010, the jury returned a verdict in favor of the plaintiff in Phase I, and in Phase II awarded $1.9 million in compensatory damages and no punitive damages. The jury also found RJR Tobacco to be 25% at fault, the decedent to be 70% at fault and the decedent’s spouse to be 5% at fault. Final judgment was entered in June 2010, in the amount of $483,682. RJR Tobacco filed a notice of appeal to the Fourth DCA, and posted a supersedeas bond in the amount of approximately $484,000. The plaintiff filed a notice of cross appeal. In June 2012, the Fourth DCA entered an opinion that affirmed the trial court’s judgment, but remanded the case for a new trial on all Phase II issues. In October 2012, RJR Tobacco filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court. In February 2014, the Florida Supreme Court declined to accept jurisdiction of the appeal of the original verdict. Retrial began on July 11, 2013. On July 31, 2013, the jury returned a verdict in favor of the plaintiff, found the decedent to be 25% at fault and RJR Tobacco to be 75% at fault, and awarded $15.35 million in compensatory damages and $22.5 million in punitive damages. Final judgment was entered in August 2013 and did not include a reduction for comparative fault. RJR Tobacco filed a notice of appeal to the Fourth DCA and the plaintiff filed a notice of cross appeal in October 2013. RJR Tobacco’s original bond was returned, and RJR Tobacco posted a new bond in the amount of $5 million. Briefing is underway. | |||||||||||||||||||||||||||||||||
On March 10, 2010, in Cohen v. R. J. Reynolds Tobacco Co., a case filed in May 2007 in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff. The plaintiff alleged that the decedent, Nathan Cohen, developed lung cancer as a result of using the defendants’ products, and sought in excess of $15,000 in compensatory damages and unspecified punitive damages. On March 24, 2010, the jury awarded the plaintiff $10 million in compensatory damages, and found the decedent to be 33.3% at fault, RJR Tobacco to be 33.3% at fault and the remaining defendant to be 33.3% at fault. The jury also awarded $20 million in punitive damages, of which $10 million was assigned to RJR Tobacco. In July 2010, the court entered final judgment against RJR Tobacco in the amount of $3.33 million in compensatory damages and $10 million in punitive damages. The court entered an amended judgment in September 2010 to include interest from the date of the verdict. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of $2.5 million. In September 2012, the Fourth DCA affirmed the liability finding and the compensatory damages award, but reversed the finding of entitlement to punitive damages, and remanded the case for a retrial limited to the issue of liability for concealment and conspiracy. The defendants and the plaintiff filed separate notices to invoke the discretionary jurisdiction of the Florida Supreme Court in January 2013. In February 2014, the Florida Supreme Court, on its own motion, consolidated the petitions for review filed by the plaintiff and RJR Tobacco and stayed the petitions pending disposition by the court of Hess v. Philip Morris USA, Inc., which deals with the application of the statute of repose as an affirmative defense to claims of fraudulent concealment and conspiracy to commit fraudulent concealment. | |||||||||||||||||||||||||||||||||
On April 26, 2010, in Putney v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Margot Putney, to be 35% at fault, RJR Tobacco to be 30% at fault and the remaining defendants to be 35% at fault, and awarded $15.1 million in compensatory damages and $2.5 million in punitive damages each against RJR Tobacco and the remaining defendants. The plaintiff alleged that the decedent suffered from nicotine addiction and lung cancer as a result of using the defendants’ products and sought an unspecified amount of compensatory and punitive damages. In August 2010, final judgment was entered against RJR Tobacco in the amount of $4.5 million in compensatory damages, and $2.5 million in punitive damages. RJR Tobacco filed a notice of appeal and the plaintiff filed a notice of cross appeal. In December 2010, the court entered an amended final judgment to provide that interest would run from April 26, 2010. The defendants filed a joint notice of appeal to the Fourth DCA of the amended final judgment, and RJR Tobacco posted a supersedeas bond in the amount of approximately $2.4 million. In June 2013, the Fourth DCA held that the court erred in denying the defendants’ motion for remittitur of the compensatory damages for loss of consortium and in striking the defendants’ statute of repose affirmative defenses. As a result, the verdict was reversed, and the case was remanded for further proceedings. The plaintiff’s motion for rehearing, written opinion on one issue, or certification of conflict to the Florida Supreme Court was denied in August 2013. The defendants and the plaintiff filed separate notices to invoke the discretionary jurisdiction of the Florida Supreme Court in September 2013. In December 2013, the Florida Supreme Court consolidated the petitions for review filed by the plaintiff and the defendants and stayed the petitions pending disposition of Hess v. Philip Morris USA Inc.,described above. | |||||||||||||||||||||||||||||||||
On May 20, 2010, in Buonomo v. R. J. Reynolds Tobacco Co., a case filed in October 2007, in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 77.5% at fault and the decedent, Matthew Buonomo, to be 22.5% at fault, and awarded $5.2 million in compensatory damages and $25 million in punitive damages. The plaintiff alleged that the decedent was addicted to cigarettes and, as a result, developed one or more smoking-related medical conditions and/or diseases and sought an unspecified amount of compensatory and punitive damages. Post-trial motions were denied, but the court, in accordance with the Florida statutory limitation on punitive damage awards, ordered the punitive damage award of $25 million be reduced to $15.7 million — three times the compensatory damages award of $5.2 million. In August 2010, the court entered final judgment in the amount of $4.06 million in compensatory damages and $15.7 million in punitive damages. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of $5 million. The plaintiff also filed a notice of appeal. In September 2013, the Fourth DCA affirmed the final judgment and damages award to the plaintiff on strict liability and negligence. However, the court reversed the judgment entered for the plaintiff on the claims for fraudulent concealment and conspiracy to commit fraud by concealment due to the erroneous striking of RJR Tobacco’s statute of repose defense. As a result, the punitive damages award was set aside and remanded for a new trial. In December 2013, the Fourth DCA denied RJR Tobacco’s motion for rehearing. In January 2014, RJR Tobacco and the plaintiff filed notices to invoke the discretionary jurisdiction of the Florida Supreme Court. In June 2014, the Florida Supreme Court stayed the petitions for review pending disposition by the court of Hess v. Philip Morris USA Inc., described above. Despite the stay, the trial court determined in October 2014 that the original $25 million punitive damages award was not excessive and would be reinstated if the plaintiff prevails on the repose issue. | |||||||||||||||||||||||||||||||||
On October 15, 2010, in Frazier v. Philip Morris USA Inc., now known as Russo v. Philip Morris USA Inc., a case filed in December 2007 in the Circuit Court, Miami-Dade County, Florida, the jury returned a verdict in favor of the defendants. The plaintiff alleged that as a result of smoking the defendants’, including RJR Tobacco’s, products she developed chronic obstructive pulmonary disease, and sought in excess of $15,000 in compensatory damages and unspecified punitive damages. Final judgment was entered in February 2011. The plaintiff filed a notice of appeal to the Third DCA, and the defendants filed a notice of cross appeal. In April 2012, the Third DCA reversed the trial court’s judgment, directed entry of judgment in the plaintiff’s favor and ordered a new trial. In July 2012, the defendants filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court. The Florida Supreme Court accepted jurisdiction of the case in September 2013. Oral argument in the Florida Supreme Court occurred on April 30, 2014. A decision is pending. The new trial began on October 14, 2014, but on October 22, 2014, the court declared a mistrial because of the inability to seat a jury. Retrial is scheduled for April 6, 2015. | |||||||||||||||||||||||||||||||||
On November 15, 2010, in Webb v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Levy County, Florida, a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 90% at fault and the decedent, James Horner, to be 10% at fault, and awarded $8 million in compensatory damages and $72 million in punitive damages. The plaintiff alleged that as a result of smoking the defendant’s products, the decedent developed one or more smoking-related diseases, and sought in excess of $15,000 in compensatory and unspecified punitive damages. The court entered judgment, and RJR Tobacco appealed to the First DCA and posted a supersedeas bond in the amount of $5 million. That court affirmed the liability verdict, but ordered a remittitur or a new trial on damages. On remand, the trial court remitted the compensatory damages award to $4 million and the punitive damages award to $25 million. The plaintiff consented to the remitted judgment, and RJR Tobacco rejected the remittitur and demanded a new trial on damages. Nonetheless, the trial court entered the remitted judgment. RJR Tobacco again appealed to the First DCA. In the second appeal, the First DCA found that the trial court erred in concluding that only the plaintiff had the right to choose between accepting the remittitur and proceeding with a new trial. The First DCA thus ordered a new trial on damages. The new trial on damages began on November 3, 2014, and on November 12, 2014, the jury returned a verdict of $900,000 in compensatory damages and $450,000 in punitive damages. Final judgment was entered against RJR Tobacco in the amount of $1.26 million, and the plaintiff’s motion for a new trial as to the amount of punitive damages was denied in December 2014. | |||||||||||||||||||||||||||||||||
On April 26, 2011, in Andy Allen v. R. J. Reynolds Tobacco Co., a case filed in September 2007, in the Circuit Court, Duval County, Florida, a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 45% at fault, the decedent, Patricia Allen, to be 40% at fault and the remaining defendant to be 15% at fault, and awarded $6 million in compensatory damages and $17 million in punitive damages against each defendant. The plaintiff alleged that as a result of smoking the defendants’ products, the decedent developed chronic obstructive pulmonary disease, and sought in excess of $15,000 in compensatory damages. Final judgment was entered against RJR Tobacco in the amount of $19.7 million in May 2011. In October 2011, the trial court entered a remittitur of the punitive damages to $8.1 million and denied all other post-trial motions. The defendants filed a joint notice of appeal, RJR Tobacco posted a supersedeas bond in the amount of $3.75 million, and the plaintiff filed a notice of cross appeal in November 2011. In May 2013, the First DCA reversed the trial court’s judgment and remanded the case for a new trial. As a result, RJR Tobacco’s bond was returned. In August 2013, the plaintiff filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court. In February 2014, the Florida Supreme Court declined to accept jurisdiction. The new trial began on November 1, 2014, and on November 26, 2014, the jury returned a verdict in favor of the plaintiff, found the decedent to be 70% at fault, RJR Tobacco to be 24% at fault and the remaining defendant to be 6% at fault, and awarded $3.1 million in compensatory damages and approximately $7.8 million in punitive damages against each defendant. Post-trial motions are pending. Final judgment has not been entered. | |||||||||||||||||||||||||||||||||
On May 20, 2011, in Jewett v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Duval County, Florida, a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 20% at fault, the decedent, Barbara Jewett, to be 70% at fault and the remaining defendant to be 10% at fault, and awarded $1.1 million in compensatory damages and no punitive damages. The plaintiff alleged that the decedent was addicted to cigarettes and as a result of her addiction, developed chronic obstructive pulmonary disease, emphysema and respiratory failure, and sought in excess of $15,000 in compensatory damages. Final judgment was entered in June 2011. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of $218,600. In November 2012, the First DCA reversed the judgment and remanded the case for a new trial. The plaintiff and the defendants filed separate notices to invoke the discretionary jurisdiction of the Florida Supreme Court in March 2013. In February 2014, the Florida Supreme Court declined to accept jurisdiction. The new trial has not been scheduled. | |||||||||||||||||||||||||||||||||
On June 16, 2011, in Soffer v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Alachua County, Florida, a jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 40% at fault, the decedent, Maurice Soffer, to be 60% at fault, and awarded $5 million in compensatory damages and no punitive damages. The plaintiff alleged that the decedent was addicted to cigarettes and, as a result, developed lung cancer and other smoking-related conditions and/or diseases, and sought in excess of $15,000 in compensatory damages. Final judgment was entered against RJR Tobacco in the amount of $2 million. The plaintiff filed a notice of appeal to the First DCA in July 2011. RJR Tobacco filed a notice of cross appeal and posted a supersedeas bond in the amount of $2 million. In October 2012, the First DCA affirmed the trial court’s ruling in full. On the direct appeal, the court held that only intentional torts could support a punitive damages claim and held that Engle Progeny plaintiffs may not seek punitive damages for negligence or strict liability because the original Engle class did not seek punitive damages for those claims. The First DCA certified the question to the Florida Supreme Court as one of great public importance. On the cross appeal, the court rejected RJR Tobacco’s arguments about the use of the Englefindings and the statute of limitations. RJR Tobacco filed a motion for rehearing or for certification to the Florida Supreme Court and the plaintiff filed a motion for rehearing or rehearing en banc. In January 2013, the First DCA granted rehearing on RJR Tobacco’s cross appeal to clarify that the trial court’s application of Engle findings did not violate RJR Tobacco’s due process rights. Otherwise, rehearing, rehearing en banc and certification were denied. RJR Tobacco and the plaintiff both filed notices to invoke the discretionary jurisdiction of the Florida Supreme Court. In February 2014, the Florida Supreme Court declined to accept jurisdiction of RJR Tobacco’s petition for review and accepted the plaintiff’s petition for review of the First DCA’s decision. Oral argument occurred on December 4, 2014. A decision is pending. | |||||||||||||||||||||||||||||||||
On July 15, 2011, in Ciccone v. R. J. Reynolds Tobacco Co., a case filed in August 2004, in the Circuit Court, Broward County, Florida, a jury returned a verdict finding the plaintiff is a member of the Engle class. The plaintiff alleged that as a result of the use of the defendant’s tobacco products, the decedent, George Ciccone, suffered from nicotine addiction and one or more smoking-related diseases and/or medical conditions, and sought an unspecified amount of compensatory and punitive damages. On July 21, 2011, the jury awarded approximately $3.2 million in compensatory damages and $50,000 in punitive damages. The jury found the decedent to be 70% at fault and RJR Tobacco to be 30% at fault. Final judgment was entered in September 2011, and RJR Tobacco filed a notice of appeal to the Fourth DCA. RJR Tobacco posted a supersedeas bond in the amount of approximately $1 million on October 17, 2011. In August 2013, the Fourth DCA affirmed the judgment of the trial court, but reversed the punitive damages award and remanded the case to the trial court for entry of a final judgment that eliminates the punitive damages award. RJR Tobacco’s motion for rehearing or rehearing en banc was denied in November 2013. The Florida Supreme Court accepted jurisdiction of the case in June 2014. Oral argument occurred on December 4, 2014. A decision is pending. | |||||||||||||||||||||||||||||||||
On September 15, 2011, in Ojeda v. R. J. Reynolds Tobacco Co., a case filed in October 2007, in the Circuit Court, Miami-Dade County, Florida, a jury returned a verdict in favor of RJR Tobacco. The plaintiff alleged that as a result of the use of the defendant’s products, the decedent, Juan Ojeda, suffered from one or more smoking-related medical conditions and/or diseases, and sought an unspecified amount of damages. Final judgment was entered in September 2011. The plaintiff filed a notice of appeal to the Third DCA in October 2012. In July 2014, the Third DCA affirmed, per curiam, the trial court’s final judgment. The plaintiff did not seek further review. | |||||||||||||||||||||||||||||||||
On January 24, 2012, in Hallgren v. R. J. Reynolds Tobacco Co., a case filed in April 2007, in the Circuit Court, Highlands County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Claire Hallgren, to be 50% at fault, RJR Tobacco to be 25% at fault, and the remaining defendant to be 25% at fault, and awarded $2 million in compensatory damages and $750,000 in punitive damages against each defendant. The plaintiff alleged that the decedent was addicted to the defendants’ products, and as a result, suffered from lung cancer, and sought in excess of $15,000 in compensatory damages and unspecified punitive damages. In March 2012, the court entered final judgment in the amount of approximately $1 million for which RJR Tobacco and the other defendant are jointly and severally liable; and $750,000 in punitive damages against each defendant. The defendants filed a joint notice of appeal to the Second DCA, and RJR Tobacco posted a supersedeas bond in the amount of approximately $1.3 million in May 2012. The plaintiff filed a notice of cross appeal. In October 2013, the Second DCA affirmed the trial court’s ruling that punitive damages can be awarded for negligence and strict liability claims as well as for the intentional tort claims brought under Engle. The court certified a conflict with the First DCA’s decision in Soffer and the Fourth DCA’s decision in Ciccone. The court also certified the following question to be of great public importance — “Are members of the Engle class who pursue individual damages actions in accordance with the decision in Engle v. Liggett Group, Inc., entitled to pursue punitive damages under claims for strict liability and negligence?” In November 2013, the defendants filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court. In June 2014, the Florida Supreme Court stayed the petition pending disposition of Russo v. Philip Morris USA Inc., described above. | |||||||||||||||||||||||||||||||||
On February 29, 2012, in Marotta v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Broward County, Florida, the court declared a mistrial during jury prequalification. The plaintiff alleged that the decedent, Phil Marotta, was addicted to cigarettes and, as a result, suffered from lung cancer. The plaintiff sought compensatory damages in excess of $75,000, punitive damages, costs and pre-judgment interest. Retrial began on March 7, 2013. On March 20, 2013, a jury returned a verdict in favor of the plaintiff, found the decedent to be 42% at fault and RJR Tobacco to be 58% at fault and awarded $6 million in compensatory damages and no punitive damages. Final judgment was entered against RJR Tobacco in the amount of $3.48 million, and RJR Tobacco filed a notice of appeal to the Fourth DCA in April 2013. The plaintiff filed a notice of cross appeal in May 2013. Briefing is underway. | |||||||||||||||||||||||||||||||||
On March 19, 2012, in McCray v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, a jury returned a verdict in favor of the defendants, including RJR Tobacco. The plaintiff alleged that the decedent, Mercedia Walker, was addicted to the defendants’ tobacco products, and as a result, suffered from one or more smoking-related diseases and/or medical conditions. The plaintiff sought compensatory damages for all injuries and losses, all recoverable costs of the case, and all legally recoverable interest. Final judgment was entered in March 2012. The plaintiff filed a notice of appeal to the Eleventh Circuit in July 2012. On September 16, 2014, the Eleventh Circuit affirmed the trial court’s judgment. At this time, it is unknown if the plaintiff will see further review. | |||||||||||||||||||||||||||||||||
On May 17, 2012, in Calloway v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Johnnie Calloway, to be 20.5% at fault, RJR Tobacco to be 27% at fault, and the remaining defendants collectively to be 52.5% at fault, and awarded $20.5 million in compensatory damages and $17.25 million in punitive damages against RJR Tobacco and $37.6 million collectively against the remaining defendants. The plaintiff alleged that as a result of using the defendants’ products, the decedent became addicted and developed smoking-related diseases and/or conditions. The plaintiff sought compensatory and punitive damages, including costs and interest. In its ruling on the post-trial motions, the court determined that the jury’s apportionment of comparative fault did not apply to the compensatory damages award. Final judgment was entered in August 2012. In September 2012, the defendants filed a notice of appeal to the Fourth DCA, and RJR Tobacco posted a supersedeas bond in the amount of $1.5 million. The plaintiff filed a notice of cross appeal. Briefing is complete. Oral argument has not been scheduled. | |||||||||||||||||||||||||||||||||
On August 1, 2012, in Hiott v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Duval County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Kenneth Hiott, to be 60% at fault and RJR Tobacco to be 40% at fault, and awarded $1.83 million in compensatory damages and no punitive damages. The plaintiff alleged that as a result of using the defendant’s product, the decedent suffered from addiction and smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of compensatory and punitive damages. In November 2012, final judgment was entered against RJR Tobacco in the amount of $730,000 in compensatory damages. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of $730,000 in December 2012. In January 2014, the First DCA affirmed the trial court’s decision. RJR Tobacco filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court in January 2014. In June 2014, the Florida Supreme Court stayed the petition pending the court’s disposition of Hess v. Philip Morris USA Inc., described above. | |||||||||||||||||||||||||||||||||
On August 10, 2012, in Hancock v. Philip Morris USA Inc., a case filed in January 2008, in the Circuit Court, Miami-Dade County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Edna Siwieck, to be 90% at fault, RJR Tobacco to be 5% at fault and the remaining defendant to be 5% at fault. However, the jury did not award compensatory damages and found that the plaintiff was not entitled to punitive damages. The court determined that the jury verdict was inconsistent due to the parties previously stipulating to $110,200 in medical expenses, which is subject to the allocation of fault. The defendants agreed to an additur for that amount. The plaintiff alleged that as a result of using the defendants’ products, the decedent suffered from chronic obstructive pulmonary disease. The plaintiff sought an unspecified amount of compensatory and punitive damages, costs and interest. Final judgment was entered against RJR Tobacco in the amount of $705 in October 2012. The stipulated amount was reduced by the defendants’ motion to reduce economic damages by collateral sources. The plaintiff filed a notice of appeal to the Fourth DCA, and the defendants filed a notice of cross appeal in November 2012. Briefing is complete. Oral argument is scheduled for March 24, 2015. | |||||||||||||||||||||||||||||||||
On September 19, 2012, in Baker v. R. J. Reynolds Tobacco Co., a case filed in November 2007, in the Circuit Court, Palm Beach County, Florida, a jury returned a verdict in favor of the defendant, RJR Tobacco. The plaintiff alleged that as a result of using the defendant’s products, the decedent, Elmer Baker, suffered from lung cancer. The plaintiff sought compensatory damages in excess of $15,000, costs and interest. Final judgment was entered in January 2013, in favor of RJR Tobacco. The plaintiff filed a notice of appeal to the Fourth DCA, and RJR Tobacco filed a notice of cross appeal in February 2013. Oral argument occurred on January 20, 2015. A decision is pending. | |||||||||||||||||||||||||||||||||
On September 20, 2012, in Sikes v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Duval County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Jimmie Sikes, to be 49% at fault and RJR Tobacco to be 51% at fault, and awarded $4.1 million in compensatory damages and $2 million in punitive damages. The plaintiff alleged that as a result of using the defendant’s product, the decedent suffered from chronic obstructive pulmonary disease, and sought in excess of $15,000 of compensatory damages. Final judgment was entered against RJR Tobacco in the amount of $6.1 million on June 3, 2013. On June 25, 2013, the court entered a corrected final judgment against RJR Tobacco in the amount of $5.5 million and vacated the June 3, 2013 final judgment. RJR Tobacco filed a notice of appeal to the First DCA, and posted a supersedeas bond in the amount of $5 million in July 2013. In July 2014, the First DCA affirmed the trial court’s decision, per curiam, but following the Hiott case, certified a conflict to the Florida Supreme Court with Hess v. Philip Morris USA Inc., both cases are described above. In August 2014, RJR Tobacco filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court. The Florida Supreme Court stayed the case pending disposition of Hess v. Philip Morris USA, Inc. | |||||||||||||||||||||||||||||||||
On October 17, 2012, in James Smith v. R. J. Reynolds Tobacco Co., a case filed in August 2007, in the U.S. District Court for the Middle District of Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Wanette Smith, to be 45% at fault and RJR Tobacco to be 55% at fault, and awarded $600,000 in compensatory damages and $20,000 in punitive damages. The plaintiff alleged that as a result of using the defendant’s products, the decedent suffered from lung cancer and chronic obstructive pulmonary disease. The plaintiff sought compensatory and punitive damages, costs and interest. Final judgment was entered against RJR Tobacco in the amount of $620,000. RJR Tobacco filed a notice of appeal to the Eleventh Circuit and posted a supersedeas bond in the amount of approximately $620,000 in September 2013. Oral argument occurred on October 17, 2014. A decision is pending. | |||||||||||||||||||||||||||||||||
On October 18, 2012, in Schlenther v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Hillsborough County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Beverly Schlenther, to be 50% at fault and RJR Tobacco to be 50% at fault, and awarded $5 million in compensatory damages and $2.5 million in punitive damages. The plaintiff alleged that as a result of using the defendant’s products, the decedent suffered from chronic obstructive pulmonary disease and heart disease. The plaintiff sought compensatory and punitive damages, costs and interest. In April 2013, the court vacated the punitive damage award, granted a new trial on entitlement to punitive damages and the amount of any such damages and abated the new trial pending the Florida Supreme Court decision in Soffer v. R. J. Reynolds Tobacco Co., described above. The plaintiff filed a notice of appeal to the Second DCA of the order granting RJR Tobacco’s motion for a new trial, and RJR Tobacco filed a notice of cross appeal of the same order. In October 2013, the trial court entered a partial final judgment against RJR Tobacco in the amount of $5.03 million in compensatory damages with no reduction for comparative fault. RJR Tobacco filed a notice of appeal of the partial final judgment. In November 2013, the plaintiff filed a motion to temporarily relinquish jurisdiction to the trial court to permit the trial court to enter a final judgment based on the decision in Hallgren, described above. The Second DCA granted the plaintiff’s motion, and jurisdiction was relinquished for 45 days. In December 2013, the trial court denied the defendant’s post-trial motions, including RJR Tobacco’s motion for a new trial, and entered final judgment against RJR Tobacco in the amount of $5 million for compensatory damages, $29,705 for funeral expenses and $2.5 million in punitive damages. Both parties filed voluntary dismissals of their prior appeals. RJR Tobacco subsequently filed a notice of appeal in December 2013 to the Second DCA of the final judgment and posted a supersedeas bond in the amount of $5 million in January 2014. In September 2014, the Second DCA affirmed the trial court’s judgment, per curiam. RJR Tobacco’s motion for certification or written opinion was denied on November 20, 2014. After evaluation of the case, on December 19, 2014, RJR Tobacco paid approximately $9.6 million in satisfaction of the judgment. | |||||||||||||||||||||||||||||||||
On October 19, 2012, in Ballard v. R. J. Reynolds Tobacco Co., a case filed in September 2007 in the Circuit Court, Miami-Dade County, Florida, a jury returned a verdict in favor of the plaintiff, found the plaintiff to be 45% at fault and RJR Tobacco to be 55% at fault, and awarded $8.55 million in compensatory damages. Punitive damages were not at issue. The plaintiff alleged that as a result of using the defendant’s products, he suffers from bladder cancer and emphysema, and sought an unspecified amount of compensatory and punitive damages. The court entered final judgment against RJR Tobacco in the amount of $4.7 million in October 2012, and in August 2013, the court entered an amended final judgment against RJR Tobacco in the amount of $5 million. RJR Tobacco filed a notice of appeal to the Third DCA and posted a supersedeas bond in the amount of $5 million in October 2013. Oral argument occurred on September 3, 2014. A decision is pending. | |||||||||||||||||||||||||||||||||
On December 12, 2012, in Virginia Williams v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Miami-Dade County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Milton Williams, to be 15% at fault and RJR Tobacco to be 85% at fault, and awarded $5 million in compensatory damages. Punitive damages were not sought. The plaintiff alleged that as a result of using the defendant’s products, the decedent suffered from pharyngeal cancer, and sought an unspecified amount of damages. Final judgment was entered against RJR Tobacco in the amount of $4.25 million in compensatory damages in January 2013. RJR Tobacco filed a notice of appeal to the Third DCA and posted a supersedeas bond in the amount of $4.25 million, and the plaintiff filed a notice of cross appeal in August 2013. In September 2014, the Third DCA affirmed the trial court’s judgment. RJR Tobacco’s motion for clarification and rehearing en banc was denied on October 21, 2014. After evaluation of the case, on November 7, 2014, RJR Tobacco paid approximately $4.7 million in satisfaction of the judgment. | |||||||||||||||||||||||||||||||||
On February 11, 2013, in Evers v. R. J. Reynolds Tobacco Co., a case filed in November 2007, in the Circuit Court, Hillsborough County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Jacqueline Loyd, to be 31% at fault, RJR Tobacco to be 60% at fault, and the remaining defendant to be 9% at fault, and awarded $3.23 million in compensatory damages and $12.36 million in punitive damages against RJR Tobacco only. The plaintiff alleged that as a result of using the defendants’ products, the decedent became addicted and suffered from smoking-related diseases and/or conditions, and sought an unspecified amount of damages. In March 2013, the court granted the defendants’ post-trial motions for directed verdict on fraudulent concealment, conspiracy and punitive damages. As a result, the $12.36 million punitive damages award was set aside. The plaintiff’s motion to reconsider directed verdict as to concealment, conspiracy and punitive damages was denied in April 2013. The plaintiff filed a notice of appeal to the Second DCA, the defendants filed a notice of cross appeal, and RJR Tobacco posted a supersedeas bond in the amount of $1.77 million in May 2013. Oral argument occurred on December 3, 2014. A decision is pending. | |||||||||||||||||||||||||||||||||
On February 13, 2013, in Schoeff v. R. J. Reynolds Tobacco Co., a case filed in November 2007, in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, James Schoeff, to be 25% at fault, RJR Tobacco to be 75% at fault, and awarded $10.5 million in compensatory damages and $30 million in punitive damages. The plaintiff alleged that as a result of using the defendant’s products, the decedent suffered from addiction and one or more smoking-related diseases and/or conditions, including lung cancer, and sought in excess of $15,000 in damages. In April 2013, final judgment was entered against RJR Tobacco in the amount of $7.88 million in compensatory damages and $30 million in punitive damages. RJR Tobacco filed a notice of appeal to the Fourth DCA, and the plaintiff filed a notice of cross appeal in May 2013. Briefing is complete. Oral argument has not been scheduled. | |||||||||||||||||||||||||||||||||
On April 1, 2013, in Searcy v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Carol LaSard, to be 40% at fault, RJR Tobacco to be 30% at fault and the remaining defendant to be 30% at fault, and awarded $6 million in compensatory damages and $10 million in punitive damages against each defendant. The plaintiff alleged that as a result of using the defendants’ products, the decedent suffered from lung cancer, and sought an unspecified amount of compensatory and punitive damages. Final judgment was entered against RJR Tobacco in the amount of $6 million in compensatory damages and $10 million in punitive damages. In September 2013, the trial court granted the defendants’ motion for a new trial, or in the alternative, reduction or remittitur of the damages awarded to the extent it sought remittitur of the damages. The compensatory damage award was remitted to $1 million, and the punitive damage award was remitted to $1.67 million against each defendant. The remaining post-trial motions were denied. The plaintiff’s motion to reconsider the trial court’s order granting in part the defendants’ motion for remittitur of the damages award was denied in October 2013. The plaintiff filed a notice of acceptance of remittitur in November 2013, and the court issued an amended final judgment. The defendants filed a joint notice of appeal to the Eleventh Circuit, and RJR Tobacco posted a supersedeas bond in the amount of approximately $2.2 million in November 2013. Oral argument occurred on October 17, 2014. A decision is pending. | |||||||||||||||||||||||||||||||||
On April 18, 2013, in Aycock v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Richard Aycock, to be 27.5% at fault and RJR Tobacco to be 72.5% at fault, and awarded $5.9 million in compensatory damages. Punitive damages were not awarded. The plaintiff alleged that the decedent was addicted to cigarettes manufactured by the defendant and, as a result, suffered from lung cancer, and sought an unspecified amount of compensatory and punitive damages. Final judgment was entered against RJR Tobacco in the amount of $4.28 million in April 2013. RJR Tobacco filed a notice of appeal to the Eleventh Circuit in September 2013, and posted a supersedeas bond in the amount of $4.32 million in October 2013. On October 16, 2014, the Eleventh Circuit reversed the final judgment and remanded the case for a new trial. In January 2015, the parties resolved the case through the “offer of judgment” process described above in “— Litigation Affecting the Cigarette Industry.” | |||||||||||||||||||||||||||||||||
On May 2, 2013, in David Cohen v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Palm Beach County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Helen Cohen, to be 40% at fault, RJR Tobacco to be 30% at fault, and the remaining defendants collectively to be 30% at fault, and awarded $2.06 million in compensatory damages. The plaintiff alleged that as a result of using the defendants’ products, the decedent became addicted and suffered from one or more smoking-related diseases and/or conditions, and sought in excess of $15,000 in compensatory damages and unspecified punitive damages. Final judgment was entered against RJR Tobacco in the amount of $617,000 in May 2013. In July 2013, the court granted the defendants’ motion for a new trial due to the plaintiff’s improper arguments during closing. The new trial date has not been scheduled. The plaintiff filed a notice of appeal to the Fourth DCA, and the defendants filed a notice of cross appeal. Briefing is underway. | |||||||||||||||||||||||||||||||||
On May 22, 2013, in John Campbell v. R. J. Reynolds Tobacco Co., a case pending in Polk County, Florida, a jury returned a verdict in favor of the defendants, including RJR Tobacco. The plaintiff alleged that as a result of smoking the defendants’ products, the decedent, Judy Campbell, became addicted to smoking cigarettes and suffered from unspecified smoking-related conditions and/or diseases, and sought an unspecified amount of damages. The plaintiff’s motion for a new trial was denied and the court entered final judgment in July 2013. The plaintiff filed a notice of appeal to the Second DCA, and the defendants filed a notice of cross appeal in August 2013. Briefing is complete. Oral argument has not been scheduled. | |||||||||||||||||||||||||||||||||
On May 23, 2013, in Earl Graham v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Faye Graham, to be 70% at fault, RJR Tobacco to be 20% at fault and the remaining defendant to be 10% at fault, and awarded $2.75 million in compensatory damages. The plaintiff alleged that as a result of smoking the defendants’ products, the decedent became addicted to smoking cigarettes which resulted in her death, and sought an unspecified amount of damages. Final judgment was entered against RJR Tobacco in the amount of $550,000 in May 2013. The defendants filed a joint notice of appeal to the Eleventh Circuit, and RJR Tobacco posted a supersedeas bond in the amount of approximately $556,000 in October 2013. Oral argument occurred on November 20, 2014. A decision is pending. | |||||||||||||||||||||||||||||||||
On June 4, 2013, in Starr-Blundell v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Duval County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Lucy Mae Starr, to be 80% at fault, RJR Tobacco to be 10% at fault and the remaining defendant to be 10% at fault, and awarded $500,000 in compensatory damages. The plaintiff alleged that as a result of smoking the defendants’ products, the decedent suffered from lung cancer and other smoking-related diseases and/or conditions, and sought in excess of $15,000 in damages. The court entered final judgment in the amount of $50,000 against each defendant in November 2013. The plaintiff filed a notice of appeal to the First DCA, and the defendants filed a notice of cross appeal in December 2013. RJR Tobacco posted a supersedeas bond in the amount of $50,000 in December 2013. Briefing is complete. Oral argument has not been scheduled. | |||||||||||||||||||||||||||||||||
On June 7, 2013, in Odum v. R. J. Reynolds Tobacco Co., a case filed in November 2007, in the Circuit Court, Duval County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Ethelene Hazouri, to be 50% at fault and RJR Tobacco to be 50% at fault, and awarded $200,000 in compensatory damages. The plaintiff alleged that as a result of smoking the defendant’s products, the decedent suffered from lung cancer, and sought an unspecified amount of damages. Final judgment was entered against RJR Tobacco in the amount of $264,000, for damages and taxable costs, in November 2013. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of approximately $264,000 in December 2013. On October 20, 2014, the First DCA affirmed the final judgment, per curiam. After evaluation of the case, on November 7, 2014, RJR Tobacco paid approximately $276,000 in satisfaction of the judgment. | |||||||||||||||||||||||||||||||||
On June 14, 2013, in Skolnick v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Palm Beach County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Leo Skolnick, to be 40% at fault, RJR Tobacco to be 30% at fault and the remaining defendant to be 30% at fault, and awarded $2.56 million in compensatory damages. The plaintiff alleged that as a result of using the defendants’ products, the decedent suffered from lung cancer, and sought in excess of $15,000 in compensatory damages and unspecified punitive damages. The court entered final judgment against RJR Tobacco in the amount of $766,500 in July 2013. The defendants filed a joint notice of appeal to the Fourth DCA, and the plaintiff filed a notice of cross appeal in December 2013. RJR Tobacco posted a supersedeas bond in the amount of $767,000 in March 2014. Briefing is complete. Oral argument has not been scheduled. | |||||||||||||||||||||||||||||||||
On June 19, 2013, in Thibault v. R. J. Reynolds Tobacco Co., a case pending in the Circuit Court, Escambia County, Florida, the jury returned a verdict in favor of the plaintiff, found the decedent, Evelyn Thibault, to be 30% at fault and RJR Tobacco to be 70% at fault, and awarded $1.75 million in compensatory damages and $1.28 million in punitive damages. The plaintiff alleged that as a result of using the defendant’s products, the decedent suffered from chronic obstructive pulmonary disease, and sought an unspecified amount of compensatory and punitive damages. The court determined that comparative fault did not apply to reduce the amount of the verdict. In June 2013, the court entered final judgment against RJR Tobacco in the amount of $3.03 million. RJR Tobacco filed a notice of appeal to the First DCA in August 2013. RJR Tobacco posted a supersedeas bond in the amount of $3.03 million in September 2013. On October 13, 2014, the First DCA affirmed the trial court’s judgment, per curiam. The First DCA also certified a conflict to the Florida Supreme Court with Hess v. Philip Morris USA, Inc., described above. On October 22, 2014, RJR Tobacco filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court. The Florida Supreme Court stayed the case pending disposition of Hess v. Philip Morris USA, Inc. | |||||||||||||||||||||||||||||||||
On September 20, 2013, in Gafney v. R. J. Reynolds Tobacco Co., a case pending in Palm Beach County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Frank Gafney, to be 34% at fault, RJR Tobacco to be 33% at fault and the remaining defendant to be 33% at fault, and awarded $5.8 million in compensatory damages. Punitive damages were not awarded. The plaintiff alleged that as a result of smoking the defendants’ products, the decedent developed chronic obstructive pulmonary disease, and sought in excess of $15,000 in compensatory damages. Final judgment was entered against RJR Tobacco in the amount of $1.9 million in September 2013. The defendants filed a joint notice of appeal to the Fourth DCA, and RJR Tobacco posted a supersedeas bond in the amount of $1.9 million in November 2013. The plaintiff filed a notice of cross appeal. Briefing is underway. | |||||||||||||||||||||||||||||||||
On November 15, 2013, in Chamberlain v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, a jury returned a verdict in favor of the defendants, including RJR Tobacco. The plaintiff alleged that as a result of smoking the defendants’ products, he suffers from chronic obstructive pulmonary disease and lung cancer, and sought an unspecified amount of compensatory and punitive damages. Final judgment was entered in favor of the defendants in November 2013. The plaintiff’s motion for a new trial was denied in April 2014. The plaintiff filed a notice of appeal to the Eleventh Circuit on June 27, 2014. On December 3, 2014, the Eleventh Circuit dismissed the plaintiff’s merits appeal for lack of jurisdiction. At this time, it is unknown if the plaintiff will seek further review. | |||||||||||||||||||||||||||||||||
On January 9, 2014, in Bush v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Escambia County, Florida, the court declared a mistrial due to the inability to seat a jury. The plaintiff alleged that as a result of his use of the defendants’ products, he suffers from nicotine addiction and one or more smoking-related diseases and/or conditions, and sought an unspecified amount of compensatory damages. The new trial has not been scheduled. | |||||||||||||||||||||||||||||||||
On January 27, 2014, in Harford v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, a jury returned a verdict in favor of the plaintiff, found the plaintiff to be 82% at fault and RJR Tobacco to be 18% at fault, and awarded $330,000 in compensatory damages. The plaintiff alleged that as a result of his use of the defendant’s products, he suffers from addiction and lung cancer, and sought an unspecified amount of compensatory and punitive damages. The court granted the plaintiff’s motion for a new trial on compensatory damages in October 2014. The new trial is scheduled for March 16, 2015. | |||||||||||||||||||||||||||||||||
On January 31, 2014, in Cheeley v. R. J. Reynolds Tobacco Co., a case filed in November 2007, in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Georgia Cheeley, to be 50% at fault and RJR Tobacco to be 50% at fault, and awarded $3 million in compensatory damages and $2 million in punitive damages. The plaintiff alleged that as a result of smoking the defendant’s products, the decedent suffered from one or more smoking-related conditions and/or diseases, and sought in excess of $15,000 in compensatory damages. The court entered final judgment against RJR Tobacco in the amount of $1.5 million in compensatory damages and $2 million in punitive damages. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of $3.5 million in April 2014. The plaintiff filed a notice of cross appeal in May 2014. Briefing is underway. | |||||||||||||||||||||||||||||||||
On February 3, 2014, in Deshaies v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, a jury returned a verdict in favor of RJR Tobacco. The plaintiff alleged that as a result of smoking the defendant’s products, he suffers from one or more smoking-related conditions and/or diseases, and sought an unspecified amount of compensatory and punitive damages. Final judgment was entered in February 2014. The plaintiff’s post-trial motions were denied on January 13, 2015. At this time, it is unknown if the plaintiff will seek further review. | |||||||||||||||||||||||||||||||||
On February 18, 2014, in Goveia v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Orange County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Mary Goveia, to be 30% at fault, RJR Tobacco to be 35% at fault, and the remaining defendant to be 35% at fault, and awarded $850,000 in compensatory damages and $2.25 million in punitive damages against each defendant. The plaintiff alleged that as a result of smoking the defendants’ products, the decedent became addicted and suffered from one or more smoking-related diseases and/or conditions, and sought an unspecified amount of compensatory and punitive damages. Post-trial motions were denied in April 2014. Final judgment was entered in the amount of $297,500 in compensatory damages and $2.25 million in punitive damages against each defendant in April 2014. The defendants filed a joint notice of appeal to the Fifth DCA, and RJR Tobacco posted a supersedeas bond in the amount of $2.5 million in April 2014. Briefing is underway. | |||||||||||||||||||||||||||||||||
On February 27, 2014, in Banks v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the defendants, including RJR Tobacco. The plaintiff alleged that as a result of using the defendants’ products, the decedent, George Banks, developed one or more smoking-related diseases and/or conditions, and sought in excess of $15,000 in compensatory damages. The plaintiff’s motion for a new trial was denied, and the court entered final judgment in favor of RJR Tobacco and the other defendant in May 2014. The plaintiff filed a notice of appeal to the Fourth DCA, and the defendants filed a notice of cross appeal in June 2014. Briefing is underway. | |||||||||||||||||||||||||||||||||
On March 17, 2014, in Clayton v. R. J. Reynolds Tobacco Co., a case filed in November 2007, in the Circuit Court, Duval County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, David Clayton, to be 90% at fault and RJR Tobacco to be 10% at fault, and awarded $600,000 in compensatory damages. Punitive damages were not awarded. The plaintiff alleged that as a result of smoking the defendant’s products, the decedent suffered from bodily injury and died, and sought an unspecified amount of damages. In July 2014, final judgment was entered against RJR Tobacco in the amount of $60,000 in compensatory damages, together with $163,469 in taxable costs, for a total of $223,469. RJR Tobacco filed a notice of appeal to the First DCA in August 2014. RJR Tobacco posted a supersedeas bond in the amount of approximately $223,000, and the plaintiff filed a notice of cross appeal in September 2014. Briefing is underway. | |||||||||||||||||||||||||||||||||
On March 26, 2014, in Bowden v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Duval County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, William Bowden, to be 40% at fault, RJR Tobacco to be 30% at fault and the remaining defendant to be 30% at fault, and awarded $5 million in compensatory damages. Punitive damages were not awarded. The plaintiff alleged that as a result of smoking the defendants’ products, the decedent suffered from unspecified injuries which resulted in his death, and sought an unspecified amount of compensatory and punitive damages. Final judgment was entered against each defendant in the amount of $1.5 million in compensatory damages in March 2014. Post-trial motions were denied in May 2014. The defendants filed a joint notice of appeal to the First DCA, the plaintiff filed a notice of cross appeal and RJR Tobacco posted a supersedeas bond in the amount of $1.5 million in June 2014. Briefing is underway. | |||||||||||||||||||||||||||||||||
On April 29, 2014, in Dupre v. Philip Morris USA Inc., a case filed in December 2007, in the Circuit Court, Manatee County, Florida, the court declared a mistrial because the jury was unable to reach a unanimous verdict. The plaintiff alleged that the decedent, Richard Dupre, was addicted to cigarettes manufactured by the defendant, and as a result, developed one or more smoking-related diseases and/or conditions. The plaintiff is seeking compensatory and punitive damages, costs and interest. Retrial is scheduled for April 27, 2015. | |||||||||||||||||||||||||||||||||
On May 16, 2014, in Burkhart v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, a jury returned a verdict in favor of the plaintiff, found the plaintiff to be 50% at fault, RJR Tobacco to be 25% at fault, and the remaining defendants collectively to be 25% at fault, and awarded $5 million in compensatory damages and $1.25 million in punitive damages against RJR Tobacco and $1.25 million in punitive damages collectively against the remaining defendants. The plaintiff alleged that she became addicted to smoking cigarettes manufactured by the defendants and suffers from one or more smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of compensatory and punitive damages, costs and interest. Final judgment was entered in June 2014, and did not include a reduction for comparative fault. In September 2014, the court denied the defendants’ post-trial motions. The defendants filed a joint notice of appeal to the Eleventh Circuit on October 10, 2014. Briefing is underway. | |||||||||||||||||||||||||||||||||
On May 19, 2014, in Starbuck v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, the court declared a mistrial because the jury was unable to reach a unanimous verdict. The plaintiff alleged that he suffers from addiction and one or more smoking-related diseases and/or conditions. The plaintiff is seeking an unspecified amount of compensatory damages. Retrial began on December 1, 2014, and on December 16, 2014, the jury returned a verdict in favor of the defendants, including RJR Tobacco. At this time, it is unknown if the plaintiff will file post-trial motions or an appeal. | |||||||||||||||||||||||||||||||||
On June 23, 2014, in Bakst v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Palm Beach County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Juanita Thurston, to be 25% at fault and RJR Tobacco to be 75% at fault, and awarded $6 million in compensatory damages plus $4,209 for funeral expenses and $14 million in punitive damages. The plaintiff alleged that as a result of using the defendant’s products, the decedent suffered from nicotine addiction and one or more smoking-related diseases and/or conditions, including lung cancer. The plaintiff sought in excess of $15,000 in compensatory damages, punitive damages, recoverable costs and interest. RJR Tobacco’s post-trial motions were denied, and final judgment was entered against RJR Tobacco in the amount of $4.5 million in compensatory damages and $14 million in punitive damages. RJR Tobacco filed a notice of appeal to the Fourth DCA and posted a supersedeas bond in the amount of $5 million in October 2014. Briefing is underway. | |||||||||||||||||||||||||||||||||
On June 25, 2014, in Davis v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, a jury returned a verdict in favor of the defendants, including RJR Tobacco. The plaintiff alleged that as a result of smoking the defendants’ products, she suffers from nicotine addiction and one or more smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of compensatory damages, costs and interest. Final judgment was entered on June 27, 2014. In October 2014, the court denied the plaintiff’s motion for a new trial. The plaintiff filed a notice of appeal to the Eleventh Circuit on December 1, 2014. On December 3, 2014, the plaintiff voluntarily dismissed the appeal. | |||||||||||||||||||||||||||||||||
On July 17, 2014, in Robinson v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Escambia County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Michael Johnson, Sr., to be 29.5% at fault and RJR Tobacco to be 70.5% at fault, and awarded $16.9 million in compensatory damages and determined that the plaintiff was entitled to punitive damages. On July 18, 2014, the jury awarded $23.6 billion in punitive damages. The plaintiff alleged that as a result of using the defendant’s products, the decedent suffered from lung cancer. The plaintiff sought an unspecified amount of damages, costs and interest. The court entered partial judgment on compensatory damages against RJR Tobacco in the amount of $16.9 million in July 2014. On January 27, 2015, the court denied the defendant’s post-trial motions, but granted the defendant’s motion for remittitur of the punitive damages award. The punitive damages award was remitted to approximately $16.9 million. Either party may object to the remittitur within 10 days of the order. If either party files an objection, the case will be scheduled for a new trial on the issue of punitive damages. | |||||||||||||||||||||||||||||||||
On July 31, 2014, in Harris v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, a jury returned a verdict in favor of the plaintiff. The jury allocated fault: (1) for the survival claim as follows: decedent — 60%, RJR Tobacco — 15%, and the remaining defendants (collectively) — 25%, and (2) for the wrongful death claim as follows: decedent — 70%, RJR Tobacco — 10%, and the remaining defendants (collectively) — 20%. The jury awarded $400,000 in compensatory damages for wrongful death and $1.3 million in compensatory damages for the survival claim. The jury declined to award punitive damages. The plaintiff alleged that as a result of smoking cigarettes manufactured by the defendants, the decedent, Gerald Harris, became addicted and suffered from unspecified smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of compensatory damages, costs and interest. Final judgment was entered in December 2014. Post-trial motions are pending. | |||||||||||||||||||||||||||||||||
On August 27, 2014, in Gore v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Indian River County, Florida, the court declared a mistrial because the jury returned a potentially inconsistent verdict. The jury found for the plaintiff on liability, but awarded no compensatory damages and determined that the plaintiff was entitled to punitive damages. The plaintiff alleged that as a result of using the defendants’ products, the decedent, Gloria Gore, suffered from addiction and one or more smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of damages. Retrial is scheduled to begin on March 9, 2015. | |||||||||||||||||||||||||||||||||
On August 28, 2014, in Wilcox v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Miami-Dade County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Cleston Wilcox, to be 30% at fault and RJR Tobacco to be 70% at fault, and awarded $7 million in compensatory damages and $8.5 million in punitive damages. The plaintiff alleged that as a result of using the defendant’s products, the decedent suffered from addiction and one or more smoking-related diseases and/or conditions. The plaintiff sought in excess of $15,000, taxable costs and interest. Final judgment was entered in September 2014 against RJR Tobacco in the amount of $4.9 million in compensatory damages and $8.5 million in punitive damages. Post-trial motions were denied on January 16, 2015. The deadline for RJR Tobacco to file a notice of appeal is February 17, 2015. | |||||||||||||||||||||||||||||||||
On August 28, 2014, in Irimi v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Broward County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, Dale Moyer, to be 70% at fault and RJR Tobacco to be 14.5% at fault, and the remaining defendants collectively to be 15.5% at fault, and awarded approximately $3.1 million in compensatory damages. The jury did not find entitlement to punitive damages. The plaintiff alleged that as a result of using the defendants’ products, the decedent suffered from one or more smoking-related illnesses and/or diseases. The plaintiff sought an unspecified amount of compensatory damages. Final judgment was entered against RJR Tobacco in the amount of approximately $453,000, and against the remaining defendants collectively in the amount of approximately $484,000. On January 29, 2015, the court granted the defendants’ motion for a new trial. The new trial has not been scheduled. | |||||||||||||||||||||||||||||||||
On August 29, 2014, in Hubbird v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Miami-Dade County, Florida, a jury returned a verdict in favor of the plaintiff, found the decedent, David Ellsworth, to be 50% at fault and RJR Tobacco to be 50% at fault, and awarded $3 million in compensatory damages and $25 million in punitive damages. The plaintiff alleged that as a result of using the defendant’s products, the decedent suffered from smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of damages. Final judgment was entered against RJR Tobacco in the amount of $28 million. RJR Tobacco filed a notice of appeal to the Third DCA and posted a supersedeas bond in the amount of $5 million in December 2014. Briefing is underway. | |||||||||||||||||||||||||||||||||
On August 29, 2014, in Cooper v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Broward County, Florida, the court declared a mistrial because the jury was unable to reach a verdict. The plaintiff alleged that as a result of using the defendants’ products, she suffers from addiction and developed one or more smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of compensatory and punitive damages, recoverable costs and interest. Retrial is scheduled for April 1, 2015. | |||||||||||||||||||||||||||||||||
On September 5, 2014, in Baum v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Miami-Dade County, Florida, a jury returned a verdict in favor of the defendants, including RJR Tobacco. The plaintiff alleged that as a result of using the defendants’ products, the decedent, Paul Baum, suffered from one or more smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of compensatory damages, costs and interest. The plaintiff’s motion for a new trial was denied in November 2014. In December 2014, the plaintiffs filed a notice of appeal to the Third DCA. The defendants filed a notice of cross appeal in January 2015. Briefing is underway. | |||||||||||||||||||||||||||||||||
On September 11, 2014, in Ellis v. R. J. Reynolds Tobacco Co., a case filed in November 2007, in the Circuit Court, Duval County, Florida, a jury returned a verdict in favor of RJR Tobacco. The plaintiff alleged that as a result of using the defendant’s products, the decedent, Betty Owens, suffered bodily injury and died. The plaintiff sought an unspecified amount of damages. Final judgment has not been entered. At this time, it is unknown if the plaintiff will file post-trial motions or an appeal. | |||||||||||||||||||||||||||||||||
On September 26, 2014, in Morse v. Philip Morris USA, Inc., a case filed in January 2008, in the Circuit Court, Brevard County, Florida, the court declared a mistrial because of improper testimony by the plaintiff’s addiction witness. The plaintiff alleged that as a result of using the defendant’s products, the decedent, Jay Morse, suffered from one or more smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of damages, costs and interest. Retrial is scheduled for August 10, 2015. | |||||||||||||||||||||||||||||||||
On September 26, 2014, in Bryant v. R. J. Reynolds Tobacco Co., a case filed in August 2007, in the Circuit Court, Hillsborough County, Florida, the jury returned a verdict in favor of RJR Tobacco. The plaintiff alleged that as a result of using the defendant’s products, the decedent, Hayward Bryant, suffered from one or more smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of compensatory and punitive damages, including costs and interest. Final judgment was entered in September 2014. The plaintiff did not seek further review. | |||||||||||||||||||||||||||||||||
On October 10, 2014, in Lourie v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Hillsborough County, Florida, the jury returned a verdict in favor of the plaintiff, found the decedent, Barbara Lourie, to be 63% at fault, RJR Tobacco to be 3% at fault and the remaining defendants collectively to be 34% at fault, and awarded approximately $1.37 million in compensatory damages. Punitive damages were not awarded. The plaintiff alleged that as a result of using the defendants’ products, the decedent suffered from addiction and one or more smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of compensatory and punitive damages, costs and interest. Post-trial motions were denied, final judgment was entered, and the defendants filed a joint notice of appeal to the Second DCA, in November 2014. RJR Tobacco posted a supersedeas bond in the amount of approximately $41,000. Briefing is underway. | |||||||||||||||||||||||||||||||||
On October 22, 2014, in Kerrivan v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, the jury returned a verdict in favor of the plaintiff, found the plaintiff to be 19% at fault, RJR Tobacco to be 31% at fault and the remaining defendant to be 50% at fault, and awarded $15.8 million in compensatory damages, and $9.6 million in punitive damages against RJR Tobacco and $15.7 million against the remaining defendant. The plaintiff alleged that as a result of using the defendants’ products, the plaintiff developed one or more smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of compensatory damages, punitive damages, costs and interest. Final judgment was entered in November 2014. RJR Tobacco filed its post-trial motions on December 11, 2014. A decision is pending. | |||||||||||||||||||||||||||||||||
On November 5, 2014, in Bishop v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Orange County, Florida, the jury returned a verdict in favor of the defendants, including RJR Tobacco. The plaintiff alleged that as a result of using the defendants’ products, the decedent, Robert Ramsay, suffered from one or more smoking-related diseases and/or conditions. Final judgment was entered in November 2014. The plaintiff’s motion for a new trial was denied in December 2014. In January 2015, the plaintiff filed a notice of appeal, and the defendants filed a notice of cross appeal to the Fifth DCA. Briefing is underway. | |||||||||||||||||||||||||||||||||
On November 7, 2014, in Taylor v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Duval County, Florida, the jury returned a verdict in favor of the plaintiff, found the plaintiff to be 42% at fault and RJR Tobacco to be 58% at fault, and awarded approximately $4.5 million in compensatory damages and approximately $521,000 in punitive damages. The plaintiff alleged that as a result of using the defendant’s products, the plaintiff suffers from chronic obstructive pulmonary disease and peripheral vascular disease. The plaintiff sought in excess of $15,000 in compensatory damages. Post-trial motions were denied, and final judgment was entered in the amount of approximately $4.64 million against RJR Tobacco. RJR Tobacco filed a notice of appeal to the First DCA and posted a supersedeas bond in the amount of approximately $4.64 million in December 2014. Briefing is underway. | |||||||||||||||||||||||||||||||||
On November 18, 2014, in Schleider v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Miami-Dade County, Florida, the jury returned a verdict in favor of the plaintiff, found the decedent, Andrew Schleider, to be 30% at fault and RJR Tobacco to be 70% at fault, and awarded $21 million in compensatory damages. The plaintiff alleged that as a result of the use of the defendant’s products, the decedent suffered from lung cancer and one or more smoking-related diseases and/or conditions. The plaintiff sought in excess of $15,000 plus taxable costs and interest. Post-trial motions are pending. | |||||||||||||||||||||||||||||||||
On November 21, 2014, in Perrotto v. R. J. Reynolds Tobacco Co., a case filed in December 2007, in the Circuit Court, Palm Beach County, Florida, the jury returned a verdict in favor of the plaintiff, found the decedent, Nicholas Perrotto, to be 49% at fault, RJR Tobacco to be 20% at fault, and the remaining defendants collectively to be 31% at fault, and awarded approximately $4.1 million in compensatory damages, but refused to award punitive damages. The plaintiff alleged that as the result of the use of the defendants’ products, the decedent suffered from one or more smoking-related diseases and/or conditions. The plaintiff sought in excess of $15,000, taxable costs and recoverable interest. Final judgment was entered, and in December 2014, the plaintiff and the defendants filed motions for a new trial. Decisions are pending. | |||||||||||||||||||||||||||||||||
On December 19, 2014, in Haliburton v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the Circuit Court, Palm Beach County, Florida, the jury returned a verdict in favor of RJR Tobacco. The plaintiff alleged that as the result of the use of the defendant’s products, the decedent, Andrew Haliburton, suffered from one or more smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of compensatory and punitive damages, costs and interest. The plaintiff’s post-trial motions are pending. | |||||||||||||||||||||||||||||||||
On January 29, 2015, in Ellen Gray v. R. J. Reynolds Tobacco Co., a case filed in January 2008, in the U.S. District Court for the Middle District of Florida, the jury returned a verdict in favor of the plaintiff, found the decedent, Henry Gray, to be 50% at fault and RJR Tobacco to be 50% at fault, and awarded $6 million in compensatory damages. Punitive damages were not awarded. The plaintiff alleged that as a result of the use of the defendant’s products, the decedent suffered from lung cancer, chronic obstructive pulmonary disease and other smoking-related diseases and/or conditions. The plaintiff sought an unspecified amount of compensatory and punitive damages, costs and interest. Final judgment has not been entered. | |||||||||||||||||||||||||||||||||
Broin II Cases | |||||||||||||||||||||||||||||||||
RJR Tobacco, B&W and other cigarette manufacturer defendants settled Broin v. Philip Morris, Inc. in October 1997. This case had been brought in Florida state court on behalf of flight attendants alleged to have suffered from diseases or ailments caused by exposure to ETS in airplane cabins. The settlement agreement required the participating tobacco companies to pay a total of $300 million in three annual $100 million installments, allocated among the companies by market share, to fund research on the early detection and cure of diseases associated with tobacco smoke. It also required those companies to pay a total of $49 million for the plaintiffs’ counsel’s fees and expenses. RJR Tobacco’s portion of these payments was approximately $86 million; B&W’s portion of these payments was approximately $57 million. The settlement agreement bars class members from bringing aggregate claims or obtaining punitive damages and also bars individual claims to the extent that they are based on fraud, misrepresentation, conspiracy to commit fraud or misrepresentation, RICO, suppression, concealment or any other alleged intentional or willful conduct. The defendants agreed that, in any individual case brought by a class member, the defendant will bear the burden of proof with respect to whether ETS can cause certain specifically enumerated diseases, referred to as “general causation.” With respect to all other issues relating to liability, including whether an individual plaintiff’s disease was caused by his or her exposure to ETS in airplane cabins, referred to as “specific causation,” the individual plaintiff will have the burden of proof. On September 7, 1999, the Florida Supreme Court approved the settlement. The Broin II cases arose out of the settlement of this case. | |||||||||||||||||||||||||||||||||
On October 5, 2000, the Broin court entered an order applicable to all Broin II cases that the terms of the Broin settlement agreement do not require the individual Broin II plaintiffs to prove the elements of strict liability, breach of warranty or negligence. Under this order, there is a rebuttable presumption in the plaintiffs’ favor on those elements, and the plaintiffs bear the burden of proving that their alleged adverse health effects actually were caused by exposure to ETS in airplane cabins, that is, specific causation. | |||||||||||||||||||||||||||||||||
As of December 31, 2014, there were 2,558 Broin II lawsuits pending in Florida. There have been no Broin II trials since 2007. | |||||||||||||||||||||||||||||||||
Class-Action Suits | |||||||||||||||||||||||||||||||||
Overview. As of December 31, 2014, eight class-action cases, excluding the shareholder cases described below, were pending in the United States against RJR Tobacco or its affiliates or indemnitees. In 1996, the Fifth Circuit Court of Appeals in Castano v. American Tobacco Co. overturned the certification of a nation-wide class of persons whose claims related to alleged addiction to tobacco products. Since this ruling by the Fifth Circuit, most class-action suits have sought certification of state-wide, rather than nation-wide, classes. Class-action suits based on claims similar to those asserted in Castano or claims that class members are at a greater risk of injury or injured by the use of tobacco or exposure to ETS are pending against RJR Tobacco and its affiliates and indemnitees in state or federal courts in California, Illinois, Louisiana, Missouri, and West Virginia. All pending class-action cases are discussed below. | |||||||||||||||||||||||||||||||||
The pending class actions against RJR Tobacco or its affiliates or indemnitees include four cases alleging that the use of the term “lights” constitutes unfair and deceptive trade practices under state law or violates the federal RICO statute. Such suits are pending in state or federal courts in Illinois and Missouri and are discussed below under “— ‘Lights’ Cases.” | |||||||||||||||||||||||||||||||||
Finally, certain third-party payers have filed health-care cost recovery actions in the form of class actions. These cases are discussed below under “— Health-Care Cost Recovery Cases.” | |||||||||||||||||||||||||||||||||
Few smoker class-action complaints have been certified or, if certified, have survived on appeal. Eighteen federal courts, including two courts of appeals, and most state courts that have considered the issue have rejected class certification in such cases. Apart from the Castano case discussed above, only two smoker class actions have been certified by a federal court — In re Simon (II) Litigation, and Schwab [McLaughlin] v. Philip Morris USA, Inc., both of which were filed in the U.S. District Court for the Eastern District of New York and ultimately decertified. | |||||||||||||||||||||||||||||||||
California Business and Professions Code Case. In Sateriale v. R. J. Reynolds Tobacco Co., a class action filed in November 2009, in the U.S. District Court for the Central District of California, the plaintiffs brought the case on behalf of all persons who tried unsuccessfully to redeem Camel Cash certificates from 1991 through March 31, 2007, or who held Camel Cash certificates as of March 31, 2007. The plaintiffs allege that in response to the defendants’ action to discontinue redemption of Camel Cash as of March 31, 2007, customers, like the plaintiffs, attempted to exchange their Camel Cash for merchandise and that the defendants, however, did not have any merchandise to exchange for Camel Cash. The plaintiffs allege unfair business practices, deceptive practices, breach of contract and promissory estoppel. The plaintiffs seek injunctive relief, actual damages, costs and expenses. In January 2010, the defendants filed a motion to dismiss, which prompted the plaintiffs to file an amended complaint in February 2010. The class definition changed to a class consisting of all persons who reside in the U.S. and tried unsuccessfully to redeem Camel Cash certificates, from October 1, 2006 (six months before the defendant ended the Camel Cash program) or who held Camel Cash certificates as of March 31, 2007. The plaintiffs also brought the class on behalf of a proposed California subclass, consisting of all California residents meeting the same criteria. In May 2010, RJR Tobacco’s motion to dismiss the amended complaint for lack of jurisdiction over subject matter and, alternatively, for failure to state a claim was granted with leave to amend. The plaintiffs filed a second amended complaint. In July 2010, RJR Tobacco’s motion to dismiss the second amended complaint was granted with leave to amend. The plaintiffs filed a third amended complaint, and RJR Tobacco filed a motion to dismiss in September 2010. In December 2010, the court granted RJR Tobacco’s motion to dismiss with prejudice. Final judgment was entered by the court, and the plaintiffs filed a notice of appeal in January 2011. In July 2012, the appellate court affirmed the dismissal of the plaintiffs’ claims under the Unfair Competition Law and the Consumer Legal Remedies Acts and reversed the dismissal of the plaintiffs’ claims for promissory estoppel and breach of contract. RJR Tobacco’s motion for rehearing or rehearing en banc was denied in October 2012. RJR Tobacco filed its answer to the plaintiffs’ third amended complaint in December 2012. In June 2014, RJR Tobacco filed a motion for summary judgment, and the plaintiff filed a motion for class certification. Oral arguments on those motions were held on September 15, 2014. On December 19, 2014, the court certified a class of California residents who hold Camel Cash certificates which were distributed between 1992 and the program’s termination on October 1, 2006. On January 2, 2015, RJR Tobacco filed a motion for reconsideration of the court’s order on class certification. Briefing on the motion is to occur in the first quarter of 2015, with a hearing scheduled for March 30, 2015. Trial is scheduled to begin November 3, 2015. | |||||||||||||||||||||||||||||||||
“Lights” Cases. As noted above, “lights” class-action cases are pending against RJR Tobacco or B&W in Illinois (2) and Missouri (2). The classes in these cases generally seek to recover $50,000 to $75,000 per class member for compensatory and punitive damages, injunctive and other forms of relief, and attorneys’ fees and costs from RJR Tobacco and/or B&W. In general, the plaintiffs allege that RJR Tobacco or B&W made false and misleading claims that “lights” cigarettes were lower in tar and nicotine and/or were less hazardous or less mutagenic than other cigarettes. The cases typically are filed pursuant to state consumer protection and related statutes. | |||||||||||||||||||||||||||||||||
Many of these “lights” cases were stayed pending review of the Good v. Altria Group, Inc. case by the U.S. Supreme Court. In that “lights” class-action case against Altria Group, Inc. and Philip Morris USA, the U.S. Supreme Court decided that these claims are not preempted by the Federal Cigarette Labeling and Advertising Act or by the Federal Trade Commission’s, referred to as FTC, historic regulation of the industry. Since this decision in December 2008, a number of the stayed cases have become active again. | |||||||||||||||||||||||||||||||||
The seminal “lights” class-action case involves RJR Tobacco’s competitor, Philip Morris, Inc. Trial began in Price v. Philip Morris, Inc. in January 2003. In March 2003, the trial judge entered judgment against Philip Morris in the amount of $7.1 billion in compensatory damages and $3 billion in punitive damages. Based on Illinois law, the bond required to stay execution of the judgment was set initially at $12 billion. Philip Morris pursued various avenues of relief from the $12 billion bond requirement. On December 15, 2005, the Illinois Supreme Court reversed the lower court’s decision and sent the case back to the trial court with instructions to dismiss the case. On December 5, 2006, the trial court granted the defendant’s motion to dismiss and for entry of final judgment. The case was dismissed with prejudice the same day. In December 2008, the plaintiffs filed a petition for relief from judgment, stating that the U.S. Supreme Court’s decision in Good v. Altria Group, Inc. rejected the basis for the reversal. The trial court granted the defendant’s motion to dismiss the plaintiffs’ petition for relief from judgment in February 2009. In March 2009, the plaintiffs filed a notice of appeal to the Illinois Appellate Court, Fifth Judicial District, requesting a reversal of the February 2009 order and remand to the circuit court. On February 24, 2011, the appellate court entered an order, concluding that the two-year time limit for filing a petition for relief from a final judgment began to run when the trial court dismissed the plaintiffs’ lawsuit on December 18, 2006. The appellate court therefore found that the petition was timely, reversed the order of the trial court, and remanded the case for further proceedings. Philip Morris filed a petition for leave to appeal to the Illinois Supreme Court. On September 28, 2011, the Illinois Supreme Court denied Philip Morris’s petition for leave to appeal and returned the case to the trial court for further proceedings. In December 2012, the trial court denied the plaintiffs’ petition for relief from the judgment. The plaintiffs filed a notice of appeal to the Illinois Appellate Court, Fifth Judicial District. In April 2014, the appellate court reinstated the 2003 verdict. In May 2014, Philip Morris filed a petition for leave to appeal to the Illinois Supreme Court and a motion for supervisory order. Philip Morris has requested the Illinois Supreme Court to direct the Fifth Judicial District to vacate its April 2014 judgment and to order the Fifth Judicial District to affirm the trial court’s denial of the plaintiff’s petition for relief from the judgment, or in the alternative, grant its petition for leave to appeal. On September 24, 2014, the Illinois Supreme Court agreed to hear Philip Morris’s appeal. Briefing is underway. | |||||||||||||||||||||||||||||||||
In Turner v. R. J. Reynolds Tobacco Co., a case filed in February 2000, in Circuit Court, Madison County, Illinois, a judge certified a class in November 2001. In June 2003, RJR Tobacco filed a motion to stay the case pending Philip Morris’s appeal of the Price v. Philip Morris, Inc. case mentioned above, which the judge denied in July 2003. In October 2003, the Illinois Fifth District Court of Appeals denied RJR Tobacco’s emergency stay/supremacy order request. In November 2003, the Illinois Supreme Court granted RJR Tobacco’s motion for a stay pending the court’s final appeal decision in Price. On October 11, 2007, the Illinois Fifth District Court of Appeals dismissed RJR Tobacco’s appeal of the court’s denial of its emergency stay/supremacy order request and remanded the case to the Circuit Court. A status conference is scheduled for February 25, 2015. | |||||||||||||||||||||||||||||||||
In Howard v. Brown & Williamson Tobacco Corp., another case filed in February 2000 in Circuit Court, Madison County, Illinois, a judge certified a class in December 2001. In June 2003, the trial judge issued an order staying all proceedings pending resolution of the Price v. Philip Morris, Inc. case mentioned above. The plaintiffs appealed this stay order to the Illinois Fifth District Court of Appeals, which affirmed the Circuit Court’s stay order in August 2005. There is currently no activity in the case. | |||||||||||||||||||||||||||||||||
A “lights” class-action case is pending against each of RJR Tobacco and B&W in Missouri. In Collora v. R. J. Reynolds Tobacco Co., a case filed in May 2000 in Circuit Court, St. Louis County, Missouri, a judge in St. Louis certified a class in December 2003. In April 2007, the court granted the plaintiffs’ motion to reassign Colloraand the following cases to a single general division: Craft v. Philip Morris Companies, Inc. and Black v. Brown & Williamson Tobacco Corp., discussed below. In April 2008, the court stayed the case pending U.S. Supreme Court review in Good v. Altria Group, Inc. A status conference is scheduled for February 22, 2016. | |||||||||||||||||||||||||||||||||
Finally, in Black v. Brown & Williamson Tobacco Corp., a case filed in November 2000 in Circuit Court, City of St. Louis, Missouri, B&W removed the case to the U.S. District Court for the Eastern District of Missouri. The plaintiffs filed a motion to remand, which was granted in March 2006. In April 2008, the court stayed the case pending U.S. Supreme Court review in Good v. Altria Group, Inc. A status conference is scheduled for February 22, 2016. | |||||||||||||||||||||||||||||||||
In the event RJR Tobacco and its affiliates or indemnitees lose one or more of the pending “lights” class-action suits, RJR Tobacco, depending upon the amount of any damages ordered, could face difficulties in its ability to pay the judgment or obtain any bond required to stay execution of the judgment which could have a material adverse effect on RJR Tobacco’s, and consequently RAI’s, results of operations, cash flows or financial position. | |||||||||||||||||||||||||||||||||
Other Class Actions. In Young v. American Tobacco Co., Inc., a case filed in November 1997 in Circuit Court, Orleans Parish, Louisiana, the plaintiffs brought an ETS class action against U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, on behalf of all residents of Louisiana who, though not themselves cigarette smokers, have been exposed to secondhand smoke from cigarettes which were manufactured by the defendants, and who allegedly suffered injury as a result of that exposure. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. In March 2013, the court entered an order staying the case, including all discovery, pending the implementation of the smoking cessation program ordered by the court in Scott v. The American Tobacco Co. | |||||||||||||||||||||||||||||||||
In Parsons v. A C & S, Inc., a case filed in February 1998 in Circuit Court, Ohio County, West Virginia, the plaintiff sued asbestos manufacturers, U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, seeking to recover $1 million in compensatory and punitive damages individually and an unspecified amount for the class in both compensatory and punitive damages. The class was brought on behalf of persons who allegedly have personal injury claims arising from their exposure to respirable asbestos fibers and cigarette smoke. The plaintiffs allege that Mrs. Parsons’ use of tobacco products and exposure to asbestos products caused her to develop lung cancer and to become addicted to tobacco. In December 2000, three defendants, Nitral Liquidators, Inc., Desseaux Corporation of North America and Armstrong World Industries, filed bankruptcy petitions in the U.S. Bankruptcy Court for the District of Delaware, In re Armstrong World Industries, Inc. Pursuant to section 362(a) of the Bankruptcy Code, Parsons is automatically stayed with respect to all defendants. | |||||||||||||||||||||||||||||||||
Finally, in Jones v. American Tobacco Co., Inc., a case filed in December 1998 in Circuit Court, Jackson County, Missouri, the defendants removed the case to the U.S. District Court for the Western District of Missouri in February 1999. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, by tobacco product users and purchasers on behalf of all similarly situated Missouri consumers. The plaintiffs allege that their use of the defendants’ tobacco products has caused them to become addicted to nicotine. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. The case was remanded to the Circuit Court in February 1999. There is currently no activity in this case. | |||||||||||||||||||||||||||||||||
Health-Care Cost Recovery Cases | |||||||||||||||||||||||||||||||||
Health-care cost recovery cases have been brought by a variety of plaintiffs. Other than certain governmental actions, these cases largely have been unsuccessful on remoteness grounds, which means that one who pays an injured person’s medical expenses is legally too remote to maintain an action against the person allegedly responsible for the injury. | |||||||||||||||||||||||||||||||||
As of December 31, 2014, two health-care cost recovery cases were pending in the United States against RJR Tobacco, B&W, as its indemnitee, or both, as discussed below after the discussion of the State Settlement Agreements. A limited number of claimants have filed suit against RJR Tobacco, its current or former affiliates, B&W and other tobacco industry defendants to recover funds for health care, medical and other assistance paid by foreign provincial governments in treating their citizens. For additional information on these cases, see “— International Cases” below. | |||||||||||||||||||||||||||||||||
State Settlement Agreements. In June 1994, the Mississippi Attorney General brought an action, Moore v. American Tobacco Co., against various industry members, including RJR Tobacco and B&W. This case was brought on behalf of the state to recover state funds paid for health care and other assistance to state citizens suffering from diseases and conditions allegedly related to tobacco use. Most other states, through their attorneys general or other state agencies, sued RJR Tobacco, B&W and other U.S. cigarette manufacturers based on similar theories. The cigarette manufacturer defendants, including RJR Tobacco and B&W, settled the first four of these cases scheduled for trial — Mississippi, Florida, Texas and Minnesota — by separate agreements with each such state. | |||||||||||||||||||||||||||||||||
On November 23, 1998, the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, entered into the Master Settlement Agreement with attorneys general representing the remaining 46 states, the District of Columbia, Puerto Rico, Guam, the Virgin Islands, American Samoa and the Northern Marianas. Effective on November 12, 1999, the MSA settled all the health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions and released various additional present and future claims. | |||||||||||||||||||||||||||||||||
In the settling jurisdictions, the MSA released RJR Tobacco, B&W, and their affiliates and indemnitees, including RAI, from: | |||||||||||||||||||||||||||||||||
• | all claims of the settling states and their respective political subdivisions and other recipients of state health-care funds, relating to past conduct arising out of the use, sale, distribution, manufacture, development, advertising, marketing or health effects of, the exposure to, or research, statements or warnings about, tobacco products; and | ||||||||||||||||||||||||||||||||
• | all monetary claims of the settling states and their respective political subdivisions and other recipients of state health-care funds, relating to future conduct arising out of the use of or exposure to, tobacco products that have been manufactured in the ordinary course of business. | ||||||||||||||||||||||||||||||||
Set forth below is the unadjusted tobacco industry settlement payment schedule for 2012 and beyond: | |||||||||||||||||||||||||||||||||
2012 | 2013 | 2014 | 2015 and | ||||||||||||||||||||||||||||||
thereafter | |||||||||||||||||||||||||||||||||
First Four States’ Settlements:(1) | |||||||||||||||||||||||||||||||||
Mississippi Annual Payment | $ | 136 | $ | 136 | $ | 136 | $ | 136 | |||||||||||||||||||||||||
Florida Annual Payment | 440 | 440 | 440 | 440 | |||||||||||||||||||||||||||||
Texas Annual Payment | 580 | 580 | 580 | 580 | |||||||||||||||||||||||||||||
Minnesota Annual Payment | 204 | 204 | 204 | 204 | |||||||||||||||||||||||||||||
Remaining Jurisdictions’ Settlement: | |||||||||||||||||||||||||||||||||
Annual Payments(1) | 8,004 | 8,004 | 8,004 | 8,004 | |||||||||||||||||||||||||||||
Total | $ | 9,364 | $ | 9,364 | $ | 9,364 | $ | 9,364 | |||||||||||||||||||||||||
-1 | Subject to adjustments for changes in sales volume, inflation and other factors. All payments are to be allocated among the companies on the basis of relative market share. For further information, see “— State Settlement Agreements — Enforcement and Validity; Adjustments” below. | ||||||||||||||||||||||||||||||||
RAI’s operating subsidiaries expenses and payments under the State Settlement Agreements for 2012, 2013 and 2014, and the projected expenses and payments for 2015 and beyond are set forth below(2). | |||||||||||||||||||||||||||||||||
2012 | 2013 | 2014 | 2015 and | ||||||||||||||||||||||||||||||
thereafter | |||||||||||||||||||||||||||||||||
Settlement expenses | $ | 2,370 | $ | 1,819 | $ | 1,917 | — | ||||||||||||||||||||||||||
Settlement cash payments | $ | 2,414 | $ | 2,582 | $ | 1,985 | — | ||||||||||||||||||||||||||
Projected settlement expenses | $ | >1,900 | |||||||||||||||||||||||||||||||
Projected settlement cash payments | $ | >1,900 | |||||||||||||||||||||||||||||||
-2 | Amounts beginning in 2013 reflect the impact of the Term Sheet described below under “— State Settlement Agreements — Enforcement and Validity; Adjustments — Partial Settlement of Certain NPM Adjustment Claims.” | ||||||||||||||||||||||||||||||||
The State Settlement Agreements also contain provisions restricting the marketing of tobacco products. Among these provisions are restrictions or prohibitions on the use of cartoon characters, brand-name sponsorships, apparel and other merchandise, outdoor and transit advertising, payments for product placement, free sampling and lobbying. Furthermore, the State Settlement Agreements required the dissolution of three industry-sponsored research and trade organizations. | |||||||||||||||||||||||||||||||||
The State Settlement Agreements have materially adversely affected RJR Tobacco’s shipment volumes. RAI believes that these settlement obligations may materially adversely affect the results of operations, cash flows or financial position of RAI and RJR Tobacco in future periods. The degree of the adverse impact will depend, among other things, on the rate of decline in U.S. cigarette sales in the premium and value categories, RJR Tobacco’s share of the domestic premium and value cigarette categories, and the effect of any resulting cost advantage of manufacturers not subject to the State Settlement Agreements. | |||||||||||||||||||||||||||||||||
U.S. Department of Justice Case. On September 22, 1999, in United States v. Philip Morris USA Inc., the U.S. Department of Justice brought an action against RJR Tobacco, B&W and other tobacco companies in the U.S. District Court for the District of Columbia. The government initially sought to recover federal funds expended by the federal government in providing health care to smokers who developed diseases and injuries alleged to be smoking-related, based on several federal statutes. In addition, the government sought, pursuant to the civil provisions of RICO, disgorgement of profits the government contends were earned as a consequence of a RICO racketeering “enterprise.” In September 2000, the court dismissed the government’s claims asserted under the Medical Care Recovery Act as well as those under the Medicare Secondary Payer provisions of the Social Security Act, but did not dismiss the RICO claims. In February 2005, the U.S. Court of Appeals for the District of Columbia ruled that disgorgement is not an available remedy in this case. The government’s petition for writ of certiorari with the U.S. Supreme Court was denied in October 2005. The non-jury, bench trial began in September 2004, and closing arguments concluded in June 2005. | |||||||||||||||||||||||||||||||||
On August 17, 2006, the court found certain defendants, including RJR Tobacco and B&W, liable for the RICO claims, but did not impose any direct financial penalties. The court instead enjoined the defendants from committing future racketeering acts, participating in certain trade organizations, making misrepresentations concerning smoking and health and youth marketing, and using certain brand descriptors such as “low tar,” “light,” “ultra light,” “mild” and “natural.” The court also ordered defendants to issue “corrective communications” on five subjects, including smoking and health and addiction, and to comply with further undertakings, including maintaining web sites of historical corporate documents and disseminating certain marketing information on a confidential basis to the government. In addition, the court placed restrictions on the ability of the defendants to dispose of certain assets for use in the United States, unless the transferee agrees to abide by the terms of the court’s order, and ordered the defendants to reimburse the U.S. Department of Justice its taxable costs incurred in connection with the case. | |||||||||||||||||||||||||||||||||
Certain defendants, including RJR Tobacco, filed notices of appeal to the U.S. Court of Appeals for the District of Columbia in September 2006. The government filed its notice of appeal in October 2006. In addition, the defendants, including RJR Tobacco, filed joint motions asking the district court to clarify and to stay its order pending the defendants’ appeal. On September 28, 2006, the district court denied the defendants’ motion to stay. On September 29, 2006, the defendants, including RJR Tobacco, filed a motion asking the court of appeals to stay the district court’s order pending the defendants’ appeal. The court granted the motion in October 2006. | |||||||||||||||||||||||||||||||||
In November 2006, the court of appeals stayed the appeals pending the trial court’s ruling on the defendants’ motion for clarification. The defendants’ motion was granted in part and denied in part. The defendants’ motion as to the meaning and applicability of the general injunctive relief of the August 2006 order was denied. The request for clarification as to the scope of the provisions in the order prohibiting the use of descriptors and requiring corrective statements at retail point of sale was granted. The court also ruled that the provisions prohibiting the use of express or implied health messages or descriptors do apply to the actions of the defendants taken outside of the United States. | |||||||||||||||||||||||||||||||||
In May 2009, the U.S. Court of Appeals largely affirmed the finding of liability against the tobacco defendants and remanded to the trial court for dismissal of the trade organizations. The court also largely affirmed the remedial order, including the denial of additional remedies, but vacated the order and remanded for further proceedings as to the following four discrete issues: | |||||||||||||||||||||||||||||||||
• | the issue of the extent of Brown & Williamson Holdings, Inc.’s control over tobacco operations was remanded for further fact finding and clarification; | ||||||||||||||||||||||||||||||||
• | the remedial order was vacated to the extent that it binds all defendants’ subsidiaries and was remanded to the lower court for determination as to whether inclusion of the subsidiaries and which of the subsidiaries satisfy Rule 65(d) of the Federal Rules of Civil Procedure; | ||||||||||||||||||||||||||||||||
• | the court held that the provision found in paragraph four of the injunction, concerning the use of any express or implied health message or health descriptor for any cigarette brand, should not be read to govern overseas sales. The issue was remanded to the lower court with instructions to reformulate it so as to exempt foreign activities that have no substantial, direct and foreseeable domestic effects; and | ||||||||||||||||||||||||||||||||
• | the remedial order was vacated regarding “point of sale” displays and remanded for the district court to evaluate and make due provisions for the rights of innocent persons, either by abandoning this part of the remedial order or re-crafting a new version reflecting the rights of third parties. | ||||||||||||||||||||||||||||||||
RJR Tobacco and the other defendants, as well as the Department of Justice, filed petitions for writ of certiorari to the U.S. Supreme Court in February 2010. In June 2010, the U.S. Supreme Court denied the parties’ petitions for writ of certiorari. | |||||||||||||||||||||||||||||||||
Post-remand proceedings are underway to determine the extent to which the original order will be implemented. On December 22, 2010, the trial court dismissed Brown & Williamson Holdings, Inc. from the litigation. On March 3, 2011, the defendants filed a motion for vacatur, in which they moved to vacate the trial court’s injunctions and factual findings and dismiss the case in its entirety. The court denied the motion on June 1, 2011. The defendants filed a notice of appeal. In addition, the parties to the lawsuit entered into an agreement concerning certain technical obligations regarding their public websites. Pursuant to this agreement, RJR Tobacco agreed to deposit $3.125 million over three years into the registry of the district court. In July 2012, the Court of Appeals for the D.C. Circuit affirmed the trial court’s denial of the defendants’ motion to vacate the injunctions. In November 2012, the trial court entered an order wherein the court determined the language to be included in the text of the corrective statements and directed the parties to engage in discussions with the Special Master to implement them. The defendants filed a notice of appeal of that order on January 25, 2013. In February 2013, the appellate court granted the defendants’ motion to hold the case in abeyance pending the District Court’s resolution of corrective-statement implementation issues. The mediation process on implementation issues has concluded, and the trial court entered an implementation order on June 2, 2014. The order stays implementation pending exhaustion of appeals on the corrective-statements remedy. On June 25, 2014, the defendants filed a notice of appeal from the implementation order. On August 8, 2014, the D.C. Circuit consolidated the appeal from the implementation order with the appeal previously held in abeyance from the court order dictating the language of the corrective statements. Briefing on that appeal has now concluded, and oral argument before the D.C. Circuit is scheduled for February 23, 2015. In light of the corrective-statements implementation order, $10 million has been accrued for the estimated costs of the corrective communications and is included in the consolidated balance sheet as of December 31, 2014. | |||||||||||||||||||||||||||||||||
Native American Tribe Case. As of December 31, 2014, one Native American tribe case was pending before a tribal court against RJR Tobacco and B&W, Crow Creek Sioux Tribe v. American Tobacco Co., a case filed in September 1997 in Tribal Court, Crow Creek Sioux, South Dakota. The plaintiffs seek to recover actual and punitive damages, restitution, funding of a clinical cessation program, funding of a corrective public education program, and disgorgement of unjust profits from sales to minors. The plaintiffs claim that the defendants are liable under the following theories: unlawful marketing and targeting of minors, contributing to the delinquency of minors, unfair and deceptive acts or practices, unreasonable restraint of trade and unfair method of competition, negligence, negligence per se, conspiracy and restitution of unjust enrichment. The case is dormant. | |||||||||||||||||||||||||||||||||
International Cases. Ten health-care reimbursement cases have been filed against RJR Tobacco, its current or former affiliates, or B&W outside the United States, by each of the Canadian provinces. In these actions, foreign governments are seeking to recover for health care, medical and other assistance paid and to be paid in treating their citizens for tobacco-related disease. No such actions are pending in the United States. Pursuant to the terms of the 1999 sale of RJR Tobacco’s international tobacco business, RJR Tobacco has tendered the defense of these actions to Japan Tobacco Inc., referred to as JTI. Subject to a reservation of rights, JTI has assumed the defense of RJR Tobacco and its current or former affiliates in nine actions and has not yet responded with respect to the Nova Scotia action, which RJR Tobacco tendered to JTI on January 26, 2015. | |||||||||||||||||||||||||||||||||
• | British Columbia — In 1997, British Columbia enacted a statute, subsequently amended, which created a civil cause of action for the government to recover the costs of health-care benefits incurred for insured populations of British Columbia residents resulting from tobacco-related disease. An action brought on behalf of the Province of British Columbia pursuant to the statute against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and certain of its affiliates, was dismissed in February 2000 when the British Columbia Supreme Court ruled that the legislation was unconstitutional and set aside service ex juris against the foreign defendants for that reason. British Columbia then enacted a revised statute, pursuant to which an action was filed in January 2001 against many of the same defendants, including RJR Tobacco and one of its affiliates, in Supreme Court, British Columbia. In that action, the British Columbia government seeks to recover the present value of its total expenditures for health-care benefits provided for insured persons resulting from tobacco-related disease or the risk of tobacco-related disease caused by alleged breaches of duty by the manufacturers, the present value of its estimated total expenditures for health-care benefits that reasonably could be expected to be provided for those insured persons resulting from tobacco-related disease or the risk of tobacco-related disease in the future, court ordered interest, and costs, or in the alternative, special or increased costs. The government alleges that the defendants are liable under the British Columbia statute by reason of their “tobacco related wrongs,” which are alleged to include: selling defective products, failure to warn, sale of cigarettes to children and adolescents, strict liability, deceit and misrepresentation, violation of trade practice and competition acts, concerted action, and joint liability. A jurisdictional challenge brought by RJR Tobacco and its affiliate was dismissed. RJR Tobacco and its affiliate filed statements of defense in January 2007. Pretrial discovery is ongoing. | ||||||||||||||||||||||||||||||||
• | New Brunswick — In March 2008, a case was filed on behalf of Her Majesty the Queen in Right of the Province of New Brunswick, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Trial Division in the Court of Queen’s Bench of New Brunswick. The claim is brought pursuant to New Brunswick legislation enacted in 2008, which legislation is substantially similar to the revised British Columbia statute described above. In this action, the New Brunswick government seeks to recover essentially the same types of damages that are being sought in the British Columbia action described above based on analogous theories of liability. RJR Tobacco and its affiliate filed statements of defense in March 2010. Pretrial discovery is ongoing. | ||||||||||||||||||||||||||||||||
• | Ontario — In September 2009, a case was filed on behalf of the Province of Ontario, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Ontario Superior Court of Justice. The claim is brought pursuant to Ontario legislation enacted in 2009, which legislation is substantially similar to the revised British Columbia statute described above. In this action, the Ontario government seeks to recover essentially the same types of damages that are being sought in the British Columbia and New Brunswick actions described above based on analogous theories of liability, although the government also asserted claims based on the illegal importation of cigarettes, which claims were deleted in an amended statement of claim filed in August 2010. A jurisdictional challenge brought by RJR Tobacco and its affiliate was dismissed. Preliminary motions are pending. | ||||||||||||||||||||||||||||||||
• | Newfoundland and Labrador — In February 2011, a case was filed on behalf of the Province of Newfoundland and Labrador, Canada against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the General Trial Division of the Supreme Court of Newfoundland and Labrador. The claim is brought pursuant to legislation passed in Newfoundland in 2001 and proclaimed in February 2011, which legislation is substantially similar to the revised British Columbia statute described above. In this action, the Newfoundland government seeks to recover essentially the same types of damages that are being sought in the British Columbia and other provincial actions described above based on analogous theories of liability. A jurisdictional challenge brought by RJR Tobacco and its affiliate was dismissed. Preliminary motions are pending. | ||||||||||||||||||||||||||||||||
• | Manitoba — In May 2012, a case was filed on behalf of the Province of Manitoba, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Court of Queen’s Bench, Winnipeg Judicial Centre, Manitoba. The claim is brought pursuant to legislation assented to in 2006 and proclaimed in 2012, which legislation is substantially similar to the revised British Columbia statute described above. In this action, the Manitoba government seeks to recover essentially the same types of damages that are being sought in the British Columbia and other provincial actions described above based on analogous theories of liability. A jurisdictional challenge brought by RJR Tobacco and its affiliate was dismissed. RJR Tobacco and its affiliate filed statements of defense in September 2014. | ||||||||||||||||||||||||||||||||
• | Quebec — In June 2012, a case was filed on behalf of the Province of Quebec, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Superior Court of the Province of Quebec, District of Montreal. The claim is brought pursuant to legislation enacted in Quebec in 2009, which legislation is substantially similar to the revised British Columbia statute described above. In this action, the Quebec government seeks to recover essentially the same types of damages that are being sought in the British Columbia and other provincial actions described above based on analogous theories of liability. RJR Tobacco and its affiliate have brought a motion challenging the jurisdiction of the Quebec court, which was dismissed. Pretrial discovery is ongoing. Separately, in August 2009, certain Canadian manufacturers filed a constitutional challenge to the Quebec statute, which was dismissed on March 5, 2014. An appeal of that decision has been filed. | ||||||||||||||||||||||||||||||||
• | Saskatchewan — In June 2012, a case was filed on behalf of the Province of Saskatchewan, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Court of Queen’s Bench, Judicial Centre of Saskatoon, Saskatchewan. The claim is brought pursuant to legislation assented to in 2007 and proclaimed in 2012, which legislation is substantially similar to the revised British Columbia statute described above. In this action, the Saskatchewan government seeks to recover essentially the same types of damages that are being sought in the British Columbia and other provincial actions described above based on analogous theories of liability. A jurisdictional challenge brought by RJR Tobacco and its affiliate was dismissed. Preliminary motions are pending. | ||||||||||||||||||||||||||||||||
• | Alberta — In June 2012, a case was filed on behalf of the Province of Alberta, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Court of Queen’s Bench of Alberta Judicial Centre, Calgary, Alberta. The claim is brought pursuant to legislation assented to in 2009 and proclaimed in 2012, which legislation is substantially similar to the revised British Columbia statute described above. In this action, the Alberta government seeks to recover essentially the same types of damages that are being sought in the British Columbia and other provincial actions described above based on analogous theories of liability. A jurisdictional challenge brought by RJR Tobacco and its affiliate was dismissed. Preliminary motions are pending. | ||||||||||||||||||||||||||||||||
• | Prince Edward Island — In September 2012, a case was filed on behalf of the Province of Prince Edward Island, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Supreme Court of Prince Edward Island (General Section), Charlottetown, Prince Edward Island. The claim is brought pursuant to legislation assented to in 2009 and proclaimed in 2012, which legislation is substantially similar to the revised British Columbia statute described above. In this action, the Prince Edward Island government seeks to recover essentially the same types of damages that are being sought in the British Columbia and other provincial actions described above based on analogous theories of liability. A jurisdictional challenge brought by RJR Tobacco and its affiliate was dismissed. Preliminary motions are pending. | ||||||||||||||||||||||||||||||||
• | Nova Scotia — In January 2015, a case was filed on behalf of the Province of Nova Scotia, Canada, against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in the Supreme Court of Nova Scotia, Halifax, Nova Scotia. The claim is brought pursuant to legislation assented to in 2005 and proclaimed in 2014, which legislation is substantially similar to the revised British Columbia statute described above. In this action, the Nova Scotia government seeks to recover essentially the same types of damages that are being sought in the British Columbia and other provincial actions described above based on analogous theories of liability. The action was served on January 20, 2015. | ||||||||||||||||||||||||||||||||
The following seven putative Canadian class actions were filed against various Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, in courts in the Provinces of Alberta, British Columbia, Manitoba, Nova Scotia, Ontario and Saskatchewan, although the plaintiffs’ counsel have been actively pursuing only the action pending in British Columbia at this time: | |||||||||||||||||||||||||||||||||
• | In Kunka v. Canadian Tobacco Manufacturers’ Council, a case filed in 2009 in the Court of Queen’s Bench of Manitoba against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiff, an individual smoker, alleging her own addiction and chronic obstructive pulmonary disease, severe asthma and lung disease resulting from the use of tobacco products, is seeking compensatory and unspecified punitive damages on behalf of a proposed class comprised of all individuals, including their estates, and their dependents and family members, who purchased or smoked cigarettes manufactured by the defendants, as well as restitution of profits and reimbursement of government expenditure for health-care benefits allegedly caused by the use of tobacco products. | ||||||||||||||||||||||||||||||||
• | In Dorion v. Canadian Tobacco Manufacturers’ Council, a case filed in June 2009, in the Court of Queen’s Bench of Alberta against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiff, an individual smoker, alleging her own addiction and chronic bronchitis resulting from the use of tobacco products, is seeking compensatory and unspecified punitive damages on behalf of a proposed class comprised of all individuals, including their estates, dependents and family members, who purchased or smoked cigarettes designed, manufactured, marketed or distributed by the defendants, as well as restitution of profits and reimbursement of government expenditure for health-care benefits allegedly caused by the use of tobacco products. | ||||||||||||||||||||||||||||||||
• | In Semple v. Canadian Tobacco Manufacturers’ Council, a case filed in June 2009 in the Supreme Court of Nova Scotia against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiff, an individual smoker, alleging his own addiction and chronic obstructive pulmonary disease resulting from the use of tobacco products, is seeking compensatory and unspecified punitive damages on behalf of a proposed class comprised of all individuals, including their estates, dependents and family members, who purchased or smoked cigarettes designed, manufactured, marketed or distributed by the defendants for the period from January 1, 1954, to the expiry of the opt-out period as set by the court, as well as restitution of profits and reimbursement of government expenditure for health-care costs allegedly caused by the use of tobacco products. | ||||||||||||||||||||||||||||||||
• | In Adams v. Canadian Tobacco Manufacturers’ Council, a case filed in July 2009 in the Court of Queen’s Bench for Saskatchewan against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiff, an individual smoker, alleging her own addiction and chronic obstructive pulmonary disease resulting from the use of tobacco products, is seeking compensatory and unspecified punitive damages on behalf of a proposed class comprised of all individuals who were alive on July 10, 2009, and who have suffered, or who currently suffer, from chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after having smoked a minimum of 25,000 cigarettes designed, manufactured, imported, marketed or distributed by the defendants, as well as disgorgement of revenues earned by the defendants. RJR Tobacco and its affiliate have brought a motion challenging the jurisdiction of the Saskatchewan court. | ||||||||||||||||||||||||||||||||
• | In Bourassa v. Imperial Tobacco Canada Limited, a case filed in June 2010 in the Supreme Court of British Columbia against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiff, the heir to a deceased smoker, alleging that the deceased was addicted to and suffered emphysema resulting from the use of tobacco products, is seeking compensatory and unspecified punitive damages on behalf of a proposed class comprised of all individuals, including their estates, who were alive on June 12, 2007, and who have suffered, or who currently suffer from chronic respiratory diseases, after having smoked a minimum of 25,000 cigarettes designed, manufactured, imported, marketed, or distributed by the defendants, as well as disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. RJR Tobacco and its affiliate have filed a challenge to the jurisdiction of the British Columbia court. The plaintiff filed a motion for certification in April 2012, and filed affidavits in support in August 2013. An amended claim was filed in December 2014. | ||||||||||||||||||||||||||||||||
• | In McDermid v. Imperial Tobacco Canada Limited, a case filed in June 2010 in the Supreme Court of British Columbia against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiff, an individual smoker, alleging his own addiction and heart disease resulting from the use of tobacco products, is seeking compensatory and unspecified punitive damages on behalf of a proposed class comprised of all individuals, including their estates, who were alive on June 12, 2007, and who have suffered, or who currently suffer from heart disease, after having smoked a minimum of 25,000 cigarettes designed, manufactured, imported, marketed, or distributed by the defendants, as well as disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. RJR Tobacco and its affiliate have filed a challenge to the jurisdiction of the British Columbia court. | ||||||||||||||||||||||||||||||||
• | In Jacklin v. Canadian Tobacco Manufacturers’ Council, a case filed in June 2012 in the Ontario Superior Court of Justice against Canadian and non-Canadian tobacco-related entities, including RJR Tobacco and one of its affiliates, the plaintiff, an individual smoker, alleging her own addiction and chronic obstructive pulmonary disease resulting from the use of tobacco products, is seeking compensatory and unspecified punitive damages on behalf of a proposed class comprised of all individuals, including their estates, who were alive on June 12, 2007, and who have suffered, or who currently suffer from chronic obstructive pulmonary disease, heart disease, or cancer, after having smoked a minimum of 25,000 cigarettes designed, manufactured, imported, marketed, or distributed by the defendants, as well as restitution of profits, and reimbursement of government expenditure for health-care benefits allegedly caused by the use of tobacco products. | ||||||||||||||||||||||||||||||||
In each of these seven cases, the plaintiffs allege fraud, fraudulent concealment, breach of warranty, breach of warranty of merchantability and of fitness for a particular purpose, failure to warn, design defects, negligence, breach of a “special duty” to children and adolescents, conspiracy, concert of action, unjust enrichment, market share liability, joint liability, and violations of various trade practices and competition statutes. Pursuant to the terms of the 1999 sale of RJR Tobacco’s international tobacco business, RJR Tobacco has tendered the defense of these seven actions to JTI. Subject to a reservation of rights, JTI has assumed the defense of RJR Tobacco and its current or former affiliates in these actions. | |||||||||||||||||||||||||||||||||
State Settlement Agreements — Enforcement and Validity; Adjustments | |||||||||||||||||||||||||||||||||
As of December 31, 2014, there were 29 cases concerning the enforcement, validity or interpretation of the State Settlement Agreements in which RJR Tobacco or B&W is a party. This number includes those cases, discussed below, relating to disputed payments under the State Settlement Agreements. | |||||||||||||||||||||||||||||||||
In April 2005, the Mississippi Attorney General notified B&W of its intent to seek approximately $3.9 million in additional payments under the Mississippi Settlement Agreement. The Mississippi Attorney General asserts that B&W failed to report in its net operating profit or its shipments, cigarettes manufactured by B&W under contract for Star Tobacco or its parent, Star Scientific, Inc. B&W advised the State that it did not owe the State any money. In August 2005, the Mississippi Attorney General filed in the Chancery Court of Jackson County, Mississippi, a Notice of Violation, Motion to Enforce Settlement Agreement, and Request for an Accounting by Defendant Brown & Williamson Holdings, Inc., formerly known as Brown & Williamson Tobacco Corporation. In this filing, Mississippi estimated that its damages exceeded $5.0 million. On August 24, 2011, the court entered an order finding in favor of the State on the Star contract manufacturing issue, and that the total amount of the underpayment from B&W was approximately $3.8 million and that interest on the underpayment was approximately $4.3 million. The court also appointed a Special Master to undertake an accounting of the benefit received by B&W for failure to include its profits from Star contract manufacturing in its net operating profits reported to the State. A report from the Special Master on the benefit received by B&W was issued on April 30, 2014. A hearing on the Special Master’s Report and Recommendation was held before the court on July 2, 2014. On September 24, 2014, the court entered an order confirming its earlier rulings and ordered B&W to pay compensatory damages (including interest) to the State in the total sum of approximately $10.8 million. A final appealable order has not yet been entered, and additional hearings on other damages issues are possible. | |||||||||||||||||||||||||||||||||
In February 2010, the Mississippi Attorney General filed a motion alleging that RJR Tobacco had improperly failed to report shipments of certain categories of cigarette volumes, and for certain years had improperly reported its net operating profit. As a result, the State alleges that settlement payments to it were improperly reduced. RJR Tobacco disputes these allegations and is vigorously defending against them. Hearings on these issues were held on January 24-25, 2012, and May 9, 2012. On May 15, 2012, the court entered an order finding in favor of RJR Tobacco on the claim related to RJR Tobacco’s reported net operating profits in the year used as a baseline for future calculations of the State’s net operating profits payment. The State had sought $3.8 million in damages for this issue, with an additional $2.7 million in interest. On June 19, 2012, the court entered an order finding in favor of the State on the remaining issues, holding that the total amount of the underpayment was approximately $3.3 million and that interest on the underpayment was also approximately $3.3 million, though the court also held that this amount should be offset by additional payments previously made by Lorillard Tobacco Company on some of these issues. The court further ordered RJR Tobacco to perform an accounting of its profits and shipments from 1999-2011. On July 10, 2012, RJR Tobacco filed a petition with the Mississippi Supreme Court requesting leave to immediately appeal the court’s ordered accounting and its entry of judgment for the State without first conducting an evidentiary hearing. On August 15, 2012, the request was denied. An independent accountant acceptable to both the State and RJR Tobacco was identified and retained. On August 8, 2013, the final report of the independent accountant was filed with the court. The report generally found that RJR Tobacco’s accounting and reporting of information in connection with settlement payment calculations was correct. In some respects, the report expressly disagreed with findings made earlier by the trial court. On December 13, 2013, the State of Mississippi filed its report as to additional damages due it from RJR Tobacco, challenging in various respects the findings set forth in the final report of the independent accountant and seeking various changes to the damages calculations. Also on December 13, 2013, RJR Tobacco filed a motion to finalize remaining damages of third round issues, and/or reconsider, the June 19, 2012 order requesting that the court implement the findings of the independent accountant in a final order on the damage issues and/or to revisit its earlier rulings “in light of the findings and determinations in the independent accountant’s report.” A hearing on these motions was held on July 2, 2014. On September 24, 2014, the court entered an order confirming its earlier rulings and ordered RJR Tobacco to pay compensatory damages (including interest) to the State in the total sum of approximately $8.0 million. A final appealable order has not yet been entered, and additional hearings on other damages issues are possible. | |||||||||||||||||||||||||||||||||
Finally, in connection with the actions brought against RJR Tobacco and B&W, the court awarded the State attorneys’ fees and expenses in an amount to be determined. On May 1, 2013, a hearing on attorneys’ fees and expenses was held before the Special Master appointed by the court. On November 19, 2013, the Special Master issued a report and recommendations on application for award of costs and attorneys’ fees. The Special Master ruled that attorneys’ fees are to be paid with respect to the settlement payment claims against B&W and RJR Tobacco at 25% of “total amounts” awarded to the State of Mississippi by the court in its August 24, 2011, ruling. On December 13, 2013, the State of Mississippi filed a statement seeking various clarifications of the Special Master’s ruling. Also on December 13, 2013, B&W and RJR Tobacco filed their objections to the ruling. A hearing on these issues was held on July 2, 2014. On September 24, 2014, the court entered an order confirming its earlier rulings and ordered RJR Tobacco and B&W to pay attorneys’ fees in the total sum of approximately $4.9 million. A final appealable order has not yet been entered, and additional hearings on other damages issues are possible. | |||||||||||||||||||||||||||||||||
In May 2006, the State of Florida filed a motion, in the Circuit Court of the Fifteenth Judicial Circuit, in and for Palm Beach County, Florida, to enforce the Florida Settlement Agreement, for an Accounting by Brown & Williamson Holdings, Inc., and for an Order of Contempt, raising substantially the same issues as raised by the Mississippi Attorney General and seeking approximately $12.4 million in additional payments under the Florida Settlement Agreement, as well as $17.0 million in interest payments. This matter is currently in the discovery phase. | |||||||||||||||||||||||||||||||||
NPM Adjustment Claims. The MSA includes an adjustment that potentially reduces the annual payment obligations of RJR Tobacco and the other PMs. Certain requirements, collectively referred to as the Adjustment Requirements, must be satisfied before the NPM Adjustment for a given year is available: | |||||||||||||||||||||||||||||||||
• | an Independent Auditor must determine that the PMs have experienced a market share loss beyond a triggering threshold to those manufacturers that do not participate in the MSA, such non-participating manufacturers, referred to as NPMs; and | ||||||||||||||||||||||||||||||||
• | in a binding arbitration proceeding, a firm of independent economic consultants must find that the disadvantages of the MSA were a significant factor contributing to the loss. This finding is known as a significant factor determination. | ||||||||||||||||||||||||||||||||
When the Adjustment Requirements are satisfied, the MSA provides that the NPM Adjustment applies to reduce the annual payment obligation of the PMs. However, an individual settling state may avoid its share of the NPM Adjustment if it had in place and diligently enforced during the entirety of the relevant year a “Qualifying Statute” that imposes escrow obligations on NPMs that are comparable to what the NPMs would have owed if they had joined the MSA. In such event, the state’s share of the NPM Adjustment is reallocated to other settling states, if any, that did not have in place and diligently enforce a Qualifying Statute. | |||||||||||||||||||||||||||||||||
NPM Adjustment Claim for 2003. For 2003, the Adjustment Requirements were satisfied. As a result, in April 2006, RJR Tobacco placed approximately $647 million of its MSA payment into a disputed payments account, in accordance with a procedure established by the MSA. That amount represented RJR Tobacco’s share of the 2003 NPM Adjustment as calculated by the Independent Auditor. In March 2007, the Independent Auditor issued revised calculations that reduced RJR Tobacco’s share of the NPM Adjustment for 2003 to approximately $615 million. As a result, in April 2007, RJR Tobacco instructed the Independent Auditor to release to the settling states approximately $32 million from the disputed payments account. | |||||||||||||||||||||||||||||||||
Following RJR Tobacco’s payment of a portion of its 2006 MSA payment into the disputed payments account, 37 of the settling states filed legal proceedings in their respective MSA courts seeking declaratory orders that they diligently enforced their Qualifying Statutes during 2003 and/or orders compelling RJR Tobacco and the other PMs that placed money in the disputed payments account to pay the disputed amounts to the settling states. In response, RJR Tobacco and other PMs, pursuant to the MSA’s arbitration provisions, moved to compel arbitration of the parties’ dispute concerning the 2003 NPM Adjustment, including the states’ diligent enforcement claims, before an arbitration panel consisting of three retired federal court judges. The settling states opposed these motions, arguing, among other things, that the issue of diligent enforcement must be resolved by MSA courts in each of the 52 settling states and territories. | |||||||||||||||||||||||||||||||||
Forty-seven of the 48 courts that addressed the question whether the dispute concerning the 2003 NPM Adjustment is arbitrable ruled that arbitration is required under the MSA. The Montana Supreme Court ruled that the State of Montana did not agree to arbitrate the question of whether it diligently enforced a Qualifying Statute. Subsequently, Montana and the PMs reached an agreement whereby the PMs agreed not to contest Montana’s claim that it diligently enforced the Qualifying Statute during 2003. | |||||||||||||||||||||||||||||||||
In January 2009, RJR Tobacco and certain other PMs entered into an Agreement Regarding Arbitration, referred to as the Arbitration Agreement, with 45 of the MSA settling states (representing approximately 90% of the allocable share of the settling states) pursuant to which those states agreed to participate in a multistate arbitration of issues related to the 2003 NPM Adjustment. Under the Arbitration Agreement, the signing states had their ultimate liability, if any, with respect to the 2003 NPM Adjustment reduced by 20%, and RJR Tobacco and the other PMs that placed their share of the disputed 2005 NPM Adjustment (discussed below) into the disputed payments account, without releasing or waiving any claims, authorized the release of those funds to the settling states. | |||||||||||||||||||||||||||||||||
The arbitration panel contemplated by the MSA and the Arbitration Agreement, referred to as the Arbitration Panel, was selected, and proceedings before the panel with respect to the 2003 NPM Adjustment claim began in July 2010. Following the completion of document and deposition discovery, on November 3, 2011, RJR Tobacco and the other PMs advised the Arbitration Panel that they were not contesting the “diligent enforcement” of 12 states and the four U.S. territories with a combined allocable share of less than 14%. The “diligent enforcement” of the remaining 33 settling states, the District of Columbia and Puerto Rico was contested and became the subject of further proceedings. A common issues hearing was held in April 2012, and state specific evidentiary hearings with respect to the contested states were initiated. | |||||||||||||||||||||||||||||||||
As a result of the partial settlement of certain NPM Adjustment claims, as described in more detail below, as well as the earlier decisions not to contest the diligent enforcement of 13 states, two of which are participants in the partial settlement, and the four U.S. territories, only 15 contested settling states required state specific diligent enforcement rulings. State specific evidentiary hearings were completed as of the end of May 2013. | |||||||||||||||||||||||||||||||||
On September 11, 2013, the Arbitration Panel issued rulings with respect to the 15 remaining contested states. The Arbitration Panel ruled that six states (representing approximately 14.68% allocable share) — Indiana, Kentucky, Maryland, Missouri, New Mexico and Pennsylvania — had not diligently enforced their Qualifying Statutes in 2003. At that time, RJR Tobacco estimated that as a result of these rulings, it was entitled to the maximum remaining amount with respect to its 2003 NPM Adjustment claim — approximately $266 million, plus interest and earnings. All six states that were found “non-diligent” by the Arbitration Panel filed motions to vacate and/or modify the diligent enforcement rulings on the 2003 NPM Adjustment claim. To date, only the state courts in Pennsylvania and Missouri have entered orders affecting the settlement payment calculations. Both courts modified the judgment reduction method that had been adopted by the Arbitration Panel, the effect of which was to reduce RJR Tobacco’s recovery from these two states by a total of $75 million. Similar motions filed by Maryland were denied by its state court. The orders in Pennsylvania and Missouri are being appealed by RJR Tobacco and the other PMs. Maryland is appealing the rulings on its motions. | |||||||||||||||||||||||||||||||||
Separately, two of the states found to be “non-diligent,” Kentucky and Indiana, subsequently joined the partial settlement of certain NPM Adjustment claims, as described in more detail below. As a result, RJR Tobacco now estimates that the maximum remaining amount of its claim with respect to the 2003 NPM Adjustment claim is $197 million, plus interest and earnings, and before reduction for the impact of the Pennsylvania and Missouri court orders. | |||||||||||||||||||||||||||||||||
In light of its joining the partial settlement, Indiana participated in a joint motion to stay indefinitely further proceedings on the motions it had filed to vacate the settlement and to modify the adverse diligent enforcement ruling against it. Similarly, Kentucky has joined in a stipulation by the parties filed with the court there to stay further proceedings on its motions, but that stipulation has not yet been signed by the court. | |||||||||||||||||||||||||||||||||
Until such time as the various remaining state motions challenging the rulings of the Arbitration Panel have been resolved, including any necessary appeals, uncertainty exists as to the timing, process and amount of RJR Tobacco’s ultimate recovery with respect to its remaining share of the 2003 NPM Adjustment claim. Due to the uncertainty over the final resolution of the 2003 NPM Adjustment claim, no amounts resulting from the rulings of the Arbitration Panel for the remaining four states have been recognized in the consolidated financial statements as of December 31, 2014. | |||||||||||||||||||||||||||||||||
NPM Adjustment Claims for 2004-2013. From 2006 to 2008, proceedings (including significant factor arbitrations before an independent economic consulting firm) were initiated with respect to the NPM Adjustment for 2004, 2005 and 2006. Ultimately, the Adjustment Requirements were satisfied with respect to each of these NPM Adjustments. | |||||||||||||||||||||||||||||||||
In June 2009, RJR Tobacco, certain other PMs and the settling states entered into an agreement with respect to the 2007, 2008 and 2009 significant factor determinations. This agreement provided that the settling states would not contest that the disadvantages of the MSA were “a significant factor contributing to” the market share loss experienced by the PMs in those years. The stipulation pertaining to each of the three years covered by the agreement became effective in February of the year a final determination by the firm of independent economic consultants would otherwise have been expected (2010, 2011 and 2012, respectively), if the issue had been arbitrated on the merits. RJR Tobacco and the PMs paid a total amount of $5 million into the States’ Antitrust/Consumer Protection Tobacco Enforcement Fund established under Section VIII(c) of the MSA for each year covered by that agreement, with RJR Tobacco paying approximately 47% of such amounts. On January 9, 2012, a new agreement with respect to significant factor determinations pertaining to 2010, 2011 and 2012 was entered into on terms essentially identical to the earlier agreement. | |||||||||||||||||||||||||||||||||
Based on the payment calculations of the Independent Auditor and the agreement described above regarding the 2007, 2008 and 2009 significant factor determinations, the Adjustment Requirements have been satisfied with respect to the NPM Adjustments for 2007, 2008 and 2009. In addition, based on the payment calculations of the Independent Auditor and the agreement described above regarding the 2010, 2011 and 2012 significant factor determinations, the Adjustment Requirements have been satisfied with respect to the NPM Adjustment for 2010 and 2011. | |||||||||||||||||||||||||||||||||
The approximate maximum principal amounts of RJR Tobacco’s share of the disputed NPM Adjustments for the years 2004 through 2011, as currently calculated by the Independent Auditor, are as follows (the amounts shown below do not include the interest or earnings thereon to which RJR Tobacco believes it would be entitled under the MSA and do not reflect any reduction as a result of the Term Sheet described below): | |||||||||||||||||||||||||||||||||
Year for which NPM Adjustment calculated | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | |||||||||||||||||||||||||
Year in which deduction for NPM Adjustment was taken | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |||||||||||||||||||||||||
RJR Tobacco’s approximate share of disputed NPM Adjustment (millions) | $ | 562 | $ | 445 | $ | 419 | $ | 435 | $ | 468 | $ | 472 | $ | 470 | $ | 421 | |||||||||||||||||
In addition to the NPM Adjustment claims described above, RJR Tobacco has filed dispute notices with respect to its annual MSA payments relating to the NPM Adjustments potentially applicable to 2012 and 2013. The amount at issue for those two years is approximately $880 million in the aggregate. | |||||||||||||||||||||||||||||||||
Preliminary discussions are currently underway with the jurisdictions that have not joined the Term Sheet for the partial settlement of certain NPM Adjustment claims, described below, to initiate arbitration proceedings with respect to the 2004 NPM Adjustment. | |||||||||||||||||||||||||||||||||
Due to the uncertainty over the final resolution of the 2004-2013 NPM Adjustment claims asserted by RJR Tobacco, no assurances can be made related to the amounts, if any, that will be realized or any amounts (including interest) that will be owed, except as described below related to the partial settlement of certain NPM Adjustment claims. | |||||||||||||||||||||||||||||||||
Partial Settlement of Certain NPM Adjustment Claims. On November 14, 2012, RJR Tobacco, certain other PMs and certain settling states entered into a Term Sheet that set forth terms on which accrued and potential NPM Adjustment claims for 2003 through 2014 could be resolved. The Term Sheet also set forth a restructured NPM Adjustment process to be applied on a going-forward basis, starting with the 2013 volume year. The Term Sheet was provided to all of the MSA settling states for their review and consideration. A total of 17 states, the District of Columbia and Puerto Rico, together representing just under 42% allocable share, joined the proposed settlement. RJR Tobacco and the other PMs indicated that they were prepared to go forward with the proposed settlement with that level of jurisdictional participation. | |||||||||||||||||||||||||||||||||
The Term Sheet provided that the Arbitration Panel in place to deal with the 2003 NPM Adjustment (and other NPM Adjustment-related matters) must review the proposed settlement and enter an appropriate order to confirm for the Independent Auditor that it should implement, as necessary, the terms of the settlement agreement. | |||||||||||||||||||||||||||||||||
On March 12, 2013, the Arbitration Panel entered a Stipulated Partial Settlement and Award, referred to as the Award, reflecting the financial terms of the Term Sheet. On March 29, 2013, the Independent Auditor issued a notice indicating that it intended to implement the financial provisions of the Term Sheet, and also issued various revised payment calculations pertaining to payment years 2009 through 2012 and final calculations pertaining to payment year 2013 that reflected implementation of the financial provisions of the Term Sheet. | |||||||||||||||||||||||||||||||||
On April 12, 2013, Oklahoma joined the Term Sheet, bringing to 20 the total number of jurisdictions that have joined the settlement, representing approximately 43% allocable share, and the Independent Auditor issued revised payment calculations reflecting the financial impact of Oklahoma’s decision to join the settlement. Subsequently, on May 24, 2013, Connecticut and South Carolina also joined the Term Sheet bringing to 22 the total number of jurisdictions that have joined the settlement, representing approximately 46% allocable share. Efforts by two states, Colorado and Ohio, to obtain injunctions to prevent implementation of the Award were unsuccessful. | |||||||||||||||||||||||||||||||||
On June 10, 2014, Kentucky, and on June 26, 2014, Indiana, joined the Term Sheet, bringing to 24 the total number of jurisdictions that have joined the settlement, representing approximately 49.87% allocable share. These states, both of which were among the states found “non-diligent” by the Arbitration Panel, joined the Term Sheet on financial terms more favorable to the industry than those received by the original signatory states. | |||||||||||||||||||||||||||||||||
As of December 31, 2014, six non-settling states have motions pending, in their respective MSA courts, to vacate and/or modify the Award. The motions filed by Idaho and Colorado have been denied. | |||||||||||||||||||||||||||||||||
For additional information related to the Term Sheet and the Award, see “— Cost of Products Sold” in note 1. | |||||||||||||||||||||||||||||||||
Other NPM Matters. Separately, on August 19, 2011, Idaho sent a letter on behalf of itself and 31 other states, stating their intent to initiate arbitration with respect to whether amounts used to measure the domestic cigarette market and to calculate PM payment obligations under the MSA should be the adjusted gross or the net number of cigarettes on which federal excise tax (including arbitrios de cigarillos) is paid. The parties also agreed to arbitrate the Independent Auditor’s calculation of the volume adjustment with respect to the treatment of “roll your own,” referred to as RYO, tobacco. On January 21, 2013, the panel ruled that adjusted gross figures should be used in payment calculations and that, in the calculation of the volume adjustment, the Independent Auditor should use 0.0325 ounces of RYO tobacco to be the equivalent of one cigarette. | |||||||||||||||||||||||||||||||||
Antitrust Case | |||||||||||||||||||||||||||||||||
A number of tobacco wholesalers and consumers have sued U.S. cigarette manufacturers, including RJR Tobacco and B&W, in federal and state courts, alleging that cigarette manufacturers combined and conspired to set the price of cigarettes in violation of antitrust statutes and various state unfair business practices statutes. In these cases, the plaintiffs asked the court to certify the lawsuits as class actions on behalf of other persons who purchased cigarettes directly or indirectly from one or more of the defendants. As of December 31, 2014, all of the federal and state court cases on behalf of indirect purchasers had been dismissed. | |||||||||||||||||||||||||||||||||
In Smith v. Philip Morris Cos., Inc., a case filed in February 2000, and pending in District Court, Seward County, Kansas, the court granted class certification in November 2001, in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, and the parent companies of the major U.S. cigarette manufacturers, including RJR, seeking to recover an unspecified amount in actual and punitive damages. The plaintiffs allege that the defendants participated in a conspiracy to fix or maintain the price of cigarettes sold in the United States. In an opinion dated March 23, 2012, the court granted summary judgment in favor of RJR Tobacco and B&W on the plaintiffs’ claims. On July 18, 2014, the Court of Appeals of the State of Kansas affirmed the grant of summary judgment. On August 18, 2014, the plaintiffs filed a petition for review with the Supreme Court of the State of Kansas. | |||||||||||||||||||||||||||||||||
Other Litigation and Developments | |||||||||||||||||||||||||||||||||
JTI Claims for Indemnification. By purchase agreement dated March 9, 1999, amended and restated as of May 11, 1999, referred to as the 1999 Purchase Agreement, RJR and RJR Tobacco sold the international tobacco business to JTI. Under the 1999 Purchase Agreement, RJR and RJR Tobacco retained certain liabilities relating to the international tobacco business sold to JTI. Under its reading of the indemnification provisions of the 1999 Purchase Agreement, JTI has requested indemnification for damages allegedly arising out of these retained liabilities. As previously reported, a number of the indemnification claims between the parties relating to the activities of Northern Brands in Canada have been resolved. The other matters for which JTI has requested indemnification for damages under the indemnification provisions of the 1999 Purchase Agreement are described below: | |||||||||||||||||||||||||||||||||
• | In a letter dated March 31, 2006, counsel for JTI stated that JTI would be seeking indemnification under the 1999 Purchase Agreement for any damages it may incur or may have incurred arising out of a Southern District of New York grand jury investigation, a now-terminated Eastern District of North Carolina grand jury investigation, and various actions filed by the European Community and others in the U.S. District Court for the Eastern District of New York, referred to as the EDNY, against RJR Tobacco and certain of its affiliates on November 3, 2000, August 6, 2001, and (as discussed in greater detail below) October 30, 2002, and against JTI on January 11, 2002. | ||||||||||||||||||||||||||||||||
• | JTI also has sought indemnification relating to a Statement of Claim filed on April 23, 2010, against JTI Macdonald Corp., referred to as JTI-MC, by the Ontario Flue-Cured Tobacco Growers’ Marketing Board, referred to as the Board, Andy J. Jacko, Brian Baswick, Ron Kichler, and Aprad Dobrenty, proceeding on their own behalf and on behalf of a putative class of Ontario tobacco producers that sold tobacco to JTI-MC during the period between January 1, 1986, and December 31, 1996, referred to as the Class Period, through the Board pursuant to certain agreements. The Statement of Claim seeks recovery for damages allegedly incurred by the class representatives and the putative class for tobacco sales during the Class Period made at the contract price for duty free or export cigarettes with respect to cigarettes that, rather than being sold duty free or for export, purportedly were sold in Canada, which allegedly breached one or more of a series of contracts dated between June 4, 1986, and July 3, 1996. A motion to dismiss on the basis of statute of limitations was denied. An application requesting leave to appeal that decision has been filed. | ||||||||||||||||||||||||||||||||
• | Finally, JTI has advised RJR and RJR Tobacco of its view that, under the terms of the 1999 Purchase Agreement, RJR and RJR Tobacco are liable for a roughly $1.7 million judgment entered in 1998, plus interest and costs, in an action filed in Brazil by Lutz Hanneman, a former employee of a former RJR Tobacco subsidiary. RJR and RJR Tobacco deny that they are liable for this judgment under the terms of the 1999 Purchase Agreement. | ||||||||||||||||||||||||||||||||
Although RJR and RJR Tobacco recognize that, under certain circumstances, they may have these and other unresolved indemnification obligations to JTI under the 1999 Purchase Agreement, RJR and RJR Tobacco disagree with JTI as to (1) what circumstances relating to any such matters may give rise to indemnification obligations by RJR and RJR Tobacco, and (2) the nature and extent of any such obligation. RJR and RJR Tobacco have conveyed their position to JTI, and the parties have agreed to resolve their differences at a later time. | |||||||||||||||||||||||||||||||||
European Community. On October 30, 2002, the European Community and ten of its member states filed a complaint in the EDNY against RJR, RJR Tobacco and several currently and formerly related companies. The complaint contains many of the same or similar allegations found in an earlier complaint, now dismissed, filed in August 2001 and also alleges that the defendants, together with certain identified and unidentified persons, engaged in money laundering and other conduct violating civil RICO and a variety of common laws. The complaint also alleges that the defendants manufactured cigarettes that were eventually sold in Iraq in violation of U.S. sanctions. The plaintiffs seek compensatory, punitive and treble damages among other types of relief. This matter had been stayed and largely inactive until November 24, 2009, when, with the court’s permission, the European Community and member states filed and served a second amended complaint. The second amended complaint added 16 member states as plaintiffs and RAI, RJR Tobacco and R. J. Reynolds Global Products Inc., referred to as GPI, as defendants. The allegations contained in the second amended complaint are in most respects either identical or similar to those found in the prior complaint, but now add new allegations primarily regarding the activities of RAI, RJR Tobacco and GPI following the B&W business combination. Pursuant to a stipulation and order, the defendants filed a motion to dismiss the plaintiffs’ second amended complaint on February 15, 2010. Ruling on part of the defendants’ motion to dismiss, on March 8, 2011, the court dismissed the plaintiffs’ RICO claims, and reserved decision as to dismissal of the plaintiffs’ state-law claims. Thereafter, on May 13, 2011, the court granted the remaining portion of the defendants’ motion and dismissed the plaintiffs’ state-law claims based on the court’s lack of subject matter jurisdiction. On May 16, 2011, the clerk of court entered a judgment dismissing the action in its entirety. On June 10, 2011, the plaintiffs filed a notice of appeal with the U.S. Court of Appeals for the Second Circuit, appealing from the May 16, 2011, judgment, as well as the March 8, 2011, and May 13, 2011, orders that respectively resulted in the dismissal of their RICO and state-law claims. Oral argument occurred on February 24, 2012. | |||||||||||||||||||||||||||||||||
On April 23, 2014, a three judge panel of the Second Circuit issued a decision on the appeal, and on April 29, 2014, a corrected decision was issued. The Second Circuit concluded that: (1) as pled, the RICO claims are within the scope of the RICO statute, and (2) the federal court does have subject matter jurisdiction over the state-law claims. Accordingly, the three judge panel of the Second Circuit decided that the judgment of the district court should be vacated, and the case remanded to the district court for further proceedings. On May 7, 2014, the defendants filed in the Second Circuit a petition for panel rehearing, or rehearing en banc, regarding the plaintiffs’ RICO claims. On August 20, 2014, the three judge panel denied panel rehearing and issued an amended opinion which holds that a civil RICO cause of action extends to extraterritorial injuries. The amended opinion adheres to the three judge panel’s April 23, 2014 ruling that the judgment of the district court should be vacated, and the case remanded to the district court for further proceedings. The parties are still awaiting a decision on the portions of the May 7, 2014 petition seeking rehearing en banc. If the Second Circuit denies further review, it is expected that after remand the district court will consider the remaining grounds for dismissal contained in the defendants’ February 15, 2010 motion to dismiss which have not previously been addressed by the district court or the Second Circuit. | |||||||||||||||||||||||||||||||||
FDA Litigation. On February 25, 2011, RJR Tobacco, Lorillard, Inc., and Lorillard Tobacco Company jointly filed a lawsuit, Lorillard, Inc. v. U.S. Food and Drug Administration, in the U.S. District Court for the District of Columbia, challenging the composition of TPSAC which had been established by the FDA under the FDA Tobacco Act. The complaint alleges that certain members of the TPSAC and certain members of its Constituents Subcommittee have financial and appearance conflicts of interest that are disqualifying under federal ethics law and regulations, and that the TPSAC is not “fairly balanced,” as required by the Federal Advisory Committee Act, referred to as FACA. In March 2011, the plaintiffs filed an amended complaint, which added an additional claim, based on a nonpublic meeting of members of the TPSAC, in violation of the FACA. The court granted the plaintiffs’ unopposed motion to file a second amended complaint adding a count addressing the FDA’s refusal to produce all documents generated by the TPSAC and its subcommittee in preparation of the menthol report. On August 1, 2012, the court denied the FDA’s motion to dismiss. The FDA filed its answer to the complaint on October 12, 2012. The parties participated in a status conference on April 22, 2013, with Lorillard and RJR Tobacco filing an amended complaint the same day. Briefing for summary judgment motions was completed on September 20, 2013. On July 21, 2014, the court granted the plaintiffs’ summary judgment motions finding that three members of the TPSAC Committee had impermissible conflicts of interest. As relief, the court ordered the FDA to reconstitute the committee in conformance with the law and enjoined the agency from using or relying on the TPSAC’s 2011 Menthol Report. On September 18, 2014, the FDA appealed the decision to the U.S. Court of Appeals for the District of Columbia. Briefing on the appeal will be completed on May 2, 2015. | |||||||||||||||||||||||||||||||||
For a detailed description of the FDA Tobacco Act, see “— Governmental Activity” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in Part II, Item 7. | |||||||||||||||||||||||||||||||||
Other Matters. In Richard Villarreal v. R. J. Reynolds Tobacco Co., a case filed June 6, 2012, the plaintiff filed a collective action complaint against R. J. Reynolds Tobacco Co., Pinstripe, Inc., and CareerBuilder, LLC, in the U.S. District Court, Northern District of Georgia. The complaint alleges unlawful discrimination with respect to the hiring of individuals to fill entry-level regional sales positions in violation of the Age Discrimination in Employment Act (29 U.S.C. §621, et seq.). Although the complaint is currently a single plaintiff case, the complaint seeks collective/class-action status. RJR Tobacco’s and Pinstripe’s motion for partial dismissal was granted on March 6, 2013, thereby eliminating the plaintiff’s disparate impact claim and limiting the relevant time period for both the plaintiff’s claims and potential class claims. RJR Tobacco and Pinstripe filed answers to the remaining disparate treatment claim on March 20, 2013. Defendant CareerBuilder was dismissed with prejudice on September 25, 2012. Discovery is currently proceeding. The plaintiff’s Fed.R.Civ.P. 54(b) motion to certify for immediate appeal the trial court’s prior dismissal of plaintiff’s disparate impact and time-barred claims was granted on May 21, 2014. Final judgment as to certain claims (those claims based on a disparate impact theory of relief and claims challenging hiring decisions made before November 19, 2009) was entered on May 21, 2014. The plaintiff filed a notice of appeal of the final judgment on June 18, 2014. The defendants filed a motion to dismiss the plaintiff’s appeal on July 3, 2014, which was granted by the Eleventh Circuit on September 22, 2014. The plaintiff’s motion for reconsideration of the dismissal was denied by the Eleventh Circuit on December 4, 2014. The plaintiff filed an unopposed motion to dismiss remaining claims on January 14, 2015. A consent order of dismissal of the remaining claims with prejudice was signed by the judge on January 16, 2015, and entered on January 20, 2015. | |||||||||||||||||||||||||||||||||
Smokeless Tobacco Litigation | |||||||||||||||||||||||||||||||||
As of December 31, 2014, American Snuff Co. was a defendant in six actions brought by individual plaintiffs in West Virginia state court seeking damages in connection with personal injuries allegedly sustained as a result of the usage of American Snuff Co.’s smokeless tobacco products. These actions are pending before the same West Virginia court as the above-described smoker cases against RJR Tobacco, B&W, as RJR Tobacco’s indemnitee, or both. Pursuant to the court’s December 3, 2001 order, the smokeless tobacco claims and defendants remain severed, and there has been no activity in these cases for the last 14 years. | |||||||||||||||||||||||||||||||||
Pursuant to a second amended complaint filed in September 2006, American Snuff Co. is a defendant in Vassallo v. United States Tobacco Company, pending in the Eleventh Circuit Court in Miami-Dade County, Florida. The individual plaintiff alleges that he sustained personal injuries, including addiction and cancer, as a result of his use of smokeless tobacco products, allegedly including products manufactured by American Snuff Co. The plaintiff seeks unspecified compensatory and consequential damages in an amount greater than $15,000. There is no punitive damages demand in this case, though the plaintiff retains the right to seek leave of court to add such a demand later. Discovery is underway. Pursuant to the court’s scheduling order, trial is anticipated to begin in the first quarter of 2016. | |||||||||||||||||||||||||||||||||
Tobacco Buyout Legislation | |||||||||||||||||||||||||||||||||
In 2004, legislation was passed eliminating the U.S. Government’s tobacco production controls and price support program. The buyout of tobacco quota holders provided for in the Fair and Equitable Tobacco Reform Act, referred to as FETRA, was funded by a direct quarterly assessment on every tobacco product manufacturer and importer, on a market-share basis measured on volume to which federal excise tax was applied. The aggregate cost of the buyout to the industry was approximately $9.9 billion, including approximately $9.6 billion payable to quota tobacco holders and growers through industry assessments over ten years, into 2014, and approximately $290 million for the liquidation of quota tobacco stock. The FETRA assessment expired in September 2014. | |||||||||||||||||||||||||||||||||
RAI’s operating subsidiaries recorded the FETRA assessment on a quarterly basis as cost of goods sold. RAI’s operating subsidiaries’ overall share of the buyout approximated $2.5 billion prior to the deduction of permitted offsets under the MSA. RAI’s operating subsidiaries’ annual expense under FETRA for 2014 was $163 million. | |||||||||||||||||||||||||||||||||
ERISA Litigation | |||||||||||||||||||||||||||||||||
In May 2002, in Tatum v. The R.J.R. Pension Investment Committee of the R. J. Reynolds Tobacco Company Capital Investment Plan, an employee of RJR Tobacco filed a class-action suit in the U.S. District Court for the Middle District of North Carolina, alleging that the defendants, RJR, RJR Tobacco, the RJR Employee Benefits Committee and the RJR Pension Investment Committee, violated the Employee Retirement Income Security Act of 1974, referred to as ERISA. The actions about which the plaintiff complains stem from a decision made in 1999 by RJR Nabisco Holdings Corp., subsequently renamed Nabisco Group Holdings Corp., referred to as NGH, to spin off RJR, thereby separating NGH’s tobacco business and food business. As part of the spin-off, the 401(k) plan for the previously related entities had to be divided into two separate plans for the now separate tobacco and food businesses. The plaintiff contends that the defendants breached their fiduciary duties to participants of the RJR 401(k) plan when the defendants removed the stock funds of the companies involved in the food business, NGH and Nabisco Holdings Corp., referred to as Nabisco, as investment options from the RJR 401(k) plan approximately six months after the spin-off. The plaintiff asserts that a November 1999 amendment (the “1999 Amendment”) that eliminated the NGH and Nabisco funds from the RJR 401(k) plan on January 31, 2000, contained sufficient discretion for the defendants to have retained the NGH and Nabisco funds after January 31, 2000, and that the failure to exercise such discretion was a breach of fiduciary duty. In his complaint, the plaintiff requests, among other things, that the court require the defendants to pay as damages to the RJR 401(k) plan an amount equal to the subsequent appreciation that was purportedly lost as a result of the liquidation of the NGH and Nabisco funds. | |||||||||||||||||||||||||||||||||
In July 2002, the defendants filed a motion to dismiss, which the court granted in December 2003. In December 2004, the U.S. Court of Appeals for the Fourth Circuit reversed the dismissal of the complaint, holding that the 1999 Amendment did contain sufficient discretion for the defendants to have retained the NGH and Nabisco funds as of February 1, 2000, and remanded the case for further proceedings. The court granted the plaintiff leave to file an amended complaint and denied all pending motions as moot. In April 2007, the defendants moved to dismiss the amended complaint. The court granted the motion in part and denied it in part, dismissing all claims against the RJR Employee Benefits Committee and the RJR Pension Investment Committee. The remaining defendants, RJR and RJR Tobacco, filed their answer and affirmative defenses in June 2007. The plaintiff filed a motion for class certification, which the court granted in September 2008. The district court ordered mediation, but no resolution of the case was reached. In September 2008, each of the plaintiffs and the defendants filed motions for summary judgment, and in January 2009, the defendants filed a motion to decertify the class. A second mediation occurred in June 2009, but again no resolution of the case was reached. The district court overruled the motions for summary judgment and the motion to decertify the class. | |||||||||||||||||||||||||||||||||
A non-jury trial was held in January and February 2010. During closing arguments, the plaintiff argued for the first time that certain facts arising at trial showed that the 1999 Amendment was not validly adopted, and then moved to amend his complaint to conform to this evidence at trial. On June 1, 2011, the court granted the plaintiff’s motion to amend his complaint and found that the 1999 Amendment was invalid. | |||||||||||||||||||||||||||||||||
The parties filed their findings of fact and conclusions of law on February 4, 2011. On February 25, 2013, the district court dismissed the case with prejudice. On March 8, 2013, the plaintiffs filed a notice of appeal. On August 4, 2014, the Fourth Circuit Court of Appeals, referred to as Fourth Circuit, reversed, holding that the district court applied the wrong standard when it held that the defendants did not cause any loss to the plan and remanded the case back to the district court to apply the correct standard. On September 2, 2014, the Fourth Circuit denied the defendants’ request for rehearing en banc. The mandate from the Fourth Circuit was issued on October 1, 2014. On November 19, 2014, the district court held a hearing and ordered briefing on various issues that remain pending on remand, with briefs due on various dates in January and February 2015. On December 1, 2014, the defendants filed a petition for writ of certiorari with the U.S. Supreme Court. Briefing on the defendants’ petition for writ of certiorari to the Supreme Court is underway. The parties are complying with the briefing schedule ordered by the district court. | |||||||||||||||||||||||||||||||||
Environmental Matters | |||||||||||||||||||||||||||||||||
RAI and its subsidiaries are subject to federal, state and local environmental laws and regulations concerning the discharge, storage, handling and disposal of hazardous or toxic substances. Such laws and regulations provide for significant fines, penalties and liabilities, sometimes without regard to whether the owner or operator of the property knew of, or was responsible for, the release or presence of hazardous or toxic substances. In addition, third parties may make claims against owners or operators of properties for personal injuries and property damage associated with releases of hazardous or toxic substances. In the past, RJR Tobacco has been named a potentially responsible party with third parties under the Comprehensive Environmental Response, Compensation and Liability Act with respect to several superfund sites. RAI and its subsidiaries are not aware of any current environmental matters that are expected to have a material adverse effect on the business, results of operations or financial position of RAI or its subsidiaries. | |||||||||||||||||||||||||||||||||
RAI and its operating subsidiaries believe that climate change is an environmental issue primarily driven by carbon dioxide emissions from the use of energy. RAI’s operating subsidiaries are working to reduce carbon dioxide emissions by minimizing the use of energy where cost effective, minimizing waste to landfills and increasing recycling. Climate change is not viewed by RAI’s operating subsidiaries as a significant direct economic risk to their businesses, but rather an indirect risk involving the potential for a longer-term general increase in the cost of doing business. Regulatory changes are difficult to predict, but the current regulatory risks to the business of RAI’s operating subsidiaries with respect to climate change are relatively low. Financial impacts will be driven more by the cost of natural gas and electricity. Efforts are made to anticipate the effect of increases in fuel costs directly impacting RAI’s operating subsidiaries by evaluating natural gas usage and market conditions. Occasionally forward contracts are purchased, limited to a two-year period, for natural gas. In addition, RAI’s operating subsidiaries are continually evaluating energy conservation measures and energy efficient equipment to mitigate impacts of increases in energy costs. | |||||||||||||||||||||||||||||||||
Regulations promulgated by the EPA and other governmental agencies under various statutes have resulted in, and likely will continue to result in, substantial expenditures for pollution control, waste treatment, facility modification and similar activities. RAI and its subsidiaries are engaged in a continuing program to comply with federal, state and local environmental laws and regulations, and dependent upon the probability of occurrence and reasonable estimation of cost, accrue or disclose any material liability. Although it is difficult to reasonably estimate the portion of capital expenditures or other costs attributable to compliance with environmental laws and regulations, RAI does not expect such expenditures or other costs to have a material adverse effect on the business, results of operations, cash flows or financial position of RAI or its subsidiaries. | |||||||||||||||||||||||||||||||||
Shareholder Cases | |||||||||||||||||||||||||||||||||
Delaware. In the third quarter of 2014, Lorillard, the members of Lorillard’s Board, RAI and BAT were named as defendants in 11 putative class action lawsuits brought in the Delaware Court of Chancery by Lorillard shareholders challenging the proposed Merger with RAI, referred to as the Delaware Actions. The complaints generally allege, among other things, that the members of the Lorillard board of directors breached their fiduciary duties to Lorillard shareholders by authorizing the proposed merger of Lorillard with RAI. The complaints also allege that RAI and BAT aided and abetted the breaches of fiduciary duties allegedly committed by the members of the Lorillard board of directors. On November 25, 2014, the court granted a motion for consolidation of the lawsuits into a single action captioned In re Lorillard, Inc. Stockholders Litigation, C.A. No. 9904-CB and for appointment of lead plaintiffs and lead counsel. On December 11, 2014, the lead plaintiffs filed a motion for a preliminary injunction and a motion to expedite. | |||||||||||||||||||||||||||||||||
Although they believe that these lawsuits are without merit and that no further disclosure was required to supplement the Joint Proxy Statement/Prospectus under applicable laws, to eliminate the burden, expense and uncertainties inherent in such litigation, on January 15, 2015, the defendants (other than BAT, which was not named in the amended complaint) entered into the Delaware Memorandum of Understanding regarding the settlement of the Delaware Actions. The Delaware Memorandum of Understanding outlines the terms of the parties’ agreement in principle to settle and release all claims which were or could have been asserted in the Delaware Actions. In consideration for such settlement and release, the parties to the Delaware Actions agreed, among other things, that Lorillard and RAI would make certain supplemental disclosures to the Joint Proxy Statement/Prospectus, which they did on January 20, 2015. The Delaware Memorandum of Understanding contemplates that the parties will negotiate in good faith to agree upon a stipulation of settlement to be submitted to the court for approval as soon as practicable. The stipulation of settlement will be subject to customary conditions, including approval by the court, which will consider the fairness, reasonableness and adequacy of such settlement. There can be no assurance that the parties will ultimately enter into a stipulation of settlement or that the court will approve the settlement even if the parties were to enter into such a stipulation. In such event, or if the transactions contemplated by the Merger Agreement are not consummated for any reason, the proposed settlement will be of no force and effect. | |||||||||||||||||||||||||||||||||
North Carolina. RAI, the members of the RAI board of directors and BAT have been named as defendants in a putative class action lawsuit captioned Corwin v. British American Tobacco PLC, et al., No. 14-CVS-8130 (N.C. Super. Ct. 2014), brought in North Carolina state court, referred to as the North Carolina Action, by a person identifying himself as a shareholder of RAI. The North Carolina Action was initiated on August 8, 2014, and an amended complaint was filed on November 7, 2014. The amended complaint generally alleges, among other things, that the members of the RAI board of directors breached their fiduciary duties to RAI shareholders by approving the Share Purchase and the sharing of technology with BAT. The amended complaint also alleges that there were various conflict of interest in the transaction, and that RAI aided and abetted the alleged breaches of fiduciary duties by its board of directors. The North Carolina Action seeks injunctive relief, damages and reimbursement of costs, among other remedies. On December 5 and December 8, 2014, all defendants filed motions to dismiss and to stay discovery until the motion to dismiss is decided. On January 2, 2015, the plaintiff in the North Carolina Action filed a motion for a preliminary injunction seeking to enjoin temporarily the RAI shareholder meeting and votes scheduled for January 28, 2015. RAI and the RAI board of directors timely opposed that motion prior to a hearing that was scheduled to occur on January 16, 2015. | |||||||||||||||||||||||||||||||||
RAI believes that the North Carolina Action is without merit and that no further disclosure was necessary to supplement the Joint Proxy Statement/Prospectus under applicable laws. However, to eliminate certain burdens, expenses and uncertainties, on January 17, 2015, RAI and the director defendants in the North Carolina Action entered into the North Carolina Memorandum of Understanding regarding the settlement of the disclosure claims asserted in that lawsuit. The North Carolina Memorandum of Understanding outlines the terms of the parties’ agreement in principle to settle and release the disclosure claims which were or could have been asserted in the North Carolina Action. In consideration of the partial settlement and release, RAI agreed to make certain supplemental disclosures to the Joint Proxy Statement/Prospectus, which it did on January 20, 2015. The North Carolina Memorandum of Understanding contemplates that the parties will negotiate in good faith to agree upon a stipulation of partial settlement to be submitted to the court for approval as soon as practicable. The stipulation of partial settlement will be subject to customary conditions, including approval by the court, which will consider the fairness, reasonableness and adequacy of the partial settlement. There can be no assurance that the parties will ultimately enter into a stipulation of partial settlement or that the court will approve the partial settlement even if the parties were to enter into such a stipulation. In that event, the proposed partial settlement will be null and void and of no force and effect. As is more fully set forth in the North Carolina Memorandum of Understanding, the partial settlement will not resolve or terminate the non-disclosure claims in the North Carolina Action and these claims will continue to be litigated. In addition, the partial settlement will not affect the consideration to be paid to Lorillard shareholders in connection with the Merger. | |||||||||||||||||||||||||||||||||
Other Contingencies | |||||||||||||||||||||||||||||||||
In connection with the sale of the international tobacco business to JTI, pursuant to the 1999 Purchase Agreement, RJR and RJR Tobacco agreed to indemnify JTI against: | |||||||||||||||||||||||||||||||||
• | any liabilities, costs and expenses arising out of the imposition or assessment of any tax with respect to the international tobacco business arising prior to the sale, other than as reflected on the closing balance sheet; | ||||||||||||||||||||||||||||||||
• | any liabilities, costs and expenses that JTI or any of its affiliates, including the acquired entities, may incur after the sale with respect to any of RJR’s or RJR Tobacco’s employee benefit and welfare plans; and | ||||||||||||||||||||||||||||||||
• | any liabilities, costs and expenses incurred by JTI or any of its affiliates arising out of certain activities of Northern Brands. | ||||||||||||||||||||||||||||||||
As described above in “— Litigation Affecting the Cigarette Industry — Other Litigation and Developments — JTI Claims for Indemnification,” RJR Tobacco has received claims for indemnification from JTI, and several of these have been resolved. Although RJR and RJR Tobacco recognize that, under certain circumstances, they may have other unresolved indemnification obligations to JTI under the 1999 Purchase Agreement, RJR and RJR Tobacco disagree what circumstances described in such claims give rise to any indemnification obligations by RJR and RJR Tobacco and the nature and extent of any such obligation. RJR and RJR Tobacco have conveyed their position to JTI, and the parties have agreed to resolve their differences at a later date. | |||||||||||||||||||||||||||||||||
RJR Tobacco, SFNTC and American Snuff Co. have entered into agreements to indemnify certain distributors and retailers from liability and related defense costs arising out of the sale or distribution of their products. Additionally, SFNTC has entered into an agreement to indemnify a supplier from liability and related defense costs arising out of the sale or use of SFNTC’s products. The cost has been, and is expected to be, insignificant. RJR Tobacco, SFNTC and American Snuff Co. believe that the indemnified claims are substantially similar in nature and extent to the claims that they are already exposed to by virtue of their having manufactured those products. | |||||||||||||||||||||||||||||||||
Except as otherwise noted above, RAI is not able to estimate the maximum potential amount of future payments, if any, related to these indemnification obligations. | |||||||||||||||||||||||||||||||||
Lease Commitments | |||||||||||||||||||||||||||||||||
RAI has operating lease agreements that are primarily for office space, automobiles, warehouse space and computer equipment. The majority of these leases expire within the next five years and some contain renewal or purchase options and escalation clauses or restrictions relating to subleases. Total rent expense was $25 million, $24 million and $19 million for 2014, 2013 and 2012, respectively. | |||||||||||||||||||||||||||||||||
Future minimum lease payments as of December 31, 2014 were as follows: | |||||||||||||||||||||||||||||||||
Noncancellable | |||||||||||||||||||||||||||||||||
Operating Leases | |||||||||||||||||||||||||||||||||
2015 | $ | 19 | |||||||||||||||||||||||||||||||
2016 | 3 | ||||||||||||||||||||||||||||||||
2017 | 3 | ||||||||||||||||||||||||||||||||
2018 | 2 | ||||||||||||||||||||||||||||||||
2019 | 2 | ||||||||||||||||||||||||||||||||
Thereafter | 1 | ||||||||||||||||||||||||||||||||
Total | $ | 30 | |||||||||||||||||||||||||||||||
Shareholders_Equity
Shareholders' Equity | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||
Shareholders' Equity | Note 13 — Shareholders’ Equity | ||||||||||||||||||||
RAI’s authorized capital stock at December 31, 2014 and 2013, consisted of 100 million shares of preferred stock, par value $.01 per share, and 1.6 billion shares of common stock, par value $.0001 per share. Four million shares of the preferred stock are designated as Series A Junior Participating Preferred Stock, none of which is issued or outstanding. The Series A Junior Participating Preferred Stock will rank junior as to dividends and upon liquidation to all other series of RAI preferred stock, unless specified otherwise. Also, of the preferred stock, one million shares are designated as Series B Preferred Stock, all of which are issued and outstanding. The Series B Preferred Stock ranks senior upon liquidation, but not with respect to dividends, to all other series of RAI capital stock, unless specified otherwise. As a part of the B&W business combination, RJR is the holder of the outstanding Series B Preferred Stock. In each of 2014, 2013 and 2012, RAI declared $43 million in dividends to RJR with respect to the Series B Preferred Stock. | |||||||||||||||||||||
In 2004, RAI’s board of directors adopted a shareholder rights plan, pursuant to which RAI declared a dividend of one preferred stock purchase right on each share of RAI common stock outstanding on July 30, 2004. The board also authorized the issuance of rights for each share of RAI common stock issued after the dividend record date, until the occurrence of certain specified events. By virtue of RAI’s two-for-one stock split in both 2006 and 2010, the number of rights associated with each share of RAI common stock was 0.25 at the time the rights expired on July 30, 2014. | |||||||||||||||||||||
RAI’s board of directors declared the following quarterly cash dividends per share of RAI common stock in 2014, 2013 and 2012: | |||||||||||||||||||||
2014 | 2013 | 2012 | |||||||||||||||||||
First | $ | 0.67 | $ | 0.59 | $ | 0.56 | |||||||||||||||
Second | $ | 0.67 | $ | 0.63 | $ | 0.59 | |||||||||||||||
Third | $ | 0.67 | $ | 0.63 | $ | 0.59 | |||||||||||||||
Fourth | $ | 0.67 | $ | 0.63 | $ | 0.59 | |||||||||||||||
Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||||
The components of accumulated other comprehensive loss, net of tax, were as follows: | |||||||||||||||||||||
Retirement | Unrealized Gain | Realized Loss | Cumulative | Total | |||||||||||||||||
Benefits | (Loss) on Long- | on Hedging | Translation | ||||||||||||||||||
Term Investments | Instruments | Adjustment and Other | |||||||||||||||||||
Balance at December 31, 2012 | $ | (265 | ) | $ | (21 | ) | $ | (14 | ) | $ | (11 | ) | $ | (311 | ) | ||||||
Other comprehensive income before reclassifications | 271 | 5 | — | 1 | 277 | ||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | (23 | ) | — | 1 | — | (22 | ) | ||||||||||||||
Net current-period other comprehensive income | 248 | 5 | 1 | 1 | 255 | ||||||||||||||||
Balance at December 31, 2013 | (17 | ) | (16 | ) | (13 | ) | (10 | ) | (56 | ) | |||||||||||
Other comprehensive income before reclassifications | (528 | ) | 2 | — | (34 | ) | (560 | ) | |||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | 251 | — | 1 | — | 252 | ||||||||||||||||
Net current-period other comprehensive income | (277 | ) | 2 | 1 | (34 | ) | (308 | ) | |||||||||||||
Balance at December 31, 2014 | $ | (294 | ) | $ | (14 | ) | $ | (12 | ) | $ | (44 | ) | $ | (364 | ) | ||||||
Details about the reclassifications out of accumulated other comprehensive loss and the affected line items in the consolidated statement of income for the years ended December 31, 2014 and 2013, were as follows: | |||||||||||||||||||||
Amounts Reclassified | Affected Line Item | ||||||||||||||||||||
Components | 2014 | 2013 | |||||||||||||||||||
Defined benefit pension and postretirement plans: | |||||||||||||||||||||
Amortization of prior service costs | $ | (21 | ) | $ | (21 | ) | Cost of products sold | ||||||||||||||
Amortization of prior service costs | (18 | ) | (18 | ) | Selling, general and administrative expenses | ||||||||||||||||
MTM adjustment | 205 | — | Cost of products sold | ||||||||||||||||||
MTM adjustment | 247 | — | Selling, general and administrative expenses | ||||||||||||||||||
413 | (39 | ) | |||||||||||||||||||
Deferred taxes | (162 | ) | 16 | Provision for income taxes | |||||||||||||||||
Net of tax | $ | 251 | $ | (23 | ) | ||||||||||||||||
Loss on hedging instruments: | |||||||||||||||||||||
Amortization of realized loss | $ | 2 | $ | 2 | Interest and debt expense | ||||||||||||||||
Deferred taxes | (1 | ) | (1 | ) | Provision for income taxes | ||||||||||||||||
Net of tax | $ | 1 | $ | 1 | |||||||||||||||||
Total reclassifications | $ | 252 | $ | (22 | ) | Net income | |||||||||||||||
Share Repurchases and Other | |||||||||||||||||||||
In November 2011, the board of directors of RAI authorized the repurchase of up to $2.5 billion of outstanding shares of RAI common stock in open-market or privately negotiated transactions. In connection with the share repurchase program, RAI and B&W entered into an agreement, pursuant to which B&W agreed to participate in the repurchase program on a basis approximately proportionate with B&W’s 42% ownership of RAI’s common stock. During 2014, RAI repurchased and cancelled 7,715,763 shares for $412 million, with total repurchases of 55,353,807 shares for $2.5 billion which concluded the above-described program. | |||||||||||||||||||||
In November 2011, RAI, B&W and BAT also entered into Amendment No. 3 to the governance agreement, pursuant to which RAI has agreed that, so long as B&W’s ownership interest has not dropped below 25%, if RAI issues shares of its common stock or any other RAI equity security to certain designated persons, including its directors, officers or employees, then RAI will repurchase a number of shares of outstanding RAI common stock so that the number of outstanding shares of RAI common stock are not increased, and B&W’s ownership interest is not decreased, by such issuance after taking into account such repurchase. | |||||||||||||||||||||
The RAI Long-Term Incentive Plan, referred to as the LTIP, a plan which expired in 2009, was replaced by the Reynolds American Inc. 2009 Omnibus Incentive Compensation Plan, referred to as the Omnibus Plan, which was approved by the shareholders of RAI in 2009. The amended and restated Omnibus Plan was approved by shareholders in 2014. | |||||||||||||||||||||
Restricted stock units granted in March 2011 under the Omnibus Plan vested in March 2014 and were settled with the issuance of 1,468,294 shares of RAI common stock. In addition, during the year ended December 31, 2014, at a cost of $28 million, RAI purchased 554,042 shares that were forfeited and cancelled with respect to tax liabilities associated with restricted stock units vesting under the Omnibus Plan. | |||||||||||||||||||||
Due to RAI’s incorporation in North Carolina, which does not recognize treasury shares, the shares repurchased were cancelled at the time of repurchase. | |||||||||||||||||||||
Changes in RAI common stock outstanding were as follows: | |||||||||||||||||||||
2014 | 2013 | 2012 | |||||||||||||||||||
Shares outstanding at beginning of year | 538,053,024 | 552,940,767 | 576,135,199 | ||||||||||||||||||
LTIP tax shares repurchased and cancelled | — | — | (921,646 | ) | |||||||||||||||||
LTIP shares issued from vesting of restricted stock units | — | — | 2,640,408 | ||||||||||||||||||
Omnibus Plan tax shares repurchased and cancelled | (554,042 | ) | (574,383 | ) | — | ||||||||||||||||
Omnibus Plan shares issued from vesting of restricted stock units | 1,468,294 | 1,572,389 | — | ||||||||||||||||||
Shares repurchased and cancelled | (7,715,763 | ) | (15,917,174 | ) | (24,944,233 | ) | |||||||||||||||
Equity incentive award plan shares issued | 32,000 | 31,425 | 31,039 | ||||||||||||||||||
Shares outstanding at end of year | 531,283,513 | 538,053,024 | 552,940,767 | ||||||||||||||||||
Stock_Plans
Stock Plans | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||
Stock Plans | Note 14 — Stock Plans | ||||||||||||||||||||
As of December 31, 2014, RAI had two stock plans, the Equity Incentive Award Plan for Directors of RAI, referred to as the EIAP, and the Omnibus Plan. | |||||||||||||||||||||
Under the EIAP, RAI currently provides grants of deferred stock units to eligible directors on a quarterly and annual basis, with the annual grant being made generally on the date of RAI’s annual shareholders’ meeting. Prior to September 13, 2012, upon election to RAI’s board of directors, an eligible director received an initial grant of 3,500 deferred stock units under the EIAP. After September 13, 2012, grants are no longer made to directors upon their initial election to the board of directors, but eligible directors initially elected to RAI’s board of directors after such date on a date other than the annual meeting date, and who therefore are not eligible to receive the annual stock award for such year, now receive a pro rata portion of the annual award upon election. Directors may elect to receive shares of common stock in lieu of their initial and annual grants of deferred stock units. A maximum of 2,000,000 shares of common stock may be issued under this plan, of which 1,053,955 shares were available for grant as of December 31, 2014. Deferred stock units granted under the EIAP have a value equal to, and bear dividend equivalents at the same rate as, one share of RAI common stock, and have no voting rights. The dividends are paid as additional units in an amount equal to the number of shares of RAI common stock that could be purchased with the dividends on the date of payment. Generally, distribution of a director’s deferred stock units will be made on January 2 following his or her last year of service on the board; however, for all grants made under the EIAP after December 31, 2007, a director may elect to receive his or her deferred stock units on the later of January 2 of a specified year or January 2 following his or her last year of service on the board. At the election of a director, distribution may be made in one lump sum or in up to ten annual installments. A director is paid in cash for the units granted quarterly and in common stock for the units granted initially and annually, unless the director elects to receive cash for the initial and annual grants. Cash payments are based on the average closing price of RAI common stock during December of the year preceding payment. Compensation expense related to the EIAP was $10 million, $7 million and $4 million during 2014, 2013 and 2012, respectively. | |||||||||||||||||||||
Awards to key employees under the Omnibus Plan may be in the form of cash awards, incentive or non-incentive stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units or other awards. Subject to adjustments as set forth in the Omnibus Plan, the number of shares of RAI common stock that may be issued with respect to awards under the Omnibus Plan will not exceed 38,000,000 shares in the aggregate. Upon retirement, a holder’s grant under the Omnibus Plan generally vests on a pro rata basis for the portion of the vesting service period that has elapsed, thereby maintaining an appropriate approximation of forfeitures related to retirement. | |||||||||||||||||||||
Information regarding restricted stock unit awards outstanding as of December 31, 2014, under the Omnibus Plan was as follows: | |||||||||||||||||||||
Grant Year | Number | Grant | Vesting Date | Number | Cumulative | Ending Date of | |||||||||||||||
of | Price | of | Dividends | Performance Period | |||||||||||||||||
Shares | Shares | ||||||||||||||||||||
Granted | Cancelled | ||||||||||||||||||||
Three-year grants | |||||||||||||||||||||
2012 | 1,222,534 | $ | 42.16 | March 1, 2015 | 269,091 | $ | 6.72 | December 31, 2014 | |||||||||||||
2013 | 1,112,436 | $ | 43.36 | 1-Mar-16 | 201,697 | $ | 7.08 | 31-Dec-15 | |||||||||||||
2014 | 1,049,348 | $ | 53.29 | 3-Mar-17 | 185,128 | $ | 8.04 | 31-Dec-16 | |||||||||||||
2014 | 25,907 | $ | 58.73 | 3-Mar-17 | — | $ | 6.03 | 31-Dec-16 | |||||||||||||
One-year grant | |||||||||||||||||||||
2014 | 149,192 | $ | 64.27 | 1-May-15 | — | $ | 2.68 | 30-Apr-15 | |||||||||||||
Other grants | |||||||||||||||||||||
2014 | 20,726 | $ | 58.73 | September 30, 2015 | — | N/A | N/A | ||||||||||||||
2014 | 37,133 | $ | 58.73 | 30-Sep-15 | — | N/A | N/A | ||||||||||||||
2014 | 20,725 | $ | 58.73 | 30-Sep-16 | — | N/A | N/A | ||||||||||||||
2014 | 37,133 | $ | 58.73 | 30-Sep-18 | — | N/A | N/A | ||||||||||||||
Three-Year Grants and Other Grants | |||||||||||||||||||||
The grant date fair value was based on the per share closing price of RAI common stock on the date of grant. The actual number of shares granted is fixed. The grants are accounted for as equity-based, and compensation expense includes the vesting period lapsed. There were no shares issued during 2014 with respect to awards outstanding as of December 31, 2014. All outstanding grants will be settled exclusively in RAI common stock. | |||||||||||||||||||||
Upon settlement, each grantee of the three-year grants will receive a number of shares of RAI’s common stock equal to the product of the number of vested units and a percentage up to 150% based on the average RAI annual incentive award plan score over the three-year period ending on December 31 of the year prior to the vesting date. The other grants do not contain a performance measure. | |||||||||||||||||||||
One-Year Grant | |||||||||||||||||||||
The actual number of shares granted is fixed. The grant is an equity-based grant where compensation expense will take into account the vesting period lapsed and will be calculated based on the per share closing price of RAI common stock as of the end of each quarter, which was $64.27 as of December 31, 2014. There were no shares issued during 2014 with respect to awards outstanding as of December 31, 2014. All outstanding grants will be settled exclusively in RAI common stock. | |||||||||||||||||||||
Upon settlement, the grantee will receive a number of shares of RAI’s common stock equal to the product of the number of vested units and a percentage up to 150% based on the overall performance of RAI and its subsidiaries during the one-year performance period beginning May 1, 2014, and ending April 30, 2015, against RAI’s 2014 annual incentive award program metrics and other performance factors. | |||||||||||||||||||||
Restricted Stock Unit Dividends | |||||||||||||||||||||
Dividends paid on shares of RAI common stock will accumulate on the restricted stock units and be paid to the grantee on the vesting date. If RAI fails to pay its shareholders cumulative dividends of at least the amounts shown above, then each award will be reduced by an amount equal to three times the percentage of the dividend underpayment, up to a maximum reduction of 50%. Dividends are accrued on the grants and included in other current liabilities, based on the vesting date of less than one year, and in other noncurrent liabilities, based on the vesting date of greater than one year, in the consolidated balance sheets as of December 31, 2014 and 2013. | |||||||||||||||||||||
The changes in the number of RAI restricted stock units during 2014 were as follows: | |||||||||||||||||||||
Number of | Weighted Average | ||||||||||||||||||||
Stock Units | Grant Date | ||||||||||||||||||||
Fair Value | |||||||||||||||||||||
Outstanding at beginning of year | 3,594,594 | $ | 39.37 | ||||||||||||||||||
Granted | 1,340,164 | 55.09 | |||||||||||||||||||
Forfeited | (530,547 | ) | 46.42 | ||||||||||||||||||
Vested | (1,384,993 | ) | 33.99 | ||||||||||||||||||
Outstanding at end of year | 3,019,218 | 47.58 | |||||||||||||||||||
Total compensation expense related to stock-based compensation and the related tax benefits recognized in selling, general and administrative expenses in the consolidated statements of income were as follows: | |||||||||||||||||||||
Grant/Type | 2014 | 2013 | 2012 | ||||||||||||||||||
2009 restricted stock units | $ | — | $ | — | $ | 2 | |||||||||||||||
2010 restricted stock units | — | 2 | 13 | ||||||||||||||||||
2011 restricted stock units | 3 | 20 | 14 | ||||||||||||||||||
2012 restricted stock units | 14 | 18 | 13 | ||||||||||||||||||
2013 restricted stock units | 15 | 15 | — | ||||||||||||||||||
2014 restricted stock units | 24 | — | — | ||||||||||||||||||
Total compensation expense | $ | 56 | $ | 55 | $ | 42 | |||||||||||||||
Total related tax benefits | $ | 20 | $ | 19 | $ | 15 | |||||||||||||||
The amounts related to the unvested Omnibus Plan restricted stock unit grants were included in the consolidated balance sheets as of December 31 as follows: | |||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||
Other current liabilities | $ | 9 | $ | 10 | |||||||||||||||||
Other noncurrent liabilities | 8 | 9 | |||||||||||||||||||
Paid-in capital | 99 | 94 | |||||||||||||||||||
As of December 31, 2014, there were $61 million of unrecognized compensation costs related to restricted stock units, calculated at the grant-date price, which are expected to be recognized over a weighted-average period of 1.73 years. The excess tax benefits related to stock-based compensation were $12 million, $14 million and $39 million in 2014, 2013 and 2012, respectively. | |||||||||||||||||||||
RAI has a policy of issuing new shares of common stock to satisfy share option exercises. There was no stock option activity during 2014 and 2013. During 2012, RAI had 40,000 stock options outstanding at the beginning of the year at a weighted average exercise price of $17.45. These options expired during 2012. | |||||||||||||||||||||
Equity compensation plan information as of December 31, 2014, was as follows: | |||||||||||||||||||||
Plan Category | Number of Securities | Weighted Average | Number of Securities | ||||||||||||||||||
to be Issued Upon | Exercise Price of | Remaining Available for | |||||||||||||||||||
Exercise of | Outstanding | Future Issuance under | |||||||||||||||||||
Outstanding Options, | Options, Warrants | Equity Compensation | |||||||||||||||||||
Warrants and Rights | and Rights | Plans (Excluding | |||||||||||||||||||
Securities Reflected in | |||||||||||||||||||||
Column (a)) | |||||||||||||||||||||
(a) | (b) | (c) | |||||||||||||||||||
Equity Compensation Plans Approved by Security Holders | 4,470,968 | (2) | $ | — | 31,616,775 | ||||||||||||||||
Equity Compensation Plans Not Approved by Security Holders(1) | — | — | 1,053,955 | ||||||||||||||||||
Total | 4,470,968 | (2) | — | 32,670,730 | |||||||||||||||||
-1 | The EIAP was approved by RJR’s sole shareholder, NGH, prior to RJR’s spin-off on June 15, 1999. | ||||||||||||||||||||
(2) | Consists of restricted stock units. These restricted stock units represent the maximum number of shares to be awarded under the best-case targets, and accordingly, may overstate expected dilution. |
Retirement_Benefits
Retirement Benefits | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||||||
Retirement Benefits | Note 15 — Retirement Benefits | ||||||||||||||||||||||||||||||||
RAI sponsors a number of non-contributory defined benefit pension plans covering most of the employees of RAI and certain of its subsidiaries, and also provides certain health and life insurance benefits for most of the retired employees of RAI and certain of its subsidiaries and their dependents. These benefits are generally no longer provided to employees hired on or after January 1, 2004. | |||||||||||||||||||||||||||||||||
The changes in benefit obligations and plan assets, as well as the funded status of these plans at December 31 were as follows: | |||||||||||||||||||||||||||||||||
Pension Benefits | Postretirement | ||||||||||||||||||||||||||||||||
Benefits | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||||||||||||||
Change in benefit obligations: | |||||||||||||||||||||||||||||||||
Obligations at beginning of year | $ | 5,618 | $ | 6,293 | $ | 1,169 | $ | 1,280 | |||||||||||||||||||||||||
Service cost | 21 | 23 | 2 | 3 | |||||||||||||||||||||||||||||
Interest cost | 266 | 247 | 53 | 50 | |||||||||||||||||||||||||||||
Actuarial (gain) loss | 941 | (540 | ) | 106 | (95 | ) | |||||||||||||||||||||||||||
Benefits paid | (457 | ) | (405 | ) | (79 | ) | (69 | ) | |||||||||||||||||||||||||
Obligations at end of year | $ | 6,389 | $ | 5,618 | $ | 1,251 | $ | 1,169 | |||||||||||||||||||||||||
Change in plan assets: | |||||||||||||||||||||||||||||||||
Fair value of plan assets at beginning of year | $ | 5,220 | $ | 5,423 | $ | 268 | $ | 258 | |||||||||||||||||||||||||
Actual return on plan assets | 536 | 142 | 14 | 31 | |||||||||||||||||||||||||||||
Employer contributions | 10 | 60 | 56 | 48 | |||||||||||||||||||||||||||||
Benefits paid | (457 | ) | (405 | ) | (79 | ) | (69 | ) | |||||||||||||||||||||||||
Fair value of plan assets at end of year | $ | 5,309 | $ | 5,220 | $ | 259 | $ | 268 | |||||||||||||||||||||||||
Funded status | $ | (1,080 | ) | $ | (398 | ) | $ | (992 | ) | $ | (901 | ) | |||||||||||||||||||||
For the pension benefit plans, the benefit obligation is the projected benefit obligation. For the postretirement benefit plans, the benefit obligation is the accumulated postretirement benefit obligation. The increase in the unfunded status for the pension and postretirement plans is primarily a result of higher obligations due to a lower discount rate, and the change in assumptions for mortality. | |||||||||||||||||||||||||||||||||
Pension Benefits | Postretirement | ||||||||||||||||||||||||||||||||
Benefits | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||||||||||||||
Amounts recognized in the consolidated balance sheets consist of: | |||||||||||||||||||||||||||||||||
Noncurrent assets — other assets and deferred charges | $ | — | $ | 1 | $ | — | $ | — | |||||||||||||||||||||||||
Accrued benefit — other current liability | (9 | ) | (9 | ) | (66 | ) | (70 | ) | |||||||||||||||||||||||||
Accrued benefit — long-term retirement benefits | (1,071 | ) | (390 | ) | (926 | ) | (831 | ) | |||||||||||||||||||||||||
Net amount recognized | (1,080 | ) | (398 | ) | (992 | ) | (901 | ) | |||||||||||||||||||||||||
Accumulated other comprehensive loss | 652 | 311 | (117 | ) | (231 | ) | |||||||||||||||||||||||||||
Net amounts recognized in the consolidated balance sheets | $ | (428 | ) | $ | (87 | ) | $ | (1,109 | ) | $ | (1,132 | ) | |||||||||||||||||||||
Amounts included in accumulated other comprehensive loss were as follows as of December 31: | |||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Pension | Postretirement | Total | Pension | Postretirement | Total | ||||||||||||||||||||||||||||
Benefits | Benefits | Benefits | Benefits | ||||||||||||||||||||||||||||||
Prior service cost (credit) | $ | 14 | $ | (178 | ) | $ | (164 | ) | $ | 17 | $ | (220 | ) | $ | (203 | ) | |||||||||||||||||
Net actuarial (gain) loss | 638 | 61 | 699 | 294 | (11 | ) | 283 | ||||||||||||||||||||||||||
Deferred income taxes | (268 | ) | 27 | (241 | ) | (134 | ) | 71 | (63 | ) | |||||||||||||||||||||||
Accumulated other comprehensive loss | $ | 384 | $ | (90 | ) | $ | 294 | $ | 177 | $ | (160 | ) | $ | 17 | |||||||||||||||||||
Changes in accumulated other comprehensive loss were as follows: | |||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Pension | Postretirement | Total | Pension | Postretirement | Total | ||||||||||||||||||||||||||||
Benefits | Benefits | Benefits | Benefits | ||||||||||||||||||||||||||||||
Net actuarial (gain) loss | $ | 764 | $ | 104 | $ | 868 | $ | (331 | ) | $ | (116 | ) | $ | (447 | ) | ||||||||||||||||||
Amortization of prior service cost (credit) | (3 | ) | 42 | 39 | (3 | ) | 42 | 39 | |||||||||||||||||||||||||
MTM adjustment | (420 | ) | (32 | ) | (452 | ) | — | — | — | ||||||||||||||||||||||||
Deferred income tax (benefit) expense | (134 | ) | (44 | ) | (178 | ) | 131 | 29 | 160 | ||||||||||||||||||||||||
Change in accumulated other comprehensive loss | $ | 207 | $ | 70 | $ | 277 | $ | (203 | ) | $ | (45 | ) | $ | (248 | ) | ||||||||||||||||||
In March 2010, the Patient Protection Affordable Care Act, referred to as the PPACA, as amended by the Health Care and Reconciliation Act of 2010, was signed into law. The PPACA mandates health-care reforms with staggered effective dates from 2010 to 2018. The additional postretirement liability resulting from the material impacts of the PPACA have been included in the accumulated postretirement benefit obligation at December 31, 2014 and 2013. Given the complexity of the PPACA and the extended time period in which implementation is expected to occur, further adjustments to the accumulated postretirement benefit obligation may be necessary in the future. | |||||||||||||||||||||||||||||||||
Pension Benefits | Postretirement | ||||||||||||||||||||||||||||||||
Benefits | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||||||||||||||
Weighted-average assumptions used to determine benefit obligations at December 31: | |||||||||||||||||||||||||||||||||
Discount rate | 4.12 | % | 4.92 | % | 4.11 | % | 4.87 | % | |||||||||||||||||||||||||
Rate of compensation increase | 4 | % | 4 | % | — | — | |||||||||||||||||||||||||||
The measurement date used for all plans was December 31. | |||||||||||||||||||||||||||||||||
The accumulated benefit obligation, which represents benefits earned to date, for all pension plans was $6,326 million and $5,557 million for the years ended December 31, 2014 and 2013, respectively. | |||||||||||||||||||||||||||||||||
Pension plans experiencing accumulated benefit obligations, which represent benefits earned to date, in excess of plan assets are summarized below: | |||||||||||||||||||||||||||||||||
December 31, | |||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Projected benefit obligation | $ | 6,389 | $ | 5,589 | |||||||||||||||||||||||||||||
Accumulated benefit obligation | 6,326 | 5,529 | |||||||||||||||||||||||||||||||
Plan assets | 5,309 | 5,190 | |||||||||||||||||||||||||||||||
The components of the total benefit (income) cost and assumptions are set forth below: | |||||||||||||||||||||||||||||||||
Pension Benefits | Postretirement Benefits | ||||||||||||||||||||||||||||||||
2014 | 2013 | 2012 | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||
Service cost | $ | 21 | $ | 23 | $ | 23 | $ | 2 | $ | 3 | $ | 3 | |||||||||||||||||||||
Interest cost | 266 | 247 | 280 | 53 | 50 | 56 | |||||||||||||||||||||||||||
Expected return on plan assets | (360 | ) | (350 | ) | (359 | ) | (12 | ) | (11 | ) | (10 | ) | |||||||||||||||||||||
Amortization of prior service cost (credit) | 3 | 3 | 4 | (42 | ) | (42 | ) | (30 | ) | ||||||||||||||||||||||||
MTM adjustment | 420 | — | 289 | 32 | — | 40 | |||||||||||||||||||||||||||
Curtailment | — | — | 4 | — | — | — | |||||||||||||||||||||||||||
Special termination benefits | — | — | 34 | — | — | — | |||||||||||||||||||||||||||
Total benefit (income) cost | $ | 350 | $ | (77 | ) | $ | 275 | $ | 33 | $ | — | $ | 59 | ||||||||||||||||||||
A workforce reduction in 2012, due to changes in the organizational structure of RJR Tobacco, RAI and RAISC, met RAI’s curtailment threshold as a major event for pension plans. As a result, curtailment charges and special termination benefits were recognized as restructuring expense. The workforce reduction did not exceed the minimum threshold for the postretirement plans, and no special postretirement termination benefits were offered. See note 5 for additional information regarding the restructuring. | |||||||||||||||||||||||||||||||||
The estimated prior service cost for the pension plans that is expected to be amortized from accumulated other comprehensive loss into net periodic benefit cost during 2015 is $3 million. The estimated prior service credit for the postretirement plans that is expected to be amortized from accumulated other comprehensive loss into net periodic benefit cost during 2015 is $42 million. | |||||||||||||||||||||||||||||||||
Pension Benefits | Postretirement Benefits | ||||||||||||||||||||||||||||||||
2014 | 2013 | 2012 | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||
Weighted-average assumptions used to determine net periodic benefit cost for years ended December 31: | |||||||||||||||||||||||||||||||||
Discount rate | 4.92 | % | 4.07 | % | 5 | % | 4.87 | % | 3.99 | % | 4.84 | % | |||||||||||||||||||||
Expected long-term return on plan assets | 7.13 | % | 6.67 | % | 6.97 | % | 4.85 | % | 4.35 | % | 4.35 | % | |||||||||||||||||||||
Rate of compensation increase | 4 | % | 4 | % | 5 | % | — | — | — | ||||||||||||||||||||||||
RAI generally uses a hypothetical bond matching analysis to determine the discount rate. The discount rate modeling process involves selecting a portfolio of high quality corporate bonds whose cash flows, via coupons and maturities, match the projected cash flows of the obligations. | |||||||||||||||||||||||||||||||||
The overall expected long-term rate of return on asset assumptions for pension and postretirement assets are based on: (1) the target asset allocation for plan assets, (2) long-term capital markets forecasts for asset classes employed, and (3) excess return expectations of active management to the extent asset classes are actively managed. | |||||||||||||||||||||||||||||||||
Plan assets are invested using active investment strategies and multiple investment management firms. Managers within each asset class cover a range of investment styles and approaches and are combined in a way that controls for capitalization, style biases, and interest rate exposures, while focusing primarily on security selection as a means to add value. Risk is controlled through diversification among asset classes, managers, styles and securities. Risk is further controlled both at the manager and asset class level by assigning excess return and tracking error targets against related benchmark indices. Investment manager performance is evaluated against these targets. | |||||||||||||||||||||||||||||||||
RAI’s risk mitigating strategy seeks to balance pension plan returns with a reasonable level of funded status volatility. Based on this framework, the asset allocation has two primary components. The first component is the “hedging portfolio,” which uses extended duration fixed income holdings and derivatives to match a portion of the interest rate risk associated with the benefit obligations, thereby reducing expected funded status volatility. The second component is the “return seeking portfolio,” which is designed to enhance portfolio returns. The return seeking portfolio is broadly diversified across asset classes. | |||||||||||||||||||||||||||||||||
Allowable investment types include domestic equity, international equity, global equity, emerging market equity, fixed income, real estate, private equity, absolute return and commodities. The range of allowable investment types utilized for pension assets provides enhanced returns and more widely diversifies the plan. Domestic equities are composed of common stocks of large, medium and small companies. International equities include equity securities issued by companies domiciled outside the United States and in depository receipts, which represent ownership of securities of non-U.S. companies. Global equities include a combination of both domestic and international equities. Emerging market equities are comprised of stocks that are domiciled in less developed, fast growing countries. Fixed income includes corporate debt obligations, fixed income securities issued or guaranteed by the U.S. government, and to a lesser extent by non-U.S. governments, mortgage backed securities, high yield securities, asset backed securities, municipal bonds and dollar-denominated obligations issued in the United States by non-U.S. banks and corporations. Real estate consists of publicly traded real estate investment trust securities and private real estate investments. Private equity consists of the unregistered securities of private and public companies. Absolute return investments are diversified portfolios utilizing multiple strategies that invest primarily in public securities, including equities and fixed income. Commodities utilize futures contracts to invest in a variety of energy, metal and agricultural goods. | |||||||||||||||||||||||||||||||||
For pension assets, futures and forward contracts are used for portfolio rebalancing and to approach fully invested portfolio positions. Otherwise, a small number of investment managers employ limited use of derivatives, including futures contracts, options on futures, forward contracts and interest rate swaps in place of direct investment in securities to gain efficient exposure to markets. | |||||||||||||||||||||||||||||||||
RAI’s pension and postretirement plans asset allocations at December 31, 2014 and 2013, by asset category were as follows: | |||||||||||||||||||||||||||||||||
Pension Plans | |||||||||||||||||||||||||||||||||
2014 Target(1) | 2014 | 2013 Target(1) | 2013 | ||||||||||||||||||||||||||||||
Asset Category: | |||||||||||||||||||||||||||||||||
Domestic equities | 10 | % | 10 | % | 10 | % | 10 | % | |||||||||||||||||||||||||
International equities | 8 | % | 8 | % | 8 | % | 9 | % | |||||||||||||||||||||||||
Global equities | 9 | % | 10 | % | 9 | % | 11 | % | |||||||||||||||||||||||||
Emerging market equities | 3 | % | 3 | % | 3 | % | 3 | % | |||||||||||||||||||||||||
Fixed income | 53 | % | 56 | % | 53 | % | 55 | % | |||||||||||||||||||||||||
Absolute return | 6 | % | 4 | % | 6 | % | 3 | % | |||||||||||||||||||||||||
Private equity | 2 | % | 1 | % | 2 | % | 1 | % | |||||||||||||||||||||||||
Real estate | 5 | % | 4 | % | 5 | % | 4 | % | |||||||||||||||||||||||||
Commodities | 4 | % | 4 | % | 4 | % | 4 | % | |||||||||||||||||||||||||
Total | 100 | % | 100 | % | 100 | % | 100 | % | |||||||||||||||||||||||||
Postretirement Plans | |||||||||||||||||||||||||||||||||
2014 Target(1) | 2014 | 2013 Target(1) | 2013 | ||||||||||||||||||||||||||||||
Asset Category: | |||||||||||||||||||||||||||||||||
Domestic equities | 21 | % | 21 | % | 21 | % | 22 | % | |||||||||||||||||||||||||
International equities | 21 | % | 20 | % | 21 | % | 22 | % | |||||||||||||||||||||||||
Fixed income | 55 | % | 54 | % | 55 | % | 51 | % | |||||||||||||||||||||||||
Cash and other | 3 | % | 5 | % | 3 | % | 5 | % | |||||||||||||||||||||||||
Total | 100 | % | 100 | % | 100 | % | 100 | % | |||||||||||||||||||||||||
-1 | Allows for a rebalancing range of up to 5 percentage points around target asset allocations. | ||||||||||||||||||||||||||||||||
RAI’s pension and postretirement plan assets, excluding uninvested cash and unsettled trades, carried at fair value on a recurring basis as of December 31, 2014 and 2013, were as follows(1): | |||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Pension Plans | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
Asset Category: | |||||||||||||||||||||||||||||||||
Domestic equities | $ | 511 | $ | — | $ | — | $ | 511 | $ | 523 | $ | — | $ | — | $ | 523 | |||||||||||||||||
International equities | 134 | 172 | — | 306 | 135 | 404 | — | 539 | |||||||||||||||||||||||||
Global equities | 570 | — | — | 570 | 535 | — | — | 535 | |||||||||||||||||||||||||
High yield fixed income | — | 19 | — | 19 | — | 18 | — | 18 | |||||||||||||||||||||||||
Absolute return | — | 126 | 223 | 349 | — | — | 176 | 176 | |||||||||||||||||||||||||
Private equity | — | — | 66 | 66 | — | — | 53 | 53 | |||||||||||||||||||||||||
Real estate | 21 | — | 188 | 209 | 22 | — | 190 | 212 | |||||||||||||||||||||||||
Commodities | — | 156 | — | 156 | — | 185 | — | 185 | |||||||||||||||||||||||||
Agency bonds | — | 21 | — | 21 | — | 17 | — | 17 | |||||||||||||||||||||||||
Asset backed securities | — | 93 | 3 | 96 | — | 89 | 3 | 92 | |||||||||||||||||||||||||
Corporate bonds | — | 1,739 | 2 | 1,741 | — | 1,568 | 2 | 1,570 | |||||||||||||||||||||||||
Government bonds | — | 153 | — | 153 | — | 152 | — | 152 | |||||||||||||||||||||||||
Mortgage backed securities | — | 42 | 25 | 67 | — | 74 | 21 | 95 | |||||||||||||||||||||||||
Municipal bonds | — | 209 | — | 209 | — | 212 | — | 212 | |||||||||||||||||||||||||
Emerging market equities | — | 52 | — | 52 | — | — | — | — | |||||||||||||||||||||||||
Treasuries | — | 414 | — | 414 | — | 398 | — | 398 | |||||||||||||||||||||||||
Other | 62 | 101 | 2 | 165 | 30 | 72 | 2 | 104 | |||||||||||||||||||||||||
Total | $ | 1,298 | $ | 3,297 | $ | 509 | $ | 5,104 | $ | 1,245 | $ | 3,189 | $ | 447 | $ | 4,881 | |||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Postretirement Plans | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
Asset Category: | |||||||||||||||||||||||||||||||||
Domestic equities | $ | — | $ | 55 | $ | — | $ | 55 | $ | — | $ | 60 | $ | — | $ | 60 | |||||||||||||||||
International equities | — | 50 | — | 50 | — | 59 | — | 59 | |||||||||||||||||||||||||
Short-term bonds | 9 | — | — | 9 | 9 | — | — | 9 | |||||||||||||||||||||||||
Intermediate bonds | — | 131 | — | 131 | — | 127 | — | 127 | |||||||||||||||||||||||||
Other | — | 7 | — | 7 | — | 7 | — | 7 | |||||||||||||||||||||||||
Total | $ | 9 | $ | 243 | $ | — | $ | 252 | $ | 9 | $ | 253 | $ | — | $ | 262 | |||||||||||||||||
-1 | See note 1 for additional information on the fair value hierarchy. | ||||||||||||||||||||||||||||||||
Transfers of pension and postretirement plan assets in and out of Level 3 during 2014, by asset category were as follows: | |||||||||||||||||||||||||||||||||
Balance as of | Purchases, Sales, | Realized | Unrealized | Transferred | Balance as of | ||||||||||||||||||||||||||||
January 1, 2014 | Issuances and | Gains | Gains | From Other | December 31, 2014 | ||||||||||||||||||||||||||||
Settlements (net) | (Losses) | Levels | |||||||||||||||||||||||||||||||
Absolute return | $ | 176 | $ | 40 | $ | 13 | $ | (6 | ) | $ | — | $ | 223 | ||||||||||||||||||||
Private equity | 53 | 6 | 7 | — | — | 66 | |||||||||||||||||||||||||||
Real estate | 190 | (24 | ) | 8 | 14 | — | 188 | ||||||||||||||||||||||||||
Asset backed securities | 3 | — | — | — | — | 3 | |||||||||||||||||||||||||||
Corporate bonds | 2 | — | — | — | — | 2 | |||||||||||||||||||||||||||
Mortgage backed securities | 21 | 2 | 1 | 1 | — | 25 | |||||||||||||||||||||||||||
Other | 2 | — | — | — | — | 2 | |||||||||||||||||||||||||||
Total | $ | 447 | $ | 24 | $ | 29 | $ | 9 | $ | — | $ | 509 | |||||||||||||||||||||
Transfers of pension and postretirement plan assets in and out of Level 3 during 2013, by asset category were as follows: | |||||||||||||||||||||||||||||||||
Balance as of | Purchases, Sales, | Realized | Unrealized | Transferred | Balance as of | ||||||||||||||||||||||||||||
January 1, 2013 | Issuances and | Gains | Gains | From Other | December 31, 2013 | ||||||||||||||||||||||||||||
Settlements (net) | (Losses) | Levels | |||||||||||||||||||||||||||||||
Absolute return | $ | 189 | $ | (32 | ) | $ | 31 | $ | (12 | ) | $ | — | $ | 176 | |||||||||||||||||||
Private equity | 47 | (1 | ) | 4 | 3 | — | 53 | ||||||||||||||||||||||||||
Real estate | 178 | (9 | ) | 4 | 17 | — | 190 | ||||||||||||||||||||||||||
Asset backed securities | 5 | (2 | ) | — | — | — | 3 | ||||||||||||||||||||||||||
Corporate bonds | 2 | — | — | — | — | 2 | |||||||||||||||||||||||||||
Mortgage backed securities | 21 | — | — | — | — | 21 | |||||||||||||||||||||||||||
Other | 2 | — | — | — | — | 2 | |||||||||||||||||||||||||||
Total | $ | 444 | $ | (44 | ) | $ | 39 | $ | 8 | $ | — | $ | 447 | ||||||||||||||||||||
For the years ended December 31, 2014 and 2013, there were no changes among the fair value hierarchy levels between Level 1 and Level 2. | |||||||||||||||||||||||||||||||||
At December 31, 2014 and 2013, the fair value of pension and postretirement assets classified as Level 2 or Level 3 was determined using a combination of third party pricing services and net asset value. In instances where the plans have invested in commingled pools, the net asset value was used as the practical expedient and no adjustments were made to the provided fair value. | |||||||||||||||||||||||||||||||||
The fair value of commingled pools classified as commodities, emerging market equities, municipal bonds, high yield fixed income, mortgage backed securities, domestic equities, international equities, intermediate bonds, other and certain of those classified as real estate, asset backed securities and absolute return, classified as Level 2 and Level 3, was determined primarily using an income approach. This approach utilized the net asset value of the underlying investment fund adjusted by the investment manager for restrictions or illiquidity of the disposition of the interest, if any, valuations provided by the fund’s cash flows, and the rights and obligations of the ownership interest of the fund. | |||||||||||||||||||||||||||||||||
The fair value of assets classified as private equity and certain of those classified as real estate and absolute return, classified as Level 3, was determined primarily using an income approach. The fair value was determined by qualified appraisers utilizing observable and unobservable data, including comparable transactions, the fair value of the underlying assets, discount rates, restrictions on disposing interests in the investment’s cash flows and other entity specific risk factors. | |||||||||||||||||||||||||||||||||
The fair value of assets classified as corporate bonds, other and certain of those classified as asset backed securities, classified as Level 3, was determined primarily using an income approach that utilized cash flow models and benchmarking strategies. This approach utilized observable inputs, including market-based interest rate curves, corporate credit spreads and corporate ratings. Additionally, unobservable factors incorporated into these models included default probability assumptions, potential recovery and discount rates. | |||||||||||||||||||||||||||||||||
Additional information relating to RAI’s significant postretirement plans is as follows: | |||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Weighted-average health-care cost trend rate assumed for the following year | 7.25 | % | 7.5 | % | |||||||||||||||||||||||||||||
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) | 5 | % | 5 | % | |||||||||||||||||||||||||||||
Year that the rate reaches the ultimate trend rate | 2020 | 2020 | |||||||||||||||||||||||||||||||
Assumed health-care cost trend rates have a significant effect on the amounts reported for the health-care plans. A one-percentage-point change in assumed health-care cost trend rates would have had the following effects at December 31, 2014: | |||||||||||||||||||||||||||||||||
1-Percentage | 1-Percentage | ||||||||||||||||||||||||||||||||
Point | Point | ||||||||||||||||||||||||||||||||
Increase | Decrease | ||||||||||||||||||||||||||||||||
Effect on total of service and interest cost components | $ | 3 | $ | (2 | ) | ||||||||||||||||||||||||||||
Effect on benefit obligation | 81 | (68 | ) | ||||||||||||||||||||||||||||||
During 2015, RAI expects to contribute $109 million to its pension plans and expects payments related to its postretirement plans to be approximately $66 million. | |||||||||||||||||||||||||||||||||
Estimated future benefit payments: | |||||||||||||||||||||||||||||||||
Pension | Postretirement Benefits | ||||||||||||||||||||||||||||||||
Year | Benefits | Gross Projected | Expected | Net Projected | |||||||||||||||||||||||||||||
Benefit Payments | Medicare | Benefit Payments | |||||||||||||||||||||||||||||||
Before Medicare | Part D | After Medicare | |||||||||||||||||||||||||||||||
Part D Subsidies | Subsidies | Part D Subsidies | |||||||||||||||||||||||||||||||
2015 | $ | 439 | $ | 97 | $ | (2 | ) | $ | 95 | ||||||||||||||||||||||||
2016 | 405 | 89 | (2 | ) | 87 | ||||||||||||||||||||||||||||
2017 | 406 | 87 | (2 | ) | 85 | ||||||||||||||||||||||||||||
2018 | 397 | 85 | (2 | ) | 83 | ||||||||||||||||||||||||||||
2019 | 394 | 84 | (3 | ) | 81 | ||||||||||||||||||||||||||||
2020-2024 | 1,897 | 390 | (15 | ) | 375 | ||||||||||||||||||||||||||||
RAI sponsors qualified defined contribution plans. The expense related to these plans was $37 million in 2014 and $34 million in 2013 and 2012. Included in the plans is a non-leveraged employee stock ownership plan, which holds shares of the Reynolds Stock Fund. Participants can elect to contribute to the fund. Dividends paid on shares are reflected as a reduction of equity. All shares are considered outstanding for earnings per share computations. |
Segment_Information
Segment Information | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Segment Information | Note 16 — Segment Information | ||||||||||||
RAI’s reportable operating segments are RJR Tobacco, American Snuff and Santa Fe. The RJR Tobacco segment consists principally of the primary operations of R. J. Reynolds Tobacco Company. The American Snuff segment consists of the primary operations of American Snuff Co. The Santa Fe segment consists of the domestic operations of SFNTC. Included in All Other, among other RAI subsidiaries, are RJR Vapor, Niconovum USA, Inc., Niconovum AB, SFRTI and various foreign subsidiaries affiliated with SFRTI. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance. Certain of RAI’s operating subsidiaries have entered into intercompany agreements for products or services with other subsidiaries. As a result, certain activities of an operating subsidiary may be included in a different segment of RAI. | |||||||||||||
RAI’s largest reportable operating segment, RJR Tobacco, is the second largest tobacco company in the United States. RJR Tobacco’s brands include two of the best-selling cigarettes in the United States: CAMEL and PALL MALL. These brands, and its other brands, including WINSTON, KOOL, DORAL, SALEM, MISTY and CAPRI, are manufactured in a variety of styles and marketed in the United States. As part of its total tobacco strategy, RJR Tobacco also offers a smoke-free tobacco product, CAMEL Snus. RJR Tobacco manages contract manufacturing of cigarette and tobacco products through arrangements with BAT affiliates, and manages the export of tobacco products to certain U.S. territories, U.S. duty-free shops and U.S. overseas military bases. RJR Tobacco manages the super-premium cigarettes, DUNHILL and STATE EXPRESS 555, which are licensed from BAT. | |||||||||||||
American Snuff is the second largest smokeless tobacco products manufacturer in the United States. American Snuff’s primary brands include its largest selling moist snuff brands, GRIZZLY and KODIAK. | |||||||||||||
Santa Fe manufactures and markets super-premium cigarettes and other tobacco products under the NATURAL AMERICAN SPIRIT brand in the United States. | |||||||||||||
RJR Vapor is a manufacturer and marketer of digital vapor cigarettes under the VUSE brand name in the United States. Niconovum USA, Inc. and Niconovum AB are marketers of nicotine replacement therapy products in the United States and Sweden, respectively, under the ZONNIC brand name. SFRTI and various foreign subsidiaries affiliated with SFRTI distribute the NATURAL AMERICAN SPIRIT brand outside of the United States. | |||||||||||||
Intersegment revenues and items below the operating income line of the consolidated statements of income are not presented by segment, since they are excluded from the measure of segment profitability reviewed by RAI’s chief operating decision maker. Additionally, information about total assets by segment is not reviewed by RAI’s chief operating decision maker and therefore is not disclosed. | |||||||||||||
Segment Data: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Net sales: | |||||||||||||
RJR Tobacco | $ | 6,767 | $ | 6,728 | $ | 6,960 | |||||||
American Snuff | 783 | 745 | 681 | ||||||||||
Santa Fe | 658 | 572 | 486 | ||||||||||
All Other | 263 | 191 | 177 | ||||||||||
Consolidated net sales | $ | 8,471 | $ | 8,236 | $ | 8,304 | |||||||
Operating income (loss): | |||||||||||||
RJR Tobacco(1)(2)(3)(4) | $ | 2,173 | $ | 2,587 | $ | 1,735 | |||||||
American Snuff(4) | 438 | 420 | 374 | ||||||||||
Santa Fe(5) | 337 | 280 | 237 | ||||||||||
All Other(2) | (234 | ) | (70 | ) | (36 | ) | |||||||
Corporate Expense(1)(4) | (183 | ) | (85 | ) | (96 | ) | |||||||
Consolidated operating income | $ | 2,531 | $ | 3,132 | $ | 2,214 | |||||||
Cash capital expenditures: | |||||||||||||
RJR Tobacco | $ | 53 | $ | 55 | $ | 36 | |||||||
American Snuff | 12 | 15 | 24 | ||||||||||
Santa Fe | 7 | 2 | 4 | ||||||||||
All Other | 132 | 81 | 24 | ||||||||||
Consolidated capital expenditures | $ | 204 | $ | 153 | $ | 88 | |||||||
Depreciation and amortization expense: | |||||||||||||
RJR Tobacco | $ | 65 | $ | 68 | $ | 99 | |||||||
American Snuff | 17 | 18 | 19 | ||||||||||
Santa Fe | 3 | 3 | 2 | ||||||||||
All Other | 21 | 14 | 11 | ||||||||||
Consolidated depreciation and amortization expense | $ | 106 | $ | 103 | $ | 131 | |||||||
Reconciliation to income from continuing operations before income taxes: | |||||||||||||
Consolidated operating income(1)(2)(3)(4)(5) | $ | 2,531 | $ | 3,132 | $ | 2,214 | |||||||
Interest and debt expense | 286 | 259 | 234 | ||||||||||
Interest income | (3 | ) | (5 | ) | (7 | ) | |||||||
Other (income) expense, net | (14 | ) | 137 | 34 | |||||||||
Income from continuing operations before income taxes | $ | 2,262 | $ | 2,741 | $ | 1,953 | |||||||
-1 | Includes restructuring and/or asset impairment charges of $149 million for the year ended December 31, 2012, see “Restructuring Charges” in note 5. | ||||||||||||
(2) | Includes trademark, goodwill and/or other intangible asset impairment charges of $32 million and $129 million for the years ended December 31, 2013 and 2012, respectively, see “Intangible Assets” in note 4. | ||||||||||||
(3) | Includes NPM Adjustment credits of $341 million and $478 million for RJR Tobacco for the years ended December 31, 2014 and 2013, respectively, see “— Cost of Products Sold” in note 1. | ||||||||||||
(4) | Includes MTM adjustment of $422 million for RJR Tobacco, $4 million for American Snuff and $26 million for Corporate Expense for the year ended December 31, 2014. Includes MTM adjustment of $300 million for RJR Tobacco, $5 million for American Snuff and $24 million for Corporate Expense for the year ended December 31, 2012. | ||||||||||||
(5) | Includes NPM Adjustment credits of $4 million and $5 million for Santa Fe for the years ended December 31, 2014 and 2013, respectively, see “— Cost of Products Sold” in note 1. | ||||||||||||
Sales to McLane Company, Inc., a distributor, constituted approximately 31% of RAI’s consolidated revenue in each of 2014, 2013 and 2012. Sales to Core-Mark International, Inc., a distributor, represented approximately 11% of RAI’s consolidated revenue in each of 2014 and 2013, and 10% in 2012. McLane Company, Inc. and Core-Mark International, Inc. are customers of RJR Tobacco, American Snuff and Santa Fe. No other customer accounted for 10% or more of RAI’s consolidated revenue during those periods. | |||||||||||||
RAI’s operating subsidiaries’ sales to foreign countries, primarily to related parties, for the years ended December 31, 2014, 2013 and 2012 were $497 million, $496 million and $493 million, respectively. |
Related_Party_Transactions
Related Party Transactions | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Related Party Transactions | Note 17 — Related Party Transactions | ||||||||||||
RAI and RAI’s operating subsidiaries engage in transactions with affiliates of BAT, which owns approximately 42% of RAI’s outstanding common stock. The following is a summary of balances and transactions with such BAT affiliates as of and for the years ended December 31: | |||||||||||||
Balances: | |||||||||||||
2014 | 2013 | ||||||||||||
Accounts receivable, related party | $ | 41 | $ | 56 | |||||||||
Due to related party | 1 | — | |||||||||||
Deferred revenue, related party | 32 | 48 | |||||||||||
Significant transactions: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Net sales | $ | 311 | $ | 337 | $ | 342 | |||||||
Purchases | 28 | 27 | 16 | ||||||||||
RAI common stock purchases from B&W | 155 | 296 | 415 | ||||||||||
Capsule royalty income | 7 | 9 | 6 | ||||||||||
Research and development services billings | 4 | 4 | 3 | ||||||||||
RJR Tobacco sells contract-manufactured cigarettes, tobacco leaf and processed tobacco to BAT affiliates. In December 2012, RJR Tobacco entered into an amendment to its contract manufacturing agreement with a BAT affiliate, which amendment, among other things, requires either party to provide three years’ notice to the other party to terminate the agreement without cause, with any such notice to be given no earlier than January 1, 2016. Net sales to BAT affiliates, primarily cigarettes, represented approximately 4% of RAI’s total net sales in each of 2014, 2013 and 2012. | |||||||||||||
RJR Tobacco recorded deferred sales revenue relating to leaf sold to BAT affiliates that had not been delivered as of December 31, in each of 2014, 2013 and 2012, given that RJR Tobacco has a legal right to bill the BAT affiliates. Leaf sales revenue to BAT affiliates is recognized when the product is shipped to the customer. RJR Tobacco recorded royalty income from the license of capsule technology to BAT affiliates. | |||||||||||||
RJR Tobacco performs certain research and development for BAT affiliates pursuant to a joint technology sharing agreement entered into as a part of the B&W business combination. These services were billed to BAT affiliates and were recorded in RJR Tobacco’s selling, general and administrative expenses, net of associated costs. | |||||||||||||
RAI’s operating subsidiaries also purchase unprocessed leaf at market prices, and import cigarettes at prices not to exceed manufacturing costs plus 10%, from BAT affiliates. | |||||||||||||
In connection with RAI’s share repurchase program, RAI and B&W entered into an agreement in November 2011, pursuant to which B&W agreed to participate in the repurchase program on a basis approximately proportionate with B&W’s 42% ownership of RAI common stock. Under this agreement, which concluded in the second quarter of 2014, RAI repurchased 2,887,715 shares of RAI common stock from B&W during 2014 and 21,702,839 shares in total. | |||||||||||||
A member of the board of directors of RAI is also a member of the board of directors of a financial institution, a subsidiary of which is a participant in RAI’s Credit Agreement. | |||||||||||||
On July 15, 2014, RAI and BAT entered into a Subscription Agreement as part of the Proposed Transactions. For additional information, see note 2. |
RAI_Guaranteed_Unsecured_Notes
RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements | 12 Months Ended | ||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||
RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements | Note 18 — RAI Guaranteed, Unsecured Notes — Condensed Consolidating Financial Statements | ||||||||||||||||||||||
The following condensed consolidating financial statements relate to the guaranties of RAI’s $5.1 billion unsecured notes. See note 11 for additional information relating to these notes. Certain of RAI’s direct, wholly owned subsidiaries and certain of its indirectly owned subsidiaries have fully and unconditionally, and jointly and severally, guaranteed these notes. The following condensed consolidating financial statements include: the accounts and activities of RAI, the parent issuer; RJR, RJR Tobacco, American Snuff Co., SFNTC and certain of RAI’s other subsidiaries, the Guarantors; other direct and indirect subsidiaries of RAI that are not Guarantors; and elimination adjustments. | |||||||||||||||||||||||
Condensed Consolidating Statements of Income | |||||||||||||||||||||||
(Dollars in Millions) | |||||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
For the Year Ended December 31, 2014 | |||||||||||||||||||||||
Net sales | $ | — | $ | 8,109 | $ | 232 | $ | (181 | ) | $ | 8,160 | ||||||||||||
Net sales, related party | — | 311 | — | — | 311 | ||||||||||||||||||
Net Sales | — | 8,420 | 232 | (181 | ) | 8,471 | |||||||||||||||||
Cost of products sold | — | 4,002 | 235 | (179 | ) | 4,058 | |||||||||||||||||
Selling, general and administrative expenses | 75 | 1,535 | 261 | — | 1,871 | ||||||||||||||||||
Amortization expense | — | 11 | — | — | 11 | ||||||||||||||||||
Operating income (loss) | (75 | ) | 2,872 | (264 | ) | (2 | ) | 2,531 | |||||||||||||||
Interest and debt expense | 286 | 79 | 6 | (85 | ) | 286 | |||||||||||||||||
Interest income | (85 | ) | (3 | ) | — | 85 | (3 | ) | |||||||||||||||
Other (income) expense, net | 4 | (44 | ) | (17 | ) | 43 | (14 | ) | |||||||||||||||
Income (loss) from continuing operations before income taxes | (280 | ) | 2,840 | (253 | ) | (45 | ) | 2,262 | |||||||||||||||
Provision for (benefit from) income taxes | (89 | ) | 1,004 | (98 | ) | — | 817 | ||||||||||||||||
Equity income from subsidiaries | 1,661 | 26 | — | (1,687 | ) | — | |||||||||||||||||
Income (loss) from continuing operations | 1,470 | 1,862 | (155 | ) | (1,732 | ) | 1,445 | ||||||||||||||||
Income from discontinued operations, net of tax | — | 25 | — | — | 25 | ||||||||||||||||||
Net income (loss) | $ | 1,470 | $ | 1,887 | $ | (155 | ) | $ | (1,732 | ) | $ | 1,470 | |||||||||||
For the Year Ended December 31, 2013 | |||||||||||||||||||||||
Net sales | $ | — | $ | 7,785 | $ | 147 | $ | (33 | ) | $ | 7,899 | ||||||||||||
Net sales, related party | — | 337 | — | — | 337 | ||||||||||||||||||
Net Sales | — | 8,122 | 147 | (33 | ) | 8,236 | |||||||||||||||||
Cost of products sold | — | 3,628 | 83 | (33 | ) | 3,678 | |||||||||||||||||
Selling, general and administrative expenses | 13 | 1,222 | 154 | — | 1,389 | ||||||||||||||||||
Amortization expense | — | 5 | — | — | 5 | ||||||||||||||||||
Trademark and other intangible asset impairment charges | — | 32 | — | — | 32 | ||||||||||||||||||
Operating income (loss) | (13 | ) | 3,235 | (90 | ) | — | 3,132 | ||||||||||||||||
Interest and debt expense | 255 | 113 | 2 | (111 | ) | 259 | |||||||||||||||||
Interest income | (111 | ) | (3 | ) | (2 | ) | 111 | (5 | ) | ||||||||||||||
Other (income) expense, net | 129 | (45 | ) | 10 | 43 | 137 | |||||||||||||||||
Income (loss) before income taxes | (286 | ) | 3,170 | (100 | ) | (43 | ) | 2,741 | |||||||||||||||
Provision for (benefit from) income taxes | (95 | ) | 1,154 | (36 | ) | — | 1,023 | ||||||||||||||||
Equity income from subsidiaries | 1,909 | 5 | — | (1,914 | ) | — | |||||||||||||||||
Net income (loss) | $ | 1,718 | $ | 2,021 | $ | (64 | ) | $ | (1,957 | ) | $ | 1,718 | |||||||||||
For the Year Ended December 31, 2012 | |||||||||||||||||||||||
Net sales | $ | — | $ | 7,857 | $ | 134 | $ | (29 | ) | $ | 7,962 | ||||||||||||
Net sales, related party | — | 342 | — | — | 342 | ||||||||||||||||||
Net Sales | — | 8,199 | 134 | (29 | ) | 8,304 | |||||||||||||||||
Cost of products sold | — | 4,316 | 34 | (29 | ) | 4,321 | |||||||||||||||||
Selling, general and administrative expenses | 23 | 1,341 | 106 | — | 1,470 | ||||||||||||||||||
Amortization expense | — | 21 | — | — | 21 | ||||||||||||||||||
Trademark and other intangible asset impairment charges | — | 82 | 47 | — | 129 | ||||||||||||||||||
Restructuring charge | 4 | 145 | — | — | 149 | ||||||||||||||||||
Operating income (loss) | (27 | ) | 2,294 | (53 | ) | — | 2,214 | ||||||||||||||||
Interest and debt expense | 228 | 119 | — | (113 | ) | 234 | |||||||||||||||||
Interest income | (113 | ) | (3 | ) | (4 | ) | 113 | (7 | ) | ||||||||||||||
Other (income) expense, net | 26 | (44 | ) | 9 | 43 | 34 | |||||||||||||||||
Income (loss) before income taxes | (168 | ) | 2,222 | (58 | ) | (43 | ) | 1,953 | |||||||||||||||
Provision for (benefit from) income taxes | (59 | ) | 762 | (21 | ) | (1 | ) | 681 | |||||||||||||||
Equity income (loss) from subsidiaries | 1,381 | (16 | ) | — | (1,365 | ) | — | ||||||||||||||||
Net income (loss) | $ | 1,272 | $ | 1,444 | $ | (37 | ) | $ | (1,407 | ) | $ | 1,272 | |||||||||||
Condensed Consolidating Statements of Comprehensive Income | |||||||||||||||||||||||
(Dollars in Millions) | |||||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
For the Year Ended December 31, 2014 | |||||||||||||||||||||||
Net income (loss) | $ | 1,470 | $ | 1,887 | $ | (155 | ) | $ | (1,732 | ) | $ | 1,470 | |||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
Retirement benefits | (277 | ) | (271 | ) | (1 | ) | 272 | (277 | ) | ||||||||||||||
Unrealized gain on long-term investments | 2 | 2 | — | (2 | ) | 2 | |||||||||||||||||
Amortization of realized loss on hedging instruments | 1 | — | — | — | 1 | ||||||||||||||||||
Cumulative translation adjustment and other | (34 | ) | (34 | ) | (48 | ) | 82 | (34 | ) | ||||||||||||||
Comprehensive income (loss) | $ | 1,162 | $ | 1,584 | $ | (204 | ) | $ | (1,380 | ) | $ | 1,162 | |||||||||||
For the Year Ended December 31, 2013 | |||||||||||||||||||||||
Net income (loss) | $ | 1,718 | $ | 2,021 | $ | (64 | ) | $ | (1,957 | ) | $ | 1,718 | |||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
Retirement benefits | 248 | 239 | (1 | ) | (238 | ) | 248 | ||||||||||||||||
Unrealized gain on long-term investments | 5 | 5 | — | (5 | ) | 5 | |||||||||||||||||
Amortization of realized loss on hedging instruments | 1 | — | — | — | 1 | ||||||||||||||||||
Cumulative translation adjustment and other | 1 | 1 | 14 | (15 | ) | 1 | |||||||||||||||||
Comprehensive income (loss) | $ | 1,973 | $ | 2,266 | $ | (51 | ) | $ | (2,215 | ) | $ | 1,973 | |||||||||||
For the Year Ended December 31, 2012 | |||||||||||||||||||||||
Net income (loss) | $ | 1,272 | $ | 1,444 | $ | (37 | ) | $ | (1,407 | ) | $ | 1,272 | |||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
Retirement benefits | 65 | 65 | — | (65 | ) | 65 | |||||||||||||||||
Unrealized gain on long-term investments | 7 | 7 | — | (7 | ) | 7 | |||||||||||||||||
Realized loss on hedging instruments | (14 | ) | — | — | — | (14 | ) | ||||||||||||||||
Cumulative translation adjustment and other | 13 | 13 | 9 | (22 | ) | 13 | |||||||||||||||||
Comprehensive income (loss) | $ | 1,343 | $ | 1,529 | $ | (28 | ) | $ | (1,501 | ) | $ | 1,343 | |||||||||||
Details about the reclassifications out of accumulated other comprehensive loss and the affected line items in the consolidating statements of income for the year ended December 31, 2014, were as follows: | |||||||||||||||||||||||
Components | Amount Reclassified | Affected Line Item | |||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
Defined benefit pension and postretirement plans: | |||||||||||||||||||||||
Amortization of prior service costs | $ | — | $ | (21 | ) | $ | — | $ | — | $ | (21 | ) | Cost of products sold | ||||||||||
Amortization of prior service costs | — | (18 | ) | — | — | (18 | ) | Selling, general and administrative expenses | |||||||||||||||
MTM adjustment | — | 205 | — | — | 205 | Cost of products sold | |||||||||||||||||
MTM adjustment | 10 | 236 | 1 | — | 247 | Selling, general and administrative expenses | |||||||||||||||||
10 | 402 | 1 | — | 413 | |||||||||||||||||||
Deferred taxes | (4 | ) | (158 | ) | — | — | (162 | ) | Provision for income taxes | ||||||||||||||
Defined benefit pension and postretirement plans | 245 | — | — | (245 | ) | — | Equity income from subsidiaries | ||||||||||||||||
Net of tax | $ | 251 | $ | 244 | $ | 1 | $ | (245 | ) | $ | 251 | ||||||||||||
Loss on hedging instruments: | |||||||||||||||||||||||
Amortization of realized loss | $ | 2 | $ | — | $ | — | $ | — | $ | 2 | Interest and debt expense | ||||||||||||
Deferred taxes | (1 | ) | — | — | — | (1 | ) | Provision for income taxes | |||||||||||||||
Net of tax | $ | 1 | $ | — | $ | — | $ | — | $ | 1 | |||||||||||||
Total reclassifications | $ | 252 | $ | 244 | $ | 1 | $ | (245 | ) | $ | 252 | Net income (loss) | |||||||||||
Details about the reclassifications out of accumulated other comprehensive loss and the affected line items in the consolidating statements of income for the year ended December 31, 2013, were as follows: | |||||||||||||||||||||||
Components | Amount Reclassified | Affected Line Item | |||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
Defined benefit pension and postretirement plans: | |||||||||||||||||||||||
Amortization of prior service costs | $ | — | $ | (21 | ) | $ | — | $ | — | $ | (21 | ) | Cost of products sold | ||||||||||
Amortization of prior service costs | — | (18 | ) | — | — | (18 | ) | Selling, general and administrative expenses | |||||||||||||||
— | (39 | ) | — | — | (39 | ) | |||||||||||||||||
Deferred taxes | — | 16 | — | — | 16 | Provision for income taxes | |||||||||||||||||
Defined benefit pension and postretirement plans | (23 | ) | — | — | 23 | — | Equity income from subsidiaries | ||||||||||||||||
Net of tax | $ | (23 | ) | $ | (23 | ) | $ | — | $ | 23 | $ | (23 | ) | ||||||||||
Loss on hedging instruments: | |||||||||||||||||||||||
Amortization of realized loss | $ | 2 | $ | — | $ | — | $ | — | $ | 2 | Interest and debt expense | ||||||||||||
Deferred taxes | (1 | ) | — | — | — | (1 | ) | Provision for income taxes | |||||||||||||||
Net of tax | $ | 1 | $ | — | $ | — | $ | — | $ | 1 | |||||||||||||
Total reclassifications | $ | (22 | ) | $ | (23 | ) | $ | — | $ | 23 | $ | (22 | ) | Net income (loss) | |||||||||
Condensed Consolidating Statements of Cash Flows | |||||||||||||||||||||||
(Dollars in Millions) | |||||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
For the Year Ended December 31, 2014 | |||||||||||||||||||||||
Cash flows from (used in) operating activities | $ | 1,277 | $ | 1,865 | $ | (179 | ) | $ | (1,340 | ) | $ | 1,623 | |||||||||||
Cash flows from (used in) investing activities: | |||||||||||||||||||||||
Capital expenditures | — | (265 | ) | (94 | ) | 155 | (204 | ) | |||||||||||||||
Proceeds from termination of joint venture | — | — | 35 | — | 35 | ||||||||||||||||||
Return of intercompany investments | 165 | — | — | (165 | ) | — | |||||||||||||||||
Other, net | 218 | 39 | 126 | (419 | ) | (36 | ) | ||||||||||||||||
Net cash flows from (used in) investing activities | 383 | (226 | ) | 67 | (429 | ) | (205 | ) | |||||||||||||||
Cash flows from (used in) financing activities: | |||||||||||||||||||||||
Dividends paid on common stock | (1,411 | ) | (1,301 | ) | — | 1,301 | (1,411 | ) | |||||||||||||||
Repurchase of common stock | (440 | ) | — | — | — | (440 | ) | ||||||||||||||||
Excess tax benefit on stock-based compensation plans | 12 | — | — | — | 12 | ||||||||||||||||||
Principal borrowings under revolving credit facility | 1,000 | — | — | — | 1,000 | ||||||||||||||||||
Repayments under revolving credit facility | (1,000 | ) | — | — | — | (1,000 | ) | ||||||||||||||||
Debt issuance costs and financing fees | (79 | ) | — | — | — | (79 | ) | ||||||||||||||||
Dividends paid on preferred stock | (43 | ) | — | — | 43 | — | |||||||||||||||||
Distribution of equity | — | (165 | ) | — | 165 | — | |||||||||||||||||
Other, net | (41 | ) | (400 | ) | 181 | 260 | — | ||||||||||||||||
Net cash flows from (used in) financing activities | (2,002 | ) | (1,866 | ) | 181 | 1,769 | (1,918 | ) | |||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | (34 | ) | — | (34 | ) | ||||||||||||||||
Net change in cash and cash equivalents | (342 | ) | (227 | ) | 35 | — | (534 | ) | |||||||||||||||
Cash and cash equivalents at beginning of year | 444 | 696 | 360 | — | 1,500 | ||||||||||||||||||
Cash and cash equivalents at end of year | $ | 102 | $ | 469 | $ | 395 | $ | — | $ | 966 | |||||||||||||
For the Year Ended December 31, 2013 | |||||||||||||||||||||||
Cash flows from (used in) operating activities | $ | 1,519 | $ | 945 | $ | (70 | ) | $ | (1,086 | ) | $ | 1,308 | |||||||||||
Cash flows from (used in) investing activities: | |||||||||||||||||||||||
Capital expenditures | — | (80 | ) | (74 | ) | 1 | (153 | ) | |||||||||||||||
Proceeds from termination of joint venture | — | — | 31 | — | 31 | ||||||||||||||||||
Return of intercompany investments | 300 | — | — | (300 | ) | — | |||||||||||||||||
Other, net | 81 | 33 | (1 | ) | (104 | ) | 9 | ||||||||||||||||
Net cash flows from (used in) investing activities | 381 | (47 | ) | (44 | ) | (403 | ) | (113 | ) | ||||||||||||||
Cash flows from (used in) financing activities: | |||||||||||||||||||||||
Dividends paid on common stock | (1,335 | ) | (1,042 | ) | — | 1,042 | (1,335 | ) | |||||||||||||||
Repurchase of common stock | (775 | ) | — | — | — | (775 | ) | ||||||||||||||||
Excess tax benefit on stock-based compensation plans | 14 | — | — | — | 14 | ||||||||||||||||||
Principal borrowings under term-loan credit facility | 500 | — | — | — | 500 | ||||||||||||||||||
Repayment under term-loan credit facility | (500 | ) | — | — | — | (500 | ) | ||||||||||||||||
Proceeds from issuance of long-term debt, net of discounts | 1,097 | — | — | — | 1,097 | ||||||||||||||||||
Repayments of long-term debt | (975 | ) | (60 | ) | — | — | (1,035 | ) | |||||||||||||||
Debt issuance costs and financing fees | (18 | ) | — | — | — | (18 | ) | ||||||||||||||||
Make-whole premium for early extinguishment of debt | (155 | ) | — | — | — | (155 | ) | ||||||||||||||||
Dividends paid on preferred stock | (43 | ) | — | — | 43 | — | |||||||||||||||||
Distribution of equity | — | (300 | ) | — | 300 | — | |||||||||||||||||
Other, net | (21 | ) | (220 | ) | 137 | 104 | — | ||||||||||||||||
Net cash flows from (used in) financing activities | (2,211 | ) | (1,622 | ) | 137 | 1,489 | (2,207 | ) | |||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | 10 | — | 10 | ||||||||||||||||||
Net change in cash and cash equivalents | (311 | ) | (724 | ) | 33 | — | (1,002 | ) | |||||||||||||||
Cash and cash equivalents at beginning of year | 755 | 1,420 | 327 | — | 2,502 | ||||||||||||||||||
Cash and cash equivalents at end of year | $ | 444 | $ | 696 | $ | 360 | $ | — | $ | 1,500 | |||||||||||||
For the Year Ended December 31, 2012 | |||||||||||||||||||||||
Cash flows from operating activities | $ | 454 | $ | 1,801 | $ | 29 | $ | (716 | ) | $ | 1,568 | ||||||||||||
Cash flows from (used in) investing activities: | |||||||||||||||||||||||
Capital expenditures | — | (79 | ) | (1 | ) | (8 | ) | (88 | ) | ||||||||||||||
Proceeds from termination of joint venture | — | — | 30 | — | 30 | ||||||||||||||||||
Return of intercompany investments | 898 | — | — | (898 | ) | — | |||||||||||||||||
Other, net | 40 | 17 | 1 | (54 | ) | 4 | |||||||||||||||||
Net cash flows from (used in) investing activities | 938 | (62 | ) | 30 | (960 | ) | (54 | ) | |||||||||||||||
Cash flows from (used in) financing activities: | |||||||||||||||||||||||
Dividends paid on common stock | (1,307 | ) | (684 | ) | — | 684 | (1,307 | ) | |||||||||||||||
Repurchase of common stock | (1,101 | ) | — | — | — | (1,101 | ) | ||||||||||||||||
Excess tax benefit on stock-based compensation plans | 39 | — | — | — | 39 | ||||||||||||||||||
Principal borrowings under term-loan credit facility | 750 | — | — | — | 750 | ||||||||||||||||||
Repayment under term-loan credit facility | (750 | ) | — | — | — | (750 | ) | ||||||||||||||||
Proceeds from issuance of long-term debt, net of discounts | 2,539 | — | — | — | 2,539 | ||||||||||||||||||
Repayments of long-term debt | (1,018 | ) | (58 | ) | — | — | (1,076 | ) | |||||||||||||||
Debt issuance costs and financing fees | (22 | ) | — | — | — | (22 | ) | ||||||||||||||||
Payment to settle forward starting interest rate contracts | (23 | ) | — | — | — | (23 | ) | ||||||||||||||||
Make-whole premium for early extinguishment of debt | (20 | ) | — | — | — | (20 | ) | ||||||||||||||||
Dividends paid on preferred stock | (43 | ) | — | — | 43 | — | |||||||||||||||||
Distribution of equity | — | (898 | ) | — | 898 | — | |||||||||||||||||
Other, net | (9 | ) | (40 | ) | (2 | ) | 51 | — | |||||||||||||||
Net cash flows used in financing activities | (965 | ) | (1,680 | ) | (2 | ) | 1,676 | (971 | ) | ||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | 3 | — | 3 | ||||||||||||||||||
Net change in cash and cash equivalents | 427 | 59 | 60 | — | 546 | ||||||||||||||||||
Cash and cash equivalents at beginning of year | 328 | 1,361 | 267 | — | 1,956 | ||||||||||||||||||
Cash and cash equivalents at end of year | $ | 755 | $ | 1,420 | $ | 327 | $ | — | $ | 2,502 | |||||||||||||
Condensed Consolidating Balance Sheets | |||||||||||||||||||||||
(Dollars in Millions) | |||||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
December 31, 2014 | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
Cash and cash equivalents | $ | 102 | $ | 469 | $ | 395 | $ | — | $ | 966 | |||||||||||||
Accounts receivable | — | 74 | 42 | — | 116 | ||||||||||||||||||
Accounts receivable, related party | — | 41 | — | — | 41 | ||||||||||||||||||
Other receivables | 70 | 1,199 | 10 | (1,267 | ) | 12 | |||||||||||||||||
Inventories | — | 1,198 | 85 | (2 | ) | 1,281 | |||||||||||||||||
Deferred income taxes, net | 5 | 688 | 10 | — | 703 | ||||||||||||||||||
Prepaid expenses and other | 50 | 151 | 1 | 2 | 204 | ||||||||||||||||||
Total current assets | 227 | 3,820 | 543 | (1,267 | ) | 3,323 | |||||||||||||||||
Property, plant and equipment, net | 3 | 1,170 | 30 | — | 1,203 | ||||||||||||||||||
Trademarks and other intangible assets, net | — | 2,417 | 4 | — | 2,421 | ||||||||||||||||||
Goodwill | — | 7,999 | 17 | — | 8,016 | ||||||||||||||||||
Long-term intercompany notes receivable | 1,593 | 190 | — | (1,783 | ) | — | |||||||||||||||||
Investment in subsidiaries | 9,598 | 450 | — | (10,048 | ) | — | |||||||||||||||||
Other assets and deferred charges | 101 | 180 | 23 | (71 | ) | 233 | |||||||||||||||||
Total assets | $ | 11,522 | $ | 16,226 | $ | 617 | $ | (13,169 | ) | $ | 15,196 | ||||||||||||
Liabilities and shareholders’ equity | |||||||||||||||||||||||
Accounts payable | $ | 1 | $ | 128 | $ | 13 | $ | — | $ | 142 | |||||||||||||
Tobacco settlement accruals | — | 1,819 | — | — | 1,819 | ||||||||||||||||||
Due to related party | — | 1 | — | — | 1 | ||||||||||||||||||
Deferred revenue, related party | — | 32 | — | — | 32 | ||||||||||||||||||
Current maturities of long-term debt | 450 | — | — | — | 450 | ||||||||||||||||||
Other current liabilities | 1,636 | 682 | 51 | (1,269 | ) | 1,100 | |||||||||||||||||
Total current liabilities | 2,087 | 2,662 | 64 | (1,269 | ) | 3,544 | |||||||||||||||||
Long-term intercompany notes payable | 190 | 1,300 | 293 | (1,783 | ) | — | |||||||||||||||||
Long-term debt (less current maturities) | 4,633 | — | — | — | 4,633 | ||||||||||||||||||
Deferred income taxes, net | — | 450 | — | (67 | ) | 383 | |||||||||||||||||
Long-term retirement benefits (less current portion) | 57 | 1,930 | 10 | — | 1,997 | ||||||||||||||||||
Other noncurrent liabilities | 33 | 83 | 1 | — | 117 | ||||||||||||||||||
Shareholders’ equity | 4,522 | 9,801 | 249 | (10,050 | ) | 4,522 | |||||||||||||||||
Total liabilities and shareholders’ equity | $ | 11,522 | $ | 16,226 | $ | 617 | $ | (13,169 | ) | $ | 15,196 | ||||||||||||
December 31, 2013 | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
Cash and cash equivalents | $ | 444 | $ | 696 | $ | 360 | $ | — | $ | 1,500 | |||||||||||||
Accounts receivable | — | 74 | 32 | — | 106 | ||||||||||||||||||
Accounts receivable, related party | — | 56 | — | — | 56 | ||||||||||||||||||
Notes receivable | — | 1 | 36 | — | 37 | ||||||||||||||||||
Other receivables | 76 | 198 | 6 | (264 | ) | 16 | |||||||||||||||||
Inventories | — | 1,069 | 59 | (1 | ) | 1,127 | |||||||||||||||||
Deferred income taxes, net | — | 614 | 1 | (9 | ) | 606 | |||||||||||||||||
Prepaid expenses and other | 29 | 172 | 7 | (1 | ) | 207 | |||||||||||||||||
Total current assets | 549 | 2,880 | 501 | (275 | ) | 3,655 | |||||||||||||||||
Property, plant and equipment, net | 5 | 986 | 83 | — | 1,074 | ||||||||||||||||||
Trademarks and other intangible assets, net | — | 2,413 | 4 | — | 2,417 | ||||||||||||||||||
Goodwill | — | 7,999 | 12 | — | 8,011 | ||||||||||||||||||
Long-term intercompany notes receivable | 1,842 | 1,295 | — | (3,137 | ) | — | |||||||||||||||||
Investment in subsidiaries | 9,736 | 473 | — | (10,209 | ) | — | |||||||||||||||||
Other assets and deferred charges | 94 | 187 | 18 | (54 | ) | 245 | |||||||||||||||||
Total assets | $ | 12,226 | $ | 16,233 | $ | 618 | $ | (13,675 | ) | $ | 15,402 | ||||||||||||
Liabilities and shareholders’ equity | |||||||||||||||||||||||
Accounts payable | $ | 1 | $ | 169 | $ | 15 | $ | — | $ | 185 | |||||||||||||
Tobacco settlement accruals | — | 1,727 | — | — | 1,727 | ||||||||||||||||||
Deferred revenue, related party | — | 48 | — | — | 48 | ||||||||||||||||||
Other current liabilities | 601 | 744 | 46 | (275 | ) | 1,116 | |||||||||||||||||
Total current liabilities | 602 | 2,688 | 61 | (275 | ) | 3,076 | |||||||||||||||||
Long-term intercompany notes payable | 1,295 | 1,700 | 142 | (3,137 | ) | — | |||||||||||||||||
Long-term debt (less current maturities) | 5,099 | — | — | — | 5,099 | ||||||||||||||||||
Deferred income taxes, net | — | 710 | 2 | (54 | ) | 658 | |||||||||||||||||
Long-term retirement benefits (less current portion) | 38 | 1,172 | 11 | — | 1,221 | ||||||||||||||||||
Other noncurrent liabilities | 25 | 156 | — | — | 181 | ||||||||||||||||||
Shareholders’ equity | 5,167 | 9,807 | 402 | (10,209 | ) | 5,167 | |||||||||||||||||
Total liabilities and shareholders’ equity | $ | 12,226 | $ | 16,233 | $ | 618 | $ | (13,675 | ) | $ | 15,402 | ||||||||||||
Quarterly_Results_of_Operation
Quarterly Results of Operations (Unaudited) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||
Quarterly Results of Operations (Unaudited) | Note 19 — Quarterly Results of Operations (Unaudited) | ||||||||||||||||
First | Second | Third | Fourth | ||||||||||||||
2014 | |||||||||||||||||
Net sales | $ | 1,935 | $ | 2,162 | $ | 2,240 | $ | 2,134 | |||||||||
Gross profit(1) | 1,005 | 1,203 | 1,206 | 999 | |||||||||||||
Income from continuing operations(1)(2) | 338 | 492 | 467 | 148 | |||||||||||||
Income from discontinued operations, net of tax | 25 | — | — | — | |||||||||||||
Net income(1)(2) | 363 | 492 | 467 | 148 | |||||||||||||
Per share data(3) : | |||||||||||||||||
Basic: | |||||||||||||||||
Income from continuing operations | 0.63 | 0.92 | 0.88 | 0.28 | |||||||||||||
Income from discontinued operations | 0.05 | — | — | — | |||||||||||||
Net income | 0.68 | 0.92 | 0.88 | 0.28 | |||||||||||||
Diluted: | |||||||||||||||||
Income from continuing operations | 0.63 | 0.92 | 0.88 | 0.28 | |||||||||||||
Income from discontinued operations | 0.04 | — | — | — | |||||||||||||
Net income | 0.67 | 0.92 | 0.88 | 0.28 | |||||||||||||
2013 | |||||||||||||||||
Net sales | $ | 1,883 | $ | 2,179 | $ | 2,135 | $ | 2,039 | |||||||||
Gross profit(4) | 1,189 | 1,180 | 1,131 | 1,058 | |||||||||||||
Net income(4)(5) | 508 | 461 | 457 | 292 | |||||||||||||
Per share data(3) : | |||||||||||||||||
Basic: | |||||||||||||||||
Net income | 0.92 | 0.84 | 0.84 | 0.54 | |||||||||||||
Diluted: | |||||||||||||||||
Net income | 0.92 | 0.84 | 0.84 | 0.54 | |||||||||||||
-1 | Includes NPM Adjustment credits of $63 million in the first quarter of 2014, $125 million in the second quarter of 2014, $82 million in the third quarter of 2014 and $75 million in the fourth quarter of 2014, see “— Cost of Products Sold” in note 1. The fourth quarter of 2014 includes an MTM adjustment of $205 million. | ||||||||||||||||
(2) | Fourth quarter of 2014 includes an additional MTM adjustment of $247 million for a total of $452 million. | ||||||||||||||||
(3) | Income per share is computed independently for each of the periods presented. The sum of the income per share amounts for the quarters may not equal the total for the year. | ||||||||||||||||
(4) | Includes NPM Adjustment credits of $261 million in the first quarter of 2013, $90 million in the second quarter of 2013, $69 million in the third quarter of 2013 and $63 million in the fourth quarter of 2013, see “— Cost of Products Sold” in note 1. | ||||||||||||||||
(5) | Fourth quarter of 2013 net income includes a $32 million trademark impairment charge. |
Business_and_Summary_of_Signif1
Business and Summary of Significant Accounting Policies (Policies) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Overview | Overview | ||||||||||||
The consolidated financial statements include the accounts of Reynolds American Inc., referred to as RAI, and its wholly owned subsidiaries. RAI’s wholly owned operating subsidiaries include R. J. Reynolds Tobacco Company; American Snuff Company, LLC, referred to as American Snuff Co.; Santa Fe Natural Tobacco Company, Inc., referred to as SFNTC; R. J. Reynolds Vapor Company, referred to as RJR Vapor; Niconovum USA, Inc.; and Niconovum AB. | |||||||||||||
RAI was incorporated as a holding company in the State of North Carolina on January 2, 2004, and its common stock is listed on the New York Stock Exchange, referred to as the NYSE, under the symbol “RAI.” On July 30, 2004, the U.S. assets, liabilities and operations of Brown & Williamson Tobacco Corporation, now known as Brown & Williamson Holdings, Inc., referred to as B&W, an indirect, wholly owned subsidiary of British American Tobacco p.l.c., referred to as BAT, were combined with R. J. Reynolds Tobacco Company, a wholly owned operating subsidiary of R.J. Reynolds Tobacco Holdings, Inc., referred to as RJR. These July 30, 2004, transactions generally are referred to as the B&W business combination. | |||||||||||||
References to RJR Tobacco prior to July 30, 2004, relate to R. J. Reynolds Tobacco Company, a New Jersey corporation and a wholly owned subsidiary of RJR. References to RJR Tobacco on and subsequent to July 30, 2004, relate to the combined U.S. assets, liabilities and operations of B&W and R. J. Reynolds Tobacco Company, a North Carolina corporation. | |||||||||||||
RAI’s reportable operating segments are RJR Tobacco, American Snuff and Santa Fe. The RJR Tobacco segment consists principally of the primary operations of R. J. Reynolds Tobacco Company. The American Snuff segment consists of the primary operations of American Snuff Co. The Santa Fe segment consists of the domestic operations of SFNTC. Included in All Other, among other RAI subsidiaries, are RJR Vapor, Niconovum USA, Inc., Niconovum AB, SFR Tobacco International GmbH, referred to as SFRTI, and various foreign subsidiaries affiliated with SFRTI. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance. Certain of RAI’s operating subsidiaries have entered into intercompany agreements for products or services with other subsidiaries. As a result, certain activities of an operating subsidiary may be included in a different segment of RAI. | |||||||||||||
RAI’s operating subsidiaries primarily conduct their business in the United States. | |||||||||||||
Basis of Presentation | Basis of Presentation | ||||||||||||
The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, referred to as GAAP, requires estimates and assumptions to be made that affect the reported amounts in the consolidated financial statements and accompanying notes. Volatile credit and equity markets, changes to regulatory and legal environments, and consumer spending may affect the uncertainty inherent in such estimates and assumptions. Actual results could differ from those estimates. | |||||||||||||
Certain reclassifications were made to conform prior years’ financial statements to the current presentation. Certain amounts presented in note 12 are rounded in the aggregate and may not sum from the individually presented components. All dollar amounts, other than per share amounts, are presented in millions, except for amounts set forth in note 12 and as otherwise noted. | |||||||||||||
Cash and Cash Equivalents | Cash and Cash Equivalents | ||||||||||||
Cash balances are recorded net of book overdrafts when a bank right-of-offset exists. All other book overdrafts are recorded in accounts payable. Cash equivalents may include money market funds, commercial paper and time deposits in major institutions to minimize investment risk. As short-term, highly liquid investments readily convertible to known amounts of cash, with remaining maturities of three months or less at the time of purchase, cash equivalents have carrying values that approximate fair values. | |||||||||||||
Fair Value Measurement | Fair Value Measurement | ||||||||||||
RAI determines the fair value of assets and liabilities, if any, using a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity, and the reporting entity’s own assumptions about market participant assumptions based on the best information available in the circumstances. | |||||||||||||
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price. | |||||||||||||
The levels of the fair value hierarchy are: | |||||||||||||
Level 1: inputs are quoted prices, unadjusted, in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. | |||||||||||||
Level 2: inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. A Level 2 input must be observable for substantially the full term of the asset or liability. | |||||||||||||
Level 3: inputs are unobservable and reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. | |||||||||||||
Investments | Investments | ||||||||||||
Marketable securities are classified as available-for-sale and are carried at fair value. RAI reviews its investments on a quarterly basis to determine if it is probable that RAI will realize some portion of the unrealized loss and to determine the classification of the impairment as temporary or other-than-temporary. For those securities which RAI does not intend to sell and for which it is more likely than not that RAI will not be required to sell the securities prior to recovery, RAI recognizes the credit loss component of an other-than-temporary impairment of its debt securities in earnings and the noncredit component in accumulated other comprehensive loss. All losses deemed to be other than temporarily impaired are recorded in earnings. | |||||||||||||
RAI evaluates its investments for possible impairment based on current economic conditions, credit loss experience and other criteria on a quarterly basis. The evaluation of investments for impairment requires significant judgments, including: | |||||||||||||
• | the identification of potentially impaired securities; | ||||||||||||
• | the determination of their estimated fair value; | ||||||||||||
• | the assessment of whether any decline in estimated fair value is other-than-temporary; and | ||||||||||||
• | the likelihood of selling before recovery. | ||||||||||||
If there is a decline in a security’s net realizable value that is other-than-temporary and it is not likely to be sold before recovery, the decline is separated into the amount of impairment related to credit loss and the amount of impairment related to all other factors. The decline related to the credit loss is recognized in earnings, while the decline related to all other factors is recognized in accumulated other comprehensive loss. | |||||||||||||
Inventories | Inventories | ||||||||||||
Inventories are stated at the lower of cost or market. The cost of tobacco inventories is determined principally under the last-in, first-out, or LIFO, method and is calculated at the end of each year. The cost of work in process and finished goods includes materials, direct labor, variable costs and overhead and full absorption of fixed manufacturing overhead. Stocks of tobacco, which have an operating cycle that exceeds 12 months due to aging requirements, are classified as current assets, consistent with recognized industry practice. | |||||||||||||
Long-lived Assets | Long-lived Assets | ||||||||||||
Long-lived assets, such as property, plant and equipment, trademarks and other intangible assets with finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the book value of the asset may not be recoverable. Impairment of the carrying value of long-lived assets would be indicated if the best estimate of future undiscounted cash flows expected to be generated by the asset grouping is less than its carrying value. If an impairment is indicated, any loss is measured as the difference between estimated fair value and carrying value and is recognized in operating income. | |||||||||||||
Property, Plant and Equipment | Property, Plant and Equipment | ||||||||||||
Property, plant and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Useful lives range from 20 to 50 years for buildings and improvements, and from 3 to 30 years for machinery and equipment. The cost and related accumulated depreciation of assets sold or retired are removed from the accounts and the gain or loss on disposition is recognized in operating income. Depreciation expense was $95 million, $98 million and $110 million for the years ended December 31, 2014, 2013 and 2012, respectively. | |||||||||||||
Software Costs | Software Costs | ||||||||||||
Computer software and software development costs incurred in connection with developing or obtaining computer software for internal use that has an extended useful life are capitalized. These costs are amortized over their estimated useful life, which is typically five years or less. The following is a summary of balances and expenses for software costs as of and for the years ended December 31: | |||||||||||||
Balances: | |||||||||||||
2014 | 2013 | ||||||||||||
Unamortized software costs balance | $ | 41 | $ | 51 | |||||||||
Software costs — capitalized or included in construction-in-process | 5 | 13 | |||||||||||
Expenses: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Software amortization expense | $ | 15 | $ | 17 | $ | 21 | |||||||
Intangible Assets | Intangible Assets | ||||||||||||
Intangible assets include goodwill, trademarks and other intangible assets and are capitalized when acquired. The determination of fair value involves considerable estimates and judgment. In particular, the fair value of a reporting unit involves, among other things, developing forecasts of future cash flows, determining an appropriate discount rate, and when goodwill impairment is implied, determining the fair value of individual assets and liabilities, including unrecorded intangibles. Although RAI believes it has based its impairment testing and impairment charges of its intangibles on reasonable estimates and assumptions, the use of different estimates and assumptions could result in materially different results. If the current legal and regulatory environment, business or competitive climate worsens, or RAI’s operating companies’ strategic initiatives adversely affect their financial performance, the fair value of goodwill, trademarks and other intangible assets could be impaired in future periods. Trademarks and other intangible assets with indefinite lives are not amortized, but are tested for impairment annually, in the fourth quarter, and more frequently if events and circumstances indicate that the asset might be impaired. | |||||||||||||
Accounting for Derivative Instruments and Hedging Activities | Accounting for Derivative Instruments and Hedging Activities | ||||||||||||
RAI measures any derivative instruments, including certain derivative instruments embedded in other contracts, at fair value and records them in the balance sheet as either an asset or liability. Changes in fair value of derivatives are recorded in earnings unless hedge accounting criteria are met. For derivatives designated as fair value hedges, the changes in fair value of both the derivative instrument and the hedged item are recorded in earnings. For derivatives designated as cash flow hedges, the effective portions of changes in the fair value of the derivative are reported in accumulated other comprehensive loss. The ineffective portions of hedges are recognized in earnings in the current period. | |||||||||||||
RAI formally assesses at inception of the hedge and on an ongoing basis, whether each derivative is highly effective in offsetting changes in fair values or cash flows of the hedged item, and formally designates as a hedge those derivatives that qualify for hedge accounting. If it is determined that a derivative is not highly effective as a hedge or if a derivative ceases to be a highly effective hedge, RAI will discontinue hedge accounting prospectively. Any unrecognized gain or loss will be deferred and recognized into earnings as the formerly hedged item is recognized in earnings. At December 31, 2014 and 2013, RAI had no derivative instruments. | |||||||||||||
Revenue Recognition | Revenue Recognition | ||||||||||||
Revenue from product sales is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the seller’s price to the buyer is fixed or determinable, and collectability is reasonably assured. These criteria are generally met when title and risk of loss pass to the customer. Payments received in advance of shipments are deferred and recorded in other accrued liabilities until shipment occurs. Certain sales of leaf to a related party, considered as bill-and-hold for accounting purposes, are recorded as deferred revenue when all of the above revenue recognition criteria are met except delivery, postponed at the customer’s request. Revenue is subsequently recognized upon delivery. The revenues recorded are presented net of excise tax collected on behalf of government authorities. | |||||||||||||
Shipping and handling costs are classified as cost of products sold. Net sales include certain sales incentives, including retail discounting, promotional allowances and coupons. | |||||||||||||
Cost of Products Sold | Cost of Products Sold | ||||||||||||
Cost of products sold includes the expenses for the Master Settlement Agreement, referred to as the MSA, and other settlement agreements with the States of Mississippi, Florida, Texas and Minnesota, which together with the MSA are collectively referred to as the State Settlement Agreements; the federal tobacco quota buyout (this assessment expired September 2014); and the user fees charged by the U.S. Food and Drug Administration, referred to as the FDA; which were as follows for the years ended December 31: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
State Settlement Agreements | $ | 1,917 | $ | 1,819 | $ | 2,370 | |||||||
Federal tobacco quota buyout | 163 | 209 | 218 | ||||||||||
FDA user fees | 135 | 127 | 122 | ||||||||||
In 2012, RJR Tobacco and certain other participating manufacturers, referred to as the PMs, including SFNTC, entered into a term sheet, referred to as the Term Sheet, with 17 states, the District of Columbia and Puerto Rico to settle certain claims related to the MSA non-participating manufacturer adjustment, referred to as the NPM Adjustment. The Term Sheet resolves claims related to volume years from 2003 through 2012 and puts in place a revised method to determine future adjustments from 2013 forward as to jurisdictions that join the agreement. On March 12, 2013, a single, nationwide arbitration panel of three former federal judges, referred to as the Arbitration Panel, hearing the dispute related to the 2003 NPM Adjustment (and related matters) issued an order, referred to as the Order, authorizing the implementation of the Term Sheet. In addition, after the Order, one additional state signed the Term Sheet on April 12, 2013; and, two additional states signed the Term Sheet on May 24, 2013. The Term Sheet is binding on all signatories. | |||||||||||||
Based on the jurisdictions bound by the Term Sheet through December 31, 2013, RJR Tobacco and SFNTC, collectively, will receive credits, currently estimated to total approximately $1.1 billion, with respect to their NPM Adjustment claims for the period from 2003 through 2012. These credits will be applied against annual payments under the MSA over a five-year period, which commenced with the April 2013 MSA payment. As a result of this binding Order, expenses for the MSA were reduced by $219 million for the year ended December 31, 2013. | |||||||||||||
In June 2014, two additional states agreed to settle the NPM Adjustment disputes on similar terms as set forth in the Term Sheet, except for certain provisions related to the determination of credits to be received by the PMs. RJR Tobacco and SFNTC, collectively, will receive credits, currently estimated to total approximately $170 million, with respect to their NPM Adjustment claims from 2003 through 2012. These credits will be applied against annual payments under the MSA over a five-year period effectively beginning with the April 2014 MSA payment related to the addition of these two states. As a result, expenses for the MSA were reduced by $34 million for the year ended December 31, 2014. | |||||||||||||
In addition, as a result of meeting the performance requirements associated with the Term Sheet, RJR Tobacco and Santa Fe, collectively, recognized additional credits of $311 million and $264 million for the years ended December 31, 2014 and 2013, respectively. RJR Tobacco expects to recognize additional credits through 2017, and Santa Fe expects to recognize additional credits through 2016. | |||||||||||||
For additional information related to the NPM Adjustment settlement, see “— Litigation Affecting the Cigarette Industry — State Settlement Agreements — Enforcement and Validity; Adjustments” in note 12. | |||||||||||||
Advertising | Advertising | ||||||||||||
Advertising costs, which are expensed as incurred, were $140 million, $110 million and $72 million for the years ended December 31, 2014, 2013 and 2012, respectively. | |||||||||||||
Research and Development | Research and Development | ||||||||||||
Research and development costs, which are expensed as incurred, were $88 million, $72 million and $62 million for the years ended December 31, 2014, 2013 and 2012, respectively. | |||||||||||||
Income Taxes | Income Taxes | ||||||||||||
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Interest and penalties related to uncertain tax positions are accounted for as tax expense. Federal income taxes for RAI and its subsidiaries are calculated on a consolidated basis. State income taxes for RAI and its subsidiaries are primarily calculated on a separate return basis. | |||||||||||||
RAI accounts for uncertain tax positions which require that a position taken or expected to be taken in a tax return be recognized in the financial statements when it is more likely than not (a likelihood of more than 50%) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. | |||||||||||||
Stock-Based Compensation | Stock-Based Compensation | ||||||||||||
Stock-based compensation expense is recognized for all forms of share-based payment awards, including shares issued to employees under restricted stock units. | |||||||||||||
Litigation | Litigation | ||||||||||||
RAI discloses information concerning litigation for which an unfavorable outcome is more than remote. RAI and its subsidiaries record their legal expenses and other litigation costs and related administrative costs as selling, general and administrative expenses as those costs are incurred. RAI and its subsidiaries will record any loss related to litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated on an individual case-by-case basis. When the reasonable estimate is a range, the recorded loss will be the best estimate within the range. If no amount in the range is a better estimate than any other amount, the minimum amount of the range will be recorded. | |||||||||||||
Pension and Postretirement | Pension and Postretirement | ||||||||||||
Pension and postretirement benefits require balance sheet recognition of the net asset or liability for the overfunded or underfunded status of defined benefit pension and other postretirement benefit plans, on a plan-by-plan basis, and recognition of changes in the funded status in the year in which the changes occur. | |||||||||||||
Actuarial gains or losses are changes in the amount of either the benefit obligation or the fair value of plan assets resulting from experience different from that assumed or from changes in assumptions. Differences between actual results and actuarial assumptions are accumulated and recognized in the year in which they occur as a mark-to-market adjustment, referred to as an MTM adjustment, to the extent such net gains and losses are in excess of 10% of the greater of the fair value of plan assets or benefit obligations, referred to as the corridor. Actuarial gains and losses outside the corridor are generally recognized annually as of December 31, or when a plan is remeasured during an interim period. | |||||||||||||
Prior service costs of pension benefits, which are changes in benefit obligations due to plan amendments, are amortized on a straight-line basis over the average remaining service period for active employees, or average remaining life expectancies for inactive employees if most of the plan obligations are due to inactive employees. Prior service costs of postretirement benefits, which are changes in benefit obligations due to plan amendments, are amortized on a straight-line basis over the expected service period to full eligibility age for active employees, or average remaining life expectancies for inactive employees if most of the plan obligations are due to inactive employees. | |||||||||||||
Recently Issued Accounting Pronouncements | Recently Issued Accounting Pronouncements | ||||||||||||
In April 2014, the Financial Accounting Standards Board, referred to as the FASB, issued guidance for discontinued operations, which changes the criteria for determining which disposals should be presented as discontinued operations, modifies related disclosure requirements and requires new disclosures of certain other disposals that do not meet the definition of a discontinued operation. The guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. Early adoption is permitted, but only for those disposals that have not been reported in financial statements previously issued or available for guidance. The adoption of the amended guidance is not expected to have a material impact on RAI’s results of operations, cash flows or financial position. | |||||||||||||
In May 2014, the FASB issued amended guidance that replaces most existing GAAP revenue recognition guidance. The amended guidance is effective for RAI for interim and annual reporting periods beginning on January 1, 2017, and permits the use of either the retrospective or cumulative effect transition method. Early adoption is prohibited. RAI is evaluating the effect that this guidance will have on its consolidated financial statements and related disclosures. |
Business_and_Summary_of_Signif2
Business and Summary of Significant Accounting Policies (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Certain Component of Cost of Products Sold | Cost of products sold includes the expenses for the Master Settlement Agreement, referred to as the MSA, and other settlement agreements with the States of Mississippi, Florida, Texas and Minnesota, which together with the MSA are collectively referred to as the State Settlement Agreements; the federal tobacco quota buyout (this assessment expired September 2014); and the user fees charged by the U.S. Food and Drug Administration, referred to as the FDA; which were as follows for the years ended December 31: | ||||||||||||
2014 | 2013 | 2012 | |||||||||||
State Settlement Agreements | $ | 1,917 | $ | 1,819 | $ | 2,370 | |||||||
Federal tobacco quota buyout | 163 | 209 | 218 | ||||||||||
FDA user fees | 135 | 127 | 122 | ||||||||||
Computer Software, Intangible Asset | |||||||||||||
Summary Of Balances And Expenses For Software Costs | The following is a summary of balances and expenses for software costs as of and for the years ended December 31: | ||||||||||||
Balances: | |||||||||||||
2014 | 2013 | ||||||||||||
Unamortized software costs balance | $ | 41 | $ | 51 | |||||||||
Software costs — capitalized or included in construction-in-process | 5 | 13 | |||||||||||
Expenses: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Software amortization expense | $ | 15 | $ | 17 | $ | 21 |
Fair_Value_Measurement_Tables
Fair Value Measurement (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||||||
Fair Value of Financial Assets and Liabilities | Financial assets carried at fair value as of December 31, were as follows: | ||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||||
Cash and cash equivalents: | |||||||||||||||||||||||||||||||||
Cash equivalents | $ | 883 | $ | — | $ | — | $ | 883 | $ | 1,443 | $ | — | $ | — | $ | 1,443 | |||||||||||||||||
Other assets and deferred charges: | |||||||||||||||||||||||||||||||||
Auction rate securities | — | — | 79 | 79 | — | — | 76 | 76 | |||||||||||||||||||||||||
Mortgage-backed security | — | — | 12 | 12 | — | — | 13 | 13 | |||||||||||||||||||||||||
Marketable equity security | 2 | — | — | 2 | 4 | — | — | 4 | |||||||||||||||||||||||||
Financial Assets Classified as Level 3 Investments | Financial assets classified as Level 3 investments were as follows: | ||||||||||||||||||||||||||||||||
December 31, 2014 | December 31, 2013 | ||||||||||||||||||||||||||||||||
Cost | Gross | Estimated | Cost | Gross | Estimated | ||||||||||||||||||||||||||||
Unrealized | Fair Value | Unrealized | Fair Value | ||||||||||||||||||||||||||||||
Loss(1) | Loss(1) | ||||||||||||||||||||||||||||||||
Auction rate securities | $ | 99 | $ | (20 | ) | $ | 79 | $ | 99 | $ | (23 | ) | $ | 76 | |||||||||||||||||||
Mortgage-backed security | 18 | (6 | ) | 12 | 20 | (7 | ) | 13 | |||||||||||||||||||||||||
$ | 117 | $ | (26 | ) | $ | 91 | $ | 119 | $ | (30 | ) | $ | 89 | ||||||||||||||||||||
(1) | Unrealized losses, net of tax, are reported in accumulated other comprehensive loss in RAI’s consolidated balance sheets as of December 31, 2014 and 2013. | ||||||||||||||||||||||||||||||||
Changes in Level 3 Investments | The changes in the Level 3 investments were as follows: | ||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Auction Rate Securities | Auction Rate Securities | ||||||||||||||||||||||||||||||||
Cost | Gross | Estimated | Cost | Gross | Estimated | ||||||||||||||||||||||||||||
Unrealized | Fair Value | Unrealized | Fair Value | ||||||||||||||||||||||||||||||
Gain (Loss) | Gain (Loss) | ||||||||||||||||||||||||||||||||
Balance as of January 1 | $ | 99 | $ | (23 | ) | $ | 76 | $ | 99 | $ | (29 | ) | $ | 70 | |||||||||||||||||||
Unrealized gain | — | 3 | 3 | — | 6 | 6 | |||||||||||||||||||||||||||
Balance as of December 31 | $ | 99 | $ | (20 | ) | $ | 79 | $ | 99 | $ | (23 | ) | $ | 76 | |||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Mortgage-Backed Security | Mortgage-Backed Security | ||||||||||||||||||||||||||||||||
Cost | Gross | Estimated | Cost | Gross | Estimated | ||||||||||||||||||||||||||||
Unrealized | Fair Value | Unrealized | Fair Value | ||||||||||||||||||||||||||||||
Gain (Loss) | Gain (Loss) | ||||||||||||||||||||||||||||||||
Balance as of January 1 | $ | 20 | $ | (7 | ) | $ | 13 | $ | 22 | $ | (9 | ) | $ | 13 | |||||||||||||||||||
Unrealized gain | — | 1 | 1 | — | 2 | 2 | |||||||||||||||||||||||||||
Redemptions | (2 | ) | — | (2 | ) | (2 | ) | — | (2 | ) | |||||||||||||||||||||||
Balance as of December 31 | $ | 18 | $ | (6 | ) | $ | 12 | $ | 20 | $ | (7 | ) | $ | 13 | |||||||||||||||||||
Amortization of Net Gain Loss upon Termination of Derivative Instruments Impacted Income Statement | The amortization of derivative instruments impacted the consolidated statements of income for the years ended December 31 as follows: | ||||||||||||||||||||||||||||||||
2014 | 2013 | 2012 | |||||||||||||||||||||||||||||||
Interest and debt expense | $ | (15 | ) | $ | (24 | ) | $ | (32 | ) | ||||||||||||||||||||||||
Other (income) expense, net | — | (35 | ) | — |
Intangible_Assets_Tables
Intangible Assets (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||
Changes in Carrying Amounts of Goodwill by Segment | The changes in the carrying amounts of goodwill by segment were as follows: | ||||||||||||||||||||||||||||
RJR | American | Santa Fe | All Other | Consolidated | |||||||||||||||||||||||||
Tobacco | Snuff | ||||||||||||||||||||||||||||
Goodwill | $ | 9,065 | $ | 2,501 | $ | 197 | $ | 38 | $ | 11,801 | |||||||||||||||||||
Less: accumulated impairment charges | (3,763 | ) | (28 | ) | — | — | (3,791 | ) | |||||||||||||||||||||
Net goodwill balance as of December 31, 2011 | 5,302 | 2,473 | 197 | 38 | 8,010 | ||||||||||||||||||||||||
2012 Activity | |||||||||||||||||||||||||||||
Foreign currency translation | — | — | — | 1 | 1 | ||||||||||||||||||||||||
Net goodwill balance as of December 31, 2012 and 2013 | 5,302 | 2,473 | 197 | 39 | 8,011 | ||||||||||||||||||||||||
2014 Activity | |||||||||||||||||||||||||||||
Asset acquisition | — | — | — | 7 | 7 | ||||||||||||||||||||||||
Foreign currency translation | — | — | — | (2 | ) | (2 | ) | ||||||||||||||||||||||
— | — | — | 5 | 5 | |||||||||||||||||||||||||
Net goodwill balance as of December 31, 2014 | $ | 5,302 | $ | 2,473 | $ | 197 | $ | 44 | $ | 8,016 | |||||||||||||||||||
Carrying Amounts of Indefinite-Lived Intangible Assets by Segment Not Subject to Amortization | The changes in the carrying amounts of indefinite-lived intangible assets by segment not subject to amortization were as follows: | ||||||||||||||||||||||||||||
RJR Tobacco | American | Santa Fe | All Other | Consolidated | |||||||||||||||||||||||||
Snuff | |||||||||||||||||||||||||||||
Trademarks | Other | Trademarks | Trademarks | Other | Trademarks | Other | |||||||||||||||||||||||
Balance as of December 31, 2011 | $ | 1,109 | $ | 99 | $ | 1,136 | $ | 155 | $ | 49 | $ | 2,400 | $ | 148 | |||||||||||||||
Impairment charge | (82 | ) | — | — | — | (47 | ) | (82 | ) | (47 | ) | ||||||||||||||||||
Foreign currency translation | — | — | — | — | 3 | — | 3 | ||||||||||||||||||||||
Balance as of December 31, 2012 | 1,027 | 99 | 1,136 | 155 | 5 | 2,318 | 104 | ||||||||||||||||||||||
Impairment charge | (32 | ) | — | — | — | — | (32 | ) | — | ||||||||||||||||||||
Foreign currency translation | — | — | — | — | (1 | ) | — | (1 | ) | ||||||||||||||||||||
Reclassified to finite-lived | (18 | ) | — | — | — | — | (18 | ) | — | ||||||||||||||||||||
Balance as of December 31, 2013 | 977 | 99 | 1,136 | 155 | 4 | 2,268 | 103 | ||||||||||||||||||||||
Balance as of December 31, 2014 | $ | 977 | $ | 99 | $ | 1,136 | $ | 155 | $ | 4 | $ | 2,268 | $ | 103 | |||||||||||||||
Carrying Amounts of Finite-lived Intangible Assets by Segment Subject to Amortization | The changes in the carrying amounts of finite-lived intangible assets by segment subject to amortization were as follows: | ||||||||||||||||||||||||||||
RJR Tobacco | American | Consolidated | |||||||||||||||||||||||||||
Snuff | |||||||||||||||||||||||||||||
Trademarks | Other | Trademarks | Trademarks | Other | |||||||||||||||||||||||||
Balance as of December 31, 2011 | $ | 4 | $ | 39 | $ | 11 | $ | 15 | $ | 39 | |||||||||||||||||||
Amortization | (4 | ) | (15 | ) | (2 | ) | (6 | ) | (15 | ) | |||||||||||||||||||
Balance as of December 31, 2012 | — | 24 | 9 | 9 | 24 | ||||||||||||||||||||||||
Amortization | — | (4 | ) | (1 | ) | (1 | ) | (4 | ) | ||||||||||||||||||||
Reclassified from indefinite-lived | 18 | — | — | 18 | — | ||||||||||||||||||||||||
Balance as of December 31, 2013 | 18 | 20 | 8 | 26 | 20 | ||||||||||||||||||||||||
Amortization | (6 | ) | (4 | ) | (1 | ) | (7 | ) | (4 | ) | |||||||||||||||||||
Acquisition | — | 15 | — | — | 15 | ||||||||||||||||||||||||
Balance as of December 31, 2014 | $ | 12 | $ | 31 | $ | 7 | $ | 19 | $ | 31 | |||||||||||||||||||
Details of Finite-Lived Intangible Assets | Details of finite-lived intangible assets were as follows: | ||||||||||||||||||||||||||||
December 31, 2014 | December 31, 2013 | ||||||||||||||||||||||||||||
Gross | Accumulated | Net | Gross | Accumulated | Net | ||||||||||||||||||||||||
Amortization | Amortization | ||||||||||||||||||||||||||||
Contract manufacturing agreements | $ | 151 | $ | (135 | ) | $ | 16 | $ | 151 | $ | (131 | ) | $ | 20 | |||||||||||||||
Trademarks | 114 | (95 | ) | 19 | 114 | (88 | ) | 26 | |||||||||||||||||||||
Other intangibles | 15 | — | 15 | — | — | — | |||||||||||||||||||||||
$ | 280 | $ | (230 | ) | $ | 50 | $ | 265 | $ | (219 | ) | $ | 46 | ||||||||||||||||
Finite Lived Intangible Assets Future Amortization Expense | The estimated remaining amortization associated with finite-lived intangible assets is expected to be expensed as follows: | ||||||||||||||||||||||||||||
Year | Amount | ||||||||||||||||||||||||||||
2015 | $ | 10 | |||||||||||||||||||||||||||
2016 | 9 | ||||||||||||||||||||||||||||
2017 | 9 | ||||||||||||||||||||||||||||
2018 | 8 | ||||||||||||||||||||||||||||
2019 | 2 | ||||||||||||||||||||||||||||
Thereafter | 12 | ||||||||||||||||||||||||||||
$ | 50 | ||||||||||||||||||||||||||||
Restructuring_Charges_Tables
Restructuring Charges (Tables) | 12 Months Ended | ||||
Dec. 31, 2014 | |||||
Components of Restructuring Charge Accrued and Utilized | The components of the restructuring charge accrued and utilized were as follows: | ||||
Employee | |||||
Severance | |||||
and Benefits | |||||
Original accrual | $ | 149 | |||
Utilized in 2012 | (78 | ) | |||
Balance as of December 31, 2012 | 71 | ||||
Utilized in 2013 | (14 | ) | |||
Balance as of December 31, 2013 | 57 | ||||
Utilized in 2014 | (17 | ) | |||
Balance as of December 31, 2014 | $ | 40 | |||
Income_Per_Share_Tables
Income Per Share (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Components of Calculation of Income Per Share | The components of the calculation of income per share were as follows: | ||||||||||||
For the Years Ended December 31, | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Income from continuing operations | $ | 1,445 | $ | 1,718 | $ | 1,272 | |||||||
Income from discontinued operations | 25 | — | — | ||||||||||
Net income | $ | 1,470 | $ | 1,718 | $ | 1,272 | |||||||
Basic weighted average shares, in thousands | 533,160 | 544,925 | 565,570 | ||||||||||
Effect of dilutive potential shares: | |||||||||||||
Restricted stock units | 1,810 | 2,024 | 2,303 | ||||||||||
Diluted weighted average shares, in thousands | 534,970 | 546,949 | 567,873 | ||||||||||
Inventories_Tables
Inventories (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Components of Inventories | The major components of inventories at December 31 were as follows: | ||||||||
2014 | 2013 | ||||||||
Leaf tobacco | $ | 1,125 | $ | 1,049 | |||||
Other raw materials | 90 | 66 | |||||||
Work in process | 72 | 70 | |||||||
Finished products | 171 | 130 | |||||||
Other | 27 | 18 | |||||||
1,485 | 1,333 | ||||||||
LIFO allowance | (204 | ) | (206 | ) | |||||
$ | 1,281 | $ | 1,127 | ||||||
Other_Current_Liabilities_Tabl
Other Current Liabilities (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Other Current Liabilities | Other current liabilities at December 31 included the following: | ||||||||
2014 | 2013 | ||||||||
Payroll and employee benefits | $ | 178 | $ | 179 | |||||
Pension and other postretirement benefits | 75 | 79 | |||||||
Marketing and advertising | 134 | 117 | |||||||
Declared dividends | 356 | 339 | |||||||
Excise, franchise and property tax | 161 | 157 | |||||||
Restructuring | 32 | 19 | |||||||
Tobacco quota buyout | — | 52 | |||||||
Other | 164 | 174 | |||||||
$ | 1,100 | $ | 1,116 | ||||||
Income_Taxes_Tables
Income Taxes (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Provision for Income Taxes from Continuing Operations | The components of the provision for income taxes from continuing operations for the years ended December 31 were as follows: | ||||||||||||
2014 | 2013 | 2012 | |||||||||||
Current: | |||||||||||||
Federal | $ | 809 | $ | 563 | $ | 647 | |||||||
State and other | 188 | 148 | 78 | ||||||||||
997 | 711 | 725 | |||||||||||
Deferred: | |||||||||||||
Federal | (151 | ) | 254 | (45 | ) | ||||||||
State and other | (29 | ) | 58 | 1 | |||||||||
(180 | ) | 312 | (44 | ) | |||||||||
$ | 817 | $ | 1,023 | $ | 681 | ||||||||
Significant Components of Deferred Tax Assets and Liabilities | Significant components of deferred tax assets and liabilities for the years ended December 31 included the following: | ||||||||||||
2014 | 2013 | ||||||||||||
Deferred tax assets: | |||||||||||||
Pension and other postretirement liabilities | $ | 823 | $ | 522 | |||||||||
Tobacco settlement accruals | 711 | 677 | |||||||||||
Other accrued liabilities | 127 | 71 | |||||||||||
Other noncurrent liabilities | 139 | 150 | |||||||||||
Subtotal | 1,800 | 1,420 | |||||||||||
Less: valuation allowance | (37 | ) | (36 | ) | |||||||||
1,763 | 1,384 | ||||||||||||
Deferred tax liabilities: | |||||||||||||
LIFO inventories | (150 | ) | (156 | ) | |||||||||
Property and equipment | (260 | ) | (232 | ) | |||||||||
Trademarks and other intangibles | (913 | ) | (916 | ) | |||||||||
Other | (111 | ) | (120 | ) | |||||||||
(1,434 | ) | (1,424 | ) | ||||||||||
Net deferred tax asset (liability) | $ | 329 | $ | (40 | ) | ||||||||
Current and Noncurrent Components of Deferred Tax Assets Liabilities | The current and noncurrent components of deferred tax assets and liabilities for the years ended December 31 were as follows: | ||||||||||||
2014 | 2013 | ||||||||||||
Current deferred tax assets | $ | 703 | $ | 606 | |||||||||
Noncurrent deferred tax assets | 9 | 12 | |||||||||||
Noncurrent deferred tax liabilities | (383 | ) | (658 | ) | |||||||||
$ | 329 | $ | (40 | ) | |||||||||
Pre-Tax Income (Loss) for Domestic and Foreign Continuing Operations | Pre-tax income (loss) for domestic and foreign continuing operations for the years ended December 31 consisted of the following: | ||||||||||||
2014 | 2013 | 2012 | |||||||||||
Domestic (includes U.S. exports) | $ | 2,235 | $ | 2,737 | $ | 1,983 | |||||||
Foreign | 27 | 4 | (30 | ) | |||||||||
$ | 2,262 | $ | 2,741 | $ | 1,953 | ||||||||
Differences between Provision for Income Taxes from Continuing Operations and Income Taxes | The differences between the provision for income taxes from continuing operations and income taxes computed at statutory U.S. federal income tax rates for the years ended December 31 were as follows: | ||||||||||||
2014 | 2013 | 2012 | |||||||||||
Income taxes computed at the statutory U.S. federal income tax rate | $ | 792 | $ | 959 | $ | 684 | |||||||
State and local income taxes, net of federal tax benefits | 107 | 135 | 107 | ||||||||||
Domestic manufacturing deduction | (80 | ) | (55 | ) | (60 | ) | |||||||
Other items, net | (2 | ) | (16 | ) | (50 | ) | |||||||
Provision for income taxes from continuing operations | $ | 817 | $ | 1,023 | $ | 681 | |||||||
Effective tax rate | 36.1 | % | 37.3 | % | 34.9 | % | |||||||
Components of Deferred Tax Benefits Included in Accumulated Other Comprehensive Loss | The components of deferred tax benefits included in accumulated other comprehensive loss for the years ended December 31 were as follows: | ||||||||||||
2014 | 2013 | ||||||||||||
Retirement benefits | $ | 241 | $ | 63 | |||||||||
Unrealized gain (loss) on long-term investments | 10 | 11 | |||||||||||
Amortization of realized loss on hedging instruments | 7 | 8 | |||||||||||
Cumulative translation adjustment and other | 19 | 4 | |||||||||||
$ | 277 | $ | 86 | ||||||||||
Accruals for Gross Unrecognized Income Tax Benefits, Including Interest and Penalties | The accruals for gross unrecognized income tax benefits, including interest and penalties, reflected in other noncurrent liabilities for the years ended December 31 were as follows: | ||||||||||||
2014 | 2013 | ||||||||||||
Unrecognized tax benefits | $ | 27 | $ | 62 | |||||||||
Accrued interest | 3 | 7 | |||||||||||
Accrued penalties | 1 | 1 | |||||||||||
$ | 31 | $ | 70 | ||||||||||
Reconciliation of Gross Unrecognized Income Tax Benefits | A reconciliation of the gross unrecognized income tax benefits is as follows: | ||||||||||||
2014 | 2013 | 2012 | |||||||||||
Balance at beginning of year | $ | 62 | $ | 68 | $ | 128 | |||||||
Gross increases related to current period tax positions | 5 | 4 | 4 | ||||||||||
Gross increases related to tax positions in prior periods | — | — | 1 | ||||||||||
Gross decreases related to tax positions in prior periods | (31 | ) | (3 | ) | (7 | ) | |||||||
Gross decreases related to audit settlements | (6 | ) | (1 | ) | (31 | ) | |||||||
Gross decreases related to lapse of applicable statute of limitations | (3 | ) | (6 | ) | (27 | ) | |||||||
Balance at end of year | $ | 27 | $ | 62 | $ | 68 | |||||||
LongTerm_Debt_Tables
Long-Term Debt (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Long-Term Debt, Net of Discounts | RAI’s long-term debt, net of discounts and including adjustments associated with interest rate swaps, as of December 31, consisted of the following: | ||||||||
2014 | 2013 | ||||||||
1.05% guaranteed, notes due 2015 | $ | — | $ | 450 | |||||
3.25% guaranteed, notes due 2022 | 1,099 | 1,099 | |||||||
4.75% guaranteed, notes due 2042 | 992 | 991 | |||||||
4.85% guaranteed, notes due 2023 | 550 | 550 | |||||||
6.15% guaranteed, notes due 2043 | 547 | 547 | |||||||
6.75% guaranteed, notes due 2017 | 747 | 765 | |||||||
7.25% guaranteed, notes due 2037 | 448 | 448 | |||||||
7.75% guaranteed, notes due 2018 | 250 | 249 | |||||||
Total long-term debt (less current maturities) | 4,633 | 5,099 | |||||||
Current maturities of long-term debt | 450 | — | |||||||
$ | 5,083 | $ | 5,099 | ||||||
Maturities of RAI's Notes | As of December 31, 2014, the maturities of RAI’s notes, net of discounts, were as follows: | ||||||||
Year | Amount | ||||||||
2015 | $ | 450 | |||||||
2017 | 700 | ||||||||
2018 | 250 | ||||||||
2022 and thereafter | 3,636 | ||||||||
$ | 5,036 | ||||||||
Commitments_and_Contingencies_
Commitments and Contingencies (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||||||
U.S. Tobacco-related Cases Pending Against RJR Tobacco or its Affiliates or Indemnities | The following table lists the categories of the U.S. tobacco-related cases pending against RJR Tobacco or its affiliates or indemnitees as of December 31, 2014, compared with the number of cases pending against RJR Tobacco, its affiliates or indemnitees as of September 30, 2014, as reported in RAI’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2014, filed with the SEC on October 21, 2014, and a cross-reference to the discussion of each case type. | ||||||||||||||||||||||||||||||||
Case Type | RJR Tobacco’s | Change in | Page | ||||||||||||||||||||||||||||||
U.S. Case Numbers | Number of | Reference | |||||||||||||||||||||||||||||||
as of December 31, 2014 | Cases Since | ||||||||||||||||||||||||||||||||
September 30, 2014 | |||||||||||||||||||||||||||||||||
Increase/(Decrease) | |||||||||||||||||||||||||||||||||
Individual Smoking and Health | 96 | 1 | 123 | ||||||||||||||||||||||||||||||
West Virginia IPIC (Number of Plaintiffs)* | 1 (approx. 564) | No change | 124 | ||||||||||||||||||||||||||||||
Engle Progeny (Number of Plaintiffs)** | 3,885 (approx. 4,959) | (184) (212) | 125 | ||||||||||||||||||||||||||||||
Broin II | 2,558 | -12 | 141 | ||||||||||||||||||||||||||||||
Class Action | 20 | 3 | 141 | ||||||||||||||||||||||||||||||
Health-Care Cost Recovery | 2 | No change | 144 | ||||||||||||||||||||||||||||||
State Settlement Agreements — Enforcement and Validity; Adjustments | 29 | (1 | ) | 152 | |||||||||||||||||||||||||||||
Antitrust | 1 | No change | 158 | ||||||||||||||||||||||||||||||
Other Litigation and Developments | 12 | (1 | ) | 158 | |||||||||||||||||||||||||||||
* | Includes as one case the approximately 564 cases pending as a consolidated action In Re: Tobacco Litigation Individual Personal Injury Cases, sometimes referred to as West Virginia IPIC cases, described below. The West Virginia IPIC cases have been separated from the Individual Smoking and Health cases for reporting purposes. | ||||||||||||||||||||||||||||||||
** | The Engle Progeny cases have been separated from the Individual Smoking and Health cases for reporting purposes. The number of cases has decreased as the result of many of the federal and state court cases being dismissed or duplicate actions being consolidated. | ||||||||||||||||||||||||||||||||
Verdicts in Individual Engle Progeny Cases that have been Tried and Remain Pending | The following chart reflects the details related to Hiott, Starr-Blundell, Clayton and Webb: | ||||||||||||||||||||||||||||||||
Plaintiff Case | RJR Tobacco | Compensatory | Punitive | Appeal Status | |||||||||||||||||||||||||||||
Name | Allocation of | Damages (as | Damages | ||||||||||||||||||||||||||||||
Fault | adjusted)(1) | ||||||||||||||||||||||||||||||||
Hiott | 40 | % | $ | 730,000 | $ | — | Notice to invoke jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA Inc. | ||||||||||||||||||||||||||
Starr-Blundell | 10 | % | 50,000 | — | Pending — First DCA | ||||||||||||||||||||||||||||
Clayton | 10 | % | 60,000 | — | Pending — First DCA | ||||||||||||||||||||||||||||
Webb | 90 | % | 810,000 | 450,000 | Reversed and remanded for new trial | ||||||||||||||||||||||||||||
on damages; new trial completed on November 12, 2014; plaintiff’s motion for new trial on punitive damages was denied on December 5, 2014. | |||||||||||||||||||||||||||||||||
Totals | $ | 1,650,000 | $ | 450,000 | |||||||||||||||||||||||||||||
(1) | Compensatory damages are adjusted to reflect the reduction that may be required by the allocation of fault. Punitive damages are not adjusted and reflect the amount of the final judgment(s) signed by the trial court judge(s). The amounts listed above do not include attorneys’ fees or statutory interest. | ||||||||||||||||||||||||||||||||
The following chart reflects verdicts in all other individual Engle Progeny cases, pending as of December 31, 2014, in which a verdict has been returned against RJR Tobacco or B&W, or both, and has not been set aside on appeal. No liability for any of these cases has been recorded in RAI’s consolidated balance sheet as of December 31, 2014. This chart does not include the mistrials or verdicts returned in favor of RJR Tobacco or B&W, or both. | |||||||||||||||||||||||||||||||||
Plaintiff | RJR Tobacco | Compensatory | Punitive | Appeal Status | |||||||||||||||||||||||||||||
Case Name | Allocation of | Damages (as | Damages | ||||||||||||||||||||||||||||||
Fault | adjusted)(1) | ||||||||||||||||||||||||||||||||
Cohen | 33.3 | % | $ | 3,330,000 | $ | — | Punitive damages of $10 million set aside; remanded for partial new trial; notice to invoke jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA Inc. | ||||||||||||||||||||||||||
Putney | 30 | % | — | — | Reversed and remanded for further proceedings; notice to invoke jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA Inc. | ||||||||||||||||||||||||||||
Buonomo | 77.5 | % | 4,060,000 | — | Punitive damages of $25 million to be reinstated if plaintiff prevails on repose issue; remanded for new trial; notice to invoke jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA Inc. | ||||||||||||||||||||||||||||
Andy Allen | 24 | % | 2,475,000 | 7,756,000 | Reversed and remanded for new trial; new trial completed on November 26, 2014; final judgment has not been entered. | ||||||||||||||||||||||||||||
Jewett | 20 | % | — | — | Reversed and remanded for new trial; new trial has not been scheduled | ||||||||||||||||||||||||||||
Soffer | 40 | % | 2,000,000 | — | Pending — Florida Supreme Court | ||||||||||||||||||||||||||||
Ciccone | 30 | % | 1,000,000 | — | Pending — Florida Supreme Court | ||||||||||||||||||||||||||||
Hallgren | 25 | % | 500,000 | (2) | 750,000 | Notice to invoke jurisdiction of Florida Supreme Court pending; stayed | |||||||||||||||||||||||||||
Calloway | 27 | % | 16,100,000 | (2) | 17,250,000 | Pending — Fourth DCA | |||||||||||||||||||||||||||
Hancock | 5 | % | 700 | — | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Sikes | 51 | % | 3,520,000 | 2,000,000 | Notice to invoke jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA Inc. | ||||||||||||||||||||||||||||
James Smith | 55 | % | 600,000 | (2) | 20,000 | Pending — Eleventh Circuit | |||||||||||||||||||||||||||
Ballard | 55 | % | 5,000,000 | — | Pending — Third DCA | ||||||||||||||||||||||||||||
Evers | 60 | % | 1,938,000 | — | Punitive damages of $12.4 million set aside by trial court; pending — Second DCA | ||||||||||||||||||||||||||||
Schoeff | 75 | % | 7,875,000 | 30,000,000 | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Marotta | 58 | % | 3,480,000 | — | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Searcy | 30 | % | 1,000,000 | (2) | 1,670,000 | Pending — Eleventh Circuit | |||||||||||||||||||||||||||
Aycock | 72.5 | % | — | — | Eleventh Circuit reversed and remanded the case for a new trial | ||||||||||||||||||||||||||||
Earl Graham | 20 | % | 550,000 | — | Pending — Eleventh Circuit | ||||||||||||||||||||||||||||
Skolnick | 30 | % | 767,000 | — | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Thibault | 70 | % | 1,750,000 | (2) | 1,275,000 | First DCA affirmed the judgment, per curiam; notice to invoke the discretionary jurisdiction of Florida Supreme Court pending; stayed pending resolution of Hess v. Philip Morris USA, Inc. | |||||||||||||||||||||||||||
Grossman | 75 | % | 15,350,000 | (2) | 22,500,000 | Pending — Fourth DCA | |||||||||||||||||||||||||||
Gafney | 33 | % | 1,914,000 | — | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Harford | 18 | % | — | — | Plaintiff’s motion for new trial granted; new trial is scheduled for March 16, 2015 | ||||||||||||||||||||||||||||
Cheeley | 50 | % | 1,500,000 | 2,000,000 | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Goveia | 35 | % | 297,500 | 2,250,000 | Pending — Fifth DCA | ||||||||||||||||||||||||||||
Bowden | 30 | % | 1,500,000 | — | Pending — First DCA | ||||||||||||||||||||||||||||
Burkhart | 25 | % | 2,500,000 | (2) | 1,250,000 | Pending — Eleventh Circuit | |||||||||||||||||||||||||||
Bakst | 75 | % | 4,504,000 | 14,000,000 | Pending — Fourth DCA | ||||||||||||||||||||||||||||
Robinson | 70.5 | % | 16,900,000 | 16,900,000 | Punitive damages remitted, remaining post-trial motions denied | ||||||||||||||||||||||||||||
Harris | 15 | % | 239,000 | — | Post-trial motions are pending(3) | ||||||||||||||||||||||||||||
Wilcox | 70 | % | 4,900,000 | 8,500,000 | Post-trial motions denied | ||||||||||||||||||||||||||||
Irimi | 14.5 | % | — | — | Defendants’ motion for a new trial granted | ||||||||||||||||||||||||||||
Hubbird | 50 | % | 3,000,000 | (2) | 25,000,000 | Pending — Third DCA | |||||||||||||||||||||||||||
Lourie | 3 | % | 41,000 | — | Pending — Second DCA | ||||||||||||||||||||||||||||
Kerrivan | 31 | % | 4,898,000 | 9,600,000 | Post-trial motions are pending(3) | ||||||||||||||||||||||||||||
Taylor | 58 | % | 4,116,000 | (2) | 521,000 | Pending — First DCA | |||||||||||||||||||||||||||
Schleider | 70 | % | 14,700,000 | — | Final judgment has not been entered | ||||||||||||||||||||||||||||
Perrotto | 20 | % | 818,000 | — | Post-trial motions are pending | ||||||||||||||||||||||||||||
Ellen Gray | 50 | % | 3,000,000 | — | Final judgment has not been entered | ||||||||||||||||||||||||||||
Totals | $ | 136,123,200 | $ | 163,242,000 | |||||||||||||||||||||||||||||
(1) | Unless otherwise noted, compensatory damages in these cases are adjusted to reflect the jury’s allocation of comparative fault. Punitive damages are not so adjusted. The amounts listed above do not include attorneys’ fees or statutory interest that may apply to the judgments. | ||||||||||||||||||||||||||||||||
(2) | The court did not apply comparative fault in the final judgment. | ||||||||||||||||||||||||||||||||
(3) | Should the pending post-trial motions be denied, RJR Tobacco will likely file a notice of appeal with the appropriate appellate court. | ||||||||||||||||||||||||||||||||
Commitments and Contingencies Related to Settlements | Set forth below is the unadjusted tobacco industry settlement payment schedule for 2012 and beyond: | ||||||||||||||||||||||||||||||||
2012 | 2013 | 2014 | 2015 and | ||||||||||||||||||||||||||||||
thereafter | |||||||||||||||||||||||||||||||||
First Four States’ Settlements:(1) | |||||||||||||||||||||||||||||||||
Mississippi Annual Payment | $ | 136 | $ | 136 | $ | 136 | $ | 136 | |||||||||||||||||||||||||
Florida Annual Payment | 440 | 440 | 440 | 440 | |||||||||||||||||||||||||||||
Texas Annual Payment | 580 | 580 | 580 | 580 | |||||||||||||||||||||||||||||
Minnesota Annual Payment | 204 | 204 | 204 | 204 | |||||||||||||||||||||||||||||
Remaining Jurisdictions’ Settlement: | |||||||||||||||||||||||||||||||||
Annual Payments(1) | 8,004 | 8,004 | 8,004 | 8,004 | |||||||||||||||||||||||||||||
Total | $ | 9,364 | $ | 9,364 | $ | 9,364 | $ | 9,364 | |||||||||||||||||||||||||
-1 | Subject to adjustments for changes in sales volume, inflation and other factors. All payments are to be allocated among the companies on the basis of relative market share. For further information, see “— State Settlement Agreements — Enforcement and Validity; Adjustments” below. | ||||||||||||||||||||||||||||||||
RAI’s operating subsidiaries expenses and payments under the State Settlement Agreements for 2012, 2013 and 2014, and the projected expenses and payments for 2015 and beyond are set forth below(2). | |||||||||||||||||||||||||||||||||
2012 | 2013 | 2014 | 2015 and | ||||||||||||||||||||||||||||||
thereafter | |||||||||||||||||||||||||||||||||
Settlement expenses | $ | 2,370 | $ | 1,819 | $ | 1,917 | — | ||||||||||||||||||||||||||
Settlement cash payments | $ | 2,414 | $ | 2,582 | $ | 1,985 | — | ||||||||||||||||||||||||||
Projected settlement expenses | $ | >1,900 | |||||||||||||||||||||||||||||||
Projected settlement cash payments | $ | >1,900 | |||||||||||||||||||||||||||||||
-2 | Amounts beginning in 2013 reflect the impact of the Term Sheet described below under “— State Settlement Agreements — Enforcement and Validity; Adjustments — Partial Settlement of Certain NPM Adjustment Claims.” | ||||||||||||||||||||||||||||||||
Disputed Portion of MSA Payment Obligation | The approximate maximum principal amounts of RJR Tobacco’s share of the disputed NPM Adjustments for the years 2004 through 2011, as currently calculated by the Independent Auditor, are as follows (the amounts shown below do not include the interest or earnings thereon to which RJR Tobacco believes it would be entitled under the MSA and do not reflect any reduction as a result of the Term Sheet described below): | ||||||||||||||||||||||||||||||||
Year for which NPM Adjustment calculated | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | |||||||||||||||||||||||||
Year in which deduction for NPM Adjustment was taken | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |||||||||||||||||||||||||
RJR Tobacco’s approximate share of disputed NPM Adjustment (millions) | $ | 562 | $ | 445 | $ | 419 | $ | 435 | $ | 468 | $ | 472 | $ | 470 | $ | 421 | |||||||||||||||||
Noncancellable Operating Leases Future Minimum Lease Payments | Future minimum lease payments as of December 31, 2014 were as follows: | ||||||||||||||||||||||||||||||||
Noncancellable | |||||||||||||||||||||||||||||||||
Operating Leases | |||||||||||||||||||||||||||||||||
2015 | $ | 19 | |||||||||||||||||||||||||||||||
2016 | 3 | ||||||||||||||||||||||||||||||||
2017 | 3 | ||||||||||||||||||||||||||||||||
2018 | 2 | ||||||||||||||||||||||||||||||||
2019 | 2 | ||||||||||||||||||||||||||||||||
Thereafter | 1 | ||||||||||||||||||||||||||||||||
Total | $ | 30 | |||||||||||||||||||||||||||||||
Shareholders_Equity_Tables
Shareholders' Equity (Tables) | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||
Declared Quarterly Cash Dividends per Share of Common Stock | RAI’s board of directors declared the following quarterly cash dividends per share of RAI common stock in 2014, 2013 and 2012: | ||||||||||||||||||||
2014 | 2013 | 2012 | |||||||||||||||||||
First | $ | 0.67 | $ | 0.59 | $ | 0.56 | |||||||||||||||
Second | $ | 0.67 | $ | 0.63 | $ | 0.59 | |||||||||||||||
Third | $ | 0.67 | $ | 0.63 | $ | 0.59 | |||||||||||||||
Fourth | $ | 0.67 | $ | 0.63 | $ | 0.59 | |||||||||||||||
Components of Accumulated Other Comprehensive Ioss Net of Tax | The components of accumulated other comprehensive loss, net of tax, were as follows: | ||||||||||||||||||||
Retirement | Unrealized Gain | Realized Loss | Cumulative | Total | |||||||||||||||||
Benefits | (Loss) on Long- | on Hedging | Translation | ||||||||||||||||||
Term Investments | Instruments | Adjustment and Other | |||||||||||||||||||
Balance at December 31, 2012 | $ | (265 | ) | $ | (21 | ) | $ | (14 | ) | $ | (11 | ) | $ | (311 | ) | ||||||
Other comprehensive income before reclassifications | 271 | 5 | — | 1 | 277 | ||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | (23 | ) | — | 1 | — | (22 | ) | ||||||||||||||
Net current-period other comprehensive income | 248 | 5 | 1 | 1 | 255 | ||||||||||||||||
Balance at December 31, 2013 | (17 | ) | (16 | ) | (13 | ) | (10 | ) | (56 | ) | |||||||||||
Other comprehensive income before reclassifications | (528 | ) | 2 | — | (34 | ) | (560 | ) | |||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | 251 | — | 1 | — | 252 | ||||||||||||||||
Net current-period other comprehensive income | (277 | ) | 2 | 1 | (34 | ) | (308 | ) | |||||||||||||
Balance at December 31, 2014 | $ | (294 | ) | $ | (14 | ) | $ | (12 | ) | $ | (44 | ) | $ | (364 | ) | ||||||
Reclassification Out of Accumulated Other Comprehensive Income Net of Tax | Details about the reclassifications out of accumulated other comprehensive loss and the affected line items in the consolidated statement of income for the years ended December 31, 2014 and 2013, were as follows: | ||||||||||||||||||||
Amounts Reclassified | Affected Line Item | ||||||||||||||||||||
Components | 2014 | 2013 | |||||||||||||||||||
Defined benefit pension and postretirement plans: | |||||||||||||||||||||
Amortization of prior service costs | $ | (21 | ) | $ | (21 | ) | Cost of products sold | ||||||||||||||
Amortization of prior service costs | (18 | ) | (18 | ) | Selling, general and administrative expenses | ||||||||||||||||
MTM adjustment | 205 | — | Cost of products sold | ||||||||||||||||||
MTM adjustment | 247 | — | Selling, general and administrative expenses | ||||||||||||||||||
413 | (39 | ) | |||||||||||||||||||
Deferred taxes | (162 | ) | 16 | Provision for income taxes | |||||||||||||||||
Net of tax | $ | 251 | $ | (23 | ) | ||||||||||||||||
Loss on hedging instruments: | |||||||||||||||||||||
Amortization of realized loss | $ | 2 | $ | 2 | Interest and debt expense | ||||||||||||||||
Deferred taxes | (1 | ) | (1 | ) | Provision for income taxes | ||||||||||||||||
Net of tax | $ | 1 | $ | 1 | |||||||||||||||||
Total reclassifications | $ | 252 | $ | (22 | ) | Net income | |||||||||||||||
Changes in Common Stock Outstanding | Changes in RAI common stock outstanding were as follows: | ||||||||||||||||||||
2014 | 2013 | 2012 | |||||||||||||||||||
Shares outstanding at beginning of year | 538,053,024 | 552,940,767 | 576,135,199 | ||||||||||||||||||
LTIP tax shares repurchased and cancelled | — | — | (921,646 | ) | |||||||||||||||||
LTIP shares issued from vesting of restricted stock units | — | — | 2,640,408 | ||||||||||||||||||
Omnibus Plan tax shares repurchased and cancelled | (554,042 | ) | (574,383 | ) | — | ||||||||||||||||
Omnibus Plan shares issued from vesting of restricted stock units | 1,468,294 | 1,572,389 | — | ||||||||||||||||||
Shares repurchased and cancelled | (7,715,763 | ) | (15,917,174 | ) | (24,944,233 | ) | |||||||||||||||
Equity incentive award plan shares issued | 32,000 | 31,425 | 31,039 | ||||||||||||||||||
Shares outstanding at end of year | 531,283,513 | 538,053,024 | 552,940,767 | ||||||||||||||||||
Stock_Plans_Tables
Stock Plans (Tables) | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||
Information Regarding Stock-based Awards Outstanding | Information regarding restricted stock unit awards outstanding as of December 31, 2014, under the Omnibus Plan was as follows: | ||||||||||||||||||||
Grant Year | Number | Grant | Vesting Date | Number | Cumulative | Ending Date of | |||||||||||||||
of | Price | of | Dividends | Performance Period | |||||||||||||||||
Shares | Shares | ||||||||||||||||||||
Granted | Cancelled | ||||||||||||||||||||
Three-year grants | |||||||||||||||||||||
2012 | 1,222,534 | $ | 42.16 | March 1, 2015 | 269,091 | $ | 6.72 | December 31, 2014 | |||||||||||||
2013 | 1,112,436 | $ | 43.36 | 1-Mar-16 | 201,697 | $ | 7.08 | 31-Dec-15 | |||||||||||||
2014 | 1,049,348 | $ | 53.29 | 3-Mar-17 | 185,128 | $ | 8.04 | 31-Dec-16 | |||||||||||||
2014 | 25,907 | $ | 58.73 | 3-Mar-17 | — | $ | 6.03 | 31-Dec-16 | |||||||||||||
One-year grant | |||||||||||||||||||||
2014 | 149,192 | $ | 64.27 | 1-May-15 | — | $ | 2.68 | 30-Apr-15 | |||||||||||||
Other grants | |||||||||||||||||||||
2014 | 20,726 | $ | 58.73 | September 30, 2015 | — | N/A | N/A | ||||||||||||||
2014 | 37,133 | $ | 58.73 | 30-Sep-15 | — | N/A | N/A | ||||||||||||||
2014 | 20,725 | $ | 58.73 | 30-Sep-16 | — | N/A | N/A | ||||||||||||||
2014 | 37,133 | $ | 58.73 | 30-Sep-18 | — | N/A | N/A | ||||||||||||||
Changes in Restricted RAI Common Stock and Restricted Stock Units | The changes in the number of RAI restricted stock units during 2014 were as follows: | ||||||||||||||||||||
Number of | Weighted Average | ||||||||||||||||||||
Stock Units | Grant Date | ||||||||||||||||||||
Fair Value | |||||||||||||||||||||
Outstanding at beginning of year | 3,594,594 | $ | 39.37 | ||||||||||||||||||
Granted | 1,340,164 | 55.09 | |||||||||||||||||||
Forfeited | (530,547 | ) | 46.42 | ||||||||||||||||||
Vested | (1,384,993 | ) | 33.99 | ||||||||||||||||||
Outstanding at end of year | 3,019,218 | 47.58 | |||||||||||||||||||
Compensation Expense Related to Stock Based Compensation and Related Tax Benefits | Total compensation expense related to stock-based compensation and the related tax benefits recognized in selling, general and administrative expenses in the consolidated statements of income were as follows: | ||||||||||||||||||||
Grant/Type | 2014 | 2013 | 2012 | ||||||||||||||||||
2009 restricted stock units | $ | — | $ | — | $ | 2 | |||||||||||||||
2010 restricted stock units | — | 2 | 13 | ||||||||||||||||||
2011 restricted stock units | 3 | 20 | 14 | ||||||||||||||||||
2012 restricted stock units | 14 | 18 | 13 | ||||||||||||||||||
2013 restricted stock units | 15 | 15 | — | ||||||||||||||||||
2014 restricted stock units | 24 | — | — | ||||||||||||||||||
Total compensation expense | $ | 56 | $ | 55 | $ | 42 | |||||||||||||||
Total related tax benefits | $ | 20 | $ | 19 | $ | 15 | |||||||||||||||
Amounts Related to Performance Share Grants, Restricted Stock Grants, Restricted Stock Units Grant | The amounts related to the unvested Omnibus Plan restricted stock unit grants were included in the consolidated balance sheets as of December 31 as follows: | ||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||
Other current liabilities | $ | 9 | $ | 10 | |||||||||||||||||
Other noncurrent liabilities | 8 | 9 | |||||||||||||||||||
Paid-in capital | 99 | 94 | |||||||||||||||||||
Equity Compensation Plan Information | Equity compensation plan information as of December 31, 2014, was as follows: | ||||||||||||||||||||
Plan Category | Number of Securities | Weighted Average | Number of Securities | ||||||||||||||||||
to be Issued Upon | Exercise Price of | Remaining Available for | |||||||||||||||||||
Exercise of | Outstanding | Future Issuance under | |||||||||||||||||||
Outstanding Options, | Options, Warrants | Equity Compensation | |||||||||||||||||||
Warrants and Rights | and Rights | Plans (Excluding | |||||||||||||||||||
Securities Reflected in | |||||||||||||||||||||
Column (a)) | |||||||||||||||||||||
(a) | (b) | (c) | |||||||||||||||||||
Equity Compensation Plans Approved by Security Holders | 4,470,968 | (2) | $ | — | 31,616,775 | ||||||||||||||||
Equity Compensation Plans Not Approved by Security Holders(1) | — | — | 1,053,955 | ||||||||||||||||||
Total | 4,470,968 | (2) | — | 32,670,730 | |||||||||||||||||
-1 | The EIAP was approved by RJR’s sole shareholder, NGH, prior to RJR’s spin-off on June 15, 1999. | ||||||||||||||||||||
(2) | Consists of restricted stock units. These restricted stock units represent the maximum number of shares to be awarded under the best-case targets, and accordingly, may overstate expected dilution. |
Retirement_Benefits_Tables
Retirement Benefits (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||||||
Changes in Benefit Obligations | The changes in benefit obligations and plan assets, as well as the funded status of these plans at December 31 were as follows: | ||||||||||||||||||||||||||||||||
Pension Benefits | Postretirement | ||||||||||||||||||||||||||||||||
Benefits | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||||||||||||||
Change in benefit obligations: | |||||||||||||||||||||||||||||||||
Obligations at beginning of year | $ | 5,618 | $ | 6,293 | $ | 1,169 | $ | 1,280 | |||||||||||||||||||||||||
Service cost | 21 | 23 | 2 | 3 | |||||||||||||||||||||||||||||
Interest cost | 266 | 247 | 53 | 50 | |||||||||||||||||||||||||||||
Actuarial (gain) loss | 941 | (540 | ) | 106 | (95 | ) | |||||||||||||||||||||||||||
Benefits paid | (457 | ) | (405 | ) | (79 | ) | (69 | ) | |||||||||||||||||||||||||
Obligations at end of year | $ | 6,389 | $ | 5,618 | $ | 1,251 | $ | 1,169 | |||||||||||||||||||||||||
Change in plan assets: | |||||||||||||||||||||||||||||||||
Fair value of plan assets at beginning of year | $ | 5,220 | $ | 5,423 | $ | 268 | $ | 258 | |||||||||||||||||||||||||
Actual return on plan assets | 536 | 142 | 14 | 31 | |||||||||||||||||||||||||||||
Employer contributions | 10 | 60 | 56 | 48 | |||||||||||||||||||||||||||||
Benefits paid | (457 | ) | (405 | ) | (79 | ) | (69 | ) | |||||||||||||||||||||||||
Fair value of plan assets at end of year | $ | 5,309 | $ | 5,220 | $ | 259 | $ | 268 | |||||||||||||||||||||||||
Funded status | $ | (1,080 | ) | $ | (398 | ) | $ | (992 | ) | $ | (901 | ) | |||||||||||||||||||||
Amounts Recognized in Consolidated Balance Sheets | |||||||||||||||||||||||||||||||||
Pension Benefits | Postretirement | ||||||||||||||||||||||||||||||||
Benefits | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||||||||||||||
Amounts recognized in the consolidated balance sheets consist of: | |||||||||||||||||||||||||||||||||
Noncurrent assets — other assets and deferred charges | $ | — | $ | 1 | $ | — | $ | — | |||||||||||||||||||||||||
Accrued benefit — other current liability | (9 | ) | (9 | ) | (66 | ) | (70 | ) | |||||||||||||||||||||||||
Accrued benefit — long-term retirement benefits | (1,071 | ) | (390 | ) | (926 | ) | (831 | ) | |||||||||||||||||||||||||
Net amount recognized | (1,080 | ) | (398 | ) | (992 | ) | (901 | ) | |||||||||||||||||||||||||
Accumulated other comprehensive loss | 652 | 311 | (117 | ) | (231 | ) | |||||||||||||||||||||||||||
Net amounts recognized in the consolidated balance sheets | $ | (428 | ) | $ | (87 | ) | $ | (1,109 | ) | $ | (1,132 | ) | |||||||||||||||||||||
Amounts Included in Accumulated Other Comprehensive Loss | Amounts included in accumulated other comprehensive loss were as follows as of December 31: | ||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Pension | Postretirement | Total | Pension | Postretirement | Total | ||||||||||||||||||||||||||||
Benefits | Benefits | Benefits | Benefits | ||||||||||||||||||||||||||||||
Prior service cost (credit) | $ | 14 | $ | (178 | ) | $ | (164 | ) | $ | 17 | $ | (220 | ) | $ | (203 | ) | |||||||||||||||||
Net actuarial (gain) loss | 638 | 61 | 699 | 294 | (11 | ) | 283 | ||||||||||||||||||||||||||
Deferred income taxes | (268 | ) | 27 | (241 | ) | (134 | ) | 71 | (63 | ) | |||||||||||||||||||||||
Accumulated other comprehensive loss | $ | 384 | $ | (90 | ) | $ | 294 | $ | 177 | $ | (160 | ) | $ | 17 | |||||||||||||||||||
Changes in Accumulated Other Comprehensive Loss | Changes in accumulated other comprehensive loss were as follows: | ||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Pension | Postretirement | Total | Pension | Postretirement | Total | ||||||||||||||||||||||||||||
Benefits | Benefits | Benefits | Benefits | ||||||||||||||||||||||||||||||
Net actuarial (gain) loss | $ | 764 | $ | 104 | $ | 868 | $ | (331 | ) | $ | (116 | ) | $ | (447 | ) | ||||||||||||||||||
Amortization of prior service cost (credit) | (3 | ) | 42 | 39 | (3 | ) | 42 | 39 | |||||||||||||||||||||||||
MTM adjustment | (420 | ) | (32 | ) | (452 | ) | — | — | — | ||||||||||||||||||||||||
Deferred income tax (benefit) expense | (134 | ) | (44 | ) | (178 | ) | 131 | 29 | 160 | ||||||||||||||||||||||||
Change in accumulated other comprehensive loss | $ | 207 | $ | 70 | $ | 277 | $ | (203 | ) | $ | (45 | ) | $ | (248 | ) | ||||||||||||||||||
Weighted Average Assumptions Used to Determine Benefit Obligations | |||||||||||||||||||||||||||||||||
Pension Benefits | Postretirement | ||||||||||||||||||||||||||||||||
Benefits | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||||||||||||||
Weighted-average assumptions used to determine benefit obligations at December 31: | |||||||||||||||||||||||||||||||||
Discount rate | 4.12 | % | 4.92 | % | 4.11 | % | 4.87 | % | |||||||||||||||||||||||||
Rate of compensation increase | 4 | % | 4 | % | — | — | |||||||||||||||||||||||||||
Accumulated Benefit Obligations | Pension plans experiencing accumulated benefit obligations, which represent benefits earned to date, in excess of plan assets are summarized below: | ||||||||||||||||||||||||||||||||
December 31, | |||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Projected benefit obligation | $ | 6,389 | $ | 5,589 | |||||||||||||||||||||||||||||
Accumulated benefit obligation | 6,326 | 5,529 | |||||||||||||||||||||||||||||||
Plan assets | 5,309 | 5,190 | |||||||||||||||||||||||||||||||
Components of Pension Benefits (Income) and Postretirement Benefits | The components of the total benefit (income) cost and assumptions are set forth below: | ||||||||||||||||||||||||||||||||
Pension Benefits | Postretirement Benefits | ||||||||||||||||||||||||||||||||
2014 | 2013 | 2012 | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||
Service cost | $ | 21 | $ | 23 | $ | 23 | $ | 2 | $ | 3 | $ | 3 | |||||||||||||||||||||
Interest cost | 266 | 247 | 280 | 53 | 50 | 56 | |||||||||||||||||||||||||||
Expected return on plan assets | (360 | ) | (350 | ) | (359 | ) | (12 | ) | (11 | ) | (10 | ) | |||||||||||||||||||||
Amortization of prior service cost (credit) | 3 | 3 | 4 | (42 | ) | (42 | ) | (30 | ) | ||||||||||||||||||||||||
MTM adjustment | 420 | — | 289 | 32 | — | 40 | |||||||||||||||||||||||||||
Curtailment | — | — | 4 | — | — | — | |||||||||||||||||||||||||||
Special termination benefits | — | — | 34 | — | — | — | |||||||||||||||||||||||||||
Total benefit (income) cost | $ | 350 | $ | (77 | ) | $ | 275 | $ | 33 | $ | — | $ | 59 | ||||||||||||||||||||
Weighted Average Assumptions | |||||||||||||||||||||||||||||||||
Pension Benefits | Postretirement Benefits | ||||||||||||||||||||||||||||||||
2014 | 2013 | 2012 | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||
Weighted-average assumptions used to determine net periodic benefit cost for years ended December 31: | |||||||||||||||||||||||||||||||||
Discount rate | 4.92 | % | 4.07 | % | 5 | % | 4.87 | % | 3.99 | % | 4.84 | % | |||||||||||||||||||||
Expected long-term return on plan assets | 7.13 | % | 6.67 | % | 6.97 | % | 4.85 | % | 4.35 | % | 4.35 | % | |||||||||||||||||||||
Rate of compensation increase | 4 | % | 4 | % | 5 | % | — | — | — | ||||||||||||||||||||||||
Pension and Postretirement Plans Asset Allocations | RAI’s pension and postretirement plans asset allocations at December 31, 2014 and 2013, by asset category were as follows: | ||||||||||||||||||||||||||||||||
Pension Plans | |||||||||||||||||||||||||||||||||
2014 Target(1) | 2014 | 2013 Target(1) | 2013 | ||||||||||||||||||||||||||||||
Asset Category: | |||||||||||||||||||||||||||||||||
Domestic equities | 10 | % | 10 | % | 10 | % | 10 | % | |||||||||||||||||||||||||
International equities | 8 | % | 8 | % | 8 | % | 9 | % | |||||||||||||||||||||||||
Global equities | 9 | % | 10 | % | 9 | % | 11 | % | |||||||||||||||||||||||||
Emerging market equities | 3 | % | 3 | % | 3 | % | 3 | % | |||||||||||||||||||||||||
Fixed income | 53 | % | 56 | % | 53 | % | 55 | % | |||||||||||||||||||||||||
Absolute return | 6 | % | 4 | % | 6 | % | 3 | % | |||||||||||||||||||||||||
Private equity | 2 | % | 1 | % | 2 | % | 1 | % | |||||||||||||||||||||||||
Real estate | 5 | % | 4 | % | 5 | % | 4 | % | |||||||||||||||||||||||||
Commodities | 4 | % | 4 | % | 4 | % | 4 | % | |||||||||||||||||||||||||
Total | 100 | % | 100 | % | 100 | % | 100 | % | |||||||||||||||||||||||||
Postretirement Plans | |||||||||||||||||||||||||||||||||
2014 Target(1) | 2014 | 2013 Target(1) | 2013 | ||||||||||||||||||||||||||||||
Asset Category: | |||||||||||||||||||||||||||||||||
Domestic equities | 21 | % | 21 | % | 21 | % | 22 | % | |||||||||||||||||||||||||
International equities | 21 | % | 20 | % | 21 | % | 22 | % | |||||||||||||||||||||||||
Fixed income | 55 | % | 54 | % | 55 | % | 51 | % | |||||||||||||||||||||||||
Cash and other | 3 | % | 5 | % | 3 | % | 5 | % | |||||||||||||||||||||||||
Total | 100 | % | 100 | % | 100 | % | 100 | % | |||||||||||||||||||||||||
-1 | Allows for a rebalancing range of up to 5 percentage points around target asset allocations. | ||||||||||||||||||||||||||||||||
Plan Assets Carried at Fair Value | RAI’s pension and postretirement plan assets, excluding uninvested cash and unsettled trades, carried at fair value on a recurring basis as of December 31, 2014 and 2013, were as follows(1): | ||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Pension Plans | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
Asset Category: | |||||||||||||||||||||||||||||||||
Domestic equities | $ | 511 | $ | — | $ | — | $ | 511 | $ | 523 | $ | — | $ | — | $ | 523 | |||||||||||||||||
International equities | 134 | 172 | — | 306 | 135 | 404 | — | 539 | |||||||||||||||||||||||||
Global equities | 570 | — | — | 570 | 535 | — | — | 535 | |||||||||||||||||||||||||
High yield fixed income | — | 19 | — | 19 | — | 18 | — | 18 | |||||||||||||||||||||||||
Absolute return | — | 126 | 223 | 349 | — | — | 176 | 176 | |||||||||||||||||||||||||
Private equity | — | — | 66 | 66 | — | — | 53 | 53 | |||||||||||||||||||||||||
Real estate | 21 | — | 188 | 209 | 22 | — | 190 | 212 | |||||||||||||||||||||||||
Commodities | — | 156 | — | 156 | — | 185 | — | 185 | |||||||||||||||||||||||||
Agency bonds | — | 21 | — | 21 | — | 17 | — | 17 | |||||||||||||||||||||||||
Asset backed securities | — | 93 | 3 | 96 | — | 89 | 3 | 92 | |||||||||||||||||||||||||
Corporate bonds | — | 1,739 | 2 | 1,741 | — | 1,568 | 2 | 1,570 | |||||||||||||||||||||||||
Government bonds | — | 153 | — | 153 | — | 152 | — | 152 | |||||||||||||||||||||||||
Mortgage backed securities | — | 42 | 25 | 67 | — | 74 | 21 | 95 | |||||||||||||||||||||||||
Municipal bonds | — | 209 | — | 209 | — | 212 | — | 212 | |||||||||||||||||||||||||
Emerging market equities | — | 52 | — | 52 | — | — | — | — | |||||||||||||||||||||||||
Treasuries | — | 414 | — | 414 | — | 398 | — | 398 | |||||||||||||||||||||||||
Other | 62 | 101 | 2 | 165 | 30 | 72 | 2 | 104 | |||||||||||||||||||||||||
Total | $ | 1,298 | $ | 3,297 | $ | 509 | $ | 5,104 | $ | 1,245 | $ | 3,189 | $ | 447 | $ | 4,881 | |||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Postretirement Plans | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
Asset Category: | |||||||||||||||||||||||||||||||||
Domestic equities | $ | — | $ | 55 | $ | — | $ | 55 | $ | — | $ | 60 | $ | — | $ | 60 | |||||||||||||||||
International equities | — | 50 | — | 50 | — | 59 | — | 59 | |||||||||||||||||||||||||
Short-term bonds | 9 | — | — | 9 | 9 | — | — | 9 | |||||||||||||||||||||||||
Intermediate bonds | — | 131 | — | 131 | — | 127 | — | 127 | |||||||||||||||||||||||||
Other | — | 7 | — | 7 | — | 7 | — | 7 | |||||||||||||||||||||||||
Total | $ | 9 | $ | 243 | $ | — | $ | 252 | $ | 9 | $ | 253 | $ | — | $ | 262 | |||||||||||||||||
-1 | See note 1 for additional information on the fair value hierarchy. | ||||||||||||||||||||||||||||||||
Transfers of Plan Assets by Asset Category | Transfers of pension and postretirement plan assets in and out of Level 3 during 2014, by asset category were as follows: | ||||||||||||||||||||||||||||||||
Balance as of | Purchases, Sales, | Realized | Unrealized | Transferred | Balance as of | ||||||||||||||||||||||||||||
January 1, 2014 | Issuances and | Gains | Gains | From Other | December 31, 2014 | ||||||||||||||||||||||||||||
Settlements (net) | (Losses) | Levels | |||||||||||||||||||||||||||||||
Absolute return | $ | 176 | $ | 40 | $ | 13 | $ | (6 | ) | $ | — | $ | 223 | ||||||||||||||||||||
Private equity | 53 | 6 | 7 | — | — | 66 | |||||||||||||||||||||||||||
Real estate | 190 | (24 | ) | 8 | 14 | — | 188 | ||||||||||||||||||||||||||
Asset backed securities | 3 | — | — | — | — | 3 | |||||||||||||||||||||||||||
Corporate bonds | 2 | — | — | — | — | 2 | |||||||||||||||||||||||||||
Mortgage backed securities | 21 | 2 | 1 | 1 | — | 25 | |||||||||||||||||||||||||||
Other | 2 | — | — | — | — | 2 | |||||||||||||||||||||||||||
Total | $ | 447 | $ | 24 | $ | 29 | $ | 9 | $ | — | $ | 509 | |||||||||||||||||||||
Transfers of pension and postretirement plan assets in and out of Level 3 during 2013, by asset category were as follows: | |||||||||||||||||||||||||||||||||
Balance as of | Purchases, Sales, | Realized | Unrealized | Transferred | Balance as of | ||||||||||||||||||||||||||||
January 1, 2013 | Issuances and | Gains | Gains | From Other | December 31, 2013 | ||||||||||||||||||||||||||||
Settlements (net) | (Losses) | Levels | |||||||||||||||||||||||||||||||
Absolute return | $ | 189 | $ | (32 | ) | $ | 31 | $ | (12 | ) | $ | — | $ | 176 | |||||||||||||||||||
Private equity | 47 | (1 | ) | 4 | 3 | — | 53 | ||||||||||||||||||||||||||
Real estate | 178 | (9 | ) | 4 | 17 | — | 190 | ||||||||||||||||||||||||||
Asset backed securities | 5 | (2 | ) | — | — | — | 3 | ||||||||||||||||||||||||||
Corporate bonds | 2 | — | — | — | — | 2 | |||||||||||||||||||||||||||
Mortgage backed securities | 21 | — | — | — | — | 21 | |||||||||||||||||||||||||||
Other | 2 | — | — | — | — | 2 | |||||||||||||||||||||||||||
Total | $ | 444 | $ | (44 | ) | $ | 39 | $ | 8 | $ | — | $ | 447 | ||||||||||||||||||||
Weighted Average Health Care Cost Trend | Additional information relating to RAI’s significant postretirement plans is as follows: | ||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||
Weighted-average health-care cost trend rate assumed for the following year | 7.25 | % | 7.5 | % | |||||||||||||||||||||||||||||
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) | 5 | % | 5 | % | |||||||||||||||||||||||||||||
Year that the rate reaches the ultimate trend rate | 2020 | 2020 | |||||||||||||||||||||||||||||||
Assumed Health Care Cost Trend | A one-percentage-point change in assumed health-care cost trend rates would have had the following effects at December 31, 2014: | ||||||||||||||||||||||||||||||||
1-Percentage | 1-Percentage | ||||||||||||||||||||||||||||||||
Point | Point | ||||||||||||||||||||||||||||||||
Increase | Decrease | ||||||||||||||||||||||||||||||||
Effect on total of service and interest cost components | $ | 3 | $ | (2 | ) | ||||||||||||||||||||||||||||
Effect on benefit obligation | 81 | (68 | ) | ||||||||||||||||||||||||||||||
Estimated Future Benefit Payments | Estimated future benefit payments: | ||||||||||||||||||||||||||||||||
Pension | Postretirement Benefits | ||||||||||||||||||||||||||||||||
Year | Benefits | Gross Projected | Expected | Net Projected | |||||||||||||||||||||||||||||
Benefit Payments | Medicare | Benefit Payments | |||||||||||||||||||||||||||||||
Before Medicare | Part D | After Medicare | |||||||||||||||||||||||||||||||
Part D Subsidies | Subsidies | Part D Subsidies | |||||||||||||||||||||||||||||||
2015 | $ | 439 | $ | 97 | $ | (2 | ) | $ | 95 | ||||||||||||||||||||||||
2016 | 405 | 89 | (2 | ) | 87 | ||||||||||||||||||||||||||||
2017 | 406 | 87 | (2 | ) | 85 | ||||||||||||||||||||||||||||
2018 | 397 | 85 | (2 | ) | 83 | ||||||||||||||||||||||||||||
2019 | 394 | 84 | (3 | ) | 81 | ||||||||||||||||||||||||||||
2020-2024 | 1,897 | 390 | (15 | ) | 375 |
Segment_Information_Tables
Segment Information (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Segment Information Related to Sales, Income, and Assets | Segment Data: | ||||||||||||
2014 | 2013 | 2012 | |||||||||||
Net sales: | |||||||||||||
RJR Tobacco | $ | 6,767 | $ | 6,728 | $ | 6,960 | |||||||
American Snuff | 783 | 745 | 681 | ||||||||||
Santa Fe | 658 | 572 | 486 | ||||||||||
All Other | 263 | 191 | 177 | ||||||||||
Consolidated net sales | $ | 8,471 | $ | 8,236 | $ | 8,304 | |||||||
Operating income (loss): | |||||||||||||
RJR Tobacco(1)(2)(3)(4) | $ | 2,173 | $ | 2,587 | $ | 1,735 | |||||||
American Snuff(4) | 438 | 420 | 374 | ||||||||||
Santa Fe(5) | 337 | 280 | 237 | ||||||||||
All Other(2) | (234 | ) | (70 | ) | (36 | ) | |||||||
Corporate Expense(1)(4) | (183 | ) | (85 | ) | (96 | ) | |||||||
Consolidated operating income | $ | 2,531 | $ | 3,132 | $ | 2,214 | |||||||
Cash capital expenditures: | |||||||||||||
RJR Tobacco | $ | 53 | $ | 55 | $ | 36 | |||||||
American Snuff | 12 | 15 | 24 | ||||||||||
Santa Fe | 7 | 2 | 4 | ||||||||||
All Other | 132 | 81 | 24 | ||||||||||
Consolidated capital expenditures | $ | 204 | $ | 153 | $ | 88 | |||||||
Depreciation and amortization expense: | |||||||||||||
RJR Tobacco | $ | 65 | $ | 68 | $ | 99 | |||||||
American Snuff | 17 | 18 | 19 | ||||||||||
Santa Fe | 3 | 3 | 2 | ||||||||||
All Other | 21 | 14 | 11 | ||||||||||
Consolidated depreciation and amortization expense | $ | 106 | $ | 103 | $ | 131 | |||||||
Reconciliation to income from continuing operations before income taxes: | |||||||||||||
Consolidated operating income(1)(2)(3)(4)(5) | $ | 2,531 | $ | 3,132 | $ | 2,214 | |||||||
Interest and debt expense | 286 | 259 | 234 | ||||||||||
Interest income | (3 | ) | (5 | ) | (7 | ) | |||||||
Other (income) expense, net | (14 | ) | 137 | 34 | |||||||||
Income from continuing operations before income taxes | $ | 2,262 | $ | 2,741 | $ | 1,953 | |||||||
-1 | Includes restructuring and/or asset impairment charges of $149 million for the year ended December 31, 2012, see “Restructuring Charges” in note 5. | ||||||||||||
(2) | Includes trademark, goodwill and/or other intangible asset impairment charges of $32 million and $129 million for the years ended December 31, 2013 and 2012, respectively, see “Intangible Assets” in note 4. | ||||||||||||
(3) | Includes NPM Adjustment credits of $341 million and $478 million for RJR Tobacco for the years ended December 31, 2014 and 2013, respectively, see “— Cost of Products Sold” in note 1. | ||||||||||||
(4) | Includes MTM adjustment of $422 million for RJR Tobacco, $4 million for American Snuff and $26 million for Corporate Expense for the year ended December 31, 2014. Includes MTM adjustment of $300 million for RJR Tobacco, $5 million for American Snuff and $24 million for Corporate Expense for the year ended December 31, 2012. | ||||||||||||
(5) | Includes NPM Adjustment credits of $4 million and $5 million for Santa Fe for the years ended December 31, 2014 and 2013, respectively, see “— Cost of Products Sold” in note 1. |
Related_Party_Transactions_Tab
Related Party Transactions (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Summary of Balances and Transactions | The following is a summary of balances and transactions with such BAT affiliates as of and for the years ended December 31: | ||||||||||||
Balances: | |||||||||||||
2014 | 2013 | ||||||||||||
Accounts receivable, related party | $ | 41 | $ | 56 | |||||||||
Due to related party | 1 | — | |||||||||||
Deferred revenue, related party | 32 | 48 | |||||||||||
Significant transactions: | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Net sales | $ | 311 | $ | 337 | $ | 342 | |||||||
Purchases | 28 | 27 | 16 | ||||||||||
RAI common stock purchases from B&W | 155 | 296 | 415 | ||||||||||
Capsule royalty income | 7 | 9 | 6 | ||||||||||
Research and development services billings | 4 | 4 | 3 |
RAI_Guaranteed_Unsecured_Notes1
RAI Guaranteed, Unsecured Notes - Condensed Consolidating Financial Statements (Tables) | 12 Months Ended | ||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||
Condensed Consolidating Statements of Income | Condensed Consolidating Statements of Income | ||||||||||||||||||||||
(Dollars in Millions) | |||||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
For the Year Ended December 31, 2014 | |||||||||||||||||||||||
Net sales | $ | — | $ | 8,109 | $ | 232 | $ | (181 | ) | $ | 8,160 | ||||||||||||
Net sales, related party | — | 311 | — | — | 311 | ||||||||||||||||||
Net Sales | — | 8,420 | 232 | (181 | ) | 8,471 | |||||||||||||||||
Cost of products sold | — | 4,002 | 235 | (179 | ) | 4,058 | |||||||||||||||||
Selling, general and administrative expenses | 75 | 1,535 | 261 | — | 1,871 | ||||||||||||||||||
Amortization expense | — | 11 | — | — | 11 | ||||||||||||||||||
Operating income (loss) | (75 | ) | 2,872 | (264 | ) | (2 | ) | 2,531 | |||||||||||||||
Interest and debt expense | 286 | 79 | 6 | (85 | ) | 286 | |||||||||||||||||
Interest income | (85 | ) | (3 | ) | — | 85 | (3 | ) | |||||||||||||||
Other (income) expense, net | 4 | (44 | ) | (17 | ) | 43 | (14 | ) | |||||||||||||||
Income (loss) from continuing operations before income taxes | (280 | ) | 2,840 | (253 | ) | (45 | ) | 2,262 | |||||||||||||||
Provision for (benefit from) income taxes | (89 | ) | 1,004 | (98 | ) | — | 817 | ||||||||||||||||
Equity income from subsidiaries | 1,661 | 26 | — | (1,687 | ) | — | |||||||||||||||||
Income (loss) from continuing operations | 1,470 | 1,862 | (155 | ) | (1,732 | ) | 1,445 | ||||||||||||||||
Income from discontinued operations, net of tax | — | 25 | — | — | 25 | ||||||||||||||||||
Net income (loss) | $ | 1,470 | $ | 1,887 | $ | (155 | ) | $ | (1,732 | ) | $ | 1,470 | |||||||||||
For the Year Ended December 31, 2013 | |||||||||||||||||||||||
Net sales | $ | — | $ | 7,785 | $ | 147 | $ | (33 | ) | $ | 7,899 | ||||||||||||
Net sales, related party | — | 337 | — | — | 337 | ||||||||||||||||||
Net Sales | — | 8,122 | 147 | (33 | ) | 8,236 | |||||||||||||||||
Cost of products sold | — | 3,628 | 83 | (33 | ) | 3,678 | |||||||||||||||||
Selling, general and administrative expenses | 13 | 1,222 | 154 | — | 1,389 | ||||||||||||||||||
Amortization expense | — | 5 | — | — | 5 | ||||||||||||||||||
Trademark and other intangible asset impairment charges | — | 32 | — | — | 32 | ||||||||||||||||||
Operating income (loss) | (13 | ) | 3,235 | (90 | ) | — | 3,132 | ||||||||||||||||
Interest and debt expense | 255 | 113 | 2 | (111 | ) | 259 | |||||||||||||||||
Interest income | (111 | ) | (3 | ) | (2 | ) | 111 | (5 | ) | ||||||||||||||
Other (income) expense, net | 129 | (45 | ) | 10 | 43 | 137 | |||||||||||||||||
Income (loss) before income taxes | (286 | ) | 3,170 | (100 | ) | (43 | ) | 2,741 | |||||||||||||||
Provision for (benefit from) income taxes | (95 | ) | 1,154 | (36 | ) | — | 1,023 | ||||||||||||||||
Equity income from subsidiaries | 1,909 | 5 | — | (1,914 | ) | — | |||||||||||||||||
Net income (loss) | $ | 1,718 | $ | 2,021 | $ | (64 | ) | $ | (1,957 | ) | $ | 1,718 | |||||||||||
For the Year Ended December 31, 2012 | |||||||||||||||||||||||
Net sales | $ | — | $ | 7,857 | $ | 134 | $ | (29 | ) | $ | 7,962 | ||||||||||||
Net sales, related party | — | 342 | — | — | 342 | ||||||||||||||||||
Net Sales | — | 8,199 | 134 | (29 | ) | 8,304 | |||||||||||||||||
Cost of products sold | — | 4,316 | 34 | (29 | ) | 4,321 | |||||||||||||||||
Selling, general and administrative expenses | 23 | 1,341 | 106 | — | 1,470 | ||||||||||||||||||
Amortization expense | — | 21 | — | — | 21 | ||||||||||||||||||
Trademark and other intangible asset impairment charges | — | 82 | 47 | — | 129 | ||||||||||||||||||
Restructuring charge | 4 | 145 | — | — | 149 | ||||||||||||||||||
Operating income (loss) | (27 | ) | 2,294 | (53 | ) | — | 2,214 | ||||||||||||||||
Interest and debt expense | 228 | 119 | — | (113 | ) | 234 | |||||||||||||||||
Interest income | (113 | ) | (3 | ) | (4 | ) | 113 | (7 | ) | ||||||||||||||
Other (income) expense, net | 26 | (44 | ) | 9 | 43 | 34 | |||||||||||||||||
Income (loss) before income taxes | (168 | ) | 2,222 | (58 | ) | (43 | ) | 1,953 | |||||||||||||||
Provision for (benefit from) income taxes | (59 | ) | 762 | (21 | ) | (1 | ) | 681 | |||||||||||||||
Equity income (loss) from subsidiaries | 1,381 | (16 | ) | — | (1,365 | ) | — | ||||||||||||||||
Net income (loss) | $ | 1,272 | $ | 1,444 | $ | (37 | ) | $ | (1,407 | ) | $ | 1,272 | |||||||||||
Condensed Consolidating Statements of Comprehensive Income | Condensed Consolidating Statements of Comprehensive Income | ||||||||||||||||||||||
(Dollars in Millions) | |||||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
For the Year Ended December 31, 2014 | |||||||||||||||||||||||
Net income (loss) | $ | 1,470 | $ | 1,887 | $ | (155 | ) | $ | (1,732 | ) | $ | 1,470 | |||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
Retirement benefits | (277 | ) | (271 | ) | (1 | ) | 272 | (277 | ) | ||||||||||||||
Unrealized gain on long-term investments | 2 | 2 | — | (2 | ) | 2 | |||||||||||||||||
Amortization of realized loss on hedging instruments | 1 | — | — | — | 1 | ||||||||||||||||||
Cumulative translation adjustment and other | (34 | ) | (34 | ) | (48 | ) | 82 | (34 | ) | ||||||||||||||
Comprehensive income (loss) | $ | 1,162 | $ | 1,584 | $ | (204 | ) | $ | (1,380 | ) | $ | 1,162 | |||||||||||
For the Year Ended December 31, 2013 | |||||||||||||||||||||||
Net income (loss) | $ | 1,718 | $ | 2,021 | $ | (64 | ) | $ | (1,957 | ) | $ | 1,718 | |||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
Retirement benefits | 248 | 239 | (1 | ) | (238 | ) | 248 | ||||||||||||||||
Unrealized gain on long-term investments | 5 | 5 | — | (5 | ) | 5 | |||||||||||||||||
Amortization of realized loss on hedging instruments | 1 | — | — | — | 1 | ||||||||||||||||||
Cumulative translation adjustment and other | 1 | 1 | 14 | (15 | ) | 1 | |||||||||||||||||
Comprehensive income (loss) | $ | 1,973 | $ | 2,266 | $ | (51 | ) | $ | (2,215 | ) | $ | 1,973 | |||||||||||
For the Year Ended December 31, 2012 | |||||||||||||||||||||||
Net income (loss) | $ | 1,272 | $ | 1,444 | $ | (37 | ) | $ | (1,407 | ) | $ | 1,272 | |||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
Retirement benefits | 65 | 65 | — | (65 | ) | 65 | |||||||||||||||||
Unrealized gain on long-term investments | 7 | 7 | — | (7 | ) | 7 | |||||||||||||||||
Realized loss on hedging instruments | (14 | ) | — | — | — | (14 | ) | ||||||||||||||||
Cumulative translation adjustment and other | 13 | 13 | 9 | (22 | ) | 13 | |||||||||||||||||
Comprehensive income (loss) | $ | 1,343 | $ | 1,529 | $ | (28 | ) | $ | (1,501 | ) | $ | 1,343 | |||||||||||
Reclassification Out of Accumulated Other Comprehensive Income Net of Tax | Details about the reclassifications out of accumulated other comprehensive loss and the affected line items in the consolidating statements of income for the year ended December 31, 2014, were as follows: | ||||||||||||||||||||||
Components | Amount Reclassified | Affected Line Item | |||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
Defined benefit pension and postretirement plans: | |||||||||||||||||||||||
Amortization of prior service costs | $ | — | $ | (21 | ) | $ | — | $ | — | $ | (21 | ) | Cost of products sold | ||||||||||
Amortization of prior service costs | — | (18 | ) | — | — | (18 | ) | Selling, general and administrative expenses | |||||||||||||||
MTM adjustment | — | 205 | — | — | 205 | Cost of products sold | |||||||||||||||||
MTM adjustment | 10 | 236 | 1 | — | 247 | Selling, general and administrative expenses | |||||||||||||||||
10 | 402 | 1 | — | 413 | |||||||||||||||||||
Deferred taxes | (4 | ) | (158 | ) | — | — | (162 | ) | Provision for income taxes | ||||||||||||||
Defined benefit pension and postretirement plans | 245 | — | — | (245 | ) | — | Equity income from subsidiaries | ||||||||||||||||
Net of tax | $ | 251 | $ | 244 | $ | 1 | $ | (245 | ) | $ | 251 | ||||||||||||
Loss on hedging instruments: | |||||||||||||||||||||||
Amortization of realized loss | $ | 2 | $ | — | $ | — | $ | — | $ | 2 | Interest and debt expense | ||||||||||||
Deferred taxes | (1 | ) | — | — | — | (1 | ) | Provision for income taxes | |||||||||||||||
Net of tax | $ | 1 | $ | — | $ | — | $ | — | $ | 1 | |||||||||||||
Total reclassifications | $ | 252 | $ | 244 | $ | 1 | $ | (245 | ) | $ | 252 | Net income (loss) | |||||||||||
Details about the reclassifications out of accumulated other comprehensive loss and the affected line items in the consolidating statements of income for the year ended December 31, 2013, were as follows: | |||||||||||||||||||||||
Components | Amount Reclassified | Affected Line Item | |||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
Defined benefit pension and postretirement plans: | |||||||||||||||||||||||
Amortization of prior service costs | $ | — | $ | (21 | ) | $ | — | $ | — | $ | (21 | ) | Cost of products sold | ||||||||||
Amortization of prior service costs | — | (18 | ) | — | — | (18 | ) | Selling, general and administrative expenses | |||||||||||||||
— | (39 | ) | — | — | (39 | ) | |||||||||||||||||
Deferred taxes | — | 16 | — | — | 16 | Provision for income taxes | |||||||||||||||||
Defined benefit pension and postretirement plans | (23 | ) | — | — | 23 | — | Equity income from subsidiaries | ||||||||||||||||
Net of tax | $ | (23 | ) | $ | (23 | ) | $ | — | $ | 23 | $ | (23 | ) | ||||||||||
Loss on hedging instruments: | |||||||||||||||||||||||
Amortization of realized loss | $ | 2 | $ | — | $ | — | $ | — | $ | 2 | Interest and debt expense | ||||||||||||
Deferred taxes | (1 | ) | — | — | — | (1 | ) | Provision for income taxes | |||||||||||||||
Net of tax | $ | 1 | $ | — | $ | — | $ | — | $ | 1 | |||||||||||||
Total reclassifications | $ | (22 | ) | $ | (23 | ) | $ | — | $ | 23 | $ | (22 | ) | Net income (loss) | |||||||||
Condensed Consolidating Statements of Cash Flows | Condensed Consolidating Statements of Cash Flows | ||||||||||||||||||||||
(Dollars in Millions) | |||||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
For the Year Ended December 31, 2014 | |||||||||||||||||||||||
Cash flows from (used in) operating activities | $ | 1,277 | $ | 1,865 | $ | (179 | ) | $ | (1,340 | ) | $ | 1,623 | |||||||||||
Cash flows from (used in) investing activities: | |||||||||||||||||||||||
Capital expenditures | — | (265 | ) | (94 | ) | 155 | (204 | ) | |||||||||||||||
Proceeds from termination of joint venture | — | — | 35 | — | 35 | ||||||||||||||||||
Return of intercompany investments | 165 | — | — | (165 | ) | — | |||||||||||||||||
Other, net | 218 | 39 | 126 | (419 | ) | (36 | ) | ||||||||||||||||
Net cash flows from (used in) investing activities | 383 | (226 | ) | 67 | (429 | ) | (205 | ) | |||||||||||||||
Cash flows from (used in) financing activities: | |||||||||||||||||||||||
Dividends paid on common stock | (1,411 | ) | (1,301 | ) | — | 1,301 | (1,411 | ) | |||||||||||||||
Repurchase of common stock | (440 | ) | — | — | — | (440 | ) | ||||||||||||||||
Excess tax benefit on stock-based compensation plans | 12 | — | — | — | 12 | ||||||||||||||||||
Principal borrowings under revolving credit facility | 1,000 | — | — | — | 1,000 | ||||||||||||||||||
Repayments under revolving credit facility | (1,000 | ) | — | — | — | (1,000 | ) | ||||||||||||||||
Debt issuance costs and financing fees | (79 | ) | — | — | — | (79 | ) | ||||||||||||||||
Dividends paid on preferred stock | (43 | ) | — | — | 43 | — | |||||||||||||||||
Distribution of equity | — | (165 | ) | — | 165 | — | |||||||||||||||||
Other, net | (41 | ) | (400 | ) | 181 | 260 | — | ||||||||||||||||
Net cash flows from (used in) financing activities | (2,002 | ) | (1,866 | ) | 181 | 1,769 | (1,918 | ) | |||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | (34 | ) | — | (34 | ) | ||||||||||||||||
Net change in cash and cash equivalents | (342 | ) | (227 | ) | 35 | — | (534 | ) | |||||||||||||||
Cash and cash equivalents at beginning of year | 444 | 696 | 360 | — | 1,500 | ||||||||||||||||||
Cash and cash equivalents at end of year | $ | 102 | $ | 469 | $ | 395 | $ | — | $ | 966 | |||||||||||||
For the Year Ended December 31, 2013 | |||||||||||||||||||||||
Cash flows from (used in) operating activities | $ | 1,519 | $ | 945 | $ | (70 | ) | $ | (1,086 | ) | $ | 1,308 | |||||||||||
Cash flows from (used in) investing activities: | |||||||||||||||||||||||
Capital expenditures | — | (80 | ) | (74 | ) | 1 | (153 | ) | |||||||||||||||
Proceeds from termination of joint venture | — | — | 31 | — | 31 | ||||||||||||||||||
Return of intercompany investments | 300 | — | — | (300 | ) | — | |||||||||||||||||
Other, net | 81 | 33 | (1 | ) | (104 | ) | 9 | ||||||||||||||||
Net cash flows from (used in) investing activities | 381 | (47 | ) | (44 | ) | (403 | ) | (113 | ) | ||||||||||||||
Cash flows from (used in) financing activities: | |||||||||||||||||||||||
Dividends paid on common stock | (1,335 | ) | (1,042 | ) | — | 1,042 | (1,335 | ) | |||||||||||||||
Repurchase of common stock | (775 | ) | — | — | — | (775 | ) | ||||||||||||||||
Excess tax benefit on stock-based compensation plans | 14 | — | — | — | 14 | ||||||||||||||||||
Principal borrowings under term-loan credit facility | 500 | — | — | — | 500 | ||||||||||||||||||
Repayment under term-loan credit facility | (500 | ) | — | — | — | (500 | ) | ||||||||||||||||
Proceeds from issuance of long-term debt, net of discounts | 1,097 | — | — | — | 1,097 | ||||||||||||||||||
Repayments of long-term debt | (975 | ) | (60 | ) | — | — | (1,035 | ) | |||||||||||||||
Debt issuance costs and financing fees | (18 | ) | — | — | — | (18 | ) | ||||||||||||||||
Make-whole premium for early extinguishment of debt | (155 | ) | — | — | — | (155 | ) | ||||||||||||||||
Dividends paid on preferred stock | (43 | ) | — | — | 43 | — | |||||||||||||||||
Distribution of equity | — | (300 | ) | — | 300 | — | |||||||||||||||||
Other, net | (21 | ) | (220 | ) | 137 | 104 | — | ||||||||||||||||
Net cash flows from (used in) financing activities | (2,211 | ) | (1,622 | ) | 137 | 1,489 | (2,207 | ) | |||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | 10 | — | 10 | ||||||||||||||||||
Net change in cash and cash equivalents | (311 | ) | (724 | ) | 33 | — | (1,002 | ) | |||||||||||||||
Cash and cash equivalents at beginning of year | 755 | 1,420 | 327 | — | 2,502 | ||||||||||||||||||
Cash and cash equivalents at end of year | $ | 444 | $ | 696 | $ | 360 | $ | — | $ | 1,500 | |||||||||||||
For the Year Ended December 31, 2012 | |||||||||||||||||||||||
Cash flows from operating activities | $ | 454 | $ | 1,801 | $ | 29 | $ | (716 | ) | $ | 1,568 | ||||||||||||
Cash flows from (used in) investing activities: | |||||||||||||||||||||||
Capital expenditures | — | (79 | ) | (1 | ) | (8 | ) | (88 | ) | ||||||||||||||
Proceeds from termination of joint venture | — | — | 30 | — | 30 | ||||||||||||||||||
Return of intercompany investments | 898 | — | — | (898 | ) | — | |||||||||||||||||
Other, net | 40 | 17 | 1 | (54 | ) | 4 | |||||||||||||||||
Net cash flows from (used in) investing activities | 938 | (62 | ) | 30 | (960 | ) | (54 | ) | |||||||||||||||
Cash flows from (used in) financing activities: | |||||||||||||||||||||||
Dividends paid on common stock | (1,307 | ) | (684 | ) | — | 684 | (1,307 | ) | |||||||||||||||
Repurchase of common stock | (1,101 | ) | — | — | — | (1,101 | ) | ||||||||||||||||
Excess tax benefit on stock-based compensation plans | 39 | — | — | — | 39 | ||||||||||||||||||
Principal borrowings under term-loan credit facility | 750 | — | — | — | 750 | ||||||||||||||||||
Repayment under term-loan credit facility | (750 | ) | — | — | — | (750 | ) | ||||||||||||||||
Proceeds from issuance of long-term debt, net of discounts | 2,539 | — | — | — | 2,539 | ||||||||||||||||||
Repayments of long-term debt | (1,018 | ) | (58 | ) | — | — | (1,076 | ) | |||||||||||||||
Debt issuance costs and financing fees | (22 | ) | — | — | — | (22 | ) | ||||||||||||||||
Payment to settle forward starting interest rate contracts | (23 | ) | — | — | — | (23 | ) | ||||||||||||||||
Make-whole premium for early extinguishment of debt | (20 | ) | — | — | — | (20 | ) | ||||||||||||||||
Dividends paid on preferred stock | (43 | ) | — | — | 43 | — | |||||||||||||||||
Distribution of equity | — | (898 | ) | — | 898 | — | |||||||||||||||||
Other, net | (9 | ) | (40 | ) | (2 | ) | 51 | — | |||||||||||||||
Net cash flows used in financing activities | (965 | ) | (1,680 | ) | (2 | ) | 1,676 | (971 | ) | ||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | 3 | — | 3 | ||||||||||||||||||
Net change in cash and cash equivalents | 427 | 59 | 60 | — | 546 | ||||||||||||||||||
Cash and cash equivalents at beginning of year | 328 | 1,361 | 267 | — | 1,956 | ||||||||||||||||||
Cash and cash equivalents at end of year | $ | 755 | $ | 1,420 | $ | 327 | $ | — | $ | 2,502 | |||||||||||||
Condensed Consolidating Balance Sheets | Condensed Consolidating Balance Sheets | ||||||||||||||||||||||
(Dollars in Millions) | |||||||||||||||||||||||
Parent | Guarantors | Non- | Eliminations | Consolidated | |||||||||||||||||||
Issuer | Guarantors | ||||||||||||||||||||||
December 31, 2014 | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
Cash and cash equivalents | $ | 102 | $ | 469 | $ | 395 | $ | — | $ | 966 | |||||||||||||
Accounts receivable | — | 74 | 42 | — | 116 | ||||||||||||||||||
Accounts receivable, related party | — | 41 | — | — | 41 | ||||||||||||||||||
Other receivables | 70 | 1,199 | 10 | (1,267 | ) | 12 | |||||||||||||||||
Inventories | — | 1,198 | 85 | (2 | ) | 1,281 | |||||||||||||||||
Deferred income taxes, net | 5 | 688 | 10 | — | 703 | ||||||||||||||||||
Prepaid expenses and other | 50 | 151 | 1 | 2 | 204 | ||||||||||||||||||
Total current assets | 227 | 3,820 | 543 | (1,267 | ) | 3,323 | |||||||||||||||||
Property, plant and equipment, net | 3 | 1,170 | 30 | — | 1,203 | ||||||||||||||||||
Trademarks and other intangible assets, net | — | 2,417 | 4 | — | 2,421 | ||||||||||||||||||
Goodwill | — | 7,999 | 17 | — | 8,016 | ||||||||||||||||||
Long-term intercompany notes receivable | 1,593 | 190 | — | (1,783 | ) | — | |||||||||||||||||
Investment in subsidiaries | 9,598 | 450 | — | (10,048 | ) | — | |||||||||||||||||
Other assets and deferred charges | 101 | 180 | 23 | (71 | ) | 233 | |||||||||||||||||
Total assets | $ | 11,522 | $ | 16,226 | $ | 617 | $ | (13,169 | ) | $ | 15,196 | ||||||||||||
Liabilities and shareholders’ equity | |||||||||||||||||||||||
Accounts payable | $ | 1 | $ | 128 | $ | 13 | $ | — | $ | 142 | |||||||||||||
Tobacco settlement accruals | — | 1,819 | — | — | 1,819 | ||||||||||||||||||
Due to related party | — | 1 | — | — | 1 | ||||||||||||||||||
Deferred revenue, related party | — | 32 | — | — | 32 | ||||||||||||||||||
Current maturities of long-term debt | 450 | — | — | — | 450 | ||||||||||||||||||
Other current liabilities | 1,636 | 682 | 51 | (1,269 | ) | 1,100 | |||||||||||||||||
Total current liabilities | 2,087 | 2,662 | 64 | (1,269 | ) | 3,544 | |||||||||||||||||
Long-term intercompany notes payable | 190 | 1,300 | 293 | (1,783 | ) | — | |||||||||||||||||
Long-term debt (less current maturities) | 4,633 | — | — | — | 4,633 | ||||||||||||||||||
Deferred income taxes, net | — | 450 | — | (67 | ) | 383 | |||||||||||||||||
Long-term retirement benefits (less current portion) | 57 | 1,930 | 10 | — | 1,997 | ||||||||||||||||||
Other noncurrent liabilities | 33 | 83 | 1 | — | 117 | ||||||||||||||||||
Shareholders’ equity | 4,522 | 9,801 | 249 | (10,050 | ) | 4,522 | |||||||||||||||||
Total liabilities and shareholders’ equity | $ | 11,522 | $ | 16,226 | $ | 617 | $ | (13,169 | ) | $ | 15,196 | ||||||||||||
December 31, 2013 | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
Cash and cash equivalents | $ | 444 | $ | 696 | $ | 360 | $ | — | $ | 1,500 | |||||||||||||
Accounts receivable | — | 74 | 32 | — | 106 | ||||||||||||||||||
Accounts receivable, related party | — | 56 | — | — | 56 | ||||||||||||||||||
Notes receivable | — | 1 | 36 | — | 37 | ||||||||||||||||||
Other receivables | 76 | 198 | 6 | (264 | ) | 16 | |||||||||||||||||
Inventories | — | 1,069 | 59 | (1 | ) | 1,127 | |||||||||||||||||
Deferred income taxes, net | — | 614 | 1 | (9 | ) | 606 | |||||||||||||||||
Prepaid expenses and other | 29 | 172 | 7 | (1 | ) | 207 | |||||||||||||||||
Total current assets | 549 | 2,880 | 501 | (275 | ) | 3,655 | |||||||||||||||||
Property, plant and equipment, net | 5 | 986 | 83 | — | 1,074 | ||||||||||||||||||
Trademarks and other intangible assets, net | — | 2,413 | 4 | — | 2,417 | ||||||||||||||||||
Goodwill | — | 7,999 | 12 | — | 8,011 | ||||||||||||||||||
Long-term intercompany notes receivable | 1,842 | 1,295 | — | (3,137 | ) | — | |||||||||||||||||
Investment in subsidiaries | 9,736 | 473 | — | (10,209 | ) | — | |||||||||||||||||
Other assets and deferred charges | 94 | 187 | 18 | (54 | ) | 245 | |||||||||||||||||
Total assets | $ | 12,226 | $ | 16,233 | $ | 618 | $ | (13,675 | ) | $ | 15,402 | ||||||||||||
Liabilities and shareholders’ equity | |||||||||||||||||||||||
Accounts payable | $ | 1 | $ | 169 | $ | 15 | $ | — | $ | 185 | |||||||||||||
Tobacco settlement accruals | — | 1,727 | — | — | 1,727 | ||||||||||||||||||
Deferred revenue, related party | — | 48 | — | — | 48 | ||||||||||||||||||
Other current liabilities | 601 | 744 | 46 | (275 | ) | 1,116 | |||||||||||||||||
Total current liabilities | 602 | 2,688 | 61 | (275 | ) | 3,076 | |||||||||||||||||
Long-term intercompany notes payable | 1,295 | 1,700 | 142 | (3,137 | ) | — | |||||||||||||||||
Long-term debt (less current maturities) | 5,099 | — | — | — | 5,099 | ||||||||||||||||||
Deferred income taxes, net | — | 710 | 2 | (54 | ) | 658 | |||||||||||||||||
Long-term retirement benefits (less current portion) | 38 | 1,172 | 11 | — | 1,221 | ||||||||||||||||||
Other noncurrent liabilities | 25 | 156 | — | — | 181 | ||||||||||||||||||
Shareholders’ equity | 5,167 | 9,807 | 402 | (10,209 | ) | 5,167 | |||||||||||||||||
Total liabilities and shareholders’ equity | $ | 12,226 | $ | 16,233 | $ | 618 | $ | (13,675 | ) | $ | 15,402 | ||||||||||||
Quarterly_Results_of_Operation1
Quarterly Results of Operations (Unaudited) (Tables) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||
Quarterly Results of Operations | |||||||||||||||||
First | Second | Third | Fourth | ||||||||||||||
2014 | |||||||||||||||||
Net sales | $ | 1,935 | $ | 2,162 | $ | 2,240 | $ | 2,134 | |||||||||
Gross profit(1) | 1,005 | 1,203 | 1,206 | 999 | |||||||||||||
Income from continuing operations(1)(2) | 338 | 492 | 467 | 148 | |||||||||||||
Income from discontinued operations, net of tax | 25 | — | — | — | |||||||||||||
Net income(1)(2) | 363 | 492 | 467 | 148 | |||||||||||||
Per share data(3) : | |||||||||||||||||
Basic: | |||||||||||||||||
Income from continuing operations | 0.63 | 0.92 | 0.88 | 0.28 | |||||||||||||
Income from discontinued operations | 0.05 | — | — | — | |||||||||||||
Net income | 0.68 | 0.92 | 0.88 | 0.28 | |||||||||||||
Diluted: | |||||||||||||||||
Income from continuing operations | 0.63 | 0.92 | 0.88 | 0.28 | |||||||||||||
Income from discontinued operations | 0.04 | — | — | — | |||||||||||||
Net income | 0.67 | 0.92 | 0.88 | 0.28 | |||||||||||||
2013 | |||||||||||||||||
Net sales | $ | 1,883 | $ | 2,179 | $ | 2,135 | $ | 2,039 | |||||||||
Gross profit(4) | 1,189 | 1,180 | 1,131 | 1,058 | |||||||||||||
Net income(4)(5) | 508 | 461 | 457 | 292 | |||||||||||||
Per share data(3) : | |||||||||||||||||
Basic: | |||||||||||||||||
Net income | 0.92 | 0.84 | 0.84 | 0.54 | |||||||||||||
Diluted: | |||||||||||||||||
Net income | 0.92 | 0.84 | 0.84 | 0.54 | |||||||||||||
-1 | Includes NPM Adjustment credits of $63 million in the first quarter of 2014, $125 million in the second quarter of 2014, $82 million in the third quarter of 2014 and $75 million in the fourth quarter of 2014, see “— Cost of Products Sold” in note 1. The fourth quarter of 2014 includes an MTM adjustment of $205 million. | ||||||||||||||||
(2) | Fourth quarter of 2014 includes an additional MTM adjustment of $247 million for a total of $452 million. | ||||||||||||||||
(3) | Income per share is computed independently for each of the periods presented. The sum of the income per share amounts for the quarters may not equal the total for the year. | ||||||||||||||||
(4) | Includes NPM Adjustment credits of $261 million in the first quarter of 2013, $90 million in the second quarter of 2013, $69 million in the third quarter of 2013 and $63 million in the fourth quarter of 2013, see “— Cost of Products Sold” in note 1. | ||||||||||||||||
(5) | Fourth quarter of 2013 net income includes a $32 million trademark impairment charge. |
Business_and_Summary_of_Signif3
Business and Summary of Significant Accounting Policies - Additional Information (Detail) (USD $) | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||
In Millions, unless otherwise specified | Jun. 30, 2014 | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items] | ||||||||||||
Operating cycle period of inventories | 12 months | |||||||||||
NPM Adjustment credits | $170 | $75 | $82 | $125 | $63 | $63 | $69 | $90 | $261 | $1,100 | ||
NPM historical adjustment | 34 | 219 | ||||||||||
NPM performance adjustment | 311 | 264 | ||||||||||
Advertising costs incurred | 140 | 110 | 72 | |||||||||
Research and development costs | $88 | $72 | $62 | |||||||||
Recognized tax position realized upon ultimate settlement | 50.00% | |||||||||||
Defined benefit plan corridor percentage | 10.00% | |||||||||||
Buildings and improvements | Minimum | ||||||||||||
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items] | ||||||||||||
Estimated useful lives (in years) | 20 years | |||||||||||
Buildings and improvements | Maximum | ||||||||||||
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items] | ||||||||||||
Estimated useful lives (in years) | 50 years | |||||||||||
Machinery and equipment | Minimum | ||||||||||||
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items] | ||||||||||||
Estimated useful lives (in years) | 3 years | |||||||||||
Machinery and equipment | Maximum | ||||||||||||
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items] | ||||||||||||
Estimated useful lives (in years) | 30 years | |||||||||||
Computer Software, Intangible Asset | Maximum | ||||||||||||
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items] | ||||||||||||
Estimated useful lives (in years) | 5 years |
Summary_of_Balances_and_Expens
Summary of Balances and Expenses for Software Costs (Detail) (USD $) | 12 Months Ended | ||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |
Balances: | |||
Unamortized software costs balance | $41 | $51 | |
Software costs - capitalized or included in construction-in-process | 5 | 13 | |
Expenses: | |||
Software amortization expense | $15,000,000 | $17,000,000 | $21,000,000 |
Certain_Component_of_Cost_of_P
Certain Component of Cost of Products Sold (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||
State Settlement Agreements | $1,917 | $1,819 | $2,370 |
Federal tobacco quota buyout | 163 | 209 | 218 |
FDA user fees | $135 | $127 | $122 |
Proposed_Transactions_Addition
Proposed Transactions - Additional Information (Detail) (USD $) | 0 Months Ended | 12 Months Ended | ||
Jul. 15, 2014 | Jul. 02, 2014 | Sep. 23, 2014 | Dec. 31, 2014 | |
Summary Of Significant Transactions [Line Items] | ||||
Asset sale | $7,100,000,000 | |||
BAT ownership | 42.00% | 42.00% | ||
BAT investment | 4,700,000,000 | |||
Automatic Extension of Contract Terms | 6 months | |||
Bridge Facility | ||||
Summary Of Significant Transactions [Line Items] | ||||
Period of senior unsecured term loan | 364 days | 364 days | ||
Term loan bridge facility | 9,000,000,000 | |||
Lorillard, Inc. | ||||
Summary Of Significant Transactions [Line Items] | ||||
Acquisition | $27,400,000,000 | |||
Conversion ratio of Lorillard common stock to RAI common stock | 0.2909 | |||
Cash consideration per share | $50.50 |
Fair_Value_of_Financial_Assets
Fair Value of Financial Assets (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Cash and cash equivalents: | ||
Cash equivalents | $883 | $1,443 |
Other assets and deferred charges: | ||
Auction rate securities | 79 | 76 |
Mortgage-backed security | 12 | 13 |
Marketable equity security | 2 | 4 |
Level 1 | ||
Cash and cash equivalents: | ||
Cash equivalents | 883 | 1,443 |
Other assets and deferred charges: | ||
Marketable equity security | 2 | 4 |
Level 3 | ||
Other assets and deferred charges: | ||
Auction rate securities | 79 | 76 |
Mortgage-backed security | $12 | $13 |
Fair_Value_Additional_Informat
Fair Value - Additional Information (Detail) (USD $) | 1 Months Ended | 12 Months Ended | 1 Months Ended | |||||
Sep. 30, 2011 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Oct. 31, 2012 | 1-May-12 | Sep. 30, 2013 | Dec. 31, 2009 | |
Derivative [Line Items] | ||||||||
Fair value transfers between levels | $0 | $0 | ||||||
Estimated fair value of RAI's and RJR's outstanding debt | 5,400,000,000 | 5,200,000,000 | ||||||
Debt weighted average interest rate | 4.50% | 4.50% | ||||||
Notional amount, interest rate contracts | 1,000,000,000 | |||||||
Proceeds from termination of interest rate swaps | 186,000,000 | |||||||
Loss on extinguishment of debt | -124,000,000 | -21,000,000 | ||||||
Total RAI debt | 2,550,000,000 | |||||||
Associated losses settled with cash payments | -23,000,000 | -23,000,000 | ||||||
1.05% guaranteed, notes due 2015 | ||||||||
Derivative [Line Items] | ||||||||
Debt instrument maturity date | 30-Oct-15 | |||||||
Debt instrument interest rate | 1.05% | 1.05% | ||||||
Total RAI debt | 450,000,000 | |||||||
3.25% guaranteed, notes due 2022 | ||||||||
Derivative [Line Items] | ||||||||
Debt instrument maturity date | 1-Nov-22 | |||||||
Debt instrument interest rate | 3.25% | 3.25% | ||||||
Total RAI debt | 1,100,000,000 | |||||||
4.75% guaranteed, notes due 2042 | ||||||||
Derivative [Line Items] | ||||||||
Debt instrument maturity date | 1-Nov-42 | |||||||
Debt instrument interest rate | 4.75% | 4.75% | ||||||
Total RAI debt | 1,000,000,000 | |||||||
7.625% guaranteed, notes due 2016 | ||||||||
Derivative [Line Items] | ||||||||
Outstanding principle amount of debt redeemed | 775,000,000 | |||||||
Debt instrument interest rate | 7.63% | 7.63% | ||||||
Loss on extinguishment of debt | -124,000,000 | -124,000,000 | ||||||
Loss on extinguishment of debt, swap balance | 35,000,000 | |||||||
Debt Covered by Interest Rate Swap Agreement | ||||||||
Derivative [Line Items] | ||||||||
Outstanding principle amount of debt redeemed | 450,000,000 | |||||||
Debt covered by fixed interest rate | 700,000,000 | 700,000,000 | ||||||
Derivative fixed rate of interest | 3.80% | 3.80% | ||||||
Floating to Fixed | ||||||||
Derivative [Line Items] | ||||||||
Notional amount, interest rate contracts | 1,500,000,000 | |||||||
Floating to Fixed | Minimum | ||||||||
Derivative [Line Items] | ||||||||
Debt instrument maturity date | 1-Jun-12 | |||||||
Floating to Fixed | Maximum | ||||||||
Derivative [Line Items] | ||||||||
Debt instrument maturity date | 15-Jun-17 | |||||||
Fixed to Floating | ||||||||
Derivative [Line Items] | ||||||||
Notional amount, interest rate contracts | $1,500,000,000 |
Financial_Assets_Classified_as
Financial Assets Classified as Level 3 Investments (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||
In Millions, unless otherwise specified | |||||
Schedule of Available-for-sale Securities [Line Items] | |||||
Cost | $117 | $119 | |||
Gross Unrealized Loss | -26 | [1] | -30 | [1] | |
Estimated Fair Value | 91 | 89 | |||
Auction Rate Securities | |||||
Schedule of Available-for-sale Securities [Line Items] | |||||
Cost | 99 | 99 | 99 | ||
Gross Unrealized Loss | -20 | [1] | -23 | [1] | |
Estimated Fair Value | 79 | 76 | 70 | ||
Mortgage Backed Securities | |||||
Schedule of Available-for-sale Securities [Line Items] | |||||
Cost | 18 | 20 | 22 | ||
Gross Unrealized Loss | -6 | [1] | -7 | [1] | |
Estimated Fair Value | $12 | $13 | $13 | ||
[1] | Unrealized losses, net of tax, are reported in accumulated other comprehensive loss in RAI's consolidated balance sheets as of December 31, 2014 and 2013. |
Changes_in_Level_3_Investments
Changes in Level 3 Investments (Detail) (USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Schedule of Available-for-sale Securities [Line Items] | ||
Cost, Ending Balance | $117 | $119 |
Estimated Fair Value, Ending Balance | 91 | 89 |
Auction Rate Securities | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Cost, Beginning Balance | 99 | 99 |
Unrealized gain | 0 | 0 |
Cost, Ending Balance | 99 | 99 |
Estimated Fair Value, Beginning Balance | 76 | 70 |
Unrealized gain | 3 | 6 |
Estimated Fair Value, Ending Balance | 79 | 76 |
Gross Unrealized Gain (Loss), Beginning Balance | -23 | -29 |
Unrealized gain | 3 | 6 |
Gross Unrealized Gain (Loss), Ending Balance | -20 | -23 |
Mortgage Backed Securities | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Cost, Beginning Balance | 20 | 22 |
Unrealized gain | 0 | 0 |
Redemptions | -2 | -2 |
Cost, Ending Balance | 18 | 20 |
Estimated Fair Value, Beginning Balance | 13 | 13 |
Unrealized gain | 1 | 2 |
Redemptions | -2 | -2 |
Estimated Fair Value, Ending Balance | 12 | 13 |
Gross Unrealized Gain (Loss), Beginning Balance | -7 | -9 |
Unrealized gain | 1 | 2 |
Gross Unrealized Gain (Loss), Ending Balance | ($6) | ($7) |
Amortization_of_Derivative_Ins
Amortization of Derivative Instruments Impacted Income Statement (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Derivative Instruments, Gain (Loss) [Line Items] | |||
Interest and debt expense | ($15) | ($24) | ($32) |
Other (income) expense, net | ($35) |
Changes_in_Carrying_Amounts_of
Changes in Carrying Amounts of Goodwill by Segment (Detail) (USD $) | 12 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2011 |
Goodwill [Line Items] | ||||
Asset acquisition | $7 | |||
Goodwill | 11,801 | |||
Foreign currency translation | -2 | 1 | ||
Accumulated impairment charges | -3,791 | |||
Goodwill, Translation and Purchase Accounting Adjustments, Total | 5 | |||
Net goodwill balance | 8,016 | 8,011 | 8,011 | 8,010 |
RJR Tobacco | ||||
Goodwill [Line Items] | ||||
Goodwill | 9,065 | |||
Accumulated impairment charges | -3,763 | |||
Net goodwill balance | 5,302 | 5,302 | 5,302 | 5,302 |
American Snuff | ||||
Goodwill [Line Items] | ||||
Goodwill | 2,501 | |||
Accumulated impairment charges | -28 | |||
Net goodwill balance | 2,473 | 2,473 | 2,473 | 2,473 |
Santa Fe | ||||
Goodwill [Line Items] | ||||
Goodwill | 197 | |||
Net goodwill balance | 197 | 197 | 197 | 197 |
All Other | ||||
Goodwill [Line Items] | ||||
Asset acquisition | 7 | |||
Goodwill | 38 | |||
Foreign currency translation | -2 | 1 | ||
Goodwill, Translation and Purchase Accounting Adjustments, Total | 5 | |||
Net goodwill balance | $44 | $39 | $39 | $38 |
Intangible_Assets_Additional_I
Intangible Assets - Additional Information (Detail) (USD $) | 3 Months Ended | 12 Months Ended | 0 Months Ended | 3 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Jul. 01, 2014 | Dec. 31, 2012 |
Intangible Assets Disclosure [Line Items] | ||||||
Cash paid to acquire business | $31 | |||||
Estimated future cash flows discount rate | 10.00% | 10.00% | 10.00% | |||
Impairment of other intangible assets | 32 | 32 | 129 | |||
Trademarks | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Impairment of other intangible assets | 32 | 82 | ||||
Other | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Acquisition of intellectual property | 15 | |||||
Other | Minimum | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Amortization of intellectual property | 1 year | |||||
Other | Maximum | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Amortization of intellectual property | 8 years | |||||
Other | Maximum | Trademarks | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Impairment of other intangible assets | 0 | |||||
RJR Tobacco | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Estimated future cash flows discount rate | 9.75% | 9.75% | 9.75% | |||
RJR Tobacco | Trademarks | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Impairment of other intangible assets | 32 | 82 | ||||
RJR Tobacco | Intellectual Property | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Acquisition of intellectual property | 15 | |||||
Amortization of intellectual property | 15 years | |||||
RJR Tobacco | Other | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Acquisition of intellectual property | 15 | |||||
All Other | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Impairment of other intangible assets | $47 | |||||
American Snuff | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Estimated future cash flows discount rate | 9.75% | 9.75% | 9.75% | |||
Santa Fe | ||||||
Intangible Assets Disclosure [Line Items] | ||||||
Estimated future cash flows discount rate | 10.25% | 10.25% | 10.25% |
Carrying_Amounts_of_Indefinite
Carrying Amounts of Indefinite-Lived Intangible Assets by Segment not Subject to Amortization (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2014 | Dec. 31, 2011 |
Indefinite-lived Intangible Assets [Line Items] | |||||
Impairment charge | ($32) | ($32) | ($129) | ||
Trademarks | |||||
Indefinite-lived Intangible Assets [Line Items] | |||||
Beginning Balance | 2,318 | 2,400 | 2,268 | ||
Impairment charge | -32 | -82 | |||
Reclassified to finite-lived | -18 | ||||
Ending Balance | 2,268 | 2,268 | 2,318 | 2,268 | |
Trademarks | RJR Tobacco | |||||
Indefinite-lived Intangible Assets [Line Items] | |||||
Beginning Balance | 1,027 | 1,109 | 977 | ||
Impairment charge | -32 | -82 | |||
Reclassified to finite-lived | -18 | ||||
Ending Balance | 977 | 977 | 1,027 | 977 | |
Trademarks | American Snuff | |||||
Indefinite-lived Intangible Assets [Line Items] | |||||
Beginning Balance | 1,136 | 1,136 | |||
Ending Balance | 1,136 | 1,136 | 1,136 | 1,136 | 1,136 |
Trademarks | Santa Fe | |||||
Indefinite-lived Intangible Assets [Line Items] | |||||
Beginning Balance | 155 | 155 | |||
Ending Balance | 155 | 155 | 155 | 155 | 155 |
Other | |||||
Indefinite-lived Intangible Assets [Line Items] | |||||
Beginning Balance | 104 | 148 | 103 | ||
Impairment charge | -47 | ||||
Foreign currency translation | -1 | 3 | |||
Ending Balance | 103 | 103 | 104 | 103 | |
Other | RJR Tobacco | |||||
Indefinite-lived Intangible Assets [Line Items] | |||||
Beginning Balance | 99 | 99 | |||
Ending Balance | 99 | 99 | 99 | 99 | 99 |
Other | All Other | |||||
Indefinite-lived Intangible Assets [Line Items] | |||||
Beginning Balance | 5 | 49 | 4 | ||
Impairment charge | -47 | ||||
Foreign currency translation | -1 | 3 | |||
Ending Balance | $4 | $4 | $5 | $4 |
Carrying_Amounts_of_FiniteLive
Carrying Amounts of Finite-Lived Intangible Assets by Segment Subject to Amortization (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Finite-Lived Intangible Assets [Line Items] | |||
Beginning Balance | $46 | ||
Amortization | -11 | -5 | -21 |
Ending Balance | 50 | 46 | |
Trademarks | |||
Finite-Lived Intangible Assets [Line Items] | |||
Beginning Balance | 26 | 9 | 15 |
Amortization | -7 | -1 | -6 |
Reclassified from indefinite-lived | 18 | ||
Ending Balance | 19 | 26 | 9 |
Other | |||
Finite-Lived Intangible Assets [Line Items] | |||
Beginning Balance | 20 | 24 | 39 |
Amortization | -4 | -4 | -15 |
Acquisition | 15 | ||
Ending Balance | 31 | 20 | 24 |
RJR Tobacco | Trademarks | |||
Finite-Lived Intangible Assets [Line Items] | |||
Beginning Balance | 18 | 4 | |
Amortization | -6 | -4 | |
Reclassified from indefinite-lived | 18 | ||
Ending Balance | 12 | 18 | |
RJR Tobacco | Other | |||
Finite-Lived Intangible Assets [Line Items] | |||
Beginning Balance | 20 | 24 | 39 |
Amortization | -4 | -4 | -15 |
Acquisition | 15 | ||
Ending Balance | 31 | 20 | 24 |
American Snuff | Trademarks | |||
Finite-Lived Intangible Assets [Line Items] | |||
Beginning Balance | 8 | 9 | 11 |
Amortization | -1 | -1 | -2 |
Ending Balance | $7 | $8 | $9 |
Details_of_FiniteLived_Intangi
Details of Finite-Lived Intangible Assets (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Millions, unless otherwise specified | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Gross | $280 | $265 | ||
Accumulated Amortization | -230 | -219 | ||
Net | 50 | 46 | ||
Contract manufacturing agreements | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Gross | 151 | 151 | ||
Accumulated Amortization | -135 | -131 | ||
Net | 16 | 20 | ||
Trademarks | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Gross | 114 | 114 | ||
Accumulated Amortization | -95 | -88 | ||
Net | 19 | 26 | 9 | 15 |
Other Intangibles | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Gross | 15 | |||
Net | $15 |
Finite_Lived_Intangible_Assets
Finite Lived Intangible Assets Future Amortization Expense (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Expected Amortization Expense [Line Items] | ||
2015 | $10 | |
2016 | 9 | |
2017 | 9 | |
2018 | 8 | |
2019 | 2 | |
Thereafter | 12 | |
Net | $50 | $46 |
Restructuring_Charges_Addition
Restructuring Charges - Additional Information (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2012 | Dec. 31, 2013 |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Percentage of workforce declination | 10.00% | ||
Completion date of all cash payments related to restructuring | 31-Dec-15 | ||
Restructuring charge, amount utilized | $109 | $149 | |
Other current liabilities | 32 | 19 | |
Other noncurrent liabilities | 8 | ||
Restructuring charge | 149 | ||
RJR Tobacco | |||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Restructuring charge | 138 | ||
Employee Severance | |||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Restructuring reserve, cash portion | 111 | ||
Pension Costs | |||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Restructuring reserve, cash portion | $38 |
Components_of_Restructuring_Ch
Components of Restructuring Charge Accrued and Utilized (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Restructuring Cost and Reserve [Line Items] | |||
Beginning Balance | $57 | $71 | $149 |
Utilized | -17 | -14 | -78 |
Ending Balance | $40 | $57 | $71 |
Components_of_Calculation_of_I
Components of Calculation of Income Per Share (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||||||
In Millions, except Share data in Thousands, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||||||||
Net Income Per Share [Line Items] | |||||||||||||||||||
Income from continuing operations | $148 | [1],[2] | $467 | [1],[2] | $492 | [1],[2] | $338 | [1],[2] | $1,445 | $1,718 | $1,272 | ||||||||
Income from discontinued operations | 25 | 25 | |||||||||||||||||
Net income | $148 | [1],[2] | $467 | [1],[2] | $492 | [1],[2] | $363 | [1],[2] | $292 | [3],[4] | $457 | [3],[4] | $461 | [3],[4] | $508 | [3],[4] | $1,470 | $1,718 | $1,272 |
Basic weighted average shares, in thousands | 533,160 | 544,925 | 565,570 | ||||||||||||||||
Effect of dilutive potential shares: | |||||||||||||||||||
Restricted stock units | 1,810 | 2,024 | 2,303 | ||||||||||||||||
Diluted weighted average shares, in thousands | 534,970 | 546,949 | 567,873 | ||||||||||||||||
[1] | Includes NPM Adjustment credits of $63 million in the first quarter of 2014, $125 million in the second quarter of 2014, $82 million in the third quarter of 2014 and $75 million in the fourth quarter of 2014, see "- Cost of Products Sold" in note 1. The fourth quarter of 2014 includes an MTM adjustment of $205 million. | ||||||||||||||||||
[2] | Fourth quarter of 2014 includes an additional MTM adjustment of $247 million for a total of $452 million. | ||||||||||||||||||
[3] | Includes NPM Adjustment credits of $261 million in the first quarter of 2013, $90 million in the second quarter of 2013, $69 million in the third quarter of 2013 and $63 million in the fourth quarter of 2013, see "- Cost of Products Sold" in note 1. | ||||||||||||||||||
[4] | Fourth quarter of 2013 net income includes a $32 million trademark impairment charge. |
Components_of_Inventories_Deta
Components of Inventories (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Inventory [Line Items] | ||
Leaf tobacco | $1,125 | $1,049 |
Other raw materials | 90 | 66 |
Work in process | 72 | 70 |
Finished products | 171 | 130 |
Other | 27 | 18 |
Total | 1,485 | 1,333 |
LIFO allowance | -204 | -206 |
Inventory Net | $1,281 | $1,127 |
Inventories_Additional_Informa
Inventories - Additional Information (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Inventory [Line Items] | |||
Inventories valued under LIFO | $456 | $519 | |
Effect of LIFO Inventory Liquidation on Income | $2 | ($14) | ($7) |
Other_Current_Liabilities_Deta
Other Current Liabilities (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Other Liabilities [Line Items] | ||
Payroll and employee benefits | $178 | $179 |
Pension and other postretirement benefits | 75 | 79 |
Marketing and advertising | 134 | 117 |
Declared dividends | 356 | 339 |
Excise, franchise and property tax | 161 | 157 |
Restructuring | 32 | 19 |
Tobacco quota buyout | 52 | |
Other | 164 | 174 |
Total | $1,100 | $1,116 |
Provision_for_Income_Taxes_fro
Provision for Income Taxes from Continuing Operations (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Current: | |||
Federal | $809 | $563 | $647 |
State and other | 188 | 148 | 78 |
Subtotal | 997 | 711 | 725 |
Deferred: | |||
Federal | -151 | 254 | -45 |
State and other | -29 | 58 | 1 |
Subtotal | -180 | 312 | -44 |
Provision for income taxes | $817 | $1,023 | $681 |
Significant_Components_of_Defe
Significant Components of Deferred Tax Assets and Liabilities (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2011 |
In Millions, unless otherwise specified | |||
Deferred tax assets: | |||
Pension and other postretirement liabilities | $823 | $522 | |
Tobacco settlement accruals | 711 | 677 | |
Other accrued liabilities | 127 | 71 | |
Other noncurrent liabilities | 139 | 150 | |
Subtotal | 1,800 | 1,420 | |
Less: valuation allowance | -37 | -36 | -33 |
Deferred tax asset | 1,763 | 1,384 | |
Deferred tax liabilities: | |||
LIFO inventories | -150 | -156 | |
Property and equipment | -260 | -232 | |
Trademarks and other intangibles | -913 | -916 | |
Other | -111 | -120 | |
Total deferred tax liabilities | -1,434 | -1,424 | |
Net deferred tax asset (liability) | $329 | ($40) |
Current_and_Noncurrent_Compone
Current and Noncurrent Components of Deferred Tax Assets and Liabilities (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Current and noncurrent components of deferred tax assets and liabilities | ||
Current deferred tax assets | $703 | $606 |
Noncurrent deferred tax assets | 9 | 12 |
Noncurrent deferred tax liabilities | -383 | -658 |
Net deferred tax asset (liability) | $329 | ($40) |
Income_Taxes_Additional_Inform
Income Taxes - Additional Information (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2014 | Mar. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2011 | |
Income Taxes [Line Items] | |||||
Capital loss carryforwards | $108,000,000 | $108,000,000 | $105,000,000 | ||
Valuation allowance | 37,000,000 | 37,000,000 | 36,000,000 | 33,000,000 | |
Increase in valuation allowance | 1,000,000 | 3,000,000 | |||
Federal statutory rate | 35.00% | 35.00% | |||
Income (loss) from discontinued operations | 25,000,000 | 25,000,000 | |||
Undistributed foreign earnings | 486,000,000 | 486,000,000 | |||
Overseas investment of foreign earnings | 25,000,000 | 25,000,000 | |||
Planned overseas investment of foreign earnings | 56,000,000 | 56,000,000 | |||
Undistributed Foreign Earnings | 405,000,000 | 405,000,000 | |||
Unrecognized Tax Benefits That Would Impact Effective Tax Rate | 21,000,000 | 21,000,000 | |||
Other deferred tax assets | |||||
Income Taxes [Line Items] | |||||
Valuation allowance | $0 | $0 | $0 |
PreTax_Income_loss_for_Domesti
Pre-Tax Income (loss) for Domestic and Foreign Continuing Operations (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Pre-tax income for domestic and foreign operations | |||
Domestic (includes U.S. exports) | $2,235 | $2,737 | $1,983 |
Foreign | 27 | 4 | -30 |
Income (loss) from continuing operations before income taxes | $2,262 | $2,741 | $1,953 |
Differences_between_Provision_
Differences between Provision for Income Taxes from Continuing Operations and Income Taxes (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Differences between the provision for income taxes from continuing operations and income taxes | |||
Income taxes computed at the statutory U.S. federal income tax rate | $792 | $959 | $684 |
State and local income taxes, net of federal tax benefits | 107 | 135 | 107 |
Domestic manufacturing deduction | -80 | -55 | -60 |
Other items, net | -2 | -16 | -50 |
Provision for income taxes | $817 | $1,023 | $681 |
Effective tax rate | 36.10% | 37.30% | 34.90% |
Components_of_Deferred_Tax_Ben
Components of Deferred Tax Benefits Included in Accumulated Other Comprehensive Loss (Detail) (USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Deferred Income Taxes And Tax Credits [Line Items] | ||
Retirement benefits | $241 | $63 |
Unrealized gain (loss) on long-term investments | 10 | 11 |
Amortization of realized loss on hedging instruments | 7 | 8 |
Cumulative translation adjustment and other | 19 | 4 |
Other Comprehensive Income (Loss), Tax | $277 | $86 |
Accruals_for_Gross_Unrecognize
Accruals for Gross Unrecognized Income Tax Benefits, Including Interest and Penalties (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Millions, unless otherwise specified | ||||
Income Tax Contingency [Line Items] | ||||
Unrecognized tax benefits | $27 | $62 | $68 | $128 |
Accrued interest | 3 | 7 | ||
Accrued penalties | 1 | 1 | ||
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total | $31 | $70 |
Reconciliation_of_Gross_Unreco
Reconciliation of Gross Unrecognized Income Tax Benefits (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Reconciliation of the unrecognized gross tax benefits | |||
Balance at beginning of year | $62 | $68 | $128 |
Gross increases related to current period tax positions | 5 | 4 | 4 |
Gross increases related to tax positions in prior periods | 1 | ||
Gross decreases related to tax positions in prior periods | -31 | -3 | -7 |
Gross decreases related to audit settlements | -6 | -1 | -31 |
Gross decreases related to lapse of applicable statute of limitations | -3 | -6 | -27 |
Balance at end of year | $27 | $62 | $68 |
Borrowing_Arrangements_Additio
Borrowing Arrangements - Additional Information (Detail) (USD $) | 0 Months Ended | 12 Months Ended | ||
Dec. 18, 2014 | Oct. 08, 2013 | Sep. 23, 2014 | Dec. 31, 2014 | |
Line of Credit Facility [Line Items] | ||||
Letters of credit outstanding amount | 5,000,000 | |||
Borrowings outstanding under the Credit Agreement | 0 | |||
Credit Agreement | ||||
Line of Credit Facility [Line Items] | ||||
Period of senior unsecured revolving credit facility | 4 years | |||
Credit facility under current borrowing capacity | 1,350,000,000 | |||
Sublimit on the aggregate amount of letters of credit | 300,000,000 | |||
Credit facility maturity date | 8-Oct-17 | |||
Line of credit facility, maximum borrowing capacity for acquisition | 500,000,000 | |||
Interest Rate | 2.00% | |||
Credit Agreement | Minimum | ||||
Line of Credit Facility [Line Items] | ||||
Pay rate of commitment fee per annum | 0.10% | |||
Credit Agreement | Maximum | ||||
Line of Credit Facility [Line Items] | ||||
Pay rate of commitment fee per annum | 0.28% | |||
Credit Agreement | Federal Funds | ||||
Line of Credit Facility [Line Items] | ||||
Debt instrument, basis spread on variable rate | 0.50% | |||
Credit Agreement | Eurodollar | ||||
Line of Credit Facility [Line Items] | ||||
Debt instrument, basis spread on variable rate | 1.00% | |||
New Credit Agreement | ||||
Line of Credit Facility [Line Items] | ||||
Period of senior unsecured revolving credit facility | 5 years | |||
Credit facility under maximum borrowing capacity | 2,350,000,000 | |||
Credit facility under current borrowing capacity | 2,000,000,000 | |||
Credit facility maturity date | 18-Dec-19 | |||
New Credit Agreement | Minimum | For any Reference Period ending on the last day of a fiscal quarter | ||||
Line of Credit Facility [Line Items] | ||||
Ratio of EBITDA to interest expense | 4.00 to 1.00 | |||
New Credit Agreement | Maximum | As of the last day of any period of four consecutive fiscal quarters, referred to as a Reference Period, ending prior to the closing of the Merger | ||||
Line of Credit Facility [Line Items] | ||||
Ratio of debt to EBITDA | 3.00 to 1.00 | |||
New Credit Agreement | Maximum | For the Reference Periods ending on the last day of the fiscal quarter in which the Merger closes and on the last day of the next two succeeding fiscal quarters | ||||
Line of Credit Facility [Line Items] | ||||
Ratio of debt to EBITDA | 4.50 to 1.00 | |||
New Credit Agreement | Maximum | For the Reference Periods ending on the last day of the next three succeeding quarters | ||||
Line of Credit Facility [Line Items] | ||||
Ratio of debt to EBITDA | 4.25 to 1.00 | |||
New Credit Agreement | Maximum | For the Reference Periods ending on the last day of the next three succeeding quarters | ||||
Line of Credit Facility [Line Items] | ||||
Ratio of debt to EBITDA | 3.75 to 1.00 | |||
New Credit Agreement | Maximum | Thereafter | ||||
Line of Credit Facility [Line Items] | ||||
Ratio of debt to EBITDA | 3.50 to 1.00 | |||
Bridge Facility | ||||
Line of Credit Facility [Line Items] | ||||
Term loan bridge facility | $9,000,000,000 | |||
Period of senior unsecured term loan | 364 days | 364 days | ||
Credit facility interest rate description | Borrowings under the Bridge Facility bear interest at a rate per annum equal to, at RAIbs election: adjusted LIBOR for a one, two, three or six month period; or the greatest of the (1) prime rate, (2) federal funds effective rate plus 50 basis points or (3) one-month adjusted LIBOR plus 100 basis points, plus, in each case, an applicable margin ranging from 50 to 275 basis points that depends upon RAIbs index debt rating established by rating services and the length of time that elapses from initial funding of the Bridge Facility until repayment thereof. | |||
Bridge Facility | Minimum | ||||
Line of Credit Facility [Line Items] | ||||
Debt instrument, basis spread on variable rate | 0.50% | |||
Bridge Facility | Minimum | For any Reference Period ending on the last day of a fiscal quarter | ||||
Line of Credit Facility [Line Items] | ||||
Ratio of EBITDA to interest expense | 3.00 to 1.00 | |||
Bridge Facility | Maximum | ||||
Line of Credit Facility [Line Items] | ||||
Debt instrument, basis spread on variable rate | 2.75% | |||
Bridge Facility | Maximum | For the Reference Periods ending on the last day of the fiscal quarter in which the Merger closes and on the last day of the next two succeeding fiscal quarters | ||||
Line of Credit Facility [Line Items] | ||||
Ratio of debt to EBITDA | 4.50 to 1.00 | |||
Bridge Facility | Maximum | Thereafter | ||||
Line of Credit Facility [Line Items] | ||||
Ratio of debt to EBITDA | 4.25 to 1.00 | |||
Bridge Facility | Federal Funds Effective Swap Rate | ||||
Line of Credit Facility [Line Items] | ||||
Debt instrument, basis spread on variable rate | 0.50% | |||
Bridge Facility | London Interbank Offered Rate (LIBOR) | ||||
Line of Credit Facility [Line Items] | ||||
Debt instrument, basis spread on variable rate | 1.00% |
LongTerm_Debt_Net_of_Discounts
Long-Term Debt Net of Discounts (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Oct. 31, 2012 | Sep. 30, 2013 |
Debt Instrument [Line Items] | ||||
Long-term debt (less current maturities) | $4,633,000,000 | $5,099,000,000 | ||
Current maturities of long-term debt | 450,000,000 | |||
Total debt | 5,083,000,000 | 5,099,000,000 | ||
1.05% guaranteed, notes due 2015 | ||||
Debt Instrument [Line Items] | ||||
Long-term debt (less current maturities) | 450,000,000 | 450,000,000 | ||
3.25% guaranteed, notes due 2022 | ||||
Debt Instrument [Line Items] | ||||
Long-term debt (less current maturities) | 1,099,000,000 | 1,099,000,000 | 1,100,000,000 | |
4.75% guaranteed, notes due 2042 | ||||
Debt Instrument [Line Items] | ||||
Long-term debt (less current maturities) | 992,000,000 | 991,000,000 | 1,000,000,000 | |
4.85% guaranteed, notes due 2023 | ||||
Debt Instrument [Line Items] | ||||
Long-term debt (less current maturities) | 550,000,000 | 550,000,000 | 550,000,000 | |
6.15% guaranteed, notes due 2043 | ||||
Debt Instrument [Line Items] | ||||
Long-term debt (less current maturities) | 547,000,000 | 547,000,000 | 550,000,000 | |
6.75% guaranteed, notes due 2017 | ||||
Debt Instrument [Line Items] | ||||
Long-term debt (less current maturities) | 747,000,000 | 765,000,000 | ||
7.25% guaranteed, notes due 2037 | ||||
Debt Instrument [Line Items] | ||||
Long-term debt (less current maturities) | 448,000,000 | 448,000,000 | ||
7.75% guaranteed, notes due 2018 | ||||
Debt Instrument [Line Items] | ||||
Long-term debt (less current maturities) | $250,000,000 | $249,000,000 |
Maturities_of_RAIs_Notes_Detai
Maturities of RAI's Notes (Detail) (USD $) | Dec. 31, 2014 |
In Millions, unless otherwise specified | |
Debt Instrument [Line Items] | |
2015 | $450 |
2017 | 700 |
2018 | 250 |
2022 and thereafter | 3,636 |
Long Term Debt Net Of Discounts, Total | $5,036 |
LongTerm_Debt_Additional_Infor
Long-Term Debt - Additional Information (Detail) (USD $) | 1 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | ||||
Jun. 30, 2012 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Aug. 31, 2013 | Oct. 31, 2012 | Sep. 30, 2013 | Oct. 31, 2012 | |
Debt Instrument [Line Items] | ||||||||
Repayment of debt | $450,000,000 | $1,035,000,000 | $1,076,000,000 | |||||
Sale of senior debt | 2,550,000,000 | 1,100,000,000 | 2,550,000,000 | |||||
Outstanding principle amount of debt redeemed | 450,000,000 | |||||||
Loss on early extinguishment of debt | -124,000,000 | -21,000,000 | ||||||
Notes, interest payment, terms | Interest on these notes is paid semi-annually. | |||||||
Debt outstanding | 5,083,000,000 | 5,099,000,000 | ||||||
R.J. Reynolds Tobacco Holdings, Inc. | ||||||||
Debt Instrument [Line Items] | ||||||||
Repayment of debt | 60,000,000 | |||||||
Debt outstanding | 0 | |||||||
1.05% guaranteed, notes due 2015 | ||||||||
Debt Instrument [Line Items] | ||||||||
Total RAI debt | 450,000,000 | 450,000,000 | 450,000,000 | |||||
Interest Rate of Debt | 1.05% | 1.05% | 1.05% | |||||
Long term debt maturity date | 30-Oct-15 | |||||||
3.25% guaranteed, notes due 2022 | ||||||||
Debt Instrument [Line Items] | ||||||||
Total RAI debt | 1,099,000,000 | 1,099,000,000 | 1,100,000,000 | 1,100,000,000 | ||||
Interest Rate of Debt | 3.25% | 3.25% | 3.25% | |||||
Long term debt maturity date | 1-Nov-22 | |||||||
4.75% guaranteed, notes due 2042 | ||||||||
Debt Instrument [Line Items] | ||||||||
Total RAI debt | 992,000,000 | 991,000,000 | 1,000,000,000 | 1,000,000,000 | ||||
Interest Rate of Debt | 4.75% | 4.75% | 4.75% | |||||
Long term debt maturity date | 1-Nov-42 | |||||||
4.85% guaranteed, notes due 2023 | ||||||||
Debt Instrument [Line Items] | ||||||||
Total RAI debt | 550,000,000 | 550,000,000 | 550,000,000 | |||||
Interest Rate of Debt | 4.85% | |||||||
Long term debt maturity date | 15-Sep-23 | |||||||
6.15% guaranteed, notes due 2043 | ||||||||
Debt Instrument [Line Items] | ||||||||
Total RAI debt | 547,000,000 | 547,000,000 | 550,000,000 | |||||
Interest Rate of Debt | 6.15% | |||||||
Long term debt maturity date | 15-Sep-43 | |||||||
7.30% guaranteed, notes due 2015 | ||||||||
Debt Instrument [Line Items] | ||||||||
Interest Rate of Debt | 7.30% | |||||||
Outstanding principle amount of debt redeemed | 200,000,000 | |||||||
Long term debt maturity year | 2015 | |||||||
7.625% guaranteed, notes due 2016 | ||||||||
Debt Instrument [Line Items] | ||||||||
Interest Rate of Debt | 7.63% | 7.63% | ||||||
Outstanding principle amount of debt redeemed | 775,000,000 | |||||||
Long term debt maturity year | 2016 | |||||||
Loss on early extinguishment of debt | -124,000,000 | -124,000,000 | ||||||
7.625% guaranteed, notes due 2016 | Interest Rate Swap | ||||||||
Debt Instrument [Line Items] | ||||||||
Loss on early extinguishment of debt | -35,000,000 | |||||||
7.25% guaranteed, notes due 2013 | ||||||||
Debt Instrument [Line Items] | ||||||||
Interest Rate of Debt | 7.25% | 7.25% | ||||||
Outstanding principle amount of debt redeemed | 625,000,000 | 625,000,000 | ||||||
Long term debt maturity year | 2013 | |||||||
Loss on early extinguishment of debt | ($21,000,000) |
Commitments_and_Contingencies_1
Commitments and Contingencies - Additional Information (Detail) (USD $) | 1 Months Ended | 3 Months Ended | 12 Months Ended | 0 Months Ended | 3 Months Ended | 0 Months Ended | 1 Months Ended | 0 Months Ended | 1 Months Ended | 0 Months Ended | 1 Months Ended | 0 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nov. 30, 1998 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Sep. 24, 2014 | 31-May-13 | Sep. 20, 2013 | Jul. 31, 2014 | Jan. 27, 2015 | Sep. 11, 2013 | Nov. 03, 2011 | 24-May-13 | Apr. 30, 2013 | Dec. 19, 2014 | Dec. 31, 2013 | Nov. 30, 2013 | Nov. 07, 2014 | Jun. 23, 2014 | Nov. 19, 2013 | Jun. 19, 2012 | 15-May-12 | Aug. 24, 2011 | Oct. 31, 2013 | Jul. 31, 2013 | Mar. 31, 2013 | 31-May-12 | Mar. 20, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Aug. 31, 2013 | Oct. 31, 2012 | Feb. 13, 2013 | Apr. 01, 2013 | 2-May-13 | Apr. 30, 2014 | Mar. 31, 2014 | Jan. 31, 2014 | Feb. 18, 2014 | Feb. 27, 2014 | Mar. 17, 2014 | Jun. 30, 2014 | Mar. 26, 2014 | Jul. 21, 2014 | Jul. 18, 2014 | Jul. 17, 2014 | Dec. 31, 2006 | Apr. 12, 2013 | Jun. 26, 2014 | Nov. 30, 2014 | Oct. 10, 2014 | Oct. 22, 2014 | Nov. 18, 2014 | Nov. 21, 2014 | Nov. 12, 2014 | Nov. 26, 2014 | Oct. 17, 2011 | Jun. 03, 2013 | Jan. 31, 2013 | Feb. 11, 2013 | Apr. 18, 2013 | 23-May-13 | Jun. 04, 2013 | Jun. 07, 2013 | Jun. 14, 2013 | Jun. 19, 2013 | Jan. 27, 2014 | Oct. 31, 2014 | Sep. 30, 2014 | Aug. 28, 2014 | Aug. 29, 2014 | Jan. 29, 2015 | |||
LegalMatter | LegalMatter | LegalMatter | LegalMatter | LegalMatter | State | State | State | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
State | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount accrued | $13,900,000 | $13,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrued estimated cost for corrective communication | 10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment for litigation settlement | 213,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment for attorney fees and interest | 51,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Growers Trust Fund | 5,200,000,000 | 5,200,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases filed | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending | 177 | 177 | 165 | 165 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending in federal court | 14 | 14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending in state court | 146 | 146 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment for compensatory and punitive damages | 162,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 136,123,200 | [1] | 136,123,200 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 163,242,000 | 163,242,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Engle Outstanding Judgments | 299,365,200 | 299,365,200 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of states involved in MSA | 46 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previously settled cases | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cases scheduled for trial | 6 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating Leases, Rent Expense | 25,000,000 | 24,000,000 | 19,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mississippi | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment Sought Under State Settlement Agreement | 3,900,000 | 3,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Damages state settlement agreement 1 | 5,000,000 | 5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Damages State Settlement Agreement 2 | 3,300,000 | 3,800,000 | 3,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest Payment Sought Under State Settlement Agreement | 3,300,000 | 2,700,000 | 4,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Attorneys' fees awarded as percentage of total amounts awarded to the State | 25.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Attorneys' fees awarded | 4,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Florida | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending in state court | 26 | 26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Florida Bond Cap Total | 200,000,000 | 200,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Florida Bond Cap Per Case | 5,000,000 | 5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment Sought Under State Settlement Agreement | 12,400,000 | 12,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest Payment Sought Under State Settlement Agreement | 17,000,000 | 17,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 States Plus District of Columbia and Puerto Rico | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Combined allocable shares percentage maximum | 42.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNITED STATES | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending | 161 | 161 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Canada | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending | 16 | 16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Maryland | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending in state court | 29 | 29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Missouri | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending in state court | 18 | 18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
New York | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending in state court | 13 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rjr Tobacco Indemnitee or Both | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending | 96 | 96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liggett | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 145,000,000,000 | 145,000,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Engle | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrual | 3,900,000 | 3,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment for litigation settlement | 14,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment for compensatory damages | 12,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment for attorney fees and interest | 2,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending | 3,885 | 3,885 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of plaintiffs | 4,959 | 4,959 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending in federal court | 697 | 697 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending in state court | 3,188 | 3,188 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 145,000,000,000 | 145,000,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases filed but not served | 16 | 16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases tried | 11 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cases scheduled for trial | 76 | 76 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of plaintiffs | 4,959 | [2] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages 2 | 36,300,000,000 | 36,300,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages 3 | 17,600,000,000 | 17,600,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Engle | Florida | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases tried | 121 | 121 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Grossman | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 0 | 22,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 15,350,000 | [1],[3] | 15,350,000 | [1],[3] | 483,682 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 22,500,000 | 22,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 70.00% | 25.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,900,000 | 15,350,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 484,000 | 5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Grossman | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 25.00% | 75.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Grossman | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 5.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cohen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 20,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 3,330,000 | [1] | 3,330,000 | [1] | 3,330,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 33.30% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 2,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cohen | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 33.30% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cohen | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 33.30% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putney | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 2,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 4,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 2,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 35.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 15,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 2,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putney | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putney | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 35.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jewett | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 70.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 218,600 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jewett | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 20.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jewett | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 10.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hallgren | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 750,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 500,000 | [1],[3] | 500,000 | [1],[3] | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 750,000 | 750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 1,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hallgren | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 25.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hallgren | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 25.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Marotta | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 3,480,000 | [1] | 3,480,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 42.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 3,480,000 | 6,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 75,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Marotta | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 58.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Calloway | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 17,250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 16,100,000 | [1],[3] | 16,100,000 | [1],[3] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 17,250,000 | 17,250,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 20.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 20,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 1,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share of damages | 37,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Calloway | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 27.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Calloway | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 52.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hiott | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 730,000 | [4] | 730,000 | [4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 60.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 40.00% | 40.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,830,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 730,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 730,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hiott | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 40.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
James Smith | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 20,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 600,000 | [1],[3] | 600,000 | [1],[3] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 20,000 | 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 45.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 620,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 620,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
James Smith | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 55.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ballard | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 5,000,000 | [1] | 5,000,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 45.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 8,550,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amended Final Judgment | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount of final judgment | 4,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ballard | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 55.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schoeff | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 30,000,000 | 30,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 7,875,000 | [1] | 7,875,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 30,000,000 | 30,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 25.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 10,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 7,880,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schoeff | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 75.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Searcy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,000,000 | [1],[3] | 1,000,000 | [1],[3] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 1,670,000 | 1,670,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 40.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 6,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 2,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Remitted compensatory damages | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Remitted punitive damages | 1,670,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Searcy | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Searcy | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
David Cohen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment for compensatory and punitive damages | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 617,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 40.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 2,060,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
David Cohen | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
David Cohen | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gafney | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,914,000 | [1] | 1,914,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 34.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 5,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 1,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Final Judgment | 1,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gafney | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 33.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gafney | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 33.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cheeley | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 2,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,500,000 | [1] | 1,500,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 2,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,500,000 | 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 3,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cheeley | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goveia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 2,250,000 | 2,250,000 | 2,250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 297,500 | [1] | 297,500 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 2,250,000 | 2,250,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 30.00% | 30.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 35.00% | 35.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 850,000 | 850,000 | 297,500 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 2,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goveia | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 35.00% | 35.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Banks | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clayton | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 60,000 | [4] | 60,000 | [4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 90.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 60,000 | 600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 223,000 | 223,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount of final judgment | 223,469 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages - adjusted | 163,469 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clayton | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 10.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bowden | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,500,000 | [1] | 1,500,000 | [1] | 1,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 40.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 1,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bowden | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bowden | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Robinson | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 23,600,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 16,900,000 | [1] | 16,900,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 16,900,000 | 16,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 29.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 70.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 16,900,000 | 16,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Robinson | Subsequent Event | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Remitted punitive damages | 16,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Remittitur, objection period | 10 days | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Broin | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 300,000,000 | 300,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Annual installment of settlement | 100,000,000 | 100,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fees and expenses | 49,000,000 | 49,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fees And Expenses 1 | 86,000,000 | 86,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fees And Expenses 2 | 57,000,000 | 57,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Light Case | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lower range of damages | 50,000 | 50,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Upper range of damages | 75,000 | 75,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Light Case | Philip Morris | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 3,000,000,000 | 3,000,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 7,100,000,000 | 7,100,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 12,000,000,000 | 12,000,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Parsons | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 1,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brown and Williamson Tobacco Corp | Mississippi | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount accrued for compensatory damages | 10,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco | Mississippi | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount accrued for compensatory damages | 8,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Npm Adjustment Claim For 2003 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MSA Disputed Payment | 647,000,000 | 647,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted MSA Payment | 615,000,000 | 615,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Released MSA Payment | 32,000,000 | 32,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of states seeking declaratory orders for Qualifying Statuses | 37 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of states in arbitration for diligent enforcement | 52 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Courts deciding whether dispute is arbitrable | 47 | 47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of Allocable shares | 90.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of Reduction in Ultimate Liability | 20.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Combined allocable shares percentage maximum | 14.68% | 14.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Arbitration Panel ruling | 197,000,000 | 266,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reduction in recovery from claims due to modification of judgment reduction method | -75,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Npm Adjustment Claim For 2003 | Maximum | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Courts deciding whether dispute is arbitrable | 48 | 48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Npm Adjustment Claim For 2009 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Antitrust/CPTEF | 5,000,000 | 5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of amount to Fund States' Antitrust/Consumer Protection Tobacco | 47.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Npm Adjustment Claim For 2011 And 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disputed Notices | 880,000,000 | 880,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Settlement Agreement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of jurisdictions that have joined the settlement | 22 | 20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of non-settling states that motions pending to vacate and/or modify the Award | 6 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Settlement Agreement | 20 Jurisdictions Including Oklahoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of Allocable shares | 43.00% | 46.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Settlement Agreement | Kentucky And Indiana | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of Allocable shares | 49.87% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of jurisdictions that have joined the settlement | 24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vassallo | Minimum | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FETRA Buyout | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Cost of FETRA buyout | 9,900,000,000 | 9,900,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FETRA payable to Quota tobacco holders | 9,600,000,000 | 9,600,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liquidation of Quota tobacco stock | 290,000,000 | 290,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assessment expiry date | 30-Sep-14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share of Fetra buyout | 2,500,000,000 | 2,500,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Annual expense under FETRA for 2014 | 163,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nonsmoking And Health Cases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cases scheduled for trial | 2 | 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Smoking And Health Cases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cases scheduled for trial | 4 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Smoking And Health Cases | Rjr Tobacco Indemnitee or Both | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending | 94 | 94 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lourie | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 41,000 | [1] | 41,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 63.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 3.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,370,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 41,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lourie | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 34.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Environmental Tobacco Smoke | Rjr Tobacco Indemnitee or Both | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending | 2 | 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
JTI Judgment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Entered Against JTI in Brazil That JTI Believes RJR and RJR Tobacco Liable For | 1,700,000 | 1,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hiott and Starr-Blundell and Clayton | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount accrued for compensatory damages | 2,100,000 | 2,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount accrued for attorneys' fees and statutory interest | 1,800,000 | 1,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
West Virginia Ipic | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending | 564 | 564 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of plaintiffs | 564 | [5] | 30 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of plaintiff claims dismissed | 600 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lawsuits pending | 564 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Broin II | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending | 2,558 | 2,558 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lawsuits pending | 2,558 | 2,558 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tribal Court | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases pending | 1 | 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Smoking And Health Engle Progeny And Healthcare Cost Recovery Cases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases tried | 127 | 127 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of mistrials declared | 7 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Verdicts returned for tobacco companies | 64 | 64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of verdicts returned for tobacco companies by mistrial | 19 | 19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Smoking And Health Engle Progeny And Healthcare Cost Recovery Cases | Florida | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases tried | 61 | 61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Verdicts returned for plaintiff | 58 | 58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases dismissed | 3 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Smoking And Health Engle Progeny And Healthcare Cost Recovery Cases | Missouri | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases tried | 1 | 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Smoking And Health Engle Progeny And Healthcare Cost Recovery Cases | New York | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Verdicts returned for plaintiff | 1 | 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Smoking And Health Engle Progeny And Healthcare Cost Recovery Cases | West Virginia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of cases tried | 2 | 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kerrivan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 9,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 4,898,000 | [1] | 4,898,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 9,600,000 | [6] | 9,600,000 | [6] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 19.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 31.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 15,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kerrivan | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 15,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taylor | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 521,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 4,116,000 | [1],[3] | 4,116,000 | [1],[3] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 521,000 | 521,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 42.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 58.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 4,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 4,640,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 4,640,000 | 4,640,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Webb | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 450,000 | 450,000 | 72,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 810,000 | [4] | 810,000 | [4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 450,000 | 450,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 10.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 90.00% | 90.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 900,000 | 900,000 | 8,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 1,260,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Remitted compensatory damages | 4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Remitted punitive damages | 25,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Webb | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 90.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schleider | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 14,700,000 | [1] | 14,700,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 70.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 21,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perrotto | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 818,000 | [1] | 818,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 49.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 20.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 4,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perrotto | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 31.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 7,800,000 | 7,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 2,475,000 | [1] | 2,475,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 7,756,000 | 7,756,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 70.00% | 70.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 24.00% | 24.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 3,100,000 | 3,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allen | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Izzarelli | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 3,970,000 | 3,970,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 8,080,000 | 8,080,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 42.00% | 42.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 58.00% | 58.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 13,900,000 | 13,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 11,950,000 | 11,950,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment interest awarded | 15,800,000 | 15,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Interest Per Day Awarded | 4,000 | 4,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amended Final Judgment | 28,100,000 | 28,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Izzarelli | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 58.00% | 58.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Buonomo | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 25,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 4,060,000 | [1] | 4,060,000 | [1] | 4,060,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 15,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 22.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 5,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Buonomo | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 77.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Frazier | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Andy Allen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 17,000,000 | 7,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 8,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 40.00% | 70.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 24.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 6,000,000 | 3,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 19,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 3,750,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Andy Allen | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 45.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Andy Allen | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 15.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Soffer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 2,000,000 | [1] | 2,000,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 60.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Soffer | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 40.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ciccone | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,000,000 | [1] | 1,000,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 70.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 3,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ciccone | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hancock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 700 | [1] | 700 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 90.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 110,200 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 705 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hancock | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 5.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hancock | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 5.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Baker | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sikes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 3,520,000 | [1] | 3,520,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 2,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 49.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 4,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amended Final Judgment | 5,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount of final judgment | 6,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sikes | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 51.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schlenther | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 2,500,000 | 2,500,000 | 2,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 5,000,000 | 5,000,000 | 5,000,000 | 5,030,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 5,000,000 | 5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Relinquishment Period for plaintiff's motion, and jurisdiction granted | 45 days | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Funeral Expenses | 29,705 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment in satisfaction of judgment | 9,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schlenther | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Williams | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 15.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 4,250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 4,250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment in satisfaction of judgment | 4,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Williams | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 85.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evers | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 12,360,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,938,000 | [1] | 1,938,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 31.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 3,230,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 1,770,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evers | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 60.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evers | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 9.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aycock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 4,280,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 27.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 5,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 4,320,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aycock | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 72.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earl Graham | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 550,000 | [1] | 550,000 | [1] | 550,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 70.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 2,750,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 556,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earl Graham | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 20.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earl Graham | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 10.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Starr-Blundell | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 50,000 | [4] | 50,000 | [4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 80.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 50,000 | 50,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Final Judgment | 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Starr-Blundell | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 10.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Starr-Blundell | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 10.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Odum | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 264,000 | 264,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payment in satisfaction of judgment | 276,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Final Judgment | 264,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Odum | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Skolnick | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 767,000 | [1] | 767,000 | [1] | 766,500 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 40.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 2,560,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 767,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Skolnick | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Skolnick | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thibault | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 1,280,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,750,000 | [1],[3] | 1,750,000 | [1],[3] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 1,275,000 | 1,275,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,750,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 3,030,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 3,030,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thibault | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 70.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Harford | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 82.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 330,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Harford | RJR Tobacco 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 18.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bakst | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 14,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 4,504,000 | [1] | 4,504,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 14,000,000 | 14,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 4,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Wilcox | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 8,500,000 | 8,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 4,900,000 | [1] | 4,900,000 | [1] | 4,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 8,500,000 | 8,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 30.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 70.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Judgment Sought Against Each Defendant | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DOJ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrued estimated cost for corrective communication | 10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deposit Into Court Registry Regarding Public Website | 3,125,000 | 3,125,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Irimi | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 70.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 14.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 3,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 453,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Irimi | Other Defendant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 15.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 484,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hubbird | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 25,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 3,000,000 | [1],[3] | 3,000,000 | [1],[3] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive Damages - Adjusted | 25,000,000 | 25,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 3,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total damages | 28,000,000 | 28,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bond | 5,000,000 | 5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Harris | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 239,000 | [1] | 239,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Harris | Survival claim | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 60.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 15.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 1,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Harris | Wrongful death claim | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 70.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 10.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Harris | Other Defendant | Survival claim | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 25.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Harris | Other Defendant | Wrongful death claim | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 20.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ellen Gray | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | 3,000,000 | [1] | 3,000,000 | [1] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ellen Gray | Subsequent Event | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Punitive damages | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allocation of fault to plaintiff | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RJR Tobacco Allocation of Fault | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensatory damages | $6,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[1] | Unless otherwise noted, compensatory damages in these cases are adjusted to reflect the jury's allocation of comparative fault. Punitive damages are not so adjusted. The amounts listed above do not include attorneys' fees or statutory interest that may apply to the judgments. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[2] | The Engle Progeny cases have been separated from the Individual Smoking and Health cases for reporting purposes. The number of cases has decreased as the result of many of the federal and state court cases being dismissed or duplicate actions being consolidated. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[3] | The court did not apply comparative fault in the final judgment. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[4] | Compensatory damages are adjusted to reflect the reduction that may be required by the allocation of fault. Punitive damages are not adjusted and reflect the amount of the final judgment(s) signed by the trial court judge(s). The amounts listed above do not include attorneys' fees or statutory interest. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[5] | Includes as one case the approximately 564 cases pending as a consolidated action In Re: Tobacco Litigation Individual Personal Injury Cases, sometimes referred to as West Virginia IPIC cases, described below. The West Virginia IPIC cases have been separated from the Individual Smoking and Health cases for reporting purposes. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[6] | Should the pending post-trial motions be denied, RJR Tobacco will likely file a notice of appeal with the appropriate appellate court. |
Categories_of_US_TobaccoRelate
Categories of U.S. Tobacco-Related Cases Pending against RJR Tobacco (Detail) | 3 Months Ended | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2014 | ||
LegalMatter | Plaintiff | ||
Plaintiff | |||
West Virginia Ipic | |||
Contingent Liabilities [Line Items] | |||
RJR Tobacco's U.S. Case Numbers as of December 31, 2014 | 1 | [1] | |
Number of plaintiffs | 564 | [1] | 30 |
September 30, 2014 Increase/(Decrease) | No change | [1] | |
Individual Smoking And Health Cases | |||
Contingent Liabilities [Line Items] | |||
RJR Tobacco's U.S. Case Numbers as of December 31, 2014 | 96 | ||
Change in Number of Cases Since September 30, 2014 Increase/(Decrease) | 1 | ||
Engle | |||
Contingent Liabilities [Line Items] | |||
RJR Tobacco's U.S. Case Numbers as of December 31, 2014 | 3,885 | [2] | |
Number of plaintiffs | 4,959 | [2] | |
Change in Number of Cases Since September 30, 2014 Increase/(Decrease) | -184 | [2] | |
Increase/ (Decrease) in Number of Plaintiffs | -212 | [2] | |
Broin II | |||
Contingent Liabilities [Line Items] | |||
RJR Tobacco's U.S. Case Numbers as of December 31, 2014 | 2,558 | ||
September 30, 2014 Increase/(Decrease) | -12 | ||
Class Action | |||
Contingent Liabilities [Line Items] | |||
RJR Tobacco's U.S. Case Numbers as of December 31, 2014 | 20 | ||
September 30, 2014 Increase/(Decrease) | 3 | ||
Healthcare Cost Recovery Cases | |||
Contingent Liabilities [Line Items] | |||
RJR Tobacco's U.S. Case Numbers as of December 31, 2014 | 2 | ||
September 30, 2014 Increase/(Decrease) | No change | ||
State Settlement Agreements Enforcement And Validity Adjustments | |||
Contingent Liabilities [Line Items] | |||
RJR Tobacco's U.S. Case Numbers as of December 31, 2014 | 29 | ||
September 30, 2014 Increase/(Decrease) | -1 | ||
Antitrust | |||
Contingent Liabilities [Line Items] | |||
RJR Tobacco's U.S. Case Numbers as of December 31, 2014 | 1 | ||
September 30, 2014 Increase/(Decrease) | No change | ||
Other Litigation And Developments | |||
Contingent Liabilities [Line Items] | |||
RJR Tobacco's U.S. Case Numbers as of December 31, 2014 | 12 | ||
September 30, 2014 Increase/(Decrease) | -1 | ||
[1] | Includes as one case the approximately 564 cases pending as a consolidated action In Re: Tobacco Litigation Individual Personal Injury Cases, sometimes referred to as West Virginia IPIC cases, described below. The West Virginia IPIC cases have been separated from the Individual Smoking and Health cases for reporting purposes. | ||
[2] | The Engle Progeny cases have been separated from the Individual Smoking and Health cases for reporting purposes. The number of cases has decreased as the result of many of the federal and state court cases being dismissed or duplicate actions being consolidated. |
Categories_of_US_TobaccoRelate1
Categories of U.S. Tobacco-Related Cases Pending against RJR Tobacco (Parenthetical) (Detail) | Dec. 31, 2014 | Dec. 31, 2013 |
LegalMatter | LegalMatter | |
Contingent Liabilities [Line Items] | ||
Number of cases pending | 177 | 165 |
West Virginia Ipic | ||
Contingent Liabilities [Line Items] | ||
Number of cases pending | 564 |
Verdicts_in_Individual_Engle_P
Verdicts in Individual Engle Progeny Cases have been Tried and Remain Pending (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2012 | Mar. 31, 2013 | Apr. 30, 2013 | 31-May-13 | Jul. 31, 2013 | Mar. 26, 2014 | Jul. 17, 2014 | Sep. 30, 2014 | Aug. 28, 2014 | Aug. 29, 2014 | Oct. 10, 2014 | Oct. 22, 2014 | Nov. 07, 2014 | Nov. 18, 2014 | Nov. 12, 2014 | |
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | $136,123,200 | [1] | |||||||||||||||
Punitive Damages | 163,242,000 | ||||||||||||||||
Verdicts In Individual Cases Pending | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 1,650,000 | [2] | |||||||||||||||
Punitive Damages | 450,000 | ||||||||||||||||
Hiott | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 40.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 730,000 | [2] | |||||||||||||||
Starr-Blundell | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 10.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 50,000 | [2] | |||||||||||||||
Clayton | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 10.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 60,000 | [2] | |||||||||||||||
Cohen | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 3,330,000 | [1] | 3,330,000 | ||||||||||||||
Punitive Damages | 10,000,000 | ||||||||||||||||
Cohen | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 33.30% | ||||||||||||||||
Putney | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 4,500,000 | ||||||||||||||||
Punitive Damages | 2,500,000 | ||||||||||||||||
Putney | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | ||||||||||||||||
Buonomo | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 4,060,000 | [1] | 4,060,000 | ||||||||||||||
Punitive Damages | 15,700,000 | ||||||||||||||||
Buonomo | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 77.50% | ||||||||||||||||
Webb | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 90.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 810,000 | [2] | |||||||||||||||
Punitive Damages | 450,000 | ||||||||||||||||
Allen | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 24.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 2,475,000 | [1] | |||||||||||||||
Punitive Damages | 7,756,000 | ||||||||||||||||
Allen | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 24.00% | ||||||||||||||||
Jewett | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 20.00% | ||||||||||||||||
Soffer | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 2,000,000 | [1] | |||||||||||||||
Soffer | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 40.00% | ||||||||||||||||
Ciccone | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 1,000,000 | [1] | |||||||||||||||
Ciccone | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | ||||||||||||||||
Hallgren | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 500,000 | [1],[3] | 1,000,000 | ||||||||||||||
Punitive Damages | 750,000 | ||||||||||||||||
Hallgren | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 25.00% | ||||||||||||||||
Calloway | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 16,100,000 | [1],[3] | |||||||||||||||
Punitive Damages | 17,250,000 | ||||||||||||||||
Calloway | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 27.00% | ||||||||||||||||
Hancock | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 700 | [1] | |||||||||||||||
Hancock | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 5.00% | ||||||||||||||||
Sikes | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 3,520,000 | [1] | |||||||||||||||
Punitive Damages | 2,000,000 | ||||||||||||||||
Sikes | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 51.00% | ||||||||||||||||
James Smith | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 600,000 | [1],[3] | |||||||||||||||
Punitive Damages | 20,000 | ||||||||||||||||
James Smith | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 55.00% | ||||||||||||||||
Ballard | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 5,000,000 | [1] | |||||||||||||||
Ballard | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 55.00% | ||||||||||||||||
Evers | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 1,938,000 | [1] | |||||||||||||||
Evers | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 60.00% | ||||||||||||||||
Schoeff | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 7,875,000 | [1] | |||||||||||||||
Punitive Damages | 30,000,000 | ||||||||||||||||
Schoeff | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 75.00% | ||||||||||||||||
Marotta | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 3,480,000 | [1] | |||||||||||||||
Marotta | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 58.00% | ||||||||||||||||
Searcy | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 1,000,000 | [1],[3] | |||||||||||||||
Punitive Damages | 1,670,000 | ||||||||||||||||
Searcy | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | ||||||||||||||||
Aycock | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 4,280,000 | ||||||||||||||||
Aycock | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 72.50% | ||||||||||||||||
Earl Graham | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 550,000 | [1] | 550,000 | ||||||||||||||
Earl Graham | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 20.00% | ||||||||||||||||
Skolnick | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 767,000 | [1] | 766,500 | ||||||||||||||
Skolnick | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | ||||||||||||||||
Thibault | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 1,750,000 | [1],[3] | |||||||||||||||
Punitive Damages | 1,275,000 | ||||||||||||||||
Thibault | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 70.00% | ||||||||||||||||
Grossman | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 15,350,000 | [1],[3] | 483,682 | ||||||||||||||
Punitive Damages | 22,500,000 | ||||||||||||||||
Grossman | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 75.00% | ||||||||||||||||
Gafney | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 1,914,000 | [1] | |||||||||||||||
Gafney | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 33.00% | ||||||||||||||||
Harford | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 18.00% | ||||||||||||||||
Cheeley | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 1,500,000 | [1] | |||||||||||||||
Punitive Damages | 2,000,000 | ||||||||||||||||
Cheeley | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 50.00% | ||||||||||||||||
Goveia | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 35.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 297,500 | [1] | |||||||||||||||
Punitive Damages | 2,250,000 | ||||||||||||||||
Goveia | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 35.00% | ||||||||||||||||
Bowden | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 1,500,000 | [1] | 1,500,000 | ||||||||||||||
Bowden | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 30.00% | ||||||||||||||||
Burkhart | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 2,500,000 | [1],[3] | |||||||||||||||
Punitive Damages | 1,250,000 | ||||||||||||||||
Burkhart | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 25.00% | ||||||||||||||||
Bakst | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 4,504,000 | [1] | |||||||||||||||
Punitive Damages | 14,000,000 | ||||||||||||||||
Bakst | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 75.00% | ||||||||||||||||
Robinson | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 70.50% | ||||||||||||||||
Compensatory Damages (as adjusted) | 16,900,000 | [1] | |||||||||||||||
Punitive Damages | 16,900,000 | ||||||||||||||||
Robinson | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 70.50% | ||||||||||||||||
Harris | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | 239,000 | [1] | |||||||||||||||
Harris | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 15.00% | ||||||||||||||||
Wilcox | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 70.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 4,900,000 | [1] | 4,900,000 | ||||||||||||||
Punitive Damages | 8,500,000 | ||||||||||||||||
Wilcox | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 70.00% | ||||||||||||||||
Irimi | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 14.50% | ||||||||||||||||
Irimi | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 14.50% | ||||||||||||||||
Hubbird | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 50.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 3,000,000 | [1],[3] | |||||||||||||||
Punitive Damages | 25,000,000 | ||||||||||||||||
Hubbird | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 50.00% | ||||||||||||||||
Lourie | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 3.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 41,000 | [1] | |||||||||||||||
Lourie | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 3.00% | ||||||||||||||||
Kerrivan | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 31.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 4,898,000 | [1] | |||||||||||||||
Punitive Damages | 9,600,000 | [4] | |||||||||||||||
Kerrivan | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 31.00% | ||||||||||||||||
Taylor | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 58.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 4,116,000 | [1],[3] | |||||||||||||||
Punitive Damages | 521,000 | ||||||||||||||||
Taylor | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 58.00% | ||||||||||||||||
Schleider | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 70.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 14,700,000 | [1] | |||||||||||||||
Schleider | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 70.00% | ||||||||||||||||
Perrotto | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 20.00% | ||||||||||||||||
Compensatory Damages (as adjusted) | 818,000 | [1] | |||||||||||||||
Perrotto | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 20.00% | ||||||||||||||||
Ellen Gray | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
Compensatory Damages (as adjusted) | $3,000,000 | [1] | |||||||||||||||
Ellen Gray | RJR Tobacco | |||||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||||
RJR Tobacco Allocation of Fault | 50.00% | ||||||||||||||||
[1] | Unless otherwise noted, compensatory damages in these cases are adjusted to reflect the jury's allocation of comparative fault. Punitive damages are not so adjusted. The amounts listed above do not include attorneys' fees or statutory interest that may apply to the judgments. | ||||||||||||||||
[2] | Compensatory damages are adjusted to reflect the reduction that may be required by the allocation of fault. Punitive damages are not adjusted and reflect the amount of the final judgment(s) signed by the trial court judge(s). The amounts listed above do not include attorneys' fees or statutory interest. | ||||||||||||||||
[3] | The court did not apply comparative fault in the final judgment. | ||||||||||||||||
[4] | Should the pending post-trial motions be denied, RJR Tobacco will likely file a notice of appeal with the appropriate appellate court. |
Commitments_and_Contingencies_2
Commitments and Contingencies Related to Settlements (Detail) (USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | |
2012 | ||
Remaining Jurisdictions' Settlement: | ||
Annual Payments | $8,004 | [1] |
Total | 9,364 | |
Settlement expenses | 2,370 | |
Settlement cash payments | 2,414 | |
2012 | Mississippi | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 136 | [1] |
2012 | Florida | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 440 | [1] |
2012 | Texas | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 580 | [1] |
2012 | Minnesota | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 204 | [1] |
2013 | ||
Remaining Jurisdictions' Settlement: | ||
Annual Payments | 8,004 | [1] |
Total | 9,364 | |
Settlement expenses | 1,819 | |
Settlement cash payments | 2,582 | |
2013 | Mississippi | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 136 | [1] |
2013 | Florida | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 440 | [1] |
2013 | Texas | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 580 | [1] |
2013 | Minnesota | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 204 | [1] |
2014 | ||
Remaining Jurisdictions' Settlement: | ||
Annual Payments | 8,004 | [1] |
Total | 9,364 | |
Settlement expenses | 1,917 | |
Settlement cash payments | 1,985 | |
2014 | Mississippi | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 136 | [1] |
2014 | Florida | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 440 | [1] |
2014 | Texas | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 580 | [1] |
2014 | Minnesota | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 204 | [1] |
2015 and thereafter | ||
Remaining Jurisdictions' Settlement: | ||
Annual Payments | 8,004 | [1] |
Total | 9,364 | |
2015 and thereafter | Minimum | ||
Remaining Jurisdictions' Settlement: | ||
Projected settlement expenses | 1,900 | |
Projected settlement cash payments | 1,900 | |
2015 and thereafter | Mississippi | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 136 | [1] |
2015 and thereafter | Florida | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 440 | [1] |
2015 and thereafter | Texas | ||
First Four States' Settlements: | ||
Annual Settlement Payment | 580 | [1] |
2015 and thereafter | Minnesota | ||
First Four States' Settlements: | ||
Annual Settlement Payment | $204 | [1] |
[1] | Subject to adjustments for changes in sales volume, inflation and other factors. All payments are to be allocated among the companies on the basis of relative market share. For further information, see "- State Settlement Agreements - Enforcement and Validity; Adjustments" below. |
Commitments_and_Contingencies_3
Commitments and Contingencies (Details 1) (Detail) (USD $) | 12 Months Ended |
In Millions, unless otherwise specified | Dec. 31, 2014 |
State Settlement Payment Expense [Line Items] | |
Year for which NPM Adjustment calculated year one | 2004 |
Year for which NPM Adjustment calculated year two | 2005 |
Year for which NPM Adjustment calculated year three | 2006 |
Year for which NPM Adjustment calculated year four | 2007 |
Year for which NPM Adjustment Calculated year five | 2008 |
Year for which NPM Adjustment calculated year six | 2009 |
Year for which NPM Adjustment calculated year seven | 2010 |
Year for which NPM Adjustment calculated year eight | 2011 |
Year in which deduction for NPM Adjustment was taken year one | 2007 |
Year in which deduction for NPM Adjustment was taken year two | 2008 |
Year in which deduction for NPM Adjustment was taken year three | 2009 |
Year in which deduction for NPM Adjustment was taken year four | 2010 |
Year in which deduction for NPM Adjustment was taken year five | 2011 |
Year in which deduction for NPM Adjustment was taken year six | 2012 |
Year in which deduction for NPM Adjustment was taken year seven | 2013 |
Year in which deduction for NPM Adjustment was taken year eight | 2014 |
RJR Tobacco's approximate share of disputed NPM adjustment amount year one | $562 |
RJR Tobacco's approximate share of disputed NPM adjustment amount year two | 445 |
RJR Tobacco's approximate share of disputed NPM adjustment amount year three | 419 |
RJR Tobacco's approximate share of disputed NPM adjustment amount year four | 435 |
RJR Tobacco's approximate share of disputed NPM adjustment amount year five | 468 |
RJR Tobacco's approximate share of disputed NPM adjustment amount year six | 472 |
RJR Tobacco's approximate share of disputed NPM adjustment amount year seven | 470 |
RJR Tobacco's approximate share of disputed NPM adjustment amount year eight | $421 |
Noncancellable_Operating_Lease
Noncancellable Operating Leases Future Minimum Lease Payments (Detail) (USD $) | Dec. 31, 2014 |
In Millions, unless otherwise specified | |
Schedule of Operating Leases [Line Items] | |
2015 | $19 |
2016 | 3 |
2017 | 3 |
2018 | 2 |
2019 | 2 |
Thereafter | 1 |
Total | $30 |
Shareholders_Equity_Additional
Shareholders' Equity - Additional Information (Detail) (USD $) | 12 Months Ended | 38 Months Ended | |||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2014 | Jul. 02, 2014 | |
Right | |||||
Shareholders Equity [Line Items] | |||||
Authorized preferred stock, shares | 100,000,000 | 100,000,000 | 100,000,000 | ||
Authorized preferred stock, par value | $0.01 | $0.01 | $0.01 | ||
Authorized common stock, shares | 1,600,000,000 | 1,600,000,000 | 1,600,000,000 | ||
Authorized common stock, par value | $0.00 | $0.00 | $0.00 | ||
Declaration of Dividend | 1 | ||||
Stock split | Two-for-one stock split | ||||
Number of rights associated with each share of common stock | 0.25 | ||||
Outstanding shares of RAI common stock | $2,500,000,000 | $2,500,000,000 | |||
Ownership percentage of RAI's common stock | 42.00% | 42.00% | 42.00% | ||
Shares repurchased and cancelled | 7,715,763 | 15,917,174 | 24,944,233 | ||
Common stock repurchased | 440,000,000 | 775,000,000 | 1,101,000,000 | ||
Decrease in ownership percentage of RAI's common stock | 25.00% | ||||
Issuance of shares of RAI common stock on settlement | 1,468,294 | ||||
Cost of shares purchased that forfeited with respect to tax liabilities associated with restricted stock vesting | 28,000,000 | ||||
Number of shares purchased that forfeited with respect to tax liabilities associated with restricted stock vesting under its LTIP | 554,042 | ||||
Stock Repurchase Program | |||||
Shareholders Equity [Line Items] | |||||
Shares repurchased and cancelled | 7,715,763 | 55,353,807 | |||
Common stock repurchased | 412,000,000 | 2,500,000,000 | |||
Series A Preferred Stock | |||||
Shareholders Equity [Line Items] | |||||
Authorized preferred stock, shares | 4,000,000 | 4,000,000 | |||
Series B Preferred Stock | |||||
Shareholders Equity [Line Items] | |||||
Authorized preferred stock, shares | 1,000,000 | 1,000,000 | |||
Preferred stock, issued shares | 1,000,000 | 1,000,000 | |||
Preferred stock, outstanding shares | 1,000,000 | 1,000,000 | |||
Dividends declared with respect to Series B Preferred Stock | $43,000,000 | $43,000,000 | $43,000,000 |
Declared_Quarterly_Cash_Divide
Declared Quarterly Cash Dividends per Share of Common Stock (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||
Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |
Common Stock [Line Items] | |||||||||||||||
Dividends declared per share | $0.67 | $0.67 | $0.67 | $0.67 | $0.63 | $0.63 | $0.63 | $0.59 | $0.59 | $0.59 | $0.59 | $0.56 | $2.68 | $2.48 | $2.33 |
Components_of_Accumulated_Othe
Components of Accumulated Other Comprehensive Loss Net of Tax (Detail) (USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | ($56) | ($311) |
Other comprehensive income before reclassifications | -560 | 277 |
Amounts reclassified from accumulated other comprehensive income (loss) | 252 | -22 |
Net current-period other comprehensive income | -308 | 255 |
Ending balance | -364 | -56 |
Accumulated Defined Benefit Plans Adjustment | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | -17 | -265 |
Other comprehensive income before reclassifications | -528 | 271 |
Amounts reclassified from accumulated other comprehensive income (loss) | 251 | -23 |
Net current-period other comprehensive income | -277 | 248 |
Ending balance | -294 | -17 |
Accumulated Net Unrealized Investment Gain (Loss) | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | -16 | -21 |
Other comprehensive income before reclassifications | 2 | 5 |
Net current-period other comprehensive income | 2 | 5 |
Ending balance | -14 | -16 |
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | -13 | -14 |
Amounts reclassified from accumulated other comprehensive income (loss) | 1 | 1 |
Net current-period other comprehensive income | 1 | 1 |
Ending balance | -12 | -13 |
Accumulated Translation Adjustment and Other | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | -10 | -11 |
Other comprehensive income before reclassifications | -34 | 1 |
Net current-period other comprehensive income | -34 | 1 |
Ending balance | ($44) | ($10) |
Reclassification_Out_of_Accumu
Reclassification Out of Accumulated Other Comprehensive Loss and Affected Line Items in Condensed Consolidated Statement of Income (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Cost of products sold | ($4,058) | ($3,678) | ($4,321) | ||||||||||||||||
Interest and debt expense | -286 | -259 | -234 | ||||||||||||||||
Selling, general and administrative expenses | -1,871 | -1,389 | -1,470 | ||||||||||||||||
MTM adjustment | 452 | ||||||||||||||||||
Income (loss) from continuing operations before income taxes | 2,262 | 2,741 | 1,953 | ||||||||||||||||
Provision for income taxes | -817 | -1,023 | -681 | ||||||||||||||||
Net income | 148 | [1],[2] | 467 | [1],[2] | 492 | [1],[2] | 363 | [1],[2] | 292 | [3],[4] | 457 | [3],[4] | 461 | [3],[4] | 508 | [3],[4] | 1,470 | 1,718 | 1,272 |
Cost of products sold | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | -205 | ||||||||||||||||||
Selling, General and Administrative Expenses | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | -247 | ||||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Net income | 252 | -22 | |||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Cost of products sold | -21 | -21 | |||||||||||||||||
Selling, general and administrative expenses | -18 | -18 | |||||||||||||||||
Income (loss) from continuing operations before income taxes | 413 | -39 | |||||||||||||||||
Provision for income taxes | -162 | 16 | |||||||||||||||||
Net income | 251 | -23 | |||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment | Cost of products sold | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | 205 | ||||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment | Selling, General and Administrative Expenses | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | 247 | ||||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Interest and debt expense | 2 | 2 | |||||||||||||||||
Provision for income taxes | -1 | -1 | |||||||||||||||||
Net income | $1 | $1 | |||||||||||||||||
[1] | Includes NPM Adjustment credits of $63 million in the first quarter of 2014, $125 million in the second quarter of 2014, $82 million in the third quarter of 2014 and $75 million in the fourth quarter of 2014, see "- Cost of Products Sold" in note 1. The fourth quarter of 2014 includes an MTM adjustment of $205 million. | ||||||||||||||||||
[2] | Fourth quarter of 2014 includes an additional MTM adjustment of $247 million for a total of $452 million. | ||||||||||||||||||
[3] | Includes NPM Adjustment credits of $261 million in the first quarter of 2013, $90 million in the second quarter of 2013, $69 million in the third quarter of 2013 and $63 million in the fourth quarter of 2013, see "- Cost of Products Sold" in note 1. | ||||||||||||||||||
[4] | Fourth quarter of 2013 net income includes a $32 million trademark impairment charge. |
Changes_in_Common_Stock_Outsta
Changes in Common Stock Outstanding (Detail) | 12 Months Ended | ||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |
Reconciliation of Common Stock Outstanding [Line Items] | |||
Shares outstanding at beginning of year | 538,053,024 | 552,940,767 | 576,135,199 |
Tax shares repurchased and cancelled | -554,042 | ||
Shares repurchased and cancelled | -7,715,763 | -15,917,174 | -24,944,233 |
Equity incentive award plan shares issued | 32,000 | 31,425 | 31,039 |
Shares outstanding at end of year | 531,283,513 | 538,053,024 | 552,940,767 |
LTIP | |||
Reconciliation of Common Stock Outstanding [Line Items] | |||
Tax shares repurchased and cancelled | -921,646 | ||
Shares issued from vesting of restricted stock units | 2,640,408 | ||
Omnibus Plan | |||
Reconciliation of Common Stock Outstanding [Line Items] | |||
Tax shares repurchased and cancelled | -554,042 | -574,383 | |
Shares issued from vesting of restricted stock units | 1,468,294 | 1,572,389 |
Stock_Plans_Additional_Informa
Stock Plans - Additional Information (Detail) (USD $) | 0 Months Ended | 12 Months Ended | ||
In Millions, except Share data, unless otherwise specified | Sep. 13, 2012 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Deferred stock units granted | 3,500 | |||
Issuable common stock under Equity Incentive Award Plan | 2,000,000 | |||
Shares available for grant under Equity Incentive Award Plan | 1,053,955 | |||
Compensation expense related to Equity Incentive Award Plan | $56 | $55 | $42 | |
Common shares issuable under Omnibus Plan | 38,000,000 | |||
Restricted stock unit award adjustment upper end of range | 150.00% | |||
Weighted Average Grant Date Fair Value, Outstanding | $47.58 | $39.37 | ||
Restricted stock unit award adjustment | 50.00% | |||
Unrecognized compensation costs related to restricted stock units | 61 | |||
Weighted-average period of unrecognized compensation costs | 1 year 8 months 23 days | |||
Excess tax benefit on stock-based compensation plans | 12 | 14 | 39 | |
Stock options outstanding | 40,000 | |||
Weighted average exercise price | $17.45 | |||
Equity Incentive Award Plan | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Compensation expense related to Equity Incentive Award Plan | $10 | $7 | $4 | |
Weighted Average Grant Date Fair Value, Outstanding | $64.27 | |||
Number of Shares Granted | 0 | |||
One-year grant | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Restricted stock unit award adjustment upper end of range | 150.00% | |||
One-year grant | May 1, 2014 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Ending Date of Performance Period | 30-Apr-15 |
Information_Regarding_Restrict
Information Regarding Restricted Stock-based Awards Outstanding (Detail) (USD $) | 12 Months Ended |
Dec. 31, 2014 | |
Three-year grants | Grant Year 2012 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares Granted | 1,222,534 |
Grant Price | $42.16 |
Number of Shares Cancelled | 269,091 |
Cumulative Dividends | $6.72 |
Ending Date of Performance Period | 31-Dec-14 |
Three-year grants | Grant Year 2013 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares Granted | 1,112,436 |
Grant Price | $43.36 |
Number of Shares Cancelled | 201,697 |
Cumulative Dividends | $7.08 |
Ending Date of Performance Period | 31-Dec-15 |
Three-year grants | Grant Price $53.29 | Grant Year 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares Granted | 1,049,348 |
Grant Price | $53.29 |
Number of Shares Cancelled | 185,128 |
Cumulative Dividends | $8.04 |
Ending Date of Performance Period | 31-Dec-16 |
Three-year grants | Grant Price $58.73 | Grant Year 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares Granted | 25,907 |
Grant Price | $58.73 |
Cumulative Dividends | $6.03 |
Ending Date of Performance Period | 31-Dec-16 |
One-year grant | Grant Year 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares Granted | 149,192 |
Grant Price | $64.27 |
Cumulative Dividends | $2.68 |
Ending Date of Performance Period | 30-Apr-15 |
Other grants | Grant Price $58.73 | Grant Year 2014 | September 30, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares Granted | 20,726 |
Grant Price | $58.73 |
Other grants | Grant Price $58.73 | Grant Year 2014 | September 30, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares Granted | 37,133 |
Grant Price | $58.73 |
Other grants | Grant Price $58.73 | Grant Year 2014 | September 30, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares Granted | 20,725 |
Grant Price | $58.73 |
Other grants | Grant Price $58.73 | Grant Year 2014 | September 30, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of Shares Granted | 37,133 |
Grant Price | $58.73 |
Changes_in_Number_of_RAI_Restr
Changes in Number of RAI Restricted Stock Units (Detail) (USD $) | 12 Months Ended |
Dec. 31, 2014 | |
Stock Units | |
Outstanding at beginning of year | 3,594,594 |
Granted | 1,340,164 |
Forfeited | -530,547 |
Vested | -1,384,993 |
Outstanding at end of year | 3,019,218 |
Weighted Average Grant Date Fair Value | |
Weighted Average Grant Date Fair Value, Outstanding at beginning of year | $39.37 |
Weighted Average Grant Date Fair Value, Granted | $55.09 |
Weighted Average Grant Date Fair Value, Forfeited | $46.42 |
Weighted Average Grant Date Fair Value, Vested | $33.99 |
Weighted Average Grant Date Fair Value, Outstanding at end of year | $47.58 |
Compensation_Expense_Related_t
Compensation Expense Related to Stock Based Compensation and Related Tax Benefits (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total compensation expense | $56 | $55 | $42 |
Total related tax benefits | 20 | 19 | 15 |
2008 restricted stock | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total compensation expense | 2 | ||
2009 restricted stock units | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total compensation expense | 2 | 13 | |
2010 restricted stock units | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total compensation expense | 3 | 20 | 14 |
2011 restricted stock units | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total compensation expense | 14 | 18 | 13 |
2012 restricted stock units | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total compensation expense | 15 | 15 | |
2013 restricted stock units | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total compensation expense | $24 |
Amounts_Related_to_Unvested_Om
Amounts Related to Unvested Omnibus Plan Restricted Stock Grants (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Other current liabilities | $9 | $10 |
Other noncurrent liabilities | 8 | 9 |
Paid-in capital | $99 | $94 |
Equity_Compensation_Plan_Infor
Equity Compensation Plan Information (Detail) (USD $) | 12 Months Ended | |
Dec. 31, 2014 | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights (a) | 4,470,968 | [1] |
Weighted Average Exercise Price of Outstanding Options, Warrants and Rights (b) | $0 | |
Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) (c) | 32,670,730 | |
Equity Compensation Plans Approved by Security Holders | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights (a) | 4,470,968 | [1] |
Weighted Average Exercise Price of Outstanding Options, Warrants and Rights (b) | $0 | |
Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) (c) | 31,616,775 | |
Equity Compensation Plans Not Approved by Security Holders | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted Average Exercise Price of Outstanding Options, Warrants and Rights (b) | $0 | [2] |
Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) (c) | 1,053,955 | [2] |
[1] | Consists of restricted stock units. These restricted stock units represent the maximum number of shares to be awarded under the best-case targets, and accordingly, may overstate expected dilution. | |
[2] | The EIAP was approved by RJR's sole shareholder, NGH, prior to RJR's spin-off on June 15, 1999. |
Changes_in_Benefit_Obligations
Changes in Benefit Obligations (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Pension Benefits | |||
Change in benefit obligations: | |||
Obligations at beginning of year | $5,618 | $6,293 | |
Service cost | 21 | 23 | 23 |
Interest cost | 266 | 247 | 280 |
Actuarial (gain) loss | 941 | -540 | |
Benefits paid | -457 | -405 | |
Obligations at end of year | 6,389 | 5,618 | 6,293 |
Change in plan assets: | |||
Beginning balance | 5,220 | 5,423 | |
Actual return on plan assets | 536 | 142 | |
Employer contributions | 10 | 60 | |
Benefits paid | -457 | -405 | |
Ending balance | 5,309 | 5,220 | 5,423 |
Funded status | -1,080 | -398 | |
Postretirement Benefit | |||
Change in benefit obligations: | |||
Obligations at beginning of year | 1,169 | 1,280 | |
Service cost | 2 | 3 | 3 |
Interest cost | 53 | 50 | 56 |
Actuarial (gain) loss | 106 | -95 | |
Benefits paid | -79 | -69 | |
Obligations at end of year | 1,251 | 1,169 | 1,280 |
Change in plan assets: | |||
Beginning balance | 268 | 258 | |
Actual return on plan assets | 14 | 31 | |
Employer contributions | 56 | 48 | |
Benefits paid | -79 | -69 | |
Ending balance | 259 | 268 | 258 |
Funded status | ($992) | ($901) |
Amounts_Recognized_in_Consolid
Amounts Recognized in Consolidated Balance Sheets (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Amounts recognized in the consolidated balance sheets consist of: | ||
Noncurrent assets - other assets and deferred charges | $233 | $245 |
Accrued benefit - other current liability | -75 | -79 |
Accrued benefit - long-term retirement benefits | -1,997 | -1,221 |
Pension Benefits | ||
Amounts recognized in the consolidated balance sheets consist of: | ||
Noncurrent assets - other assets and deferred charges | 1 | |
Accrued benefit - other current liability | -9 | -9 |
Accrued benefit - long-term retirement benefits | -1,071 | -390 |
Net amount recognized | -1,080 | -398 |
Accumulated other comprehensive loss | 652 | 311 |
Net amounts recognized in the consolidated balance sheets | -428 | -87 |
Postretirement Benefit | ||
Amounts recognized in the consolidated balance sheets consist of: | ||
Accrued benefit - other current liability | -66 | -70 |
Accrued benefit - long-term retirement benefits | -926 | -831 |
Net amount recognized | -992 | -901 |
Accumulated other comprehensive loss | -117 | -231 |
Net amounts recognized in the consolidated balance sheets | ($1,109) | ($1,132) |
Amounts_Included_in_Accumulate
Amounts Included in Accumulated Other Comprehensive Loss (Detail) (USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Defined Benefit Plan Disclosure [Line Items] | ||
Prior service cost (credit) | ($164) | ($203) |
Net actuarial (gain) loss | 699 | 283 |
Deferred income taxes | -241 | -63 |
Accumulated other comprehensive loss | 294 | 17 |
Pension Benefits | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Prior service cost (credit) | 14 | 17 |
Net actuarial (gain) loss | 638 | 294 |
Deferred income taxes | -268 | -134 |
Accumulated other comprehensive loss | 384 | 177 |
Postretirement Benefit | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Prior service cost (credit) | -178 | -220 |
Net actuarial (gain) loss | 61 | -11 |
Deferred income taxes | 27 | 71 |
Accumulated other comprehensive loss | ($90) | ($160) |
Changes_in_Accumulated_Other_C
Changes in Accumulated Other Comprehensive Loss (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Defined Benefit Plan Disclosure [Line Items] | |||
Net actuarial (gain) loss | $868 | ($447) | |
Amortization of prior service cost (credit) | 39 | 39 | |
MTM adjustment | -452 | ||
Tax expense (benefit), retirement benefits | -178 | 160 | 45 |
Change in accumulated other comprehensive loss | 277 | -248 | -65 |
Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Net actuarial (gain) loss | 764 | -331 | |
Amortization of prior service cost (credit) | -3 | -3 | |
MTM adjustment | -420 | ||
Tax expense (benefit), retirement benefits | -134 | 131 | |
Change in accumulated other comprehensive loss | 207 | -203 | |
Postretirement Benefit | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Net actuarial (gain) loss | 104 | -116 | |
Amortization of prior service cost (credit) | 42 | 42 | |
MTM adjustment | -32 | ||
Tax expense (benefit), retirement benefits | -44 | 29 | |
Change in accumulated other comprehensive loss | $70 | ($45) |
Weighted_Average_Assumptions_U
Weighted Average Assumptions Used to Determine Benefit Obligations (Detail) | Dec. 31, 2014 | Dec. 31, 2013 |
Pension Benefits | ||
Weighted-average assumptions used to determine benefit obligations at December 31: | ||
Discount rate | 4.12% | 4.92% |
Rate of compensation increase | 4.00% | 4.00% |
Postretirement Benefit | ||
Weighted-average assumptions used to determine benefit obligations at December 31: | ||
Discount rate | 4.11% | 4.87% |
Retirement_Benefits_Additional
Retirement Benefits - Additional Information (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Defined Benefit Plan Disclosure [Line Items] | |||
Accumulated Defined Beneift Obligation | $6,326 | $5,557 | |
Defined contribution plan expense | 37 | 34 | 34 |
Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Accumulated benefit obligation for pension plans | 3 | ||
Pension expected contributions | 109 | ||
Postretirement Benefit | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Accumulated benefit obligation for pension plans | 42 | ||
Post Retirement expected contributions | $66 |
Accumulated_Benefit_Obligation
Accumulated Benefit Obligations (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Schedule of Pension Plans with Accumulated and Projected Benefit Obligations in Excess of Plan Assets [Line Items] | ||
Projected benefit obligation | $6,389 | $5,589 |
Accumulated benefit obligation | 6,326 | 5,529 |
Plan assets | $5,309 | $5,190 |
Components_of_Pension_Benefits
Components of Pension Benefits and Postretirement Benefits (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Service cost | $21 | $23 | $23 |
Interest cost | 266 | 247 | 280 |
Expected return on plan assets | -360 | -350 | -359 |
Amortization of prior service cost (credit) | 3 | 3 | 4 |
MTM adjustment | 420 | 289 | |
Curtailment | 4 | ||
Special termination benefits | 34 | ||
Total benefit (income) cost | 350 | -77 | 275 |
Postretirement Benefit | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Service cost | 2 | 3 | 3 |
Interest cost | 53 | 50 | 56 |
Expected return on plan assets | -12 | -11 | -10 |
Amortization of prior service cost (credit) | -42 | -42 | -30 |
MTM adjustment | 32 | 40 | |
Total benefit (income) cost | $33 | $59 |
Weighted_Average_Assumptions_D
Weighted Average Assumptions (Detail) | 12 Months Ended | ||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |
Pension Benefits | |||
Weighted-average assumptions used to determine net periodic benefit cost for years ended December 31: | |||
Discount rate | 4.92% | 4.07% | 5.00% |
Expected long-term return on plan assets | 7.13% | 6.67% | 6.97% |
Rate of compensation increase | 4.00% | 4.00% | 5.00% |
Defined Benefit Postretirement | |||
Weighted-average assumptions used to determine net periodic benefit cost for years ended December 31: | |||
Discount rate | 4.87% | 3.99% | 4.84% |
Expected long-term return on plan assets | 4.85% | 4.35% | 4.35% |
Pension_and_Post_Retirement_Pl
Pension and Post Retirement Plans Asset Allocations (Detail) | 12 Months Ended | |||
Dec. 31, 2014 | Dec. 31, 2013 | |||
Pension Benefits | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 100.00% | [1] | 100.00% | [1] |
Actual Plan Asset Allocations | 100.00% | 100.00% | ||
Pension Benefits | Domestic equities | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 10.00% | [1] | 10.00% | [1] |
Actual Plan Asset Allocations | 10.00% | 10.00% | ||
Pension Benefits | International equities | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 8.00% | [1] | 8.00% | [1] |
Actual Plan Asset Allocations | 8.00% | 9.00% | ||
Pension Benefits | Global equities | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 9.00% | [1] | 9.00% | [1] |
Actual Plan Asset Allocations | 10.00% | 11.00% | ||
Pension Benefits | Emerging market equities | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 3.00% | [1] | 3.00% | [1] |
Actual Plan Asset Allocations | 3.00% | 3.00% | ||
Pension Benefits | Fixed income | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 53.00% | [1] | 53.00% | [1] |
Actual Plan Asset Allocations | 56.00% | 55.00% | ||
Pension Benefits | Absolute Return | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 6.00% | [1] | 6.00% | [1] |
Actual Plan Asset Allocations | 4.00% | 3.00% | ||
Pension Benefits | Private equity | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 2.00% | [1] | 2.00% | [1] |
Actual Plan Asset Allocations | 1.00% | 1.00% | ||
Pension Benefits | Real estate | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 5.00% | [1] | 5.00% | [1] |
Actual Plan Asset Allocations | 4.00% | 4.00% | ||
Pension Benefits | Commodities | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 4.00% | [1] | 4.00% | [1] |
Actual Plan Asset Allocations | 4.00% | 4.00% | ||
Postretirement Benefits | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 100.00% | [1] | 100.00% | [1] |
Actual Plan Asset Allocations | 100.00% | 100.00% | ||
Postretirement Benefits | Domestic equities | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 21.00% | [1] | 21.00% | [1] |
Actual Plan Asset Allocations | 21.00% | 22.00% | ||
Postretirement Benefits | International equities | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 21.00% | [1] | 21.00% | [1] |
Actual Plan Asset Allocations | 20.00% | 22.00% | ||
Postretirement Benefits | Fixed income | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 55.00% | [1] | 55.00% | [1] |
Actual Plan Asset Allocations | 54.00% | 51.00% | ||
Postretirement Benefits | Cash and other | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target Plan Asset Allocations | 3.00% | [1] | 3.00% | [1] |
Actual Plan Asset Allocations | 5.00% | 5.00% | ||
[1] | Allows for a rebalancing range of up to 5 percentage points around target asset allocations. |
Pension_and_Post_Retirement_Pl1
Pension and Post Retirement Plans Asset Allocations (Parenthetical) (Detail) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Postretirement Benefit | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Maximum Range of rebalancing of assets around target asset allocations | 5.00% | 5.00% |
Pension Benefits | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Maximum Range of rebalancing of assets around target asset allocations | 5.00% | 5.00% |
Plan_Assets_Carried_at_Fair_Va
Plan Assets Carried at Fair Value (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||
In Millions, unless otherwise specified | |||||
Level 3 | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | $509 | $447 | $444 | ||
Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 4,881 | [1] | |||
Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 5,104 | [1] | |||
Recurring | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 252 | [1] | 262 | [1] | |
Recurring | Level 1 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 1,298 | [1] | 1,245 | [1] | |
Recurring | Level 1 | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 9 | [1] | 9 | [1] | |
Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 3,297 | [1] | 3,189 | [1] | |
Recurring | Level 2 | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 243 | [1] | 253 | [1] | |
Recurring | Level 3 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 509 | [1] | 447 | [1] | |
Domestic equities | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 523 | [1] | |||
Domestic equities | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 511 | [1] | |||
Domestic equities | Recurring | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 55 | [1] | 60 | [1] | |
Domestic equities | Recurring | Level 1 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 511 | [1] | 523 | [1] | |
Domestic equities | Recurring | Level 2 | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 55 | [1] | 60 | [1] | |
International equities | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 539 | [1] | |||
International equities | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 306 | [1] | |||
International equities | Recurring | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 50 | [1] | 59 | [1] | |
International equities | Recurring | Level 1 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 134 | [1] | 135 | [1] | |
International equities | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 172 | [1] | 404 | [1] | |
International equities | Recurring | Level 2 | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 50 | [1] | 59 | [1] | |
Global equities | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 535 | [1] | |||
Global equities | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 570 | [1] | |||
Global equities | Recurring | Level 1 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 570 | [1] | 535 | [1] | |
High yield fixed income | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 18 | [1] | |||
High yield fixed income | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 19 | [1] | |||
High yield fixed income | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 19 | [1] | 18 | [1] | |
Absolute Return | Level 3 | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 223 | 176 | 189 | ||
Absolute Return | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 176 | [1] | |||
Absolute Return | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 349 | [1] | |||
Absolute Return | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 126 | [1] | |||
Absolute Return | Recurring | Level 3 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 223 | [1] | 176 | [1] | |
Private equity | Level 3 | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 66 | 53 | 47 | ||
Private equity | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 53 | [1] | |||
Private equity | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 66 | [1] | |||
Private equity | Recurring | Level 3 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 66 | [1] | 53 | [1] | |
Real estate | Level 3 | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 188 | 190 | 178 | ||
Real estate | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 212 | [1] | |||
Real estate | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 209 | [1] | |||
Real estate | Recurring | Level 1 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 21 | [1] | 22 | [1] | |
Real estate | Recurring | Level 3 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 188 | [1] | 190 | [1] | |
Commodities | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 185 | [1] | |||
Commodities | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 156 | [1] | |||
Commodities | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 156 | [1] | 185 | [1] | |
Agency Bonds | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 17 | [1] | |||
Agency Bonds | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 21 | [1] | |||
Agency Bonds | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 21 | [1] | 17 | [1] | |
Asset backed securities | Level 3 | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 3 | 3 | 5 | ||
Asset backed securities | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 92 | [1] | |||
Asset backed securities | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 96 | [1] | |||
Asset backed securities | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 93 | [1] | 89 | [1] | |
Asset backed securities | Recurring | Level 3 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 3 | [1] | 3 | [1] | |
Corporate bonds | Level 3 | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 2 | 2 | 2 | ||
Corporate bonds | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 1,570 | [1] | |||
Corporate bonds | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 1,741 | [1] | |||
Corporate bonds | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 1,739 | [1] | 1,568 | [1] | |
Corporate bonds | Recurring | Level 3 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 2 | [1] | 2 | [1] | |
Government Bonds | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 152 | [1] | |||
Government Bonds | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 153 | [1] | |||
Government Bonds | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 153 | [1] | 152 | [1] | |
Mortgage backed securities | Level 3 | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 25 | 21 | 21 | ||
Mortgage backed securities | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 95 | [1] | |||
Mortgage backed securities | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 67 | [1] | |||
Mortgage backed securities | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 42 | [1] | 74 | [1] | |
Mortgage backed securities | Recurring | Level 3 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 25 | [1] | 21 | [1] | |
Municipal Bonds | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 212 | [1] | |||
Municipal Bonds | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 209 | [1] | |||
Municipal Bonds | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 209 | [1] | 212 | [1] | |
Treasuries | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 398 | [1] | |||
Treasuries | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 414 | [1] | |||
Treasuries | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 414 | [1] | 398 | [1] | |
Other | Recurring | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 104 | [1] | |||
Other | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 165 | [1] | |||
Other | Recurring | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 7 | [1] | 7 | [1] | |
Other | Recurring | Level 1 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 62 | [1] | 30 | [1] | |
Other | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 101 | [1] | 72 | [1] | |
Other | Recurring | Level 2 | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 7 | [1] | 7 | [1] | |
Other | Recurring | Level 3 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 2 | [1] | 2 | [1] | |
Short-term bonds | Recurring | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 9 | [1] | 9 | [1] | |
Short-term bonds | Recurring | Level 1 | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 9 | [1] | 9 | [1] | |
Intermediate bonds | Recurring | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 131 | [1] | 127 | [1] | |
Intermediate bonds | Recurring | Level 2 | Postretirement Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 131 | [1] | 127 | [1] | |
Emerging market equities | Recurring | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | 52 | [1] | |||
Emerging market equities | Recurring | Level 2 | Pension Benefits | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Fair value of pension and postretirement plan assets | $52 | [1] | |||
[1] | See note 1 for additional information on the fair value hierarchy. |
Transfer_of_Plan_Assets_by_Ass
Transfer of Plan Assets by Asset Category (Detail) (Level 3, USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Defined Benefit Plan Disclosure [Line Items] | ||
Beginning balance | $447 | $444 |
Purchases, Sales, Issuances and Settlements (net) | 24 | -44 |
Realized Gains (Losses) | 29 | 39 |
Unrealized Gains (Losses) | 9 | 8 |
Transferred From Other Levels | 0 | 0 |
Ending balance | 509 | 447 |
Absolute Return | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Beginning balance | 176 | 189 |
Purchases, Sales, Issuances and Settlements (net) | 40 | -32 |
Realized Gains (Losses) | 13 | 31 |
Unrealized Gains (Losses) | -6 | -12 |
Transferred From Other Levels | 0 | 0 |
Ending balance | 223 | 176 |
Private equity | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Beginning balance | 53 | 47 |
Purchases, Sales, Issuances and Settlements (net) | 6 | -1 |
Realized Gains (Losses) | 7 | 4 |
Unrealized Gains (Losses) | 3 | |
Transferred From Other Levels | 0 | 0 |
Ending balance | 66 | 53 |
Real estate | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Beginning balance | 190 | 178 |
Purchases, Sales, Issuances and Settlements (net) | -24 | -9 |
Realized Gains (Losses) | 8 | 4 |
Unrealized Gains (Losses) | 14 | 17 |
Transferred From Other Levels | 0 | 0 |
Ending balance | 188 | 190 |
Asset backed securities | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Beginning balance | 3 | 5 |
Purchases, Sales, Issuances and Settlements (net) | -2 | |
Transferred From Other Levels | 0 | 0 |
Ending balance | 3 | 3 |
Corporate bonds | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Beginning balance | 2 | 2 |
Transferred From Other Levels | 0 | 0 |
Ending balance | 2 | 2 |
Mortgage backed securities | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Beginning balance | 21 | 21 |
Purchases, Sales, Issuances and Settlements (net) | 2 | |
Realized Gains (Losses) | 1 | |
Unrealized Gains (Losses) | 1 | |
Transferred From Other Levels | 0 | 0 |
Ending balance | 25 | 21 |
Other | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Beginning balance | 2 | 2 |
Transferred From Other Levels | 0 | 0 |
Ending balance | $2 | $2 |
Weighted_Average_Health_Care_C
Weighted Average Health Care Cost Trend (Detail) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Defined Benefit Plan Disclosure [Line Items] | ||
Weighted-average health-care cost trend rate assumed for the following year | 7.25% | 7.50% |
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) | 5.00% | 5.00% |
Year that the rate reaches the ultimate trend rate | 2020 | 2020 |
Assumed_Health_Care_Cost_Trend
Assumed Health Care Cost Trend (Detail) (USD $) | 12 Months Ended |
In Millions, unless otherwise specified | Dec. 31, 2014 |
Defined Benefit Plan Disclosure [Line Items] | |
1-Percentage Point Increase | $3 |
1-Percentage Point Decrease | -2 |
1-Percentage Point Increase | 81 |
1-Percentage Point Decrease | ($68) |
Estimated_Future_Benefit_Payme
Estimated Future Benefit Payments (Detail) (USD $) | Dec. 31, 2014 |
In Millions, unless otherwise specified | |
Estimated future benefits payments | |
2015 | $439 |
2016 | 405 |
2017 | 406 |
2018 | 397 |
2019 | 394 |
2020-2024 | 1,897 |
Gross Projected Benefit Payments Before Medicare Part D Subsidies | |
2015 | 97 |
2016 | 89 |
2017 | 87 |
2018 | 85 |
2019 | 84 |
2020-2024 | 390 |
Expected Medicare Part D Subsidies | |
2015 | -2 |
2016 | -2 |
2017 | -2 |
2018 | -2 |
2019 | -3 |
2020-2024 | -15 |
Net Projected Benefit Payments After Medicare Part D Subsidies | |
2015 | 95 |
2016 | 87 |
2017 | 85 |
2018 | 83 |
2019 | 81 |
2020-2024 | $375 |
Segment_Information_Detail
Segment Information (Detail) (USD $) | 3 Months Ended | 12 Months Ended | ||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Segment Reporting Information [Line Items] | ||||||||||||||
Net sales | $2,134 | $2,240 | $2,162 | $1,935 | $2,039 | $2,135 | $2,179 | $1,883 | $8,471 | $8,236 | $8,304 | |||
Operating income (loss) | 2,531 | [1],[2],[3],[4],[5] | 3,132 | [1],[2],[3],[4],[5] | 2,214 | [1],[2],[3],[4],[5] | ||||||||
Cash capital expenditures | 204 | 153 | 88 | |||||||||||
Depreciation and amortization expense | 106 | 103 | 131 | |||||||||||
Interest and debt expense | 286 | 259 | 234 | |||||||||||
Interest income | -3 | -5 | -7 | |||||||||||
Other (income) expense, net | -14 | 137 | 34 | |||||||||||
Income (loss) from continuing operations before income taxes | 2,262 | 2,741 | 1,953 | |||||||||||
RJR Tobacco | ||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||
Net sales | 6,767 | 6,728 | 6,960 | |||||||||||
Cash capital expenditures | 53 | 55 | 36 | |||||||||||
Depreciation and amortization expense | 65 | 68 | 99 | |||||||||||
American Snuff | ||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||
Net sales | 783 | 745 | 681 | |||||||||||
Cash capital expenditures | 12 | 15 | 24 | |||||||||||
Depreciation and amortization expense | 17 | 18 | 19 | |||||||||||
Santa Fe | ||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||
Net sales | 658 | 572 | 486 | |||||||||||
Cash capital expenditures | 7 | 2 | 4 | |||||||||||
Depreciation and amortization expense | 3 | 3 | 2 | |||||||||||
All Other | ||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||
Net sales | 263 | 191 | 177 | |||||||||||
Cash capital expenditures | 132 | 81 | 24 | |||||||||||
Depreciation and amortization expense | 21 | 14 | 11 | |||||||||||
Operating Segments | RJR Tobacco | ||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||
Operating income (loss) | 2,173 | [1],[2],[3],[4] | 2,587 | [1],[2],[3],[4] | 1,735 | [1],[2],[3],[4] | ||||||||
Operating Segments | American Snuff | ||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||
Operating income (loss) | 438 | [4] | 420 | [4] | 374 | [4] | ||||||||
Operating Segments | Santa Fe | ||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||
Operating income (loss) | 337 | [5] | 280 | [5] | 237 | [5] | ||||||||
Operating Segments | All Other | ||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||
Operating income (loss) | -234 | [2] | -70 | [2] | -36 | [2] | ||||||||
Corporate, Non-Segment | ||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||
Operating income (loss) | ($183) | [1],[4] | ($85) | [1],[4] | ($96) | [1],[4] | ||||||||
[1] | Includes restructuring and/or asset impairment charges of $149 million for the year ended December 31, 2012, see "Restructuring Charges" in note 5. | |||||||||||||
[2] | Includes trademark, goodwill and/or other intangible asset impairment charges of $32 million and $129 million for the years ended December 31, 2013 and 2012, respectively, see "Intangible Assets" in note 4. | |||||||||||||
[3] | Includes NPM Adjustment credits of $341 million and $478 million for RJR Tobacco for the years ended December 31, 2014 and 2013, respectively, see "- Cost of Products Sold" in note 1. | |||||||||||||
[4] | Includes MTM adjustment of $422 million for RJR Tobacco, $4 million for American Snuff and $26 million for Corporate Expense for the year ended December 31, 2014. Includes MTM adjustment of $300 million for RJR Tobacco, $5 million for American Snuff and $24 million for Corporate Expense for the year ended December 31, 2012. | |||||||||||||
[5] | Includes NPM Adjustment credits of $4 million and $5 million for Santa Fe for the years ended December 31, 2014 and 2013, respectively, see "- Cost of Products Sold" in note 1. |
Segment_Information_Parentheti
Segment Information (Parenthetical) (Detail) (USD $) | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||
In Millions, unless otherwise specified | Jun. 30, 2014 | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Segment Reporting Information [Line Items] | ||||||||||||
Restructuring charge | $149 | |||||||||||
Trademark, goodwill and/or other intangible asset impairment charges | 32 | 129 | ||||||||||
NPM Adjustment credits | 170 | 75 | 82 | 125 | 63 | 63 | 69 | 90 | 261 | 1,100 | ||
MTM Adjustments | -452 | |||||||||||
RJR Tobacco | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
MTM Adjustments | 422 | 300 | ||||||||||
American Snuff | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
MTM Adjustments | 4 | 5 | ||||||||||
RJR Tobacco | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Restructuring charge | 138 | |||||||||||
Operating Segments | RJR Tobacco | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
NPM Adjustment credits | 341 | 478 | ||||||||||
Operating Segments | Santa Fe | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
NPM Adjustment credits | 4 | 5 | ||||||||||
Corporate, Non-Segment | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
MTM Adjustments | $26 | $24 |
Segment_Information_Additional
Segment Information - Additional Information (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Segment Reporting Information [Line Items] | |||
Foreign sales | $497 | $496 | $493 |
Sales Revenue, Net | Customer Concentration Risk | McLane Company | |||
Segment Reporting Information [Line Items] | |||
Concentration risk percentage | 31.00% | 31.00% | 31.00% |
Sales Revenue, Net | Customer Concentration Risk | Core-Mark International, Inc | |||
Segment Reporting Information [Line Items] | |||
Concentration risk percentage | 11.00% | 11.00% | 10.00% |
Related_Party_Transactions_Add
Related Party Transactions - Additional Information (Detail) | 12 Months Ended | 38 Months Ended | |||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2014 | Jul. 02, 2014 | |
Related Party Transaction [Line Items] | |||||
Percentage of RAI's outstanding common stock | 42.00% | 42.00% | 42.00% | ||
Revenue percentage from related parties | 4.00% | 4.00% | 4.00% | ||
Percentage of maximum purchase price | 10.00% | ||||
RAI | |||||
Related Party Transaction [Line Items] | |||||
Repurchased stock from B&W | 2,887,715 | 21,702,839 |
Summary_of_Balances_and_Transa
Summary of Balances and Transactions (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Related Party Transaction [Line Items] | |||
Accounts receivable, related party | $41 | $56 | |
Due to related party | 1 | ||
Deferred revenue, related party | 32 | 48 | |
Net sales | 311 | 337 | 342 |
Purchases | 28 | 27 | 16 |
RAI common stock purchases from B&W | 155 | 296 | 415 |
Capsule royalty income | 7 | 9 | 6 |
Research and development services billings | $4 | $4 | $3 |
RAI_Guaranteed_Unsecured_Notes2
RAI Guaranteed Unsecured Notes - Condensed Consolidating Financial Statements (Detail) (USD $) | Sep. 30, 2013 | Oct. 31, 2012 | Dec. 31, 2014 |
In Billions, unless otherwise specified | |||
Condensed Financial Statements, Captions [Line Items] | |||
RAI's unsecured notes | $1.10 | $2.55 | |
RAI | |||
Condensed Financial Statements, Captions [Line Items] | |||
RAI's unsecured notes | $5.10 |
Condensed_Consolidating_Statem
Condensed Consolidating Statements of Income (Detail) (USD $) | 3 Months Ended | 12 Months Ended | ||||||||||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||||||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||||||
Net sales | $8,160 | [1] | $7,899 | [1] | $7,962 | [1] | ||||||||||||||||
Net sales, related party | 311 | 337 | 342 | |||||||||||||||||||
Net sales | 2,134 | 2,240 | 2,162 | 1,935 | 2,039 | 2,135 | 2,179 | 1,883 | 8,471 | 8,236 | 8,304 | |||||||||||
Cost of products sold | 4,058 | 3,678 | 4,321 | |||||||||||||||||||
Selling, general and administrative expenses | 1,871 | 1,389 | 1,470 | |||||||||||||||||||
Amortization expense | 11 | 5 | 21 | |||||||||||||||||||
Trademark and other intangible asset impairment charges | 32 | 32 | 129 | |||||||||||||||||||
Restructuring charge | 149 | |||||||||||||||||||||
Operating income (loss) | 2,531 | [2],[3],[4],[5],[6] | 3,132 | [2],[3],[4],[5],[6] | 2,214 | [2],[3],[4],[5],[6] | ||||||||||||||||
Interest and debt expense | 286 | 259 | 234 | |||||||||||||||||||
Interest income | -3 | -5 | -7 | |||||||||||||||||||
Other (income) expense, net | -14 | 137 | 34 | |||||||||||||||||||
Income (loss) from continuing operations before income taxes | 2,262 | 2,741 | 1,953 | |||||||||||||||||||
Provision for (benefit from) income taxes | 817 | 1,023 | 681 | |||||||||||||||||||
Income (loss) from continuing operations | 148 | [7],[8] | 467 | [7],[8] | 492 | [7],[8] | 338 | [7],[8] | 1,445 | 1,718 | 1,272 | |||||||||||
Income from discontinued operations, net of tax | 25 | 25 | ||||||||||||||||||||
Net income | 148 | [7],[8] | 467 | [7],[8] | 492 | [7],[8] | 363 | [7],[8] | 292 | [10],[9] | 457 | [10],[9] | 461 | [10],[9] | 508 | [10],[9] | 1,470 | 1,718 | 1,272 | |||
RAI | ||||||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||||||
Selling, general and administrative expenses | 75 | 13 | 23 | |||||||||||||||||||
Restructuring charge | 4 | |||||||||||||||||||||
Operating income (loss) | -75 | -13 | -27 | |||||||||||||||||||
Interest and debt expense | 286 | 255 | 228 | |||||||||||||||||||
Interest income | -85 | -111 | -113 | |||||||||||||||||||
Other (income) expense, net | 4 | 129 | 26 | |||||||||||||||||||
Income (loss) from continuing operations before income taxes | -280 | -286 | -168 | |||||||||||||||||||
Provision for (benefit from) income taxes | -89 | -95 | -59 | |||||||||||||||||||
Equity income (loss) from subsidiaries | 1,661 | 1,909 | 1,381 | |||||||||||||||||||
Income (loss) from continuing operations | 1,470 | |||||||||||||||||||||
Net income | 1,470 | 1,718 | 1,272 | |||||||||||||||||||
Guarantors | ||||||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||||||
Net sales | 8,109 | 7,785 | 7,857 | |||||||||||||||||||
Net sales, related party | 311 | 337 | 342 | |||||||||||||||||||
Net sales | 8,420 | 8,122 | 8,199 | |||||||||||||||||||
Cost of products sold | 4,002 | 3,628 | 4,316 | |||||||||||||||||||
Selling, general and administrative expenses | 1,535 | 1,222 | 1,341 | |||||||||||||||||||
Amortization expense | 11 | 5 | 21 | |||||||||||||||||||
Trademark and other intangible asset impairment charges | 32 | 82 | ||||||||||||||||||||
Restructuring charge | 145 | |||||||||||||||||||||
Operating income (loss) | 2,872 | 3,235 | 2,294 | |||||||||||||||||||
Interest and debt expense | 79 | 113 | 119 | |||||||||||||||||||
Interest income | -3 | -3 | -3 | |||||||||||||||||||
Other (income) expense, net | -44 | -45 | -44 | |||||||||||||||||||
Income (loss) from continuing operations before income taxes | 2,840 | 3,170 | 2,222 | |||||||||||||||||||
Provision for (benefit from) income taxes | 1,004 | 1,154 | 762 | |||||||||||||||||||
Equity income (loss) from subsidiaries | 26 | 5 | -16 | |||||||||||||||||||
Income (loss) from continuing operations | 1,862 | |||||||||||||||||||||
Income from discontinued operations, net of tax | 25 | |||||||||||||||||||||
Net income | 1,887 | 2,021 | 1,444 | |||||||||||||||||||
Non-Guarantors | ||||||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||||||
Net sales | 232 | 147 | 134 | |||||||||||||||||||
Net sales | 232 | 147 | 134 | |||||||||||||||||||
Cost of products sold | 235 | 83 | 34 | |||||||||||||||||||
Selling, general and administrative expenses | 261 | 154 | 106 | |||||||||||||||||||
Trademark and other intangible asset impairment charges | 47 | |||||||||||||||||||||
Operating income (loss) | -264 | -90 | -53 | |||||||||||||||||||
Interest and debt expense | 6 | 2 | ||||||||||||||||||||
Interest income | -2 | -4 | ||||||||||||||||||||
Other (income) expense, net | -17 | 10 | 9 | |||||||||||||||||||
Income (loss) from continuing operations before income taxes | -253 | -100 | -58 | |||||||||||||||||||
Provision for (benefit from) income taxes | -98 | -36 | -21 | |||||||||||||||||||
Income (loss) from continuing operations | -155 | |||||||||||||||||||||
Net income | -155 | -64 | -37 | |||||||||||||||||||
Eliminations | ||||||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||||||
Net sales | -181 | -33 | -29 | |||||||||||||||||||
Net sales | -181 | -33 | -29 | |||||||||||||||||||
Cost of products sold | -179 | -33 | -29 | |||||||||||||||||||
Operating income (loss) | -2 | |||||||||||||||||||||
Interest and debt expense | -85 | -111 | -113 | |||||||||||||||||||
Interest income | 85 | 111 | 113 | |||||||||||||||||||
Other (income) expense, net | 43 | 43 | 43 | |||||||||||||||||||
Income (loss) from continuing operations before income taxes | -45 | -43 | -43 | |||||||||||||||||||
Provision for (benefit from) income taxes | -1 | |||||||||||||||||||||
Equity income (loss) from subsidiaries | -1,687 | -1,914 | -1,365 | |||||||||||||||||||
Income (loss) from continuing operations | -1,732 | |||||||||||||||||||||
Net income | ($1,732) | ($1,957) | ($1,407) | |||||||||||||||||||
[1] | Excludes excise taxes of $3,625 million, $3,730 million and $3,923 million for the years ended December 31, 2014, 2013 and 2012, respectively. | |||||||||||||||||||||
[2] | Includes restructuring and/or asset impairment charges of $149 million for the year ended December 31, 2012, see "Restructuring Charges" in note 5. | |||||||||||||||||||||
[3] | Includes trademark, goodwill and/or other intangible asset impairment charges of $32 million and $129 million for the years ended December 31, 2013 and 2012, respectively, see "Intangible Assets" in note 4. | |||||||||||||||||||||
[4] | Includes NPM Adjustment credits of $341 million and $478 million for RJR Tobacco for the years ended December 31, 2014 and 2013, respectively, see "- Cost of Products Sold" in note 1. | |||||||||||||||||||||
[5] | Includes MTM adjustment of $422 million for RJR Tobacco, $4 million for American Snuff and $26 million for Corporate Expense for the year ended December 31, 2014. Includes MTM adjustment of $300 million for RJR Tobacco, $5 million for American Snuff and $24 million for Corporate Expense for the year ended December 31, 2012. | |||||||||||||||||||||
[6] | Includes NPM Adjustment credits of $4 million and $5 million for Santa Fe for the years ended December 31, 2014 and 2013, respectively, see "- Cost of Products Sold" in note 1. | |||||||||||||||||||||
[7] | Includes NPM Adjustment credits of $63 million in the first quarter of 2014, $125 million in the second quarter of 2014, $82 million in the third quarter of 2014 and $75 million in the fourth quarter of 2014, see "- Cost of Products Sold" in note 1. The fourth quarter of 2014 includes an MTM adjustment of $205 million. | |||||||||||||||||||||
[8] | Fourth quarter of 2014 includes an additional MTM adjustment of $247 million for a total of $452 million. | |||||||||||||||||||||
[9] | Includes NPM Adjustment credits of $261 million in the first quarter of 2013, $90 million in the second quarter of 2013, $69 million in the third quarter of 2013 and $63 million in the fourth quarter of 2013, see "- Cost of Products Sold" in note 1. | |||||||||||||||||||||
[10] | Fourth quarter of 2013 net income includes a $32 million trademark impairment charge. |
Condensed_Consolidating_Statem1
Condensed Consolidating Statements of Comprehensive Income (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||||||||
Condensed Financial Statements, Captions [Line Items] | |||||||||||||||||||
Net income (loss) | $148 | [1],[2] | $467 | [1],[2] | $492 | [1],[2] | $363 | [1],[2] | $292 | [3],[4] | $457 | [3],[4] | $461 | [3],[4] | $508 | [3],[4] | $1,470 | $1,718 | $1,272 |
Other comprehensive income (loss), net of tax: | |||||||||||||||||||
Retirement benefits, net of $178 tax benefit | -277 | 248 | 65 | ||||||||||||||||
Unrealized gain on long-term investments | 2 | 5 | 7 | ||||||||||||||||
Amortization of realized loss on hedging instruments | 1 | 1 | |||||||||||||||||
Realized loss on hedging instruments | -14 | ||||||||||||||||||
Cumulative translation adjustment and other | -34 | 1 | 13 | ||||||||||||||||
Comprehensive income (loss) | 1,162 | 1,973 | 1,343 | ||||||||||||||||
RAI | |||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | |||||||||||||||||||
Net income (loss) | 1,470 | 1,718 | 1,272 | ||||||||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||
Retirement benefits, net of $178 tax benefit | -277 | 248 | 65 | ||||||||||||||||
Unrealized gain on long-term investments | 2 | 5 | 7 | ||||||||||||||||
Amortization of realized loss on hedging instruments | 1 | 1 | |||||||||||||||||
Realized loss on hedging instruments | -14 | ||||||||||||||||||
Cumulative translation adjustment and other | -34 | 1 | 13 | ||||||||||||||||
Comprehensive income (loss) | 1,162 | 1,973 | 1,343 | ||||||||||||||||
Guarantors | |||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | |||||||||||||||||||
Net income (loss) | 1,887 | 2,021 | 1,444 | ||||||||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||
Retirement benefits, net of $178 tax benefit | -271 | 239 | 65 | ||||||||||||||||
Unrealized gain on long-term investments | 2 | 5 | 7 | ||||||||||||||||
Cumulative translation adjustment and other | -34 | 1 | 13 | ||||||||||||||||
Comprehensive income (loss) | 1,584 | 2,266 | 1,529 | ||||||||||||||||
Non-Guarantors | |||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | |||||||||||||||||||
Net income (loss) | -155 | -64 | -37 | ||||||||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||
Retirement benefits, net of $178 tax benefit | -1 | -1 | |||||||||||||||||
Cumulative translation adjustment and other | -48 | 14 | 9 | ||||||||||||||||
Comprehensive income (loss) | -204 | -51 | -28 | ||||||||||||||||
Eliminations | |||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | |||||||||||||||||||
Net income (loss) | -1,732 | -1,957 | -1,407 | ||||||||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||
Retirement benefits, net of $178 tax benefit | 272 | -238 | -65 | ||||||||||||||||
Unrealized gain on long-term investments | -2 | -5 | -7 | ||||||||||||||||
Cumulative translation adjustment and other | 82 | -15 | -22 | ||||||||||||||||
Comprehensive income (loss) | ($1,380) | ($2,215) | ($1,501) | ||||||||||||||||
[1] | Includes NPM Adjustment credits of $63 million in the first quarter of 2014, $125 million in the second quarter of 2014, $82 million in the third quarter of 2014 and $75 million in the fourth quarter of 2014, see "- Cost of Products Sold" in note 1. The fourth quarter of 2014 includes an MTM adjustment of $205 million. | ||||||||||||||||||
[2] | Fourth quarter of 2014 includes an additional MTM adjustment of $247 million for a total of $452 million. | ||||||||||||||||||
[3] | Includes NPM Adjustment credits of $261 million in the first quarter of 2013, $90 million in the second quarter of 2013, $69 million in the third quarter of 2013 and $63 million in the fourth quarter of 2013, see "- Cost of Products Sold" in note 1. | ||||||||||||||||||
[4] | Fourth quarter of 2013 net income includes a $32 million trademark impairment charge. |
Reclassification_Out_of_Accumu1
Reclassification Out of Accumulated Other Comprehensive Loss and Affected Line Items in Condensed Consolidating Statements of Income (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Cost of products sold | ($4,058) | ($3,678) | ($4,321) | ||||||||||||||||
Interest and debt expense | -286 | -259 | -234 | ||||||||||||||||
Selling, general and administrative expenses | -1,871 | -1,389 | -1,470 | ||||||||||||||||
MTM adjustment | 452 | ||||||||||||||||||
Income (loss) from continuing operations before income taxes | 2,262 | 2,741 | 1,953 | ||||||||||||||||
Provision for income taxes | -817 | -1,023 | -681 | ||||||||||||||||
Net income | 148 | [1],[2] | 467 | [1],[2] | 492 | [1],[2] | 363 | [1],[2] | 292 | [3],[4] | 457 | [3],[4] | 461 | [3],[4] | 508 | [3],[4] | 1,470 | 1,718 | 1,272 |
Cost of products sold | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | -205 | ||||||||||||||||||
Selling, General and Administrative Expenses | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | -247 | ||||||||||||||||||
RAI | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Interest and debt expense | -286 | -255 | -228 | ||||||||||||||||
Selling, general and administrative expenses | -75 | -13 | -23 | ||||||||||||||||
Income (loss) from continuing operations before income taxes | -280 | -286 | -168 | ||||||||||||||||
Provision for income taxes | 89 | 95 | 59 | ||||||||||||||||
Net income | 1,470 | 1,718 | 1,272 | ||||||||||||||||
Guarantors | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Cost of products sold | -4,002 | -3,628 | -4,316 | ||||||||||||||||
Interest and debt expense | -79 | -113 | -119 | ||||||||||||||||
Selling, general and administrative expenses | -1,535 | -1,222 | -1,341 | ||||||||||||||||
Income (loss) from continuing operations before income taxes | 2,840 | 3,170 | 2,222 | ||||||||||||||||
Provision for income taxes | -1,004 | -1,154 | -762 | ||||||||||||||||
Net income | 1,887 | 2,021 | 1,444 | ||||||||||||||||
Non-Guarantors | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Cost of products sold | -235 | -83 | -34 | ||||||||||||||||
Interest and debt expense | -6 | -2 | |||||||||||||||||
Selling, general and administrative expenses | -261 | -154 | -106 | ||||||||||||||||
Income (loss) from continuing operations before income taxes | -253 | -100 | -58 | ||||||||||||||||
Provision for income taxes | 98 | 36 | 21 | ||||||||||||||||
Net income | -155 | -64 | -37 | ||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Net income | 252 | -22 | |||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Cost of products sold | -21 | -21 | |||||||||||||||||
Selling, general and administrative expenses | -18 | -18 | |||||||||||||||||
Income (loss) from continuing operations before income taxes | 413 | -39 | |||||||||||||||||
Provision for income taxes | -162 | 16 | |||||||||||||||||
Net income | 251 | -23 | |||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment | Cost of products sold | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | 205 | ||||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment | Selling, General and Administrative Expenses | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | 247 | ||||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Interest and debt expense | 2 | 2 | |||||||||||||||||
Provision for income taxes | -1 | -1 | |||||||||||||||||
Net income | 1 | 1 | |||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | RAI | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Net income | 252 | -22 | |||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | RAI | Accumulated Defined Benefit Plans Adjustment | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Income (loss) from continuing operations before income taxes | 10 | ||||||||||||||||||
Provision for income taxes | -4 | ||||||||||||||||||
Net income | 251 | -23 | |||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | RAI | Accumulated Defined Benefit Plans Adjustment | Selling, General and Administrative Expenses | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | 10 | ||||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | RAI | Accumulated Defined Benefit Plans Adjustment | Equity Income from Subsidiaries | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | 245 | -23 | |||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | RAI | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Interest and debt expense | 2 | 2 | |||||||||||||||||
Provision for income taxes | -1 | -1 | |||||||||||||||||
Net income | 1 | 1 | |||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Guarantors | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Net income | 244 | -23 | |||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Guarantors | Accumulated Defined Benefit Plans Adjustment | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Cost of products sold | -21 | -21 | |||||||||||||||||
Selling, general and administrative expenses | -18 | -18 | |||||||||||||||||
Income (loss) from continuing operations before income taxes | 402 | -39 | |||||||||||||||||
Provision for income taxes | -158 | 16 | |||||||||||||||||
Net income | 244 | -23 | |||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Guarantors | Accumulated Defined Benefit Plans Adjustment | Cost of products sold | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | 205 | ||||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Guarantors | Accumulated Defined Benefit Plans Adjustment | Selling, General and Administrative Expenses | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | 236 | ||||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Non-Guarantors | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Net income | 1 | ||||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Non-Guarantors | Accumulated Defined Benefit Plans Adjustment | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Income (loss) from continuing operations before income taxes | 1 | ||||||||||||||||||
Net income | 1 | ||||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | Non-Guarantors | Accumulated Defined Benefit Plans Adjustment | Selling, General and Administrative Expenses | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | 1 | ||||||||||||||||||
Eliminations | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Cost of products sold | 179 | 33 | 29 | ||||||||||||||||
Interest and debt expense | 85 | 111 | 113 | ||||||||||||||||
Income (loss) from continuing operations before income taxes | -45 | -43 | -43 | ||||||||||||||||
Provision for income taxes | 1 | ||||||||||||||||||
Net income | -1,732 | -1,957 | -1,407 | ||||||||||||||||
Eliminations | Reclassification out of Accumulated Other Comprehensive Income | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Net income | -245 | 23 | |||||||||||||||||
Eliminations | Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
Net income | -245 | 23 | |||||||||||||||||
Eliminations | Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment | Equity Income from Subsidiaries | |||||||||||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||||||||||
MTM adjustment | ($245) | $23 | |||||||||||||||||
[1] | Includes NPM Adjustment credits of $63 million in the first quarter of 2014, $125 million in the second quarter of 2014, $82 million in the third quarter of 2014 and $75 million in the fourth quarter of 2014, see "- Cost of Products Sold" in note 1. The fourth quarter of 2014 includes an MTM adjustment of $205 million. | ||||||||||||||||||
[2] | Fourth quarter of 2014 includes an additional MTM adjustment of $247 million for a total of $452 million. | ||||||||||||||||||
[3] | Includes NPM Adjustment credits of $261 million in the first quarter of 2013, $90 million in the second quarter of 2013, $69 million in the third quarter of 2013 and $63 million in the fourth quarter of 2013, see "- Cost of Products Sold" in note 1. | ||||||||||||||||||
[4] | Fourth quarter of 2013 net income includes a $32 million trademark impairment charge. |
Condensed_Consolidating_Statem2
Condensed Consolidating Statements of Cash Flows (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Condensed Financial Statements, Captions [Line Items] | |||
Cash flows from (used in) operating activities | $1,623 | $1,308 | $1,568 |
Cash flows from (used in) investing activities: | |||
Capital expenditures | -204 | -153 | -88 |
Proceeds from termination of joint venture | 35 | 31 | 30 |
Other, net | -36 | 9 | 4 |
Net cash flows from (used in) investing activities | -205 | -113 | -54 |
Cash flows from (used in) financing activities: | |||
Dividends paid on common stock | -1,411 | -1,335 | -1,307 |
Repurchase of common stock | -440 | -775 | -1,101 |
Excess tax benefit on stock-based compensation plans | 12 | 14 | 39 |
Principal borrowings under term-loan credit facility | 500 | 750 | |
Principal borrowings under revolving credit facility | 1,000 | ||
Repayment under term-loan credit facility | -500 | -750 | |
Repayments under revolving credit facility | -1,000 | ||
Proceeds from issuance of long-term debt, net of discounts | 1,097 | 2,539 | |
Repayments of long-term debt | -1,035 | -1,076 | |
Debt issuance costs and financing fees | -79 | -18 | -22 |
Payment to settle forward starting interest rate contracts | -23 | ||
Make-whole premium for early extinguishment of debt | -155 | -20 | |
Net cash flows from (used in) financing activities | -1,918 | -2,207 | -971 |
Effect of exchange rate changes on cash and cash equivalents | -34 | 10 | 3 |
Net change in cash and cash equivalents | -534 | -1,002 | 546 |
Cash and cash equivalents at beginning of year | 1,500 | 2,502 | 1,956 |
Cash and cash equivalents at end of year | 966 | 1,500 | 2,502 |
RAI | |||
Condensed Financial Statements, Captions [Line Items] | |||
Cash flows from (used in) operating activities | 1,277 | 1,519 | 454 |
Cash flows from (used in) investing activities: | |||
Return of intercompany investments | 165 | 898 | |
Return of intercompany investments | 300 | ||
Other, net | 218 | 81 | 40 |
Net cash flows from (used in) investing activities | 383 | 381 | 938 |
Cash flows from (used in) financing activities: | |||
Dividends paid on common stock | -1,411 | -1,335 | -1,307 |
Repurchase of common stock | -440 | -775 | -1,101 |
Excess tax benefit on stock-based compensation plans | 12 | 14 | 39 |
Principal borrowings under term-loan credit facility | 500 | 750 | |
Principal borrowings under revolving credit facility | 1,000 | ||
Repayment under term-loan credit facility | -500 | -750 | |
Repayments under revolving credit facility | -1,000 | ||
Proceeds from issuance of long-term debt, net of discounts | 1,097 | 2,539 | |
Repayments of long-term debt | -975 | -1,018 | |
Debt issuance costs and financing fees | -79 | -18 | -22 |
Payment to settle forward starting interest rate contracts | -23 | ||
Make-whole premium for early extinguishment of debt | -155 | -20 | |
Dividends paid on preferred stock | -43 | -43 | -43 |
Other, net | -41 | -21 | -9 |
Net cash flows from (used in) financing activities | -2,002 | -2,211 | -965 |
Net change in cash and cash equivalents | -342 | -311 | 427 |
Cash and cash equivalents at beginning of year | 444 | 755 | 328 |
Cash and cash equivalents at end of year | 102 | 444 | 755 |
Guarantors | |||
Condensed Financial Statements, Captions [Line Items] | |||
Cash flows from (used in) operating activities | 1,865 | 945 | 1,801 |
Cash flows from (used in) investing activities: | |||
Capital expenditures | -265 | -80 | -79 |
Other, net | 39 | 33 | 17 |
Net cash flows from (used in) investing activities | -226 | -47 | -62 |
Cash flows from (used in) financing activities: | |||
Dividends paid on common stock | -1,301 | -1,042 | -684 |
Repayments of long-term debt | -60 | -58 | |
Distribution of equity | -165 | -300 | -898 |
Other, net | -400 | -220 | -40 |
Net cash flows from (used in) financing activities | -1,866 | -1,622 | -1,680 |
Net change in cash and cash equivalents | -227 | -724 | 59 |
Cash and cash equivalents at beginning of year | 696 | 1,420 | 1,361 |
Cash and cash equivalents at end of year | 469 | 696 | 1,420 |
Non-Guarantors | |||
Condensed Financial Statements, Captions [Line Items] | |||
Cash flows from (used in) operating activities | -179 | -70 | 29 |
Cash flows from (used in) investing activities: | |||
Capital expenditures | -94 | -74 | -1 |
Proceeds from termination of joint venture | 35 | 31 | 30 |
Other, net | 126 | -1 | 1 |
Net cash flows from (used in) investing activities | 67 | -44 | 30 |
Cash flows from (used in) financing activities: | |||
Other, net | 181 | 137 | -2 |
Net cash flows from (used in) financing activities | 181 | 137 | -2 |
Effect of exchange rate changes on cash and cash equivalents | -34 | 10 | 3 |
Net change in cash and cash equivalents | 35 | 33 | 60 |
Cash and cash equivalents at beginning of year | 360 | 327 | 267 |
Cash and cash equivalents at end of year | 395 | 360 | 327 |
Eliminations | |||
Condensed Financial Statements, Captions [Line Items] | |||
Cash flows from (used in) operating activities | -1,340 | -1,086 | -716 |
Cash flows from (used in) investing activities: | |||
Capital expenditures | 155 | 1 | -8 |
Return of intercompany investments | -165 | -898 | |
Return of intercompany investments | -300 | ||
Other, net | -419 | -104 | -54 |
Net cash flows from (used in) investing activities | -429 | -403 | -960 |
Cash flows from (used in) financing activities: | |||
Dividends paid on common stock | 1,301 | 1,042 | 684 |
Dividends paid on preferred stock | 43 | 43 | 43 |
Distribution of equity | 165 | 300 | 898 |
Other, net | 260 | 104 | 51 |
Net cash flows from (used in) financing activities | $1,769 | $1,489 | $1,676 |
Condensed_Consolidating_Balanc
Condensed Consolidating Balance Sheets (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Millions, unless otherwise specified | ||||
Assets | ||||
Cash and cash equivalents | $966 | $1,500 | $2,502 | $1,956 |
Accounts receivable | 116 | 106 | ||
Accounts receivable, related party | 41 | 56 | ||
Notes receivable | 37 | |||
Other receivables | 12 | 16 | ||
Inventories | 1,281 | 1,127 | ||
Deferred income taxes, net | 703 | 606 | ||
Prepaid expenses and other | 204 | 207 | ||
Total current assets | 3,323 | 3,655 | ||
Property, plant and equipment, net | 1,203 | 1,074 | ||
Trademarks and other intangible assets, net | 2,421 | 2,417 | ||
Goodwill | 8,016 | 8,011 | 8,011 | 8,010 |
Other assets and deferred charges | 233 | 245 | ||
Total assets | 15,196 | 15,402 | ||
Liabilities and shareholders' equity | ||||
Accounts payable | 142 | 185 | ||
Tobacco settlement accruals | 1,819 | 1,727 | ||
Due to related party | 1 | |||
Deferred revenue, related party | 32 | 48 | ||
Current maturities of long-term debt | 450 | |||
Other current liabilities | 1,100 | 1,116 | ||
Total current liabilities | 3,544 | 3,076 | ||
Long-term debt (less current maturities) | 4,633 | 5,099 | ||
Deferred income taxes, net | 383 | 658 | ||
Long-term retirement benefits (less current portion) | 1,997 | 1,221 | ||
Other noncurrent liabilities | 117 | 181 | ||
Shareholders' equity | 4,522 | 5,167 | 5,257 | 6,251 |
Total liabilities and shareholders' equity | 15,196 | 15,402 | ||
RAI | ||||
Assets | ||||
Cash and cash equivalents | 102 | 444 | 755 | 328 |
Other receivables | 70 | 76 | ||
Deferred income taxes, net | 5 | |||
Prepaid expenses and other | 50 | 29 | ||
Total current assets | 227 | 549 | ||
Property, plant and equipment, net | 3 | 5 | ||
Long-term intercompany notes receivable | 1,593 | 1,842 | ||
Investment in subsidiaries | 9,598 | 9,736 | ||
Other assets and deferred charges | 101 | 94 | ||
Total assets | 11,522 | 12,226 | ||
Liabilities and shareholders' equity | ||||
Accounts payable | 1 | 1 | ||
Current maturities of long-term debt | 450 | |||
Other current liabilities | 1,636 | 601 | ||
Total current liabilities | 2,087 | 602 | ||
Long-term intercompany notes payable | 190 | 1,295 | ||
Long-term debt (less current maturities) | 4,633 | 5,099 | ||
Long-term retirement benefits (less current portion) | 57 | 38 | ||
Other noncurrent liabilities | 33 | 25 | ||
Shareholders' equity | 4,522 | 5,167 | ||
Total liabilities and shareholders' equity | 11,522 | 12,226 | ||
Guarantors | ||||
Assets | ||||
Cash and cash equivalents | 469 | 696 | 1,420 | 1,361 |
Accounts receivable | 74 | 74 | ||
Accounts receivable, related party | 41 | 56 | ||
Notes receivable | 1 | |||
Other receivables | 1,199 | 198 | ||
Inventories | 1,198 | 1,069 | ||
Deferred income taxes, net | 688 | 614 | ||
Prepaid expenses and other | 151 | 172 | ||
Total current assets | 3,820 | 2,880 | ||
Property, plant and equipment, net | 1,170 | 986 | ||
Trademarks and other intangible assets, net | 2,417 | 2,413 | ||
Goodwill | 7,999 | 7,999 | ||
Long-term intercompany notes receivable | 190 | 1,295 | ||
Investment in subsidiaries | 450 | 473 | ||
Other assets and deferred charges | 180 | 187 | ||
Total assets | 16,226 | 16,233 | ||
Liabilities and shareholders' equity | ||||
Accounts payable | 128 | 169 | ||
Tobacco settlement accruals | 1,819 | 1,727 | ||
Due to related party | 1 | |||
Deferred revenue, related party | 32 | 48 | ||
Other current liabilities | 682 | 744 | ||
Total current liabilities | 2,662 | 2,688 | ||
Long-term intercompany notes payable | 1,300 | 1,700 | ||
Deferred income taxes, net | 450 | 710 | ||
Long-term retirement benefits (less current portion) | 1,930 | 1,172 | ||
Other noncurrent liabilities | 83 | 156 | ||
Shareholders' equity | 9,801 | 9,807 | ||
Total liabilities and shareholders' equity | 16,226 | 16,233 | ||
Non-Guarantors | ||||
Assets | ||||
Cash and cash equivalents | 395 | 360 | 327 | 267 |
Accounts receivable | 42 | 32 | ||
Notes receivable | 36 | |||
Other receivables | 10 | 6 | ||
Inventories | 85 | 59 | ||
Deferred income taxes, net | 10 | 1 | ||
Prepaid expenses and other | 1 | 7 | ||
Total current assets | 543 | 501 | ||
Property, plant and equipment, net | 30 | 83 | ||
Trademarks and other intangible assets, net | 4 | 4 | ||
Goodwill | 17 | 12 | ||
Other assets and deferred charges | 23 | 18 | ||
Total assets | 617 | 618 | ||
Liabilities and shareholders' equity | ||||
Accounts payable | 13 | 15 | ||
Other current liabilities | 51 | 46 | ||
Total current liabilities | 64 | 61 | ||
Long-term intercompany notes payable | 293 | 142 | ||
Deferred income taxes, net | 2 | |||
Long-term retirement benefits (less current portion) | 10 | 11 | ||
Other noncurrent liabilities | 1 | |||
Shareholders' equity | 249 | 402 | ||
Total liabilities and shareholders' equity | 617 | 618 | ||
Eliminations | ||||
Assets | ||||
Other receivables | -1,267 | -264 | ||
Inventories | -2 | -1 | ||
Deferred income taxes, net | -9 | |||
Prepaid expenses and other | 2 | -1 | ||
Total current assets | -1,267 | -275 | ||
Long-term intercompany notes receivable | -1,783 | -3,137 | ||
Investment in subsidiaries | -10,048 | -10,209 | ||
Other assets and deferred charges | -71 | -54 | ||
Total assets | -13,675 | |||
Liabilities and shareholders' equity | ||||
Other current liabilities | -1,269 | -275 | ||
Total current liabilities | -1,269 | -275 | ||
Long-term intercompany notes payable | -1,783 | -3,137 | ||
Deferred income taxes, net | -67 | -54 | ||
Shareholders' equity | -10,050 | -10,209 | ||
Total liabilities and shareholders' equity | ($13,169) | ($13,675) |
Quarterly_Results_of_Operation2
Quarterly Results of Operations (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||||||
In Millions, except Per Share data, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||||||||
Net sales | $2,134 | $2,240 | $2,162 | $1,935 | $2,039 | $2,135 | $2,179 | $1,883 | $8,471 | $8,236 | $8,304 | ||||||||
Gross profit | 999 | [1] | 1,206 | [1] | 1,203 | [1] | 1,005 | [1] | 1,058 | [2] | 1,131 | [2] | 1,180 | [2] | 1,189 | [2] | |||
Income from continuing operations | 148 | [1],[3] | 467 | [1],[3] | 492 | [1],[3] | 338 | [1],[3] | 1,445 | 1,718 | 1,272 | ||||||||
Income from discontinued operations, net of tax | 25 | 25 | |||||||||||||||||
Net income | $148 | [1],[3] | $467 | [1],[3] | $492 | [1],[3] | $363 | [1],[3] | $292 | [2],[4] | $457 | [2],[4] | $461 | [2],[4] | $508 | [2],[4] | $1,470 | $1,718 | $1,272 |
Basic: | |||||||||||||||||||
Income from continuing operations | $0.28 | [5] | $0.88 | [5] | $0.92 | [5] | $0.63 | [5] | $2.71 | $3.15 | $2.25 | ||||||||
Income from discontinued operations | $0.05 | [5] | $0.05 | ||||||||||||||||
Net income | $0.28 | [5] | $0.88 | [5] | $0.92 | [5] | $0.68 | [5] | $0.54 | [5] | $0.84 | [5] | $0.84 | [5] | $0.92 | [5] | $2.76 | $3.15 | $2.25 |
Diluted: | |||||||||||||||||||
Income from continuing operations | $0.28 | [5] | $0.88 | [5] | $0.92 | [5] | $0.63 | [5] | $2.70 | $3.14 | $2.24 | ||||||||
Income from discontinued operations | $0.04 | [5] | $0.05 | ||||||||||||||||
Net income | $0.28 | [5] | $0.88 | [5] | $0.92 | [5] | $0.67 | [5] | $0.54 | [5] | $0.84 | [5] | $0.84 | [5] | $0.92 | [5] | $2.75 | $3.14 | $2.24 |
[1] | Includes NPM Adjustment credits of $63 million in the first quarter of 2014, $125 million in the second quarter of 2014, $82 million in the third quarter of 2014 and $75 million in the fourth quarter of 2014, see "- Cost of Products Sold" in note 1. The fourth quarter of 2014 includes an MTM adjustment of $205 million. | ||||||||||||||||||
[2] | Includes NPM Adjustment credits of $261 million in the first quarter of 2013, $90 million in the second quarter of 2013, $69 million in the third quarter of 2013 and $63 million in the fourth quarter of 2013, see "- Cost of Products Sold" in note 1. | ||||||||||||||||||
[3] | Fourth quarter of 2014 includes an additional MTM adjustment of $247 million for a total of $452 million. | ||||||||||||||||||
[4] | Fourth quarter of 2013 net income includes a $32 million trademark impairment charge. | ||||||||||||||||||
[5] | Income per share is computed independently for each of the periods presented. The sum of the income per share amounts for the quarters may not equal the total for the year. |
Quarterly_Results_of_Operation3
Quarterly Results of Operations (Parenthetical) (Detail) (USD $) | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||
In Millions, unless otherwise specified | Jun. 30, 2014 | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
NPM Adjustment credits | $170 | $75 | $82 | $125 | $63 | $63 | $69 | $90 | $261 | $1,100 | ||
MTM Adjustments | -452 | |||||||||||
Trademark and other intangible asset impairment charges | 32 | 32 | 129 | |||||||||
Cost of products sold | ||||||||||||
MTM Adjustments | 205 | |||||||||||
Selling, General and Administrative Expenses | ||||||||||||
MTM Adjustments | $247 |